Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036481	p-korsol	nmol/l (nmol/l)	19233	41963	0.10%
3036481	s-korsol	nmol/l (nmol/l)	17198	35924	0.00%
3036481	s-korsol	— (—)	2717	3628	100.00%	Distribution not available
3036481	p-korsol	— (—)	2194	3038	100.00%	Distribution not available
3036481	p-kortisoli	nmol/l (nmol/l)	159	198	0.00%
3036481	fs-korsol	nmol/l (nmol/l)	23	25	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Spondylopathies

5224

17828

1.87

322.70

2.2

2.3

350.77

380.65

nmol/l

19.27

4773

16451

Benign neoplasms

6855

23101

1.73

322.19

2.7

2.0

357.76

383.17

nmol/l

20.17

6349

21326

Secondary hypertension

747

1660

5.39

321.06

2.8

2.3

330.61

372.95

nmol/l

6.05

698

1538

Type 1 diabetes, wide definition

1888

7540

2.80

320.94

1.9

2.3

406.68

368.68

nmol/l

10.62

1747

6965

Concussion

3222

13690

2.16

318.36

2.1

2.3

364.81

385.04

nmol/l

6.23

2962

12737

Finngen Rheumatological endpoints

6815

23546

1.73

317.54

2.1

2.3

354.15

382.80

nmol/l

24.59

6298

21722

Bronchitis

7298

29767

1.68

316.72

2.3

2.2

356.11

380.80

nmol/l

18.99

6743

27396

Other symptoms and signs involving the nervous and musculoskeletal systems

3069

15124

2.21

315.41

2.2

352.81

375.35

nmol/l

8.52

2874

13863

Hyperprolactinaemia

547

999

8.40

313.39

3.6

1.8

367.75

378.13

nmol/l

0.62

529

926

Chronic kidney disease

1958

7998

2.69

312.02

2.3

351.16

377.04

nmol/l

6.23

1848

7256

Substance abuse, excluding more controls

3492

15598

2.08

311.25

2.2

2.4

377.12

371.84

nmol/l

0.60

3178

14552

Symptoms and signs involving the urinary system

5002

22039

1.86

311.18

2.4

2.3

366.23

375.46

nmol/l

2.20

4542

20313

Diseases of the skin and subcutaneous tissue

7167

22027

1.70

309.37

2.3

2.2

365.47

380.13

nmol/l

7.15

6583

20340

Nerve, nerve root and plexus disorders

7097

27684

1.69

307.83

2.2

363.27

376.50

nmol/l

6.22

6494

25533

Gastrointestinal diseases

4581

11519

2.10

307.65

2.2

2.1

369.01

387.90

nmol/l

7.16

4251

10639

Type 2 diabetes

6741

23865

1.76

307.65

2.2

2.3

364.90

373.16

nmol/l

2.32

6155

22036

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

909

1305

5.95

307.65

2.2

3.1

338.47

402.27

nmol/l

9.51

854

1228

Hypothyroidism, strict autoimmune, 3 medication purchases required

6305

22715

2.02

307.65

2.2

2.1

371.61

380.73

nmol/l

2.91

5711

20929

Dental caries

2021

8082

2.75

307.65

3.1

2.2

355.53

373.69

nmol/l

3.27

1890

7511

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1418

1364

35.07

307.65

5.6

1.7

348.55

366.42

nmol/l

1.53

1376

1245

Infections, IBD-co-morbidities

1264

2203

4.69

307.65

2.6

2.8

354.07

394.64

nmol/l

6.24

1176

2057

Disorders of thyroid, IBD co-morbidities

1590

2799

4.67

307.65

2.3

2.6

377.35

398.96

nmol/l

3.40

1464

2609

ILD medications: azathioprine

1383

4302

3.76

307.65

2.7

2.1

309.56

389.61

nmol/l

32.92

1296

3930

Complications of surgical and medical care, not elsewhere classified

6805

28520

1.81

307.65

2.4

2.2

364.88

375.87

nmol/l

3.62

6311

26223

Benign neoplasm: Adrenal gland

1115

1842

9.70

307.65

2.3

1.8

239.45

365.64

nmol/l

45.98

1020

1673

Viral Sepsis

1608

5296

3.51

307.65

2.4

2.2

348.12

378.18

nmol/l

6.18

1482

4831

ILD medications

10596

23848

2.67

307.65

2.4

2.1

339.09

394.25

nmol/l

121.76

9871

21875

ILD medications: prednisolone, methylprednisolone, prednisone

10557

23304

2.83

307.65

2.5

2.1

336.69

394.11

nmol/l

130.63

9836

21373

Pneumonias (Asthma/COPD co-morbidities)

7407

28389

1.92

307.65

2.5

2.2

361.06

376.74

nmol/l

7.33

6839

26213

Mood disorders

8785

27278

2.29

307.65

2.0

2.3

371.44

376.64

nmol/l

1.42

7977

25281

Selective serotonin reuptake inhibitors

7530

20231

2.08

307.65

2.1

2.3

370.77

379.74

nmol/l

2.96

6849

18781

Other nutritional deficiencies

5487

24123

2.45

307.65

2.1

2.2

344.29

379.11

nmol/l

30.57

4981

22340

Asthma, unspecified (mode), excluding more controls

4040

12442

2.79

307.65

2.4

2.1

336.02

385.41

nmol/l

44.86

3733

11501

Hypertensive diseases

6242

16801

2.26

307.65

2.3

352.70

373.79

nmol/l

11.64

5788

15581

Used for control exclusion in common control thyroid runs

9584

18909

2.81

307.65

2.5

2.0

364.19

386.08

nmol/l

16.93

8849

17435

Bacterial infection, other or unspecified

3913

15135

2.56

307.65

2.7

2.2

376.36

376.52

nmol/l

0.01

3672

13812

Implicit bacterial Sepsis

2939

10196

2.95

307.65

2.3

368.17

377.88

nmol/l

1.16

2699

9323

Constipation

6092

24174

1.92

307.65

2.2

2.3

364.61

374.61

nmol/l

2.64

5506

22353

Type 1 diabetes, wide definition, subgroup 1

1853

7032

2.98

307.65

1.9

2.3

407.45

367.62

nmol/l

11.38

1715

6506

Benzodiazepine use

7864

28711

2.09

307.65

2.2

366.99

376.37

nmol/l

3.42

7104

26595

Intracranial trauma

3774

14191

2.10

307.65

2.1

2.3

371.60

385.20

nmol/l

3.25

3467

13202

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6612

26832

1.76

307.65

2.3

2.2

362.78

375.79

nmol/l

5.10

6125

24736

Autoimmune diseases excluding thyroid diseases, strict definition

7623

20698

2.18

307.65

2.1

356.88

384.86

nmol/l

22.90

7069

19132

Hypo-osmolality and hyponatraemia

2777

4152

10.17

307.65

2.3

2.2

413.70

373.88

nmol/l

12.34

2541

3758

Asthma, unspecified (mode)

4090

13115

2.69

307.65

2.4

2.1

336.39

386.77

nmol/l

47.22

3776

12103

General examination and investigation of persons without complaint and reported diagnosis

5107

12046

2.42

307.65

2.3

2.2

363.98

381.15

nmol/l

5.31

4702

11227

Osteoporosis

2099

7164

3.23

307.65

2.3

2.1

318.25

392.98

nmol/l

31.33

1913

6433

Hypopituitarism

1668

1904

20.56

307.65

4.7

2.1

308.19

366.88

nmol/l

14.42

1572

1769

Obesity

5105

23409

2.37

307.65

2.1

2.2

339.50

379.36

nmol/l

38.11

4635

21672

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7190

28175

1.90

307.65

2.5

2.2

360.94

376.29

nmol/l

6.87

6640

26015

Fever of other and unknown origin

4629

15200

3.14

307.65

2.7

2.2

356.63

381.62

nmol/l

12.13

4364

13927

Abnormalities of breathing

7862

20439

2.48

307.65

2.3

2.2

353.97

383.20

nmol/l

25.21

7234

18919

Codeine

7412

20208

2.15

307.65

2.3

2.0

356.46

386.09

nmol/l

25.74

6825

18625

Hypertension, essential

6245

16080

2.40

307.65

2.2

2.3

353.57

374.25

nmol/l

11.40

5771

14902

Disorders of the thyroid gland

8093

24253

2.37

307.65

2.6

2.1

366.41

380.44

nmol/l

6.71

7395

22381

Oedema, not elsewhere classified

2240

8137

3.04

307.65

2.5

2.2

352.36

382.55

nmol/l

8.67

2057

7405

Persons encountering health services for specific procedures and health care

8255

27773

1.96

307.65

2.5

2.1

373.12

373.34

nmol/l

0.03

7705

25513

Type 1 diabetes

2161

8600

2.81

307.65

2.0

2.3

401.95

368.63

nmol/l

9.69

2001

7951

Lower back pain or/and sciatica

7326

29632

1.81

307.65

2.2

362.61

378.80

nmol/l

8.72

6678

27373

Symptoms and signs involving the nervous and musculoskeletal systems

4168

21330

2.11

307.65

2.2

359.01

376.51

nmol/l

6.72

3889

19559

Use of hypnotics and sedatives

7350

25802

1.73

307.65

2.3

2.2

364.61

373.77

nmol/l

3.23

6755

23869

Benign neoplasm: Adrenal gland

1115

2077

8.52

307.65

2.3

2.2

239.45

373.62

nmol/l

52.25

1020

1901

Anaemias

2553

2558

7.85

307.65

2.4

1.7

360.87

375.23

nmol/l

1.96

2375

2403

Hypothyreosis and Thyroxine purchase for inclusion criteria

7915

24059

2.37

307.65

2.6

2.1

365.18

380.59

nmol/l

7.71

7228

22178

Pain (limb, back, neck, head abdominally)

5201

13621

2.01

307.65

2.2

2.3

362.65

384.81

nmol/l

11.23

4779

12605

Symptoms and signs concerning food and fluid intake

1061

2418

5.46

307.65

2.3

2.1

389.64

381.78

nmol/l

0.53

980

2195

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1418

1503

31.58

307.65

5.6

2.0

348.55

375.71

nmol/l

3.10

1376

1377

Other anaemias

2903

12388

2.48

307.65

2.4

2.2

371.03

379.60

nmol/l

1.15

2660

11268

Dyspnoea

7008

25894

2.24

307.65

2.3

2.2

353.31

379.57

nmol/l

19.52

6430

23867

Nausea and vomiting

2339

7864

3.33

307.65

2.7

2.2

370.84

385.11

nmol/l

2.40

2151

7189

Other disorders of fluid, electrolyte and acid-base balance

4197

7712

7.08

307.65

2.3

2.2

400.62

371.59

nmol/l

10.09

3845

7038

Hypothyroidism, drug reimbursement

1218

1606

6.13

307.65

2.2

1.7

365.14

372.87

nmol/l

0.55

1123

1510

Abnormal findings on diagnostic imaging of lung

3292

14432

2.43

307.65

3.1

2.2

366.69

376.59

nmol/l

1.79

3094

13168

Any gastric operation

6814

14959

2.45

307.65

2.4

1.9

365.99

386.40

nmol/l

10.53

6268

13752

Obesity, other/unspecified

2642

11821

2.47

307.65

2.1

2.2

336.30

377.90

nmol/l

21.21

2363

10937

Episodal and paroxysmal disorders

9140

23004

2.18

307.65

2.1

2.2

359.48

385.02

nmol/l

23.16

8386

21286

Syncope and collapse

3005

11123

2.59

307.65

2.2

377.01

384.44

nmol/l

0.87

2719

10149

Metabolic disorders

8129

21398

2.59

307.65

2.3

373.72

367.70

nmol/l

1.48

7471

19766

ILD differential diagnosis

6040

14799

2.17

307.65

2.3

2.1

366.80

386.75

nmol/l

9.48

5545

13679

Hyperfunction of pituitary gland

833

1455

9.07

307.65

4.0

1.8

371.85

379.37

nmol/l

0.51

795

1340

Diseases of oesophagus, stomach and duodenum

7911

26568

1.92

307.65

2.2

363.03

375.93

nmol/l

5.91

7255

24554

Depression or dysthymia

5782

12984

2.70

307.65

2.1

2.4

366.68

378.80

nmol/l

3.80

5213

12144

Soft tissue disorders

7394

23105

1.74

307.65

2.1

2.2

365.41

382.10

nmol/l

9.71

6800

21333

Dizziness and giddiness

5168

22657

1.97

307.65

2.2

2.3

372.38

375.57

nmol/l

0.53

4711

20876

Headache

5523

18117

2.80

307.65

2.3

2.1

359.10

380.52

nmol/l

12.23

5086

16621

Adrenocortical insufficiency

889

939

27.74

307.65

6.2

1.8

221.31

376.66

nmol/l

40.12

838

864

Chronic lower respiratory diseases

8705

28432

1.74

307.65

2.3

2.2

347.21

384.00

nmol/l

47.89

8041

26213

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1656

6147

3.05

307.65

5.6

1.8

402.27

365.26

nmol/l

8.42

1603

5550

Other dorsopathies, not elsewhere classified

7419

22385

1.84

307.65

2.1

2.2

364.13

384.58

nmol/l

13.59

6787

20698

GASTRO-related operations

6814

14959

2.45

307.65

2.4

1.9

365.99

386.40

nmol/l

10.53

6268

13752

Benign neoplasm of other and unspecified endocrine glands

2561

3364

14.28

307.65

4.0

1.7

302.72

371.70

nmol/l

30.31

2425

3051

Persons encountering health services in other circumstances, wide

8950

26423

1.85

307.65

2.3

2.2

363.31

378.56

nmol/l

9.10

8368

24216

6929

21764

2.13

307.65

2.5

2.1

362.73

382.65

nmol/l

10.20

6398

20080

Abdominal and pelvic pain

7254

20363

1.88

307.65

2.2

361.29

379.91

nmol/l

10.65

6701

18811

COPD differential diagnosis

6041

14804

2.17

307.65

2.3

2.1

366.70

386.78

nmol/l

9.60

5546

13683

Neurological diseases, wide definition

2799

4188

3.66

307.65

2.1

2.4

368.32

393.50

nmol/l

6.88

2606

3911

Systemic connective tissue disorders

2983

12143

2.78

307.65

2.1

346.10

381.51

nmol/l

14.78

2770

11048

Obesity related asthma

2701

11146

2.72

307.65

2.4

2.2

318.27

379.84

nmol/l

51.08

2482

10264

Antihypertensive medication - note that there are other indications

5167

12756

2.38

307.65

2.3

2.2

365.89

385.05

nmol/l

8.35

4772

11827

Dorsopathies

7295

22592

1.72

307.65

2.1

2.2

362.29

384.00

nmol/l

15.91

6692

20900

Mood [affective] disorders

8775

27242

2.30

307.65

2.0

2.3

371.51

376.65

nmol/l

1.39

7967

25249

Type 2 diabetes, wide definition

5603

18940

2.06

307.65

2.2

2.3

369.93

373.37

nmol/l

0.51

5128

17467

Intestinal infectious diseases

6688

30223

1.82

307.65

2.4

2.2

365.96

376.77

nmol/l

3.72

6177

27842

Mood disorders, excluding more controls

8173

21610

2.51

307.65

2.0

2.3

370.74

375.47

nmol/l

1.15

7407

20109

Personality disorders, excluding more controls

2085

7770

2.99

307.65

2.0

2.2

365.36

375.31

nmol/l

1.49

1892

7242

Other antidepressants

8784

20080

2.47

307.65

2.1

2.3

366.94

380.31

nmol/l

6.48

7991

18638

Other pulmonary diagnosis

6039

14832

2.16

307.65

2.2

2.1

364.29

386.55

nmol/l

11.66

5541

13713

Hypertension

6241

16783

2.26

307.65

2.3

352.67

373.87

nmol/l

11.74

5786

15564

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2833

11089

2.45

307.65

4.9

1.8

402.76

366.53

nmol/l

14.28

2719

10036

Gastro-oesophageal reflux disease

4595

22174

1.95

307.65

2.2

2.3

362.06

375.74

nmol/l

3.72

4175

20484

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8206

27067

2.37

307.65

2.4

2.2

364.45

375.57

nmol/l

4.20

7608

24918

Other anxiety disorders

3869

15034

2.51

307.65

2.0

2.1

376.62

376.17

nmol/l

0.04

3511

13959

Pain in joint

4525

12972

2.49

307.65

2.2

2.3

363.94

386.23

nmol/l

10.46

4146

12023

Disorders of other endocrine glands

5817

14851

4.87

307.65

3.6

1.9

330.76

384.83

nmol/l

49.91

5446

13566

Other CVD (FINNGEN)

991

1770

5.24

307.65

2.3

2.4

380.18

386.07

nmol/l

0.32

901

1635

Anxiety disorders, excluding more controls

7134

20343

2.54

307.65

2.1

2.3

371.97

375.27

nmol/l

0.61

6491

18929

Sleep apnoea

6959

23825

2.13

307.65

2.2

2.3

338.79

379.69

nmol/l

50.29

6367

22054

Anxiety (asthma-related co-morbidities)

5217

17445

2.59

307.65

2.0

2.2

375.99

373.69

nmol/l

0.33

4735

16242

Obesity due to excess calories

3934

16850

2.61

307.65

2.0

2.2

337.34

378.76

nmol/l

33.99

3598

15625

Asthma, excluding more controls

6246

13930

2.58

307.65

2.3

2.1

338.26

385.60

nmol/l

56.84

5784

12897

Psychiatric diseases

8549

21664

2.10

307.65

2.1

2.3

372.82

374.25

nmol/l

0.23

7791

20170

Codeine or tramadol medication

8561

26708

1.88

307.65

2.3

2.2

356.09

382.80

nmol/l

25.32

7878

24600

Exclusions for E4_PCOS_CONSORTIUM

6211

19421

2.18

307.65

3.0

1.9

362.34

379.07

nmol/l

6.91

5750

17835

Other specific joint derangements/joint disorders

5375

19775

1.93

307.65

2.2

2.3

363.45

384.34

nmol/l

11.83

4937

18245

Neurological diseases

7158

16912

2.28

307.65

2.2

2.3

364.05

387.05

nmol/l

15.47

6578

15720

Other systemic involvement of connective tissue (FG)

2163

8182

2.97

307.65

2.0

2.2

350.78

390.02

nmol/l

11.85

2014

7469

Exclusions for E4_PCOS_BROAD

3870

5416

13.70

307.65

4.7

2.0

322.80

373.13

nmol/l

25.57

3666

4984

Oxycodone

2915

9512

3.36

307.65

3.5

2.1

370.05

388.16

nmol/l

4.01

2726

8711

Sleep disorders (combined)

7990

25470

2.22

307.65

2.2

2.3

345.63

381.24

nmol/l

43.11

7325

23599

Other bacterial diseases

7058

24902

2.10

307.65

2.6

2.2

367.39

372.98

nmol/l

1.18

6583

22869

Recurrent or chronic depression

3753

8855

3.43

307.65

2.0

2.4

367.84

377.39

nmol/l

1.90

3408

8274

Heart failure and antihypertensive medication

1811

4009

3.31

307.65

2.4

2.6

360.42

380.73

nmol/l

2.74

1683

3713

Renal tubulo-interstitial diseases

6341

25825

2.01

307.65

2.3

2.2

374.27

376.01

nmol/l

0.24

5888

23713

Other soft tissue disorders, not elsewhere classified

7346

22658

2.15

307.65

2.2

358.16

382.26

nmol/l

19.22

6769

20923

Obesity and other hyperalimentation

5128

23482

2.38

307.65

2.1

2.2

339.39

379.48

nmol/l

38.72

4655

21740

Other septicaemia

2531

10623

2.56

307.65

2.5

2.2

376.36

377.38

nmol/l

0.06

2362

9652

Migraine

3856

15134

2.35

307.65

2.2

2.1

368.51

386.25

nmol/l

6.02

3557

13978

Osteopathies and chondropathies

3983

18848

2.17

307.65

2.3

2.2

338.79

381.71

nmol/l

26.12

3666

17260

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4703

20255

2.35

307.65

2.9

2.2

369.08

375.43

nmol/l

1.17

4402

18523

Care involving use of rehabilitation procedures

4435

22399

2.01

307.65

2.3

2.2

367.18

371.08

nmol/l

0.53

4147

20536

COPD/asthma/ILD related infections

7760

21804

1.88

307.65

2.3

2.1

360.57

382.75

nmol/l

15.21

7135

20115

Autoimmune diseases

9103

22240

2.24

307.65

2.2

364.95

382.84

nmol/l

11.29

8376

20560

Opioids

7970

20598

2.17

307.65

2.3

2.0

362.10

386.75

nmol/l

19.65

7352

18972

Hypothyroidism, strict autoimmune

5898

16255

2.61

307.65

2.2

1.9

372.82

390.15

nmol/l

7.94

5363

14945

Benign neoplasm of other and unspecified endocrine glands

2561

3791

12.56

307.65

4.0

2.1

302.72

376.31

nmol/l

35.90

2425

3484

Hypokalaemia

1233

2878

5.43

307.65

2.6

2.2

384.24

371.11

nmol/l

0.87

1133

2616

L04AX Other immunosuppressants

4241

21049

2.19

307.65

2.3

2.2

332.87

377.17

nmol/l

41.03

3987

19350

Diarrhoea and gastroenteritis of presumed infectious origin

5047

25434

1.91

307.65

2.4

2.1

362.23

376.42

nmol/l

4.67

4645

23419

Oral corticosteroids

10391

24106

2.90

307.65

2.4

2.1

335.19

392.05

nmol/l

127.93

9682

22133

Other heart diseases

3690

10776

2.44

307.65

2.3

2.2

365.22

375.50

nmol/l

1.89

3416

10016

Hypertensive diseases (excluding secondary)

4696

10600

2.83

307.65

2.3

348.03

373.37

nmol/l

12.78

4370

9866

Neurotic, stress-related and somatoform disorders

7560

25739

2.27

307.65

2.1

2.2

371.95

374.38

nmol/l

0.44

6880

23862

General symptoms and signs

10123

19984

2.78

307.65

2.3

2.1

366.52

378.84

nmol/l

6.33

9411

18370

Pain in limb

5736

21635

2.05

307.65

2.2

360.68

381.63

nmol/l

12.20

5294

19973

Neoplasms

5769

16673

1.96

307.65

2.9

1.6

362.89

380.48

nmol/l

8.53

5367

15310

Second line medication for Crohn's disease

4376

21636

2.20

307.65

2.3

2.2

332.72

377.45

nmol/l

43.32

4118

19899

Disorders of lipoprotein metabolism and other lipidaemias

5110

17310

1.96

307.65

2.2

2.3

371.48

366.37

nmol/l

0.89

4659

15967

Other reaction to severe stress, and adjustment disorders

2892

13265

2.38

307.65

2.4

2.1

369.61

374.75

nmol/l

0.63

2652

12316

Parasetamol

6288

15171

2.25

307.65

2.2

2.1

364.83

390.04

nmol/l

15.32

5794

14045

Asthma-related infections

4456

21249

2.23

307.65

2.4

2.2

331.11

384.01

nmol/l

58.53

4124

19494

Renal failure

3070

11871

2.60

307.65

2.3

370.85

377.65

nmol/l

0.88

2875

10788

Dorsalgia

7532

22274

1.94

307.65

2.2

361.69

384.64

nmol/l

16.17

6903

20590

Azathioprine

1383

4446

3.63

307.65

2.7

2.1

309.56

387.51

nmol/l

31.61

1296

4065

Aplastic and other anaemias

3132

13261

2.45

307.65

2.4

2.2

370.71

378.28

nmol/l

1.02

2877

12066

COPD/asthma related infections

7760

21804

1.88

307.65

2.3

2.1

360.57

382.75

nmol/l

15.21

7135

20115

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6929

21764

2.13

307.65

2.5

2.1

362.73

382.65

nmol/l

10.20

6398

20080

Diabetes, varying definitions

7396

25622

1.82

307.65

2.2

2.3

371.81

372.40

nmol/l

0.08

6786

23680

Other disorders of adrenal gland

1020

1223

19.55

307.65

6.0

1.9

233.16

377.52

nmol/l

41.90

959

1121

Diabetes mellitus

7455

25704

1.83

307.65

2.2

2.3

371.80

372.35

nmol/l

0.07

6835

23760

Drug-induced adrenocortical insufficiency

489

472

51.97

307.65

6.9

2.0

178.01

372.64

nmol/l

49.29

469

436

Diabetes medication

7147

26370

1.73

307.65

2.2

2.3

374.14

372.23

nmol/l

0.30

6535

24379

Cardiac arrhythmias

4530

14903

2.14

307.65

2.2

2.3

366.23

371.55

nmol/l

0.89

4189

13832

Endocrine, nutritional and metabolic diseases

7881

12842

3.45

307.65

2.3

2.0

368.51

381.24

nmol/l

5.03

7253

11990

Other systemic involvement of connective tissue

2198

9301

2.65

307.65

2.1

349.86

381.43

nmol/l

8.34

2046

8452

Inflammatory bowel disease treatment related agents

10707

25183

2.65

307.65

2.4

2.1

336.77

392.39

nmol/l

128.86

9953

23123

Hypothyroidism and >3 levothyroxin purchases

3077

2744

7.54

307.65

2.7

1.7

369.41

383.11

nmol/l

2.16

2816

2566

Explicit Sepsis

2941

12724

2.41

307.65

2.5

2.3

374.99

376.53

nmol/l

0.11

2743

11669

Other and unspecified anaemias

2876

12268

2.49

307.65

2.4

2.2

370.93

379.51

nmol/l

1.14

2636

11159

Asthma (only as main-diagnosis)

5659

14680

2.51

307.65

2.3

2.1

337.35

386.64

nmol/l

57.21

5233

13573

Pneumonia, organism unspecified

6667

25813

1.99

307.65

2.5

2.2

357.69

376.16

nmol/l

8.93

6141

23814

Insulin, fast-acting

2908

12438

2.60

307.65

2.1

2.3

388.27

370.62

nmol/l

3.85

2689

11428

Insulin medication

4343

18280

2.19

307.65

2.1

2.3

384.58

371.95

nmol/l

3.10

4007

16839

Depression

8325

26364

2.37

307.65

2.1

2.3

371.96

376.05

nmol/l

0.95

7562

24457

Depression medications

2819

2927

5.38

307.65

2.0

1.6

370.91

383.79

nmol/l

2.10

2583

2740

Asthma (diagnoses ohter than nonallergic)

6479

30071

1.96

307.65

2.3

2.2

334.82

383.70

nmol/l

73.57

5992

27675

Hypothyroidism, other/unspecified

7733

22919

2.43

307.65

2.6

2.1

365.15

380.69

nmol/l

7.62

7063

21139

Malaise and fatigue

5042

11748

4.16

307.65

2.3

2.2

375.93

382.46

nmol/l

1.13

4638

10728

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6666

23750

1.80

307.65

2.2

2.3

375.11

371.11

nmol/l

0.74

6100

21952

Low back pain

5521

21412

2.13

307.65

2.2

363.18

384.31

nmol/l

10.75

5021

19804

Anxiety disorders

7616

25969

2.25

307.65

2.1

2.2

372.19

374.65

nmol/l

0.45

6933

24073

3458

16055

2.33

307.65

2.4

2.1

329.44

382.33

nmol/l

47.04

3209

14741

Bacterial Sepsis

3265

11795

2.72

307.65

2.3

368.71

376.84

nmol/l

0.96

3007

10802

Autoimmune diseases excluding thyroid diseases

8100

22039

2.18

307.65

2.3

2.2

353.82

382.55

nmol/l

25.15

7516

20379

7977

25569

1.72

307.65

2.2

357.27

384.45

nmol/l

24.01

7328

23541

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4112

11611

4.45

307.65

3.8

2.0

350.11

376.30

nmol/l

10.62

3866

10623

Tramadol

6126

17953

2.36

307.65

2.3

2.1

351.84

383.15

nmol/l

22.95

5626

16535

Asthma (only as main-diagnosis), excluding more controls

5575

13930

2.58

307.65

2.3

2.1

337.09

385.60

nmol/l

54.65

5157

12897

Symptoms and signs involving cognition, perception, emotional state and behaviour

7072

27112

1.94

307.65

2.1

2.2

372.99

373.79

nmol/l

0.12

6471

25046

Insulin, intermediate and long-acting

3920

18821

2.21

307.65

2.1

2.3

389.12

372.75

nmol/l

4.49

3617

17296

Benign neoplasms

5615

17353

1.93

307.65

2.7

1.6

358.21

379.09

nmol/l

11.68

5206

15930

Other diseases of intestines

7901

25943

1.87

307.65

2.2

363.82

376.75

nmol/l

6.12

7271

24009

Certain infectious and parasitic diseases

7397

20865

1.87

307.65

2.3

2.1

369.88

378.67

nmol/l

2.63

6828

19215

Cardiovascular diseases (excluding rheumatic etc)

5435

14402

2.35

307.65

2.3

2.1

358.99

378.94

nmol/l

10.25

5059

13374

Insulin, fast-acting or short human

2919

12865

2.51

307.65

2.1

2.3

388.44

370.12

nmol/l

4.14

2700

11814

Heart failure, not strict

5412

17896

2.26

307.65

2.4

359.40

375.29

nmol/l

4.94

5003

16503

Septicaemia

2773

11846

2.45

307.65

2.5

2.2

375.19

376.42

nmol/l

0.08

2585

10790

All pneumoniae

7459

28515

1.92

307.65

2.5

2.2

360.97

376.63

nmol/l

7.35

6882

26337

ILD medications: immunosuppressive drugs

5483

20201

2.90

307.65

2.3

2.1

330.53

392.37

nmol/l

95.49

5178

18559

Implicit viral Sepsis

1606

5275

3.52

307.65

2.4

2.2

348.09

378.31

nmol/l

6.24

1480

4811

Condition for Implicit Sepsis (Organ dysfunction codes)

6530

22760

2.25

307.65

2.2

2.3

371.50

374.11

nmol/l

0.42

5988

20957

Autoimmune diseases related-to ILD

6494

29725

2.06

307.65

2.2

349.20

380.29

nmol/l

27.59

6005

27370

Symptoms and signs involving the circulatory and respiratory systems

8144

20543

2.11

307.65

2.2

362.54

383.14

nmol/l

14.00

7503

19014

Asthma

6386

14680

2.52

307.65

2.3

2.1

338.25

386.64

nmol/l

60.50

5905

13573

Asthma, hospital admission 2, infections

4456

21249

2.23

307.65

2.4

2.2

331.11

384.01

nmol/l

58.53

4124

19494

Hypothyroidism, levothyroxine purchases

3077

2744

7.54

307.65

2.7

1.7

369.41

383.11

nmol/l

2.16

2816

2566

Diabetes, insulin treatment (Kela reimbursement)

6870

25375

1.74

307.65

2.2

2.3

375.68

370.72

nmol/l

1.04

6286

23448

Other headache syndromes

3204

14418

2.42

307.65

2.2

361.58

385.14

nmol/l

8.93

2935

13287

Asthma, hospital admissions , main diagnosis only

5857

30451

1.82

307.65

2.3

2.2

336.94

382.02

nmol/l

57.67

5420

28026

Sleep apnoea, including avohilmo

7429

24489

2.12

307.65

2.2

2.3

340.48

380.85

nmol/l

52.47

6806

22677

Cardiovascular diseases

5138

12880

2.33

307.65

2.3

2.1

362.47

382.11

nmol/l

9.25

4779

11947

Asthma, including avohilmo

8401

29498

1.74

307.65

2.2

343.27

383.90

nmol/l

60.64

7745

27188

Polyarthropathies

4816

17212

1.98

307.65

2.1

2.3

348.07

381.55

nmol/l

23.64

4489

15851

Examination and observation for other reasons

4309

11963

2.34

307.65

2.3

2.2

368.52

381.24

nmol/l

3.40

3935

11156

Influenza and pneumonia

7916

28719

1.92

307.65

2.5

2.1

361.23

377.60

nmol/l

8.45

7322

26506

Insulin, combination of fast acting with intermediate-acting or long-acting

4347

20293

2.12

307.65

2.1

2.3

384.63

372.76

nmol/l

2.82

4010

18629

Excluding asthma or asthma-COPD overlap

6100

14832

2.19

307.65

2.3

2.1

366.90

386.55

nmol/l

9.28

5597

13713

Implicit Sepsis

5796

19869

2.48

307.65

2.2

2.3

370.29

375.30

nmol/l

0.91

5310

18268

Asthma (mode)

6246

14799

2.50

307.65

2.3

2.1

337.98

386.75

nmol/l

60.93

5771

13679

Other heart diseases, wide

6649

23925

1.82

307.65

2.3

2.2

366.63

371.52

nmol/l

1.03

6145

22118

Symptoms and signs involving the digestive system and abdomen

7411

20374

1.92

307.65

2.2

363.11

379.79

nmol/l

8.85

6834

18822

Lung cancer and mesothelioma

1389

3610

3.72

307.65

5.3

2.1

426.78

387.73

nmol/l

7.33

1337

3289

Any reimbursement code in KELA

4858

9700

2.70

307.65

2.3

1.7

368.77

387.04

nmol/l

6.82

4515

8908

Hypothyroidism (congenital or acquired)

3133

2768

7.62

307.65

2.7

1.7

369.90

382.56

nmol/l

1.91

2869

2589

Any mental disorder

8683

22197

2.08

307.65

2.1

2.3

372.95

374.46

nmol/l

0.25

7895

20656

First line medication for Crohn's disease

10879

22181

2.96

307.65

2.8

1.8

339.74

397.39

nmol/l

127.76

10140

20297

Other functional intestinal disorders

3335

14390

2.40

307.65

2.3

2.2

372.65

378.27

nmol/l

0.72

3069

13229

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8058

26297

1.84

307.65

2.3

2.2

361.83

378.47

nmol/l

9.76

7562

24121

All anxiety disorders

5283

19214

2.42

307.65

2.0

2.1

377.34

374.09

nmol/l

0.53

4797

17864

Other special examinations and investigations of persons without complaint or reported diagnosis

5016

12064

2.23

307.65

2.2

368.26

381.18

nmol/l

3.62

4638

11237

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2842

4810

3.17

307.65

2.1

2.0

370.87

387.19

nmol/l

3.29

2621

4436

Pain in throat and chest

6350

19225

2.15

307.65

2.2

360.07

382.42

nmol/l

13.72

5812

17783

Medical observation and evaluation for suspected diseases and conditions

5737

12063

2.63

307.65

2.4

2.2

365.75

381.18

nmol/l

5.79

5179

11237

Pain, not elsewhere classified

2083

7573

3.06

307.65

2.4

2.1

355.06

380.41

nmol/l

4.69

1920

6924

Abnormalities of heart beat

2519

10710

2.54

307.65

2.1

2.2

373.30

387.52

nmol/l

2.78

2324

9852

Complications of medical and surgical care

4861

26556

1.84

303.89

2.4

2.2

368.79

375.68

nmol/l

1.39

4501

24400

Dentinal caries

1777

7058

2.79

301.89

2.9

2.2

355.57

372.17

nmol/l

2.64

1656

6554

Nutritional anaemias

3251

16174

2.10

297.88

2.3

2.2

367.14

378.35

nmol/l

1.84

2957

14787

Acute renal failure

1484

5479

3.06

296.19

2.3

388.00

373.89

nmol/l

1.36

1381

4960

Dermatitis and eczema

7375

30648

1.65

296.16

2.3

2.2

361.83

377.96

nmol/l

8.93

6743

28323

Convulsions, not elsewhere classified

1667

6395

2.82

295.23

2.3

2.2

382.95

381.41

nmol/l

0.08

1528

5854

Non-invasive ventilation

1426

4762

3.07

295.16

2.2

2.6

391.50

375.22

nmol/l

1.87

1320

4455

Complications of procedures, not elsewhere classified

5341

27362

1.78

294.43

2.4

2.2

365.44

376.03

nmol/l

3.13

4952

25162

Cerebrovascular diseases (FINNGEN)

2103

6310

2.57

293.72

2.3

2.4

370.18

376.88

nmol/l

0.74

1936

5859

Persons encountering health services for examination and investigation

4443

12064

1.93

291.15

2.2

369.90

381.18

nmol/l

2.64

4065

11237

Acute upper respiratory infections

7064

27841

1.66

289.68

2.2

357.40

381.06

nmol/l

17.70

6486

25634

Non-selective monoamine reuptake inhibitors

2549

11670

2.28

288.68

2.2

2.3

351.09

378.62

nmol/l

8.95

2319

10793

Diseases of the respiratory system

4502

12331

1.92

287.87

2.3

2.1

367.97

391.05

nmol/l

9.55

4126

11390

Other diseases of urinary system

6912

24368

1.67

281.82

2.1

2.2

370.25

378.40

nmol/l

2.47

6346

22535

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1128

3444

3.51

279.79

5.7

1.8

425.79

367.17

nmol/l

14.30

1089

3070

Behavioural syndromes associated with physiological disturbances and physical factors

2504

11974

2.29

279.70

2.0

2.1

374.14

377.62

nmol/l

0.38

2282

11033

Asthma/COPD (KELA code 203)

6430

28288

1.67

278.48

2.3

2.2

337.66

383.97

nmol/l

61.44

5951

26075

Asthma-related pneumonia

2438

11511

2.29

278.23

2.5

2.1

319.58

386.29

nmol/l

48.22

2254

10477

Asthma-related pneumonia or sepsis

2443

11547

2.29

278.00

2.5

2.1

319.52

386.19

nmol/l

48.34

2259

10510

Asthma, hospital admissions 3, pneumonia

2443

11547

2.29

278.00

2.5

2.1

319.52

386.19

nmol/l

48.34

2259

10510

Fibromyalgia

896

2593

4.22

276.71

2.2

2.1

346.03

381.80

nmol/l

6.09

821

2393

L04AA Selective immunosuppressants

1782

7476

2.70

276.48

2.5

2.2

310.52

372.54

nmol/l

38.09

1698

6880

Other intervertebral disc disorders

5447

19867

1.76

274.49

2.2

2.3

361.13

381.90

nmol/l

11.01

4954

18374

Cystitis

5803

21540

1.73

273.48

2.2

369.52

381.26

nmol/l

4.04

5314

19878

Bleeding

5190

22478

1.77

272.85

2.3

373.05

372.30

nmol/l

0.08

4796

20650

Iron deficiency anaemia

2804

13939

2.15

272.53

2.3

2.2

363.58

379.45

nmol/l

2.81

2554

12717

Other disorders of urethra and urinary system

4650

20189

1.82

271.31

2.2

365.71

380.80

nmol/l

5.03

4251

18605

Irritable bowel syndrome

2095

9449

2.44

270.80

2.1

362.82

380.58

nmol/l

3.92

1900

8680

Dermatitis

4024

22760

1.88

269.30

2.4

2.2

356.70

378.11

nmol/l

9.13

3708

20981

Disorders of mineral metabolism

763

2018

4.65

268.11

2.6

2.3

370.85

365.59

nmol/l

0.27

710

1852

Diseases of the musculoskeletal system and connective tissue

3946

10607

1.96

267.80

2.2

2.3

366.38

393.26

nmol/l

12.63

3641

9798

Persons encountering health services in other circumstances

2662

13179

2.17

267.56

2.2

2.1

365.45

379.87

nmol/l

3.00

2476

12028

Atrial fibrillation and flutter

2029

5638

2.52

267.26

2.2

2.5

365.92

374.37

nmol/l

0.85

1886

5226

Noninfective enteritis and colitis

3294

17567

2.01

266.98

2.4

2.2

348.39

375.20

nmol/l

10.95

3051

16156

Pure hypercholesterolaemia

4168

15640

1.88

266.48

2.2

2.3

376.42

366.31

nmol/l

2.32

3806

14411

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1943

8524

2.47

264.90

2.0

2.2

370.44

376.25

nmol/l

0.62

1755

7922

Acute upper respiratory infections of multiple and unspecified sites

5076

22735

1.76

264.02

2.3

2.2

356.89

379.70

nmol/l

11.97

4706

20948

L04AD Calcineurin inhibitors

1023

3341

3.71

261.60

2.9

2.3

308.24

365.74

nmol/l

16.87

986

3098

Dysphagia

1641

6786

2.66

257.42

2.3

2.2

374.69

382.86

nmol/l

0.75

1482

6214

Nonorganic sleeping disorders, excluding more controls

1358

5133

2.95

257.33

2.1

2.2

371.16

373.32

nmol/l

0.15

1242

4756

Cough

2650

12713

2.14

256.30

2.3

355.13

384.27

nmol/l

9.77

2453

11744

Heart failure,strict

3075

11479

2.06

256.18

2.2

2.4

376.41

380.39

nmol/l

0.35

2823

10537

Sub-endpoint used in defining T1D endpoints

2208

10195

2.31

256.13

2.0

2.2

401.57

369.79

nmol/l

9.26

2045

9343

Reimbursement for rheumatic diseases

3901

22184

1.87

254.90

2.1

2.2

342.44

378.62

nmol/l

23.03

3634

20340

Spondylosis

3287

15105

1.98

254.25

2.2

2.4

348.64

381.21

nmol/l

15.42

3013

13962

Epilepsy

2087

9569

2.35

254.08

2.4

2.3

378.29

379.00

nmol/l

0.05

1908

8801

Diseases of the eye and adnexa

5818

17857

1.70

250.98

2.2

365.59

377.50

nmol/l

4.20

5350

16605

Certain disorders involving the immune mechanism

1541

6328

2.76

250.37

2.6

2.2

338.82

369.05

nmol/l

8.27

1456

5831

Other and unspecified iron deficiency

2238

10684

2.28

250.31

2.4

2.1

361.24

379.95

nmol/l

3.07

2038

9740

Other and unspecified dermatitis

3402

18726

1.94

250.02

2.4

2.2

353.22

377.10

nmol/l

9.95

3133

17221

Other medical care

2579

12654

2.14

248.14

3.2

2.2

400.41

376.59

nmol/l

5.31

2449

11462

Other/unspecified dorsalgia

2522

12510

2.15

248.12

2.1

2.2

352.85

386.07

nmol/l

13.43

2325

11498

Continuous positive airway pressure

1227

3785

3.06

246.58

2.1

2.8

339.30

365.69

nmol/l

4.37

1098

3550

Acute tubulo-interstitial nephritis

3953

20159

1.84

244.43

2.3

2.2

372.65

379.42

nmol/l

1.05

3642

18437

Atrial fibrillation and flutter with reimbursement

1617

4133

2.70

243.41

2.1

2.6

368.46

379.70

nmol/l

1.13

1498

3844

Non-small cell lung cancer

1128

3992

3.20

243.40

5.7

2.1

425.79

369.87

nmol/l

13.60

1089

3602

Hernia of abdominal wall, postoperative

1148

4071

3.11

243.33

2.6

2.0

353.72

381.05

nmol/l

3.44

1059

3726

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1538

5240

2.70

241.22

5.1

1.8

425.68

366.69

nmol/l

17.23

1477

4686

Temporomandibular joint disorders

1196

4368

3.03

240.95

2.3

2.2

362.51

390.51

nmol/l

4.42

1092

4033

Vocal cord dysfunction

906

2591

3.57

239.24

2.4

2.7

352.74

386.54

nmol/l

4.38

828

2425

Transplanted organ and tissue status

879

2755

3.84

239.09

3.0

2.4

320.04

362.07

nmol/l

8.33

856

2533

Undetermined asthma, excluding more controls

952

3083

3.48

238.48

2.4

2.1

319.44

384.02

nmol/l

20.51

884

2835

Diseases of arteries, arterioles and capillaries (FINNGEN)

1520

4209

2.73

237.56

2.3

2.6

365.47

378.13

nmol/l

1.26

1389

3915

Symptoms and signs involving the skin and subcutaneous tissue

4464

26784

1.75

236.86

2.5

2.2

368.24

375.43

nmol/l

1.69

4134

24627

Other joint disorders

6039

20343

1.64

233.09

2.1

2.2

365.27

384.23

nmol/l

10.80

5563

18759

Other arrhythmias

4096

18317

1.80

232.94

2.2

2.3

370.79

372.81

nmol/l

0.25

3769

16878

Disorders of adult personality and behaviour

2191

10681

2.24

232.83

2.0

2.1

364.75

375.32

nmol/l

1.80

1991

9876

COPD (mode)

1751

6043

2.47

230.85

2.7

2.2

363.33

387.39

nmol/l

3.67

1590

5533

Codes for special purposes

3084

16918

1.95

229.78

2.3

2.1

369.47

377.53

nmol/l

1.38

2883

15542

Hypotension

1144

4214

3.07

229.43

2.2

376.73

381.87

nmol/l

0.32

1022

3807

Covid-19 confirmed case

2021

9609

2.30

229.42

2.4

2.2

364.83

378.04

nmol/l

1.88

1884

8802

Personality disorders

2085

10039

2.27

229.21

2.0

2.2

365.36

373.75

nmol/l

1.19

1892

9279

Sciatica+with lumbago

3210

16854

1.91

228.62

2.2

2.3

357.46

382.78

nmol/l

9.59

2924

15571

Undetermined asthma

952

3167

3.39

227.92

2.4

2.1

319.44

385.32

nmol/l

21.21

884

2910

Myalgia

1673

7383

2.49

227.61

2.3

2.2

364.09

386.06

nmol/l

4.21

1511

6794

Other disorders of skin and subcutaneous tissue

4237

23252

1.76

227.20

2.3

2.2

366.70

376.72

nmol/l

2.38

3885

21353

Provisional assignment of new diseases of uncertain etiology

3073

16901

1.94

227.05

2.3

2.1

369.48

377.60

nmol/l

1.39

2874

15524

Acute sinusitis

3537

18820

1.85

226.53

2.2

2.1

349.15

379.01

nmol/l

15.27

3258

17379

Diseases of pulp and periapical tissues

2320

11613

2.15

226.44

2.6

2.2

358.52

375.31

nmol/l

3.45

2118

10790

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1357

4462

2.79

226.28

5.3

1.8

427.91

368.50

nmol/l

14.66

1303

3982

Generalized anxiety disorder

1248

4858

2.89

224.59

2.1

381.74

379.79

nmol/l

0.13

1131

4517

Visual disturbances and blindness

3300

18605

1.89

224.38

2.5

2.2

366.95

377.31

nmol/l

1.68

3018

17067

Other diseases of pleura

2652

12267

2.05

224.32

2.5

2.3

373.50

376.55

nmol/l

0.24

2461

11203

Weight loss

870

2824

3.71

224.17

2.1

2.2

396.75

370.71

nmol/l

3.07

808

2574

Migraine without aura

1501

6358

2.60

223.86

2.2

2.0

367.95

385.93

nmol/l

2.97

1377

5885

Somatoform disorder

1306

5221

2.82

223.50

2.3

2.2

356.64

373.13

nmol/l

2.30

1189

4830

Diseases of the digestive system

2876

15520

1.97

222.86

2.3

2.2

376.86

374.73

nmol/l

0.17

2663

14168

Use of cabergoline

269

342

16.79

222.38

4.7

1.9

365.47

373.36

nmol/l

0.25

262

316

Abnormal findings on examination of blood, without diagnosis

2823

14189

1.99

221.50

2.4

366.51

373.05

nmol/l

0.77

2620

13053

Genitourinary diseases

4034

11665

1.81

216.30

2.3

364.48

375.67

nmol/l

2.59

3703

10887

Disorders of parathyroid gland

1422

5909

2.64

215.80

2.2

1.9

348.56

390.64

nmol/l

8.30

1308

5317

Haemorrhage from respiratory passages

1995

8887

2.22

213.26

2.5

2.3

357.75

386.29

nmol/l

7.74

1842

8180

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2870

9665

1.98

213.20

2.2

355.99

375.73

nmol/l

5.40

2683

8962

Other CVD

1270

5107

2.77

212.91

2.2

373.81

381.14

nmol/l

0.56

1139

4623

Budesonide

1038

3793

3.09

211.44

2.3

2.1

326.02

390.20

nmol/l

22.68

967

3468

Other symptoms and signs involving cognitive functions and awareness

2625

13115

2.00

210.57

2.1

2.2

380.35

377.33

nmol/l

0.24

2364

12025

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3791

22527

1.77

209.51

2.4

2.2

368.38

375.82

nmol/l

1.28

3515

20663

Diagnoses used for exclusion with ILD

1719

7937

2.37

209.39

2.4

2.2

349.45

374.17

nmol/l

4.53

1606

7264

Exposure to unspecified factor

6200

31936

1.57

208.65

2.3

2.2

362.51

376.91

nmol/l

5.53

5720

29450

Type 2 diabetes, definitions combined

5835

22582

1.60

207.71

2.2

2.3

361.53

372.74

nmol/l

3.39

5315

20843

Abnormal weight loss

787

2521

3.78

207.55

2.1

2.2

399.70

370.50

nmol/l

3.33

729

2298

Migraine with aura

1678

7689

2.37

207.27

2.1

378.26

388.28

nmol/l

1.10

1531

7100

Diseases of liver

2214

11294

2.12

206.59

2.2

2.3

360.56

372.93

nmol/l

1.60

2053

10392

Factors influencing health status and contact with health services

1977

4501

2.31

206.32

2.1

2.3

369.40

383.67

nmol/l

2.08

1818

4182

Visual disturbances

3053

17254

1.89

206.19

2.5

2.2

367.21

377.00

nmol/l

1.42

2805

15837

Hyperlipidaemia, other/unspecified

2097

9880

2.14

204.34

2.1

2.3

365.21

368.86

nmol/l

0.30

1926

9083

Disorders of eyelid, lacrimal system and orbit

5245

26478

1.62

204.14

2.3

2.2

367.01

375.88

nmol/l

2.32

4804

24373

Type 2 diabetes, strict (exclude DM1)

5840

22734

1.59

202.95

2.2

2.3

361.61

372.71

nmol/l

3.34

5318

20985

Arthropathies

6143

20444

1.58

202.85

2.1

2.3

362.78

383.73

nmol/l

12.71

5684

18855

Type 2 diabetes, definitions combined, including avohilmo

5876

22716

1.59

202.42

2.2

2.3

361.16

372.71

nmol/l

3.60

5348

20986

Presence of other functional implants

3318

13406

1.85

202.02

2.1

2.3

359.89

381.29

nmol/l

6.23

3030

12264

Polycystic ovarian syndrome, consortium definition

4925

18720

1.67

201.79

2.1

2.0

372.06

384.03

nmol/l

3.34

4486

17178

Heart failure, strict

3245

13266

1.86

201.74

2.2

2.4

376.66

378.54

nmol/l

0.15

2969

12144

Other disorders of glucose regulation and pancreatic internal secretion

773

2485

3.71

201.51

2.1

397.37

370.69

nmol/l

2.71

716

2277

Erysipelas

3142

16317

1.85

201.16

2.4

2.2

352.21

374.27

nmol/l

6.87

2885

14914

STROKE

3486

14000

1.82

200.97

2.2

2.4

367.75

371.97

nmol/l

0.58

3198

12918

Early onset COPD, excluding more controls

1200

4795

2.71

200.10

2.6

2.2

350.98

381.03

nmol/l

4.03

1082

4432

Chronic sinusitis

2828

15735

1.91

199.86

2.3

2.2

345.03

378.18

nmol/l

15.30

2618

14522

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

5637

21672

1.60

198.21

3.3

1.8

382.33

363.76

nmol/l

8.31

5333

19827

Malignant neoplasm, wide definition for exclusion

5637

21676

1.60

198.08

3.3

1.8

382.33

363.80

nmol/l

8.27

5333

19831

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

5636

21678

1.60

197.84

3.3

1.8

382.50

363.67

nmol/l

8.51

5332

19833

Specific personality disorders

1792

8631

2.27

197.07

2.0

2.1

367.41

376.36

nmol/l

1.18

1623

7980

Dialysis, with operation codes

960

3509

3.14

197.03

2.6

2.3

349.24

364.77

nmol/l

1.52

925

3218

Volume depletion

673

1989

3.89

196.78

2.4

2.2

390.75

372.18

nmol/l

1.09

617

1790

Bipolar affective disorders

1392

6056

2.53

195.78

1.9

2.2

373.03

373.10

nmol/l

0.01

1282

5623

Osteoporosis with pathological fracture (FG)

594

1646

4.42

195.71

2.4

2.2

309.13

403.34

nmol/l

13.72

549

1466

Other disorders of lacrimal gland

2259

11832

2.06

195.63

2.4

2.2

361.26

376.31

nmol/l

2.66

2060

10833

Other noninfective gastroenteritis and colitis

1749

8356

2.29

195.60

2.7

2.2

356.92

376.89

nmol/l

3.27

1625

7655

Hyperkalaemia

460

1049

5.35

195.32

2.4

2.1

376.98

369.25

nmol/l

0.26

432

945

All-cause Heart Failure

3179

13067

1.85

194.81

2.2

2.4

375.58

378.41

nmol/l

0.24

2907

11957

KRA_PSY_EATING, excluding more controls

724

2250

3.68

194.66

2.0

396.33

393.73

nmol/l

0.11

650

2102

Disorders of calcium metabolism

555

1481

4.59

192.64

2.4

2.2

376.18

364.77

nmol/l

0.57

518

1352

Other diseases of hard tissues of teeth

4077

18650

1.71

191.72

2.4

2.2

360.90

376.63

nmol/l

5.26

3727

17342

Hyperkinetic disorders, excluding more controls

792

2545

3.41

191.14

2.0

365.21

378.07

nmol/l

1.06

735

2381

Thyroiditis, ILD-related definition

990

3753

3.04

190.57

2.5

2.1

370.42

382.25

nmol/l

1.09

916

3448

Other acute lower respiratory infections

3357

18950

1.78

189.57

2.5

2.2

343.97

378.25

nmol/l

15.96

3104

17359

Dentofacial anomalies [including malocclusion]

1945

9647

2.15

189.49

2.5

2.1

353.47

377.78

nmol/l

5.10

1793

8994

Diverticular disease of intestine

4038

16400

1.71

187.47

2.2

2.3

357.19

375.66

nmol/l

6.21

3663

15140

Other (not insulin) diabetes medications

5878

23564

1.56

187.04

2.1

2.3

363.65

372.46

nmol/l

2.38

5342

21756

Hypoglycaemia, other or unspecified

647

1961

4.01

186.41

2.1

390.43

366.29

nmol/l

1.97

602

1795

Cushing syndrome

229

299

16.37

185.55

8.7

1.7

358.49

364.62

nmol/l

0.09

223

279

Disorders of lacrimal system

2662

14918

1.91

185.25

2.4

2.2

364.13

378.79

nmol/l

2.85

2426

13668

Rheumatism, unspecified

1081

4319

2.82

185.24

2.1

2.2

331.21

388.13

nmol/l

17.28

999

3972

Enlarged lymph nodes

1056

4140

2.81

185.13

2.7

2.2

362.36

379.55

nmol/l

2.00

1000

3773

Spinal stenosis

2832

12461

1.88

185.04

2.2

2.4

357.74

384.85

nmol/l

8.84

2556

11462

Other neurological diseases

4231

21349

1.67

184.30

2.3

370.97

375.46

nmol/l

0.57

3877

19586

Nephropathy related operations

937

3519

3.06

183.25

2.7

2.3

344.98

365.12

nmol/l

2.31

905

3226

Other diseases of blood and blood-forming organs, wide

1533

7167

2.36

182.83

2.6

2.2

363.21

373.93

nmol/l

1.11

1454

6582

Glomerular diseases

1277

5534

2.57

182.77

2.3

347.05

369.47

nmol/l

3.65

1204

5085

Disorders of gallbladder, biliary tract and pancreas

6042

26257

1.54

182.40

2.3

2.2

357.37

375.66

nmol/l

8.63

5566

24183

Mental and behavioural disorders due to psychoactive substance use

3618

20807

1.72

181.56

2.2

2.3

377.42

371.10

nmol/l

0.81

3292

19281

Allergic asthma (mode), excluding more controls

1567

7191

2.28

181.18

2.2

2.0

342.69

386.75

nmol/l

15.86

1455

6663

Lumbar disc prolapse

3824

18670

1.70

180.50

2.2

2.3

360.24

380.98

nmol/l

8.89

3496

17304

Irregular menses

3281

15798

1.79

180.26

2.2

2.1

372.89

380.80

nmol/l

1.26

3028

14560

Benign neoplasm of colon, rectum, anus and anal canal

3065

12619

1.82

180.24

2.3

1.8

364.58

365.90

nmol/l

0.13

2822

11477

Panic disorder

1138

4726

2.67

178.24

2.1

385.18

380.55

nmol/l

0.33

1016

4392

All influenza

1606

7683

2.26

177.67

2.4

2.2

348.16

376.11

nmol/l

6.24

1474

7048

Infections of the skin and subcutaneous tissue

3599

22002

1.71

177.63

2.4

2.2

360.29

372.99

nmol/l

3.19

3363

20296

ILD, hospital admission 2, with pulmonary infections

664

2091

3.64

175.88

2.2

342.79

385.71

nmol/l

3.76

620

1902

Sleep disorders

1560

7456

2.29

175.31

2.1

2.2

368.66

371.48

nmol/l

0.22

1427

6852

Shoulder lesions

4614

18075

1.63

175.14

2.3

358.57

379.57

nmol/l

10.13

4234

16687

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3181

18592

1.76

174.28

2.3

352.82

377.42

nmol/l

10.32

2917

17226

Substance abuse

3492

20379

1.72

174.25

2.2

2.3

377.12

370.92

nmol/l

0.77

3178

18892

Follow-up examination after treatment for conditions other than malignant neoplasms

2696

9820

1.88

174.18

2.0

2.2

377.00

385.09

nmol/l

1.20

2484

9121

Allergic asthma (mode)

1567

7310

2.24

173.86

2.2

2.0

342.69

388.09

nmol/l

16.67

1455

6768

Malignant neoplasm

5506

21771

1.56

173.04

3.4

1.9

383.43

363.90

nmol/l

9.11

5196

19928

Chronic periapical parodontitis

1374

6261

2.40

172.87

2.7

2.2

355.83

373.38

nmol/l

2.39

1258

5787

Fall on same level

7380

29030

1.47

172.61

2.2

365.42

375.55

nmol/l

3.84

6789

26866

Other endocrine disorders

557

1548

4.32

172.47

2.9

2.1

316.70

364.06

nmol/l

5.36

533

1430

Other metabolic disorders

985

3912

2.83

170.81

2.8

2.1

365.25

370.83

nmol/l

0.21

925

3607

Other disorders of teeth and supporting structures

1404

6501

2.35

169.66

2.7

2.2

374.82

375.14

nmol/l

0.02

1288

6008

Other general symptoms and signs

467

1186

4.71

169.59

2.5

2.0

359.90

379.17

nmol/l

1.31

440

1094

Acute bronchitis

2548

14152

1.87

168.55

2.4

2.2

340.54

377.38

nmol/l

14.56

2339

12913

Insulin, fast-acting (human)

1111

4703

2.62

167.07

1.8

2.1

397.87

370.29

nmol/l

4.94

1019

4305

Other diseases of upper respiratory tract

6961

25425

1.47

164.88

2.2

362.45

380.93

nmol/l

10.97

6386

23465

Other necrotizing vasculopathies (FG)

520

1477

4.25

164.63

2.3

333.50

392.53

nmol/l

6.89

483

1341

Polyneuropathies and other disorders of the peripheral nervous system

1357

6319

2.35

162.46

2.5

2.3

354.39

373.92

nmol/l

2.92

1254

5793

Non-allergic asthma (mode), excluding more controls

1187

5139

2.46

162.40

2.2

2.0

334.66

386.61

nmol/l

14.98

1097

4724

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3435

21368

1.69

160.91

2.3

2.2

369.37

375.52

nmol/l

0.90

3183

19594

Other and unspecified polyneuropathies, also in other diseases

1202

5356

2.47

160.56

2.5

2.3

354.21

373.84

nmol/l

2.55

1103

4909

Primary_lymphoid and hematopoietic malignant neoplasms

1384

6501

2.30

160.44

2.4

1.8

377.50

367.40

nmol/l

1.04

1318

5866

Functional dyspepsia

1727

8821

2.11

160.35

2.2

362.05

378.90

nmol/l

3.21

1585

8089

Diseases of oral cavity, salivary glands and jaws

5709

19836

1.52

160.03

2.3

2.2

366.20

378.33

nmol/l

3.89

5190

18366

Postprocedural endocrine and metabolic disorders, not elsewhere classified

910

3603

2.85

158.98

2.8

2.1

368.00

372.39

nmol/l

0.15

854

3321

Polymyalgia rheumatica

884

3456

2.88

158.27

1.9

2.1

338.10

384.82

nmol/l

7.01

816

3085

Any event in cancer register

5748

23364

1.51

157.57

3.2

1.9

380.45

367.40

nmol/l

4.67

5401

21412

Acromegaly and pituitary gigantism

163

173

26.16

157.08

6.0

1.7

358.25

401.18

nmol/l

1.40

155

160

989

4106

2.69

155.74

2.5

2.2

368.09

377.53

nmol/l

0.63

919

3735

Schizophrenia or delusion, excluding more controls

1780

9154

2.04

155.68

1.8

2.3

390.85

373.35

nmol/l

2.81

1633

8500

Falls/tendency to fall

7181

25562

1.45

155.49

2.1

2.2

367.61

375.61

nmol/l

2.53

6608

23652

Benign neoplasm: Colon

2610

11538

1.82

155.16

2.3

1.8

363.38

366.75

nmol/l

0.36

2397

10465

Disturbances of skin sensation

1856

9840

2.03

155.09

2.2

2.1

370.22

375.57

nmol/l

0.56

1701

9037

Other arthritis (FG)

1923

10277

2.00

155.05

2.3

346.67

384.06

nmol/l

13.13

1810

9447

Non-allergic asthma (mode)

1187

5253

2.40

154.34

2.2

2.0

334.66

387.81

nmol/l

15.54

1097

4822

Injuries to the head

6760

31305

1.45

154.30

2.1

2.2

376.14

374.11

nmol/l

0.32

6201

28911

Other necrotizing vasculopathies

591

1907

3.70

153.37

2.3

2.1

341.90

376.58

nmol/l

2.88

550

1722

External causes of morbidity and mortality

4513

14676

1.59

153.31

2.1

2.2

367.37

380.49

nmol/l

3.81

4151

13551

Disorders of lens

3810

15204

1.65

153.06

2.4

358.28

373.08

nmol/l

3.45

3513

14061

Sarcoidosis

998

4215

2.67

152.59

2.4

2.2

342.64

371.09

nmol/l

5.33

950

3864

Intracranial injury

3414

20712

1.66

152.39

2.1

2.2

376.80

376.04

nmol/l

0.07

3107

19048

Other respiratory diseases principally affecting the interstitium

1095

4810

2.50

150.93

2.1

2.2

338.99

377.65

nmol/l

6.17

1032

4368

Other retinal disorders

3519

17807

1.66

150.89

2.1

2.3

384.13

375.47

nmol/l

1.58

3199

16314

Other symptoms and signs involving the digestive system and abdomen

1092

4786

2.50

150.69

2.4

2.2

370.21

383.95

nmol/l

1.14

983

4380

Deposits [accretions] on teeth

616

1979

3.54

150.02

3.9

2.1

330.01

369.05

nmol/l

3.34

583

1848

Venous thromboembolism

3046

18208

1.70

147.86

2.5

2.2

364.90

376.91

nmol/l

2.27

2840

16627

Disorders of choroid and retina

4517

21922

1.56

147.62

2.2

2.3

382.48

372.25

nmol/l

2.59

4125

20152

Nonorganic sleeping disorders

1358

6621

2.25

145.05

2.1

2.2

371.16

372.88

nmol/l

0.12

1242

6089

Rheumatoid arthritis

1948

9654

1.94

144.65

1.9

2.3

340.28

386.78

nmol/l

18.89

1812

8836

Hyperparathyroidism

1137

5096

2.41

144.61

2.2

1.9

357.80

391.13

nmol/l

5.36

1042

4584

Other diseases of the digestive system

1814

9733

1.98

144.23

2.3

2.2

376.94

376.04

nmol/l

0.05

1679

8870

Glomerular disorders in diseases classified elsewhere

822

3258

2.85

143.65

2.1

2.2

362.64

370.60

nmol/l

0.54

771

2979

Care involving dialysis

605

2054

3.42

142.68

2.5

2.3

343.06

363.32

nmol/l

1.69

586

1872

COPD

2361

11224

1.82

142.67

2.6

2.3

357.04

388.69

nmol/l

8.65

2151

10255

Other external causes of accidental injury

5465

18786

1.50

142.66

2.1

2.3

367.32

377.69

nmol/l

3.15

5031

17380

Paroxysmal tachycardia

1325

5340

2.23

141.92

2.2

2.4

366.77

380.57

nmol/l

1.47

1205

4952

GI-bleeding

1805

9720

1.97

141.73

2.3

2.2

377.13

377.10

nmol/l

0.00

1675

8852

Other specified/unspecified arthritis

1662

8728

2.03

141.43

2.3

2.4

346.77

384.98

nmol/l

11.53

1563

8000

Phobic anxiety disorders

964

4134

2.56

140.17

2.1

378.78

376.57

nmol/l

0.12

864

3851

Migraine without aura and triptan purchases

1197

5654

2.32

138.93

2.2

2.0

365.67

377.89

nmol/l

1.40

1098

5212

Biguanides

5587

24083

1.48

138.38

2.1

2.3

367.09

374.21

nmol/l

1.58

5072

22233

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1419

6456

2.16

138.20

2.1

2.0

370.17

384.76

nmol/l

2.00

1300

5985

ILD, hospital admissions

931

3971

2.60

137.98

2.2

342.55

375.36

nmol/l

3.84

875

3625

Psychotic depression

471

1392

3.88

137.77

2.1

2.3

393.73

382.98

nmol/l

0.38

421

1291

Alcohol use disorder, Swedish definition

3132

18306

1.66

137.33

2.2

2.3

378.92

369.07

nmol/l

1.36

2865

16977

Other interstitial pulmonary diseases

935

4008

2.58

136.87

2.2

343.02

376.59

nmol/l

4.02

879

3658

Chronic rhinitis, nasopharyngitis and pharyngitis

1985

11164

1.89

136.10

2.2

354.52

376.22

nmol/l

5.47

1799

10306

Polyuria

1308

6413

2.20

136.03

2.2

2.3

354.72

377.17

nmol/l

3.98

1180

5906

Thyrotoxicosis, other and/or unspecified

1268

6154

2.23

135.99

2.2

2.0

378.14

378.18

nmol/l

0.00

1158

5647

Malignant neoplasm of respiratory system and intrathoracic organs

1186

5114

2.29

135.86

5.2

2.1

425.78

370.71

nmol/l

12.26

1139

4610

Interstitial lung disease endpoints

935

4022

2.57

135.81

2.2

343.02

376.24

nmol/l

3.94

879

3673

Interstitial lung disease

935

4022

2.57

135.81

2.2

343.02

376.24

nmol/l

3.94

879

3673

Glucagon-like peptide-1 (GLP-1) analogues

2970

15191

1.68

135.23

2.0

2.4

370.20

374.85

nmol/l

0.53

2702

13982

ILD, hospital admissions 3, with pneumonia sepsis

558

1861

3.43

134.61

2.1

342.43

379.28

nmol/l

2.59

521

1697

Pulmonary heart disease, diseases of pulmonary circulation

1797

9848

1.94

133.90

2.8

2.2

363.32

378.35

nmol/l

1.91

1679

8946

Accidents

5407

18786

1.49

133.55

2.1

2.3

368.22

377.69

nmol/l

2.70

4974

17380

3285

19323

1.63

133.44

2.2

2.3

379.70

370.00

nmol/l

1.39

3009

17909

5-aminosalicylic acid

1329

6588

2.16

133.37

2.2

331.57

387.25

nmol/l

22.44

1231

6045

Focal epilepsy

1375

6926

2.15

133.35

2.4

2.2

371.28

370.96

nmol/l

0.02

1262

6375

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1026

4620

2.43

133.10

5.2

1.8

426.10

367.51

nmol/l

13.79

989

4158

Paralytic ileus and intestinal obstruction

1430

7270

2.10

133.08

2.4

2.3

381.68

380.24

nmol/l

0.07

1310

6646

Persistent mood disorders

1256

6118

2.22

132.97

2.0

2.2

362.62

376.94

nmol/l

1.67

1126

5626

Emotionally unstable personality disorder

959

4221

2.53

132.89

1.9

2.1

370.12

379.06

nmol/l

0.75

866

3914

Post-traumatic stress disorder

649

2375

3.10

132.38

2.1

2.0

392.38

383.75

nmol/l

0.32

581

2209

Other chronic obstructive pulmonary disease

2240

10815

1.81

132.01

2.6

2.3

356.61

389.51

nmol/l

8.69

2031

9880

Inflammatory bowel disease

2032

11630

1.86

131.54

2.2

338.03

373.54

nmol/l

13.66

1886

10717

Pain and other conditions associated with female genital organs and menstrual cycle

1407

6870

2.11

130.99

1.9

2.1

369.60

388.84

nmol/l

3.34

1264

6312

3441

20026

1.60

130.69

2.2

2.3

379.01

370.43

nmol/l

1.21

3148

18555

Other sleep disorders

731

2853

2.84

130.30

2.2

357.34

378.97

nmol/l

2.26

677

2622

DVT of lower extremities and pulmonary embolism

2302

13622

1.77

129.58

2.7

2.2

364.33

377.88

nmol/l

2.11

2148

12395

Ischemic heart diseases

4307

18191

1.54

129.56

2.2

2.4

363.66

372.86

nmol/l

2.03

3964

16729

Insomnia

1138

5424

2.31

129.42

2.0

2.2

369.07

373.00

nmol/l

0.29

1044

4982

Retention of urine

1753

8056

1.94

129.23

2.3

2.4

379.68

376.23

nmol/l

0.24

1601

7402

Noninfectious colitis NAS

970

4346

2.47

128.75

2.8

2.2

356.30

375.63

nmol/l

1.79

902

3982

Diseases of the ear and mastoid process

7368

27493

1.39

128.54

2.2

360.78

378.10

nmol/l

10.93

6762

25446

Any operation in hilmo

290

237

6.61

127.99

1.9

1.2

385.89

424.24

nmol/l

1.73

262

222

Non-ischemic cardiomyopathy

1627

7118

2.00

127.81

2.2

2.3

368.97

383.39

nmol/l

1.66

1486

6470

Poisoning by drugs, medicaments and biological substances

1622

8764

1.99

127.67

2.1

2.2

370.82

373.34

nmol/l

0.19

1470

8082

Postviral fatigue syndrome

161

216

15.21

127.12

2.4

1.8

376.73

368.85

nmol/l

0.20

150

203

Rotator cuff syndrome

3391

16304

1.60

126.97

2.3

352.53

379.24

nmol/l

12.25

3123

15068

Unspecified mental disorder

2552

15669

1.71

126.42

1.9

2.2

387.77

371.35

nmol/l

2.74

2336

14436

Endocrine disorders, other/unspecified

254

524

6.83

126.11

2.9

1.8

313.95

370.29

nmol/l

2.78

239

481

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1943

11123

1.86

125.96

2.0

2.1

370.44

375.72

nmol/l

0.56

1755

10271

Focal epilepsy, strict definition

1261

6298

2.17

125.40

2.4

2.2

371.19

370.44

nmol/l

0.04

1153

5802

Other cataract

2329

10705

1.77

125.24

2.3

362.42

378.21

nmol/l

3.06

2162

9858

Ischaemic heart disease, wide definition

4210

17815

1.53

125.06

2.2

2.4

366.22

372.61

nmol/l

1.12

3866

16386

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2509

15381

1.71

123.85

2.2

2.4

380.26

368.44

nmol/l

1.50

2295

14257

Malignant neoplasm of bronchus and lung

1027

4421

2.34

123.52

5.4

2.1

428.25

370.57

nmol/l

11.18

986

3981

Mouth breathing

2385

14482

1.74

123.51

2.4

344.26

368.20

nmol/l

7.99

2200

13415

Mental and behavioural disorders due to alcohol

2872

17714

1.64

123.37

2.2

2.3

380.02

370.05

nmol/l

1.32

2626

16435

Poisoning by medicine

1482

7870

2.03

123.30

2.1

2.2

373.67

373.13

nmol/l

0.03

1343

7259

Coxibs

1746

4952

1.96

122.82

2.0

2.2

363.81

400.17

nmol/l

10.37

1593

4570

Mycoses

1614

8815

1.96

122.76

2.7

2.2

344.50

376.34

nmol/l

7.07

1485

8087

Methotrexate

939

4218

2.43

122.28

1.9

2.1

323.19

395.60

nmol/l

24.93

886

3849

Triptan medication for migraine, single purchase ok

4838

22949

1.48

121.53

2.1

2.2

369.46

375.39

nmol/l

1.24

4475

21175

Migraine, single triptan purchase ok & required. ICD-code if available is included

4838

22949

1.48

121.53

2.1

2.2

369.46

375.39

nmol/l

1.24

4475

21175

Cervical disc disorders

2021

11773

1.80

121.52

2.3

2.4

359.73

380.93

nmol/l

5.65

1835

10879

Other gastritis (incl. Duodenitis)

1325

6797

2.09

121.06

2.4

2.3

360.35

380.55

nmol/l

3.13

1223

6222

Other diseases of liver

1152

5651

2.23

121.02

2.2

2.3

356.79

370.57

nmol/l

1.12

1063

5184

Testicular dysfunction

322

814

4.90

120.87

2.3

2.0

343.42

370.43

nmol/l

2.08

299

757

Primary_lymphoid and hematopoietic malignant neoplasms

1384

7226

2.06

120.63

2.4

2.3

377.50

375.91

nmol/l

0.10

1318

6590

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

447

1402

3.72

120.29

5.6

1.8

413.44

357.92

nmol/l

5.61

434

1248

Other bacterial intestinal infections

1106

5338

2.24

120.27

2.6

2.2

350.83

376.89

nmol/l

3.54

1027

4877

Later onset COPD, excluding more controls

1008

3566

2.35

120.14

2.6

2.1

363.29

397.02

nmol/l

4.37

922

3205

Migraine with aura and triptan purchases

1094

5286

2.27

119.78

2.1

2.0

367.28

377.02

nmol/l

0.77

998

4875

Gingivitis and periodontal diseases

5377

19660

1.45

119.54

2.2

368.11

378.79

nmol/l

3.07

4893

18217

Pulmonary embolism

1627

8963

1.93

119.30

2.8

2.1

363.61

377.93

nmol/l

1.65

1524

8154

Urticaria and erythema

2292

13926

1.74

119.16

2.3

2.1

347.53

375.59

nmol/l

9.79

2126

12810

Disorders of synovium and tendon

3017

17525

1.61

118.59

2.1

2.3

361.17

382.29

nmol/l

7.54

2770

16188

Amenorrhoea

587

2166

3.09

118.36

2.8

2.1

386.02

389.38

nmol/l

0.13

546

1995

Excessive, frequent and irregular menstruation

2646

9033

1.71

118.23

2.0

2.1

374.44

389.27

nmol/l

2.87

2389

8261

Unspecified haematuria

2156

10959

1.77

118.12

2.6

2.4

370.02

376.18

nmol/l

0.58

1963

10093

Triptan medication for migraine, min. 3 purchases

3548

18685

1.56

118.10

2.1

366.98

375.81

nmol/l

1.80

3287

17247

Pulmonary heart disease

1627

8992

1.92

118.07

2.8

2.1

363.61

377.90

nmol/l

1.65

1524

8180

Cervicalgia

1249

6340

2.11

117.73

2.1

2.2

358.84

385.65

nmol/l

4.72

1142

5817

Dental pulpitis 1

6669

25530

1.39

117.58

2.2

366.69

381.33

nmol/l

6.63

6100

23575

Pleural effusion

882

3926

2.45

117.41

2.7

2.2

398.51

375.45

nmol/l

1.68

820

3575

Diseases of pulp and periapical tissues, including avohilmo

6659

25488

1.39

117.40

2.2

366.34

381.35

nmol/l

6.97

6092

23534

Dental pulpitis 4

6667

25526

1.39

117.28

2.2

366.52

381.32

nmol/l

6.78

6097

23572

Senile cataract

3286

13251

1.60

116.73

2.3

2.4

361.92

375.11

nmol/l

2.37

3008

12242

Statin medication

4362

16809

1.50

116.53

2.1

2.3

361.02

371.74

nmol/l

2.83

4005

15601

ILD, hospital admissions 1, main diag only

819

3560

2.55

116.49

2.1

2.2

344.63

374.81

nmol/l

2.88

770

3243

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

846

3723

2.49

115.93

6.8

1.8

374.50

366.19

nmol/l

0.63

810

3355

Benign neoplasm of colon, rectum, anus and anal canal

3217

19113

1.58

115.77

2.3

364.71

376.54

nmol/l

2.71

2953

17526

Substance use, excluding alcohol

1266

6508

2.09

115.70

2.3

2.2

365.03

371.27

nmol/l

0.45

1131

6001

Cerebral cysts

478

1607

3.51

115.61

2.3

2.0

393.37

373.42

nmol/l

0.59

446

1472

Disorders of skin appendages

2874

18537

1.62

115.55

2.3

2.2

371.00

374.50

nmol/l

0.40

2632

17089

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

872

3900

2.44

115.11

4.6

1.8

386.61

367.66

nmol/l

2.11

839

3517

Malignant melanoma, excluding all cancers (controls excluding all cancers)

972

4543

2.32

114.77

6.3

1.8

377.14

368.06

nmol/l

0.69

927

4084

Diaphragmatic hernia

2031

12071

1.78

114.57

2.2

362.86

378.77

nmol/l

2.72

1835

11026

Other chronic obstructive pulmonary disease, including avohilmo

2737

14453

1.64

114.25

2.5

2.3

353.81

377.82

nmol/l

6.14

2487

13253

Gout

1351

6429

2.02

114.11

2.1

2.5

349.71

388.29

nmol/l

8.81

1251

5887

Sulfasalazine

1624

9059

1.89

113.51

2.0

2.2

343.84

391.72

nmol/l

21.29

1509

8295

Diabetes insipidus

163

251

12.09

113.45

5.3

1.7

299.38

382.50

nmol/l

4.31

153

232

Bacterial pneumoniae

2200

11770

1.73

112.96

2.4

2.2

367.11

379.21

nmol/l

1.45

2041

10765

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

572

2142

3.05

112.38

2.4

2.1

343.16

375.50

nmol/l

3.54

523

1939

Hypoparathyroidism

342

960

4.50

112.17

2.5

1.9

317.83

381.84

nmol/l

3.21

317

871

Asthma and allergy, excluding more controls

867

3842

2.40

112.01

2.3

1.9

338.96

386.23

nmol/l

10.73

808

3570

Fungal Sepsis

325

876

4.58

111.88

2.8

2.1

339.56

368.98

nmol/l

1.35

301

802

Elevated blood glucose level

608

2358

2.94

111.65

2.5

2.2

376.08

369.20

nmol/l

0.30

555

2166

Asthma and allergy

866

3851

2.39

110.94

2.3

1.9

339.31

385.95

nmol/l

10.45

807

3580

Focal epilepsy, mode (most common among epilepsy diagnosis)

1174

5979

2.12

110.50

2.3

2.2

373.33

370.52

nmol/l

0.18

1081

5497

Hypertensive heart and/or renal disease

1244

4890

2.08

110.45

2.2

2.4

365.55

383.04

nmol/l

1.62

1135

4464

Injury, poisoning and certain other consequences of external causes

3563

11832

1.56

110.21

2.1

2.2

369.07

381.91

nmol/l

3.06

3276

10916

Myocarditis

343

951

4.11

110.05

2.3

2.1

357.68

372.52

nmol/l

0.59

324

881

Implicit fungal Sepsis

305

798

4.77

109.72

2.8

2.0

338.46

369.66

nmol/l

1.40

282

731

Chronic gastritis

1517

8387

1.92

109.66

2.2

363.97

380.97

nmol/l

2.46

1356

7665

Ulcer of lower limb, not elsewhere classified

827

3698

2.46

109.58

2.2

367.66

376.41

nmol/l

0.53

758

3369

Other arthrosis

2831

12993

1.62

109.56

2.2

2.4

360.67

381.27

nmol/l

5.96

2591

11983

Viral pneumonia

788

3463

2.49

108.45

2.6

2.2

339.46

376.57

nmol/l

5.02

716

3179

Symptoms and signs involving speech and voice

1909

11340

1.78

108.29

2.2

364.39

375.83

nmol/l

1.73

1748

10402

Alcohol use disorder, ICD-based

2289

14208

1.69

108.09

2.1

2.4

376.42

368.85

nmol/l

0.90

2091

13156

Polyarthrosis

1143

5544

2.12

108.02

2.2

2.3

357.80

392.61

nmol/l

5.84

1026

5050

Viral infections characterized by skin and mucous membrane lesions

2425

15303

1.66

107.26

2.4

2.2

353.32

373.31

nmol/l

5.18

2266

14069

Coagulation defects, purpura and other haemorrhagic conditions

1212

6315

2.07

107.11

2.3

2.2

354.95

372.06

nmol/l

1.90

1142

5789

Hyperhidrosis

281

700

4.90

107.08

2.1

1.8

346.05

386.59

nmol/l

2.30

258

637

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

648

2644

2.77

107.03

2.7

2.1

359.42

371.24

nmol/l

0.72

605

2417

Carpal tunnel syndrome

3410

20857

1.53

106.85

2.1

2.2

357.96

376.31

nmol/l

6.42

3108

19202

Testicular hypofunction

287

731

4.87

106.84

2.2

2.0

347.60

370.38

nmol/l

1.46

270

680

Deforming dorsopathies

1616

9179

1.86

106.75

2.2

352.90

385.59

nmol/l

7.92

1465

8452

Gastroduodenal ulcer

1355

7268

1.96

106.39

2.3

367.07

381.84

nmol/l

1.68

1242

6634

Bacterial intestinal infections, IBD co-morbidities

1099

5539

2.14

106.34

2.6

2.2

350.98

376.61

nmol/l

3.47

1019

5060

Hyperaldosteronism

275

691

5.16

105.66

2.4

2.0

324.87

373.81

nmol/l

2.97

261

637

Type 1 diabetes, definitions combined

760

3332

2.51

105.14

2.1

2.2

432.18

364.39

nmol/l

12.21

716

3096

Dental caries 3 and operation codes

5355

19894

1.42

104.77

2.2

365.37

380.84

nmol/l

5.91

4877

18402

Bacterial pneumonia (organism specified)

2386

13675

1.66

104.68

2.4

2.2

367.34

379.66

nmol/l

1.55

2217

12443

Bacterial pneumonia, not elsewhere classified

2058

11043

1.72

104.35

2.4

2.2

367.44

379.69

nmol/l

1.46

1912

10097

Eating disorder

725

3151

2.58

103.86

2.0

396.29

389.18

nmol/l

0.39

651

2901

Vasomotor and allergic rhinitis

2317

14356

1.66

103.73

2.2

2.1

357.64

379.14

nmol/l

6.64

2134

13299

Thyrotoxicosis

1554

8841

1.88

103.50

2.2

2.1

375.02

376.33

nmol/l

0.10

1423

8065

Heart failure and bmi 25plus

1817

7292

1.81

103.39

2.1

2.4

362.54

362.86

nmol/l

0.02

1646

6645

Sequelae of external causes of morbidity and mortality

1458

8137

1.91

103.29

2.4

2.2

367.20

376.52

nmol/l

0.90

1376

7449

Hard cardiovascular diseases

4207

18958

1.47

103.25

2.2

2.4

367.64

371.32

nmol/l

0.51

3853

17472

Type 1 diabetes, strict (exclude DM2)

756

3337

2.49

103.03

2.1

2.2

432.35

364.23

nmol/l

12.22

712

3101

Ulcerative colitis

1525

8636

1.88

102.54

2.3

2.2

332.10

373.18

nmol/l

14.01

1420

7955

Other complications of surgical and medical care, not elsewhere classified

682

2901

2.63

102.44

3.0

2.1

362.71

371.25

nmol/l

0.46

649

2652

Dental caries 1 and operation codes

5073

18754

1.43

102.06

2.2

364.76

381.72

nmol/l

6.68

4630

17328

Non-rheumatic valve diseases

2407

11049

1.65

101.92

2.2

2.4

381.34

372.98

nmol/l

0.86

2201

10153

Kela-code for severe mental illness

2218

13879

1.68

101.90

1.9

2.2

387.18

370.27

nmol/l

2.46

2021

12787

Non-small cell lung cancer, adenocarcinoma, helper endpoint

447

1549

3.34

101.81

5.6

2.2

413.44

370.49

nmol/l

3.57

434

1391

Non-small cell lung cancer, adenocarcinoma

447

1549

3.34

101.81

5.6

2.2

413.44

370.49

nmol/l

3.57

434

1391

Pain in thoracic spine

946

4586

2.23

101.69

2.4

2.2

353.06

382.03

nmol/l

4.26

875

4218

Valvular heart disease excluding rheumatic fever

2424

11176

1.65

101.24

2.2

2.4

381.40

372.24

nmol/l

0.99

2216

10274

Cholelithiasis, broad definition with cholecystitis

4873

24187

1.42

101.00

2.2

352.70

377.55

nmol/l

13.45

4468

22242

IBD patients in KELA-register

1460

8208

1.89

100.77

2.2

331.59

372.24

nmol/l

13.97

1358

7564

Acetic acid derivatives and related substances

1677

4888

1.86

100.64

2.0

2.2

369.84

399.58

nmol/l

5.47

1529

4509

COPD, hospital admissions

2239

11838

1.67

100.30

2.6

2.3

355.97

378.47

nmol/l

4.47

2027

10848

Arthrosis

4034

15426

1.48

100.22

2.1

2.3

355.11

379.78

nmol/l

11.85

3711

14214

Dental operations

3720

13043

1.51

99.79

2.2

368.02

381.52

nmol/l

3.51

3387

12023

COPD, early/later onset

2252

11915

1.67

99.52

2.6

2.3

356.57

378.47

nmol/l

4.29

2041

10920

Unknown and unspecified causes of morbidity

478

1721

3.08

99.42

2.5

2.0

340.60

380.90

nmol/l

5.01

453

1549

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1405

7844

1.91

99.39

2.1

2.4

340.60

369.19

nmol/l

6.54

1290

7295

Cholelithiasis

4702

23821

1.43

99.38

2.2

351.97

377.76

nmol/l

14.04

4313

21900

Hypertensive Heart Disease

1091

4510

2.08

98.83

2.3

2.4

366.80

382.52

nmol/l

1.20

989

4106

Intestinal stricture

1651

9659

1.81

98.65

2.5

2.2

379.74

374.23

nmol/l

0.36

1515

8821

Other problems related to primary support group, including family circumstances

869

4045

2.31

98.39

3.0

2.1

336.17

373.63

nmol/l

6.49

813

3752

Temporomandibular joint disorders, including avohilmo

2580

16851

1.60

98.08

2.1

370.31

379.00

nmol/l

1.46

2368

15520

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

660

2804

2.57

97.95

5.1

1.8

397.23

365.98

nmol/l

3.47

632

2516

Chronic pancreatitis

751

3386

2.44

97.78

2.4

2.3

382.50

369.01

nmol/l

0.89

702

3113

Disturbance of activity and attention

762

3417

2.43

97.67

2.0

2.1

363.99

377.99

nmol/l

1.24

707

3171

Postmenopausal osteoporosis with pathological fracture

448

1601

3.30

97.64

2.2

2.0

325.30

388.81

nmol/l

5.57

407

1426

Diseases of arteries, arterioles and capillaries

3411

17451

1.51

97.48

2.3

381.91

374.97

nmol/l

0.97

3122

15982

Dental caries 1

4555

16598

1.44

97.44

2.2

363.66

383.28

nmol/l

7.79

4157

15356

Cerebrovascular diseases

3828

19202

1.48

97.29

2.2

2.3

377.24

373.43

nmol/l

0.49

3476

17678

COPD related to multimorbidity

1902

9677

1.73

97.26

2.4

2.3

356.92

378.92

nmol/l

3.61

1717

8837

Dental caries, including avohilmo

4549

16585

1.44

97.12

2.2

363.51

383.23

nmol/l

7.86

4151

15343

Eating disorders

814

3818

2.35

96.58

1.9

2.0

396.14

385.79

nmol/l

0.71

736

3513

Kidney transplant status

420

1458

3.40

96.41

3.0

2.3

317.97

363.33

nmol/l

4.90

412

1362

Collagenous colitis

628

2656

2.67

96.19

2.7

2.1

355.60

372.66

nmol/l

1.22

590

2428

Suicide or other Intentional self-harm

1544

8947

1.83

96.05

2.1

2.2

372.21

372.12

nmol/l

0.01

1385

8255

Extracorporeal dialysis

442

1584

3.24

95.16

2.5

2.3

337.13

367.53

nmol/l

2.68

429

1462

Hernia

5329

26799

1.38

95.14

2.2

362.66

374.32

nmol/l

3.38

4895

24701

COPD, hospital admission 2, with asthma infections

1578

7790

1.82

94.86

2.6

2.3

349.00

378.88

nmol/l

5.24

1425

7120

Candidiasis

885

4319

2.25

94.78

2.6

2.1

351.72

375.89

nmol/l

2.64

811

3960

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1118

5917

2.04

94.39

2.0

2.2

374.88

374.43

nmol/l

0.02

1002

5460

Cervicobrachial syndrome

1277

7022

1.93

94.22

2.0

2.3

367.02

380.66

nmol/l

1.74

1177

6473

Inflammatory diseases of female pelvic organs

3723

19739

1.48

93.98

2.1

2.0

375.78

381.74

nmol/l

1.03

3384

18138

Benign neoplasm: Colon

2644

17153

1.57

93.77

2.3

363.21

377.62

nmol/l

3.18

2426

15707

Dental caries 3

4828

17896

1.42

93.55

2.2

364.34

382.03

nmol/l

6.90

4396

16578

Ulcerative colitis, NAS

925

4603

2.18

93.40

2.4

2.2

324.06

372.97

nmol/l

12.48

864

4231

Other disorders of skin and subcutaneous tissue, not elsewhere classified

877

4277

2.23

93.39

2.6

2.2

348.05

375.56

nmol/l

3.85

791

3905

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1817

10958

1.73

93.27

2.5

2.0

355.42

377.37

nmol/l

5.17

1679

10119

Chronic periodontitis

864

4187

2.23

93.10

2.7

2.3

366.47

373.54

nmol/l

0.42

805

3872

Fentanyl

557

2235

2.70

92.68

3.7

2.0

374.32

396.77

nmol/l

1.21

519

2005

Subjective visual disturbances

1443

8297

1.85

92.56

2.1

2.2

370.60

376.10

nmol/l

0.42

1319

7605

Other or unspecified ileus, impaction or obstruction

972

4909

2.11

92.42

2.5

2.3

390.92

382.27

nmol/l

0.38

884

4487

Crohn disease

881

4328

2.22

92.34

2.1

2.2

335.39

373.72

nmol/l

7.28

819

3974

Inflammatory bowel disease, strict (require KELA)

1460

8432

1.84

91.98

2.2

331.59

371.91

nmol/l

13.80

1358

7775

Disorders of ocular muscles, binocular movement, accommodation and refraction

2745

18266

1.55

91.92

2.4

2.2

364.65

375.57

nmol/l

2.16

2541

16833

Dental pulpitis 2

4071

14736

1.45

91.29

2.2

366.31

384.98

nmol/l

6.29

3709

13647

Enterocolitis due to Clostridium difficile

664

2926

2.50

91.25

2.6

2.1

343.43

377.88

nmol/l

3.45

613

2651

Emotional disorders starting during childhood or adolecense, excluding more controls

348

1075

3.58

91.19

2.2

2.0

385.95

394.85

nmol/l

0.29

317

1004

Purpura and other haemorrhagic conditions

855

4180

2.24

90.96

2.3

2.2

358.52

371.39

nmol/l

0.87

808

3821

Syndrome of inappropriate secretion of antidiuretic hormone

105

127

19.02

90.93

3.4

1.7

412.52

387.33

nmol/l

0.45

112

Other respiratory disorders and diseases

1068

5614

2.03

90.76

2.2

345.59

375.93

nmol/l

4.10

982

5099

Other diseases of the respiratory system

1068

5614

2.03

90.76

2.2

345.59

375.93

nmol/l

4.10

982

5099

Extrapyramidal and movement disorders

1935

12056

1.68

90.64

2.1

2.2

376.71

376.85

nmol/l

0.01

1757

11022

Dental pulpitis 2, only avohilmo

4156

15115

1.45

90.54

2.2

366.04

384.83

nmol/l

6.43

3786

13998

Other enthesopathies

1657

9934

1.75

89.93

2.2

2.3

355.23

379.59

nmol/l

5.63

1514

9180

Agranulocytosis

735

3415

2.39

89.82

2.6

2.2

375.10

371.41

nmol/l

0.15

696

3127

Seropositive rheumatoid arthritis

1403

8032

1.84

89.49

1.9

2.3

333.79

388.43

nmol/l

19.58

1308

7351

Hyperkinetic disorders

799

3783

2.29

89.40

2.0

2.1

364.52

375.53

nmol/l

0.91

742

3509

Disorders of conjunctiva

4771

29579

1.39

89.14

2.3

2.2

357.80

378.34

nmol/l

10.92

4404

27251

Giant cell arteritis

328

1034

3.82

89.07

2.2

2.1

344.89

382.35

nmol/l

2.68

298

929

Injuries to the abdomen, lower back, lumbar spine and pelvis

2131

13545

1.63

88.68

2.2

356.39

380.16

nmol/l

5.72

1939

12360

Dental pulpitis 4, only avohilmo

6592

26399

1.33

88.65

2.2

365.43

380.90

nmol/l

7.46

6041

24377

Direct fill therapy

891

4466

2.18

88.64

3.0

2.2

357.59

368.42

nmol/l

0.74

829

4132

Biological medication for rheuma

1035

5464

2.05

88.37

2.1

2.2

317.45

371.81

nmol/l

17.71

988

5046

Urticaria

1823

11295

1.70

87.96

2.3

2.1

351.74

375.54

nmol/l

5.89

1690

10383

Soft tissue disorders related to use, overuse and pressure

1433

8318

1.82

87.80

2.2

2.3

359.51

382.58

nmol/l

3.85

1325

7664

Gonarthrosis [arthrosis of knee](FG)

3981

16704

1.44

87.63

2.1

2.4

356.82

380.72

nmol/l

11.39

3635

15393

Other and unspecified drugs and medicaments

590

2531

2.63

87.62

2.8

2.1

359.25

370.78

nmol/l

0.64

553

2309

Cutaneous abscess, furuncle and carbuncle

1484

8735

1.80

87.06

2.4

2.2

359.02

372.12

nmol/l

1.68

1393

8036

Mixed and other personality disorders

595

2566

2.59

86.93

2.0

2.1

364.45

370.73

nmol/l

0.35

533

2399

Other diseases of anus and rectum

1536

9093

1.77

86.91

2.3

2.2

355.56

381.31

nmol/l

5.40

1410

8324

Benign neoplasm of meninges

624

2742

2.52

86.90

2.8

1.8

368.90

369.25

nmol/l

0.01

579

2458

Gout, FINNGEN

1351

7729

1.84

86.70

2.1

2.4

349.71

380.24

nmol/l

6.07

1251

7047

Sequelae with surgical and medical care as external cause

1143

6257

1.96

86.69

2.3

2.2

367.82

375.45

nmol/l

0.56

1078

5717

Dental pulpitis 1, only avohilmo

6592

26485

1.33

86.66

2.2

365.62

380.82

nmol/l

7.22

6036

24457

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

491

1936

2.83

86.39

2.2

1.8

370.35

365.78

nmol/l

0.17

459

1735

Rheumatoid arthritis, including avohilmo

2135

13781

1.62

86.14

1.9

2.2

341.10

378.51

nmol/l

14.48

1989

12567

Unspecified kidney failure

552

2295

2.64

86.08

2.5

2.2

362.17

376.27

nmol/l

0.83

520

2069

Diseases of the myoneural junction and muscle

731

3437

2.33

85.96

2.3

2.2

359.61

370.15

nmol/l

0.69

664

3143

Biological medicines for asthma

179

385

6.83

85.86

3.2

1.9

262.17

374.29

nmol/l

12.34

174

356

Injuries to the thorax

2320

15263

1.58

85.03

2.1

2.3

364.32

375.05

nmol/l

1.67

2132

13989

Coronary atherosclerosis

3431

15512

1.47

85.00

2.1

2.4

367.26

374.67

nmol/l

1.20

3152

14251

Problems related to lifestyle

661

2992

2.41

84.88

2.2

365.41

377.12

nmol/l

0.74

605

2723

Dialysis

327

1058

3.68

84.80

3.0

2.3

330.50

358.96

nmol/l

1.81

320

987

Exposure to other specified factors

4162

28607

1.40

84.24

2.1

2.2

363.02

375.02

nmol/l

3.50

3790

26465

Other eating disorders

439

1674

3.02

83.93

1.9

2.0

390.01

392.97

nmol/l

0.10

394

1536

Disorders of pituitary gland, other and/or unspecified

108

147

14.00

83.69

5.8

1.8

297.22

389.55

nmol/l

3.74

102

135

Nonalcoholic fatty liver disease

630

2832

2.48

83.68

2.0

2.2

344.68

369.91

nmol/l

2.63

580

2601

Obsessive-compulsive disorder

466

1820

2.85

83.51

1.9

2.0

395.75

381.62

nmol/l

0.70

419

1690

Gastric ulcer

930

4800

2.06

83.21

2.2

2.3

368.04

382.74

nmol/l

1.29

848

4372

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

578

2501

2.53

82.54

5.1

1.8

394.56

363.87

nmol/l

3.01

552

2251

Missing teeth due to accident, extraction or parodontitis

701

3292

2.32

82.50

3.0

2.2

374.46

376.01

nmol/l

0.07

642

3043

Injuries to the knee and lower leg

6893

30810

1.31

82.45

2.2

357.69

379.21

nmol/l

15.47

6365

28391

Paracetamol of NSAID medication

1085

2816

2.01

82.23

2.0

2.2

381.14

394.72

nmol/l

1.16

1004

2621

Oxicams

1326

4214

1.87

81.96

2.2

359.49

397.10

nmol/l

7.68

1217

3881

Internal derangement of knee

2023

12983

1.61

81.66

2.2

2.4

358.59

382.52

nmol/l

6.86

1855

11966

Early onset COPD

1200

6784

1.88

81.14

2.6

2.3

350.98

371.59

nmol/l

2.19

1082

6272

Delirium, not induced by alcohol and other psychoactive substances

608

2701

2.44

81.11

2.1

395.49

380.56

nmol/l

0.87

558

2453

Viral and other specified intestinal infections

1291

7263

1.83

81.00

2.5

1.9

363.99

382.17

nmol/l

2.54

1202

6673

Menorrhagia

2179

7739

1.63

80.95

2.0

2.1

369.23

383.91

nmol/l

2.66

1958

7076

Eosinophilic disease (BM)

156

305

6.67

80.78

3.1

2.1

316.88

364.57

nmol/l

2.37

151

286

Other extrapyramidal and movement disorders in other diseases

1239

7092

1.86

80.74

2.1

2.2

364.32

376.14

nmol/l

1.28

1132

6494

Other and unspecified effects of external causes

1644

10148

1.71

80.52

2.3

2.2

362.77

373.93

nmol/l

0.98

1526

9342

TMD related operations

1053

5776

1.96

79.72

2.3

2.2

363.08

371.91

nmol/l

0.63

954

5325

Abnormal results of function studies

563

2460

2.54

79.57

2.3

2.1

374.05

369.28

nmol/l

0.19

517

2258

Monoamine oxidase A inhibitors

682

3203

2.30

79.51

2.2

2.4

351.60

379.27

nmol/l

3.35

628

2965

Other pleural conditions

570

2493

2.50

79.36

2.7

2.2

396.31

376.76

nmol/l

0.92

531

2256

Ovarian cyst

2277

8616

1.59

78.56

2.0

2.1

366.93

387.66

nmol/l

4.97

2088

7885

Arthropathies in other diseases classified elsewhere

291

918

3.75

78.40

2.3

2.2

386.65

378.75

nmol/l

0.20

276

840

Drug-induced osteoporosis with pathological fracture

177

405

6.18

78.39

3.1

2.0

277.44

371.30

nmol/l

4.35

169

371

Type 1 diabetes, strict definition, subgroup 1

584

2602

2.47

78.18

1.8

2.2

444.41

364.67

nmol/l

11.75

546

2424

Pain associated with micturition

719

3485

2.25

78.12

2.0

2.2

374.52

376.10

nmol/l

0.07

652

3195

Other disorders of white blood cells

403

1529

3.03

77.88

2.7

2.2

338.02

369.19

nmol/l

2.59

385

1399

Gonarthrosis

3403

13813

1.45

77.78

2.1

2.4

357.15

380.51

nmol/l

9.42

3107

12718

COPD, hospital admissions 3, with asthma pneumonia sepsis

1272

6234

1.82

77.56

2.6

2.2

345.74

379.61

nmol/l

5.10

1150

5671

Benign neoplasm: Cerebral meninges

562

2482

2.51

77.47

2.8

1.7

372.62

369.71

nmol/l

0.11

522

2227

Immunodeficiencies

387

1449

3.12

77.33

3.3

2.1

327.91

369.16

nmol/l

3.62

362

1341

Abnormal involuntary movements

793

4005

2.15

76.90

2.2

2.3

365.13

376.65

nmol/l

0.86

729

3664

Type 1 diabetes, strict definition

607

2766

2.41

76.84

1.8

2.2

441.31

364.35

nmol/l

11.62

569

2580

Temporal arteritis

288

920

3.77

76.63

2.2

2.0

338.99

385.26

nmol/l

3.49

260

824

Disorders of sclera, cornea, iris and ciliary body

2952

20796

1.47

76.62

2.3

2.2

360.17

374.97

nmol/l

4.12

2731

19094

Conduction disorders

1426

7070

1.75

76.31

2.3

2.4

363.69

377.81

nmol/l

1.33

1295

6457

Dental caries 3, only avohilmo

4825

18481

1.37

76.31

2.1

2.3

363.98

381.75

nmol/l

6.86

4387

17125

Voice disturbances

1493

9125

1.73

76.30

2.3

2.2

358.49

374.28

nmol/l

2.48

1370

8387

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5274

26237

1.34

76.15

2.2

2.3

364.16

373.23

nmol/l

2.41

4891

24149

Dental caries 1, only avohilmo

4542

17250

1.38

75.94

2.2

2.3

363.87

382.60

nmol/l

7.21

4144

15966

Conjunctivitis

4305

28062

1.37

75.79

2.3

2.1

358.45

377.71

nmol/l

9.00

3976

25859

All influenza (not pneumonia)

863

4499

2.05

75.36

2.4

2.2

349.70

371.99

nmol/l

2.43

803

4139

Hirsutism in women

213

573

4.84

75.09

2.2

1.9

369.10

380.61

nmol/l

0.33

194

538

Vasculitis limited to skin, not elsewhere classified

236

677

4.35

74.98

2.9

2.0

317.67

374.65

nmol/l

4.13

222

621

Disorders of vestibular function (Vertigo)

2431

16480

1.52

74.96

2.1

2.2

358.88

378.69

nmol/l

5.64

2194

15104

Malignant melanoma

817

4209

2.10

74.75

6.5

2.1

376.69

371.74

nmol/l

0.28

779

3848

Respiratory insufficiency

399

1507

2.86

74.72

2.0

2.1

331.46

379.58

nmol/l

3.70

364

1361

Sicca syndrome [Sjögren]

584

2668

2.44

74.71

2.1

353.16

379.60

nmol/l

1.58

545

2425

Cellulitis

1205

6992

1.83

74.56

2.4

2.2

365.04

372.80

nmol/l

0.56

1127

6415

Social phobias

549

2444

2.45

73.49

2.0

380.08

376.34

nmol/l

0.15

489

2276

Hypertrichosis

231

667

4.40

73.20

2.1

1.9

362.05

383.86

nmol/l

0.82

211

620

Zoster [herpes zoster]

973

5345

1.94

72.81

2.3

2.2

361.40

378.85

nmol/l

1.64

895

4889

Benign neoplasm of other and ill-defined parts of digestive system

914

4921

1.98

72.68

2.5

1.8

363.49

367.60

nmol/l

0.24

824

4438

Viral hepatitis, IBD co-morbidity

276

861

3.46

72.59

2.3

2.4

353.96

393.77

nmol/l

2.61

251

796

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

355

1305

3.10

72.39

2.7

1.9

334.91

357.65

nmol/l

0.51

336

1188

Giant cell arteritis with polymyalgia rheumatica

288

954

3.62

72.23

2.2

2.0

338.99

381.85

nmol/l

3.11

260

856

Injuries to the ankle and foot

3920

26565

1.38

71.96

2.2

367.96

373.90

nmol/l

1.01

3610

24581

Malignant melanoma of skin

661

3206

2.25

71.87

7.2

2.1

373.08

369.74

nmol/l

0.18

634

2927

Cholecystectomy

3762

24579

1.39

71.86

2.2

354.43

377.54

nmol/l

9.47

3466

22536

Ovarian dysfunction

535

2395

2.48

71.55

2.4

1.7

365.72

391.60

nmol/l

1.78

499

2190

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

455

1893

2.67

71.54

2.9

1.8

340.15

362.82

nmol/l

0.69

434

1711

Hypermobility syndrome

426

1742

2.79

70.76

2.3

2.0

357.30

383.56

nmol/l

1.88

401

1603

Tumor necrosis factor alpha inhibitors

901

4894

1.98

70.50

2.1

2.2

317.91

372.25

nmol/l

15.36

862

4520

Glomerulonephritis

626

2999

2.29

70.45

2.6

2.3

325.43

368.74

nmol/l

6.48

596

2758

Persons with potential health hazards related to communicable diseases

2263

15312

1.52

70.03

2.3

2.1

359.42

375.50

nmol/l

3.10

2168

14119

Other and unspecified vasculitis limited to skin

217

620

4.38

69.48

3.0

2.0

318.32

376.78

nmol/l

4.06

207

571

Postprocedural disorders of nervous system

525

2366

2.47

69.35

2.3

2.0

365.99

374.36

nmol/l

0.48

494

2188

Transport accidents

2510

15428

1.49

69.31

2.0

2.3

376.97

378.09

nmol/l

0.08

2332

14243

Immunodeficiency with predominantly antibody defects

246

764

3.99

69.29

3.4

2.0

322.17

370.47

nmol/l

2.93

229

707

Endometriosis

2107

8303

1.57

69.16

2.0

2.1

377.53

385.86

nmol/l

1.07

1942

7604

Diabetic retinopathy, excluding more controls

1572

5506

1.71

68.97

1.9

2.3

384.09

373.12

nmol/l

1.13

1438

5019

Benign intracranial hypertension

127

243

7.55

68.94

2.4

1.9

378.72

384.83

nmol/l

0.10

120

223

Benign neoplasm of meninges

624

3017

2.28

68.91

2.8

2.1

368.90

374.15

nmol/l

0.23

579

2740

Hernia of abdominal wall

2306

15850

1.51

68.50

2.3

360.17

374.18

nmol/l

2.24

2133

14589

Disorders of adrenal gland, other and/or unspecified

116

14.00

68.38

5.7

1.7

298.18

383.81

nmol/l

1.08

104

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2588

12272

1.48

68.21

3.7

1.8

375.50

366.48

nmol/l

1.34

2394

11107

Chronic ulcer of skin, not elsewhere classified

424

1749

2.70

68.18

2.7

2.1

342.11

378.41

nmol/l

2.84

387

1581

Visual field defects

525

2378

2.43

68.10

3.4

2.1

357.00

371.77

nmol/l

0.43

482

2169

Other diseases of lip and oral mucosa

890

4852

1.95

68.07

2.7

2.2

364.91

376.03

nmol/l

0.89

825

4488

Other disorders starting during childhood or adolecense, excluding more controls

330

1153

3.06

67.65

2.3

2.1

354.59

368.91

nmol/l

0.63

306

1075

L01XE Protein kinase inhibitors

393

1582

2.85

67.62

5.6

2.2

402.90

370.02

nmol/l

2.82

384

1445

Thyrotoxicosis with diffuse goitre

810

4297

2.02

67.61

2.1

2.0

373.72

377.31

nmol/l

0.20

743

3955

Pacemaker

1497

9133

1.66

67.40

2.1

2.2

374.17

382.76

nmol/l

0.74

1360

8270

Dental operations, only avohilmo

3841

14510

1.39

67.21

2.2

2.3

367.38

380.56

nmol/l

3.47

3491

13385

Disorder of lipoprotein metabolism, unspecified

652

3205

2.17

67.09

2.6

2.3

359.83

370.06

nmol/l

0.58

589

2923

Fracture of lumbar spine and pelvis

1100

6398

1.81

67.01

2.2

2.1

360.68

382.14

nmol/l

2.29

994

5769

Allergic rhinitis

1841

12066

1.58

66.27

2.2

2.1

357.24

373.65

nmol/l

3.34

1692

11137

Fracture of rib(s), sternum and thoracic spine

1454

9145

1.66

65.45

2.2

2.3

362.67

375.02

nmol/l

1.38

1317

8371

Spondylolisthesis/Spondylolysis

963

5439

1.87

65.29

2.1

2.3

354.04

383.24

nmol/l

4.43

872

5016

Schizophrenia, schizotypal and delusional disorders

1787

11792

1.58

65.14

1.8

2.2

390.62

370.85

nmol/l

3.56

1638

10876

Mixed connective tissue disease

463

2040

2.56

65.11

2.1

365.24

371.14

nmol/l

0.18

439

1860

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

326

1223

3.10

64.92

2.0

2.2

383.12

359.80

nmol/l

1.56

314

1155

Diseases of inner ear

2748

19264

1.44

64.91

2.1

2.2

361.22

377.64

nmol/l

4.10

2487

17677

Iron deficiency anaemia secondary to blood loss (chronic)

860

4708

1.94

64.91

2.2

2.1

368.16

379.49

nmol/l

0.71

781

4277

Schizophrenia or delusion

1780

11747

1.58

64.87

1.8

2.2

390.85

370.75

nmol/l

3.66

1633

10835

Dissociative [conversion] disorders

298

1061

3.22

64.71

2.2

1.9

364.63

385.51

nmol/l

0.92

272

982

Diabetic nephropathy, excluding more controls

885

4073

1.96

64.62

1.9

2.3

381.07

372.10

nmol/l

0.62

824

3698

Peripheral artery disease

2005

10836

1.54

64.52

2.2

2.3

380.22

379.63

nmol/l

0.04

1825

9858

Thrombocytopenia, unspecified

451

1965

2.56

64.50

2.2

2.1

350.86

371.60

nmol/l

1.30

430

1799

Cluster headache, strict

259

856

3.47

63.90

2.3

2.1

339.58

378.62

nmol/l

2.91

239

797

Open wound of head

2597

18164

1.45

63.89

2.2

2.3

378.76

371.91

nmol/l

0.90

2371

16730

Angina pectoris

2888

13982

1.44

63.78

2.1

2.4

369.93

375.84

nmol/l

0.69

2654

12828

Cluster headache, wide

272

925

3.35

63.75

2.3

2.1

336.55

379.74

nmol/l

3.52

251

859

SLE (Finngen)

261

871

3.47

63.71

2.1

2.0

346.27

381.71

nmol/l

1.94

237

797

Total colectomy operation

315

1171

3.11

63.57

2.9

2.1

354.60

372.31

nmol/l

0.75

300

1085

Total colectomy

315

1171

3.11

63.57

2.9

2.1

354.60

372.31

nmol/l

0.75

300

1085

Neuromuscular dysfunction of bladder

525

2440

2.34

63.49

2.2

364.42

375.66

nmol/l

0.61

481

2225

Unspecified fall

2534

17820

1.46

63.43

2.1

2.2

365.53

376.11

nmol/l

1.74

2336

16309

Enthesopathies of lower limb, excluding foot

1168

7015

1.75

63.28

2.1

2.3

359.29

380.62

nmol/l

2.99

1066

6473

Papulosquamous disorders

2064

14122

1.52

63.05

2.2

354.00

372.41

nmol/l

3.76

1884

12985

Presence of cardiac and vascular implants and grafts

2035

10402

1.53

62.84

2.0

2.4

378.98

380.94

nmol/l

0.14

1849

9517

Other disorders of ear

4894

25327

1.32

62.81

2.2

2.3

363.11

374.10

nmol/l

3.35

4463

23367

Speech and linguistic disorders, excluding more controls

466

1934

2.44

62.64

2.7

2.1

342.51

373.86

nmol/l

2.65

430

1789

Other diseases of intestine

634

3173

2.14

62.52

2.7

2.4

373.24

377.75

nmol/l

0.16

593

2922

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

663

3375

2.10

62.25

2.3

1.8

370.43

366.97

nmol/l

0.17

630

3024

Fenamates

883

3244

1.93

62.17

2.3

2.2

365.23

402.29

nmol/l

5.85

813

2982

Other specified and unspecified personality disorders

595

2934

2.21

61.98

2.1

358.15

374.37

nmol/l

1.34

535

2718

Other disorders of bladder

610

3023

2.16

61.82

2.3

341.96

372.12

nmol/l

2.88

551

2775

Use of pramipexole

1143

6889

1.75

61.76

2.1

2.2

357.70

377.56

nmol/l

2.91

1044

6285

Heartburn

572

2771

2.22

61.67

2.1

2.2

359.64

385.88

nmol/l

2.28

517

2557

Other and unspecified mood [affective] disorders

458

2039

2.45

61.46

2.0

2.1

401.86

381.54

nmol/l

1.26

422

1887

FESS (DNB20)

749

4009

2.01

61.40

2.6

2.2

327.17

368.88

nmol/l

5.63

700

3706

Chronic diseases of tonsils and adenoids

4463

21734

1.33

61.07

2.2

370.20

378.55

nmol/l

2.06

4125

20145

AV-block

792

3872

1.95

61.02

2.3

2.4

364.77

379.18

nmol/l

1.05

713

3518

Ethmoidectomy

772

4182

1.99

60.93

2.6

2.2

324.82

370.59

nmol/l

6.86

722

3865

Benign neoplasm: Cerebral meninges

562

2742

2.25

60.71

2.8

2.1

372.62

371.13

nmol/l

0.05

522

2492

Gout, idiopatic and unspecified

1106

6625

1.75

60.57

2.1

2.4

349.39

375.72

nmol/l

3.77

1017

6081

Other symptoms and signs involving the circulatory and respiratory systems

380

1566

2.66

60.56

2.4

2.2

355.11

383.60

nmol/l

2.05

357

1432

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

286

1033

3.17

60.52

5.9

1.8

384.83

362.26

nmol/l

1.10

277

928

Adverse effects, not elsewhere classified

1156

7032

1.74

60.49

2.5

2.2

355.16

372.94

nmol/l

2.11

1074

6464

Diseases of salivary glands

1037

6116

1.79

60.35

2.4

2.1

362.30

376.95

nmol/l

1.63

950

5661

Special screening examination for infectious and parasitic diseases

1273

5817

1.69

60.32

1.9

2.0

386.37

379.72

nmol/l

0.57

1104

5440

Intestinal malabsorption

334

1314

2.91

60.20

2.4

2.0

374.06

372.09

nmol/l

0.06

313

1207

Chronic laryngitis and laryngotracheitis

775

4210

1.96

60.16

2.3

2.2

335.00

380.52

nmol/l

7.65

701

3869

Other and unspecified myopathies

486

2241

2.37

60.15

2.2

2.1

357.87

371.52

nmol/l

0.69

433

2039

Short stature, not elsewhere classified

226

675

3.86

60.14

2.7

2.5

320.22

350.39

nmol/l

1.57

220

639

Benign neoplasm: Colon, unspecified

1073

6350

1.76

60.11

2.4

1.8

356.02

367.78

nmol/l

1.12

979

5686

Brachial plexus disorders

591

2940

2.18

60.05

2.2

369.59

371.89

nmol/l

0.11

550

2725

Adalimumab

583

2892

2.20

60.04

2.1

314.06

372.84

nmol/l

12.70

558

2676

Malignant neoplasm of urinary organs

536

2569

2.27

59.98

5.1

2.2

396.92

371.02

nmol/l

2.29

516

2333

Noninflammatory disorders of female genital tract

2606

9245

1.46

59.97

2.0

2.1

382.17

390.43

nmol/l

1.13

2376

8458

Other shoulder lesions

550

2660

2.24

59.90

2.3

2.2

363.95

379.78

nmol/l

1.03

504

2449

Childhood asthma (age<16), excluding more controls

774

3276

1.97

59.80

2.0

1.8

376.55

394.11

nmol/l

1.53

716

3050

Preparation and fitting of bite rail to mouth

835

4667

1.92

59.65

2.3

2.2

362.54

372.31

nmol/l

0.60

758

4321

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1632

10775

1.58

59.50

2.3

2.2

355.55

375.40

nmol/l

3.90

1494

9894

Carbimazole or st.post thyroidectomy, condition for graves disease

1190

7328

1.72

59.40

2.3

2.2

373.01

375.54

nmol/l

0.15

1097

6715

Trochanteric bursitis

748

4034

1.98

59.40

2.2

354.40

388.67

nmol/l

4.91

686

3681

Stroke, including SAH

2995

16219

1.40

59.30

2.1

2.3

380.12

374.16

nmol/l

0.78

2718

14907

Pneumonia due to other infectious organisms, not elsewhere classified

233

761

3.56

59.11

2.4

2.1

360.53

363.37

nmol/l

0.05

223

703

Crohn's disease NAS

444

1995

2.47

59.05

2.1

319.13

374.64

nmol/l

8.32

416

1841

Abnormal findings on diagnostic imaging of central nervous system

328

1291

2.91

59.04

2.6

2.1

362.08

376.52

nmol/l

0.64

309

1187

Other viral diseases

1673

11096

1.57

58.99

2.5

2.2

350.18

372.96

nmol/l

5.02

1560

10243

Crohn's disease of small intestine

465

2131

2.41

58.95

2.2

2.1

339.97

376.71

nmol/l

3.69

434

1963

Other specified/unspecified systemic involvement of connective tissue

409

1782

2.58

58.90

2.0

2.1

366.84

374.94

nmol/l

0.23

387

1623

Transient ischemic attack

2448

14427

1.45

58.60

2.2

2.3

375.47

377.19

nmol/l

0.13

2225

13208

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

738

3982

1.98

58.58

2.1

2.3

369.19

368.53

nmol/l

0.02

684

3648

Childhood asthma (age<16)

774

3302

1.95

58.47

2.0

1.8

376.55

394.00

nmol/l

1.51

716

3077

Suggestive for eosinophilic asthma

530

2556

2.25

58.44

2.7

2.1

294.99

379.32

nmol/l

22.15

494

2339

Nephrotic syndrome

256

897

3.38

58.20

3.4

2.3

310.47

362.16

nmol/l

3.69

248

835

Stroke, excluding SAH

2802

15120

1.42

58.16

2.1

2.3

380.89

375.13

nmol/l

0.70

2542

13878

Other dialysis

245

841

3.49

58.03

2.6

2.3

340.57

357.38

nmol/l

0.64

239

785

Meniscus derangement

2820

13996

1.41

57.93

2.2

2.4

358.02

380.49

nmol/l

7.94

2613

12907

Alcohol dependence

1343

8538

1.64

57.69

2.2

2.4

373.14

367.29

nmol/l

0.44

1221

7937

Pemphigoid

201

614

3.91

57.36

2.5

1.9

349.71

384.90

nmol/l

1.47

184

548

Adjustment and management of implanted device

847

4781

1.86

57.28

2.0

2.2

381.29

378.62

nmol/l

0.13

789

4282

Pruritus

644

3356

2.07

57.19

2.3

2.1

342.72

376.64

nmol/l

4.52

586

3065

Radiculopathy

833

4688

1.87

57.01

2.3

359.97

388.37

nmol/l

3.72

762

4304

Coxarthrosis [arthrosis of hip](FG)

2512

12976

1.44

56.98

2.2

2.5

363.29

384.93

nmol/l

5.39

2274

11921

Type of accident

1512

9919

1.59

56.89

2.3

2.2

356.28

375.54

nmol/l

3.47

1385

9097

Other Crohn's disease

467

2175

2.37

56.82

2.0

2.1

324.07

376.70

nmol/l

7.39

440

2011

Excessive attrition of teeth

2288

8673

1.48

56.81

2.2

2.1

361.27

374.57

nmol/l

2.59

2085

8088

Mucosal proctocolitis

756

4156

1.94

56.69

2.3

2.2

331.33

374.11

nmol/l

8.48

707

3824

Acute pancreatitis

974

5747

1.78

56.55

2.3

354.83

373.32

nmol/l

1.73

895

5294

Lung diseases due to external agents

677

3584

2.00

56.44

2.5

2.2

362.29

376.29

nmol/l

0.77

615

3267

Gout, unspecified

919

5342

1.81

56.39

2.1

2.4

352.91

376.46

nmol/l

2.60

854

4898

Diabetic retinopathy, strict definition

1085

5818

1.76

56.38

1.8

2.2

390.92

371.96

nmol/l

2.43

989

5338

Malignant neoplasm of kidney, except renal pelvis

494

2356

2.28

56.11

5.2

2.2

393.52

371.98

nmol/l

1.59

474

2142

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

946

5567

1.80

56.04

2.3

2.2

328.52

371.31

nmol/l

10.71

878

5117

Other (seronegative) rheumatoid arthritis, wide

1044

6314

1.75

55.82

1.9

2.2

337.59

377.69

nmol/l

8.00

962

5763

Extreme obesity with alveolar hypoventilation

283

1065

3.06

55.75

2.2

2.1

313.69

375.94

nmol/l

5.12

260

989

Traumatic subdural haemorrhage

539

2591

2.15

55.60

2.0

2.4

419.02

385.77

nmol/l

2.25

487

2392

Localized swelling, mass and lump of skin and subcutaneous tissue

1612

10783

1.56

55.22

2.6

2.2

372.67

374.42

nmol/l

0.13

1499

9903

Benign paroxysmal vertigo

1469

9660

1.59

54.91

2.1

2.2

353.45

380.18

nmol/l

6.42

1324

8824

Other symptoms and signs involving the urinary system

550

2747

2.15

54.85

2.6

2.2

350.17

371.33

nmol/l

1.77

514

2535

Mental and behavioural disorders due to sedatives or hypnotics

446

2073

2.37

54.55

2.4

2.1

358.30

370.76

nmol/l

0.64

385

1930

Eosinophilia

157

427

4.70

54.36

3.2

2.1

316.78

370.72

nmol/l

2.87

152

394

Ulcerative colitis (strict definition, require KELA)

969

5789

1.77

54.25

2.3

2.2

327.41

372.37

nmol/l

11.91

900

5325

Cervicocranial syndrome

605

3140

2.06

53.99

2.2

369.20

381.77

nmol/l

0.91

555

2893

Other degenerative diseases of the nervous system

1168

5457

1.68

53.95

1.8

2.4

392.62

387.78

nmol/l

0.33

1013

5035

Gout, strict definition

802

4546

1.86

53.83

2.0

2.3

351.04

376.82

nmol/l

2.54

738

4166

Other and unspecified urticaria

1134

7070

1.69

53.79

2.3

2.2

350.10

374.15

nmol/l

4.00

1042

6512

Oter anti-inflammatory and antirheumatic agents, non-steroids

1121

3735

1.72

53.72

2.1

2.3

355.84

398.70

nmol/l

9.44

1009

3453

Seronegative rheumatoid arthritis

651

3471

2.00

53.59

1.9

2.3

333.05

391.30

nmol/l

10.18

602

3158

Other and unspecified nerve root and plexus disorders, also in other diseases

978

5869

1.76

53.58

2.2

2.3

361.49

371.88

nmol/l

0.92

890

5421

Bullous pemphigoid

168

479

4.28

53.56

2.5

1.9

335.72

380.74

nmol/l

2.06

151

431

Coxarthrosis

2327

11224

1.44

53.52

2.2

2.5

362.27

384.07

nmol/l

4.99

2113

10309

Special screening examination for other diseases and disorders

457

2143

2.27

53.23

2.3

2.1

388.21

383.33

nmol/l

0.21

421

1969

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

287

1113

2.90

52.75

2.3

1.8

353.24

360.71

nmol/l

0.22

263

991

Ventral hernia

1205

7641

1.65

52.75

2.4

2.2

365.20

376.31

nmol/l

0.83

1109

7010

Diplopia

706

3892

1.94

52.54

2.4

2.1

356.54

373.51

nmol/l

1.43

653

3559

Stomatitis and related lesions

496

2430

2.21

52.37

2.8

2.1

363.70

377.99

nmol/l

0.88

455

2255

Injuries to the hip and thigh

2234

14634

1.44

52.23

2.1

2.2

369.02

378.28

nmol/l

0.97

2033

13344

Propionic acid derivatives

1638

5429

1.56

51.98

2.1

2.2

374.52

394.61

nmol/l

3.30

1491

5024

Bullous disorders

354

1526

2.58

51.95

2.4

2.1

348.32

372.02

nmol/l

1.43

329

1390

Erosion of teeth, including avohilmo

1131

6849

1.67

51.89

2.3

2.1

360.85

373.64

nmol/l

1.39

1039

6407

Disorders of magnesium metabolism

157

8.44

51.78

3.1

2.0

389.39

353.98

nmol/l

0.62

143

Spondyloarthritis

947

5678

1.75

51.69

2.2

2.1

345.74

379.40

nmol/l

5.70

877

5220

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1023

6278

1.72

51.56

2.3

2.2

329.03

372.24

nmol/l

11.41

950

5770

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

499

2471

2.20

51.55

3.4

1.8

378.36

364.45

nmol/l

0.33

473

2246

Organic, including symptomatic, mental disorders

2177

11157

1.45

51.53

1.9

2.2

388.21

380.08

nmol/l

1.01

1923

10188

Seropositive rheumatoid arthritis, wide

1401

9243

1.58

51.51

1.9

2.2

333.91

377.75

nmol/l

13.36

1307

8432

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

238

840

3.09

51.21

6.7

1.7

427.64

369.56

nmol/l

3.34

231

742

Other obstetric conditions, not elsewhere classified

1954

8849

1.49

51.06

2.0

374.09

384.75

nmol/l

1.57

1816

8183

Diseases of male genital organs

2491

9048

1.43

51.04

2.4

2.5

355.80

365.04

nmol/l

1.26

2293

8504

Neuralgia and neuritis, unspecified

321

1336

2.67

50.69

2.2

2.1

356.38

383.92

nmol/l

1.68

300

1225

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1911

8624

1.49

50.69

2.0

1.9

374.32

385.31

nmol/l

1.60

1777

7970

Drug-induced neutropenia

438

2087

2.32

50.60

2.9

2.2

368.47

367.14

nmol/l

0.04

421

1911

6-mercaptopurine

225

787

3.27

50.54

2.5

1.8

338.89

379.95

nmol/l

2.80

214

736

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1363

8986

1.58

50.33

1.9

2.2

332.56

376.80

nmol/l

13.25

1271

8209

Disorders of refraction and accommodation

1459

9718

1.56

50.32

2.3

2.2

363.94

374.22

nmol/l

1.18

1348

8971

Restless leg syndrome

681

3772

1.94

50.28

2.2

361.14

373.51

nmol/l

0.83

628

3445

Other abnormal uterine and vaginal bleeding

1256

5735

1.63

50.03

1.9

2.2

372.82

385.71

nmol/l

1.35

1127

5207

Other diseases of pericardium

262

994

2.94

50.02

2.9

2.3

328.90

363.73

nmol/l

2.20

249

910

COPD-related respiratory insufficiency

554

2860

2.06

50.01

2.2

2.3

321.56

376.76

nmol/l

7.36

499

2599

Fissure and fistula of anal and rectal regions

1215

7805

1.62

49.97

2.1

2.3

366.75

376.02

nmol/l

0.91

1096

7184

Other and unspecified nonorganic psychotic disorders

1091

6850

1.67

49.95

1.8

2.1

400.03

371.45

nmol/l

4.77

1004

6315

Vitamin deficiency

311

1287

2.70

49.94

2.2

2.1

375.21

380.17

nmol/l

0.14

281

1179

Vitamin deficiency, wide

311

1287

2.70

49.94

2.2

2.1

375.21

380.17

nmol/l

0.14

281

1179

Benign neoplasm of other and ill-defined parts of digestive system

914

5502

1.76

49.87

2.5

2.2

363.49

375.63

nmol/l

1.05

824

5028

Misadventures to patients during surgical and medical care

749

4269

1.87

49.80

2.7

2.1

376.82

372.21

nmol/l

0.23

693

3911

Disorders of muscles

545

2808

2.07

49.65

2.2

359.69

379.92

nmol/l

1.14

511

2582

Clear cell adenocarcinoma of kidney

286

1147

2.83

49.51

5.9

2.1

384.83

370.03

nmol/l

0.61

277

1050

Cardiomyopathy

804

4662

1.81

49.49

2.4

382.00

371.46

nmol/l

0.68

762

4305

Faecal incontinence

473

2323

2.19

49.46

2.1

355.57

391.60

nmol/l

2.94

426

2111

Correction of physiology of bite - demanding therapy visit

465

2286

2.24

49.44

2.4

2.1

358.78

375.71

nmol/l

0.83

418

2110

Abnormal findings on diagnostic imaging of other body structures

686

3823

1.92

49.40

2.5

2.1

378.30

374.53

nmol/l

0.16

642

3496

Fibrosis and cirrhosis of liver

427

2029

2.31

49.38

2.1

2.2

362.62

372.31

nmol/l

0.29

404

1856

Emotional disorders and disorders of social functioning with onset specific to childhood

373

1655

2.45

49.32

2.1

382.57

392.51

nmol/l

0.37

337

1537

Acidosis

150

418

4.31

49.17

2.3

2.2

397.16

360.02

nmol/l

1.00

135

384

Other inflammatory liver diseases

406

1896

2.36

49.13

2.8

2.1

344.68

374.77

nmol/l

2.45

382

1730

Anorexia (incl.atypical)

420

1989

2.31

48.90

1.9

2.0

424.74

382.86

nmol/l

3.63

379

1818

Other/unspecified seropositive rheumatoid arthritis

1374

9129

1.57

48.89

1.9

2.2

333.12

377.59

nmol/l

13.50

1282

8335

Status epilepticus

227

809

3.15

48.85

2.3

2.1

360.11

383.58

nmol/l

1.01

209

740

Other disorders of eye and adnexa

794

4638

1.82

48.65

2.2

2.1

375.58

373.39

nmol/l

0.10

727

4260

Injuries to the shoulder and upper arm

4249

28197

1.29

48.59

2.2

2.3

360.89

375.90

nmol/l

5.27

3908

25977

Injuries to the neck

1228

7976

1.61

48.56

2.1

2.2

370.44

374.27

nmol/l

0.24

1125

7344

Ascites

379

1722

2.39

48.47

2.5

2.3

425.00

379.13

nmol/l

2.05

366

1572

Malignant neoplasm of eye, brain and central nervous system

285

1151

2.79

48.46

2.7

2.1

329.73

366.77

nmol/l

2.79

271

1057

Polycystic ovarian syndrome

378

1725

2.42

48.45

2.3

1.7

359.87

390.20

nmol/l

2.37

350

1570

Asthma mixed form (mode), excluding more controls

297

1208

2.66

48.36

2.3

2.0

315.64

379.45

nmol/l

7.36

278

1111

Anankastic personality disorder

279

1119

2.83

48.33

2.0

2.1

365.02

369.26

nmol/l

0.16

257

1045

Explicit bacterial Sepsis

506

2562

2.10

48.23

2.5

2.2

362.65

372.89

nmol/l

0.39

475

2346

Parodontitis or operation codes

4653

27397

1.28

48.14

2.4

2.2

364.87

373.75

nmol/l

2.18

4237

25313

Abnormalities of gait and mobility

601

3239

1.98

48.07

1.9

2.3

372.07

372.16

nmol/l

0.00

557

2951

Other and unspecified local infections of skin and subcutaneous tissue

538

2803

2.07

47.95

2.6

2.2

357.89

368.46

nmol/l

0.55

504

2565

Malignant neoplasm of brain

238

887

3.08

47.81

2.5

2.1

324.87

369.42

nmol/l

3.19

225

817

Non-follicular lymphoma, hilmo, excluding all cancers

463

2285

2.18

47.74

2.1

1.8

371.45

364.53

nmol/l

0.31

443

2063

Other disorders of kidney and ureter

664

3702

1.91

47.71

2.4

2.3

351.86

369.94

nmol/l

1.51

627

3385

Artrosis, including avohilmo

4617

20132

1.28

47.68

2.1

2.3

355.56

376.14

nmol/l

9.16

4248

18636

Persons encountering health services for specific procedures, not carried out

444

2168

2.22

47.42

2.3

2.0

367.80

376.50

nmol/l

0.39

402

1982

Pneumocystosis

147

422

4.45

47.27

2.9

2.0

354.72

379.14

nmol/l

0.41

141

387

Psoriatic and enteropathic arthropathies

637

3510

1.93

47.27

2.1

2.4

335.54

382.40

nmol/l

6.60

589

3241

Agoraphobia

229

838

3.09

47.18

1.8

2.0

366.37

377.07

nmol/l

0.30

196

785

Parodontitis

4639

27399

1.27

47.06

2.4

2.2

364.96

373.76

nmol/l

2.14

4225

25315

Autoimmune hyperthyroidism

366

1663

2.40

46.99

2.1

375.95

380.65

nmol/l

0.19

340

1522

Disorders resulting from impaired renal tubular function

250

968

2.98

46.86

2.6

2.2

347.17

364.29

nmol/l

0.76

245

893

Complications of internal orthopaedic prosthetic devices, implants and grafts

1037

6526

1.66

46.84

2.2

365.09

381.92

nmol/l

1.06

937

5914

Other local infections of skin and subcutaneous tissue

563

3000

2.02

46.83

2.5

2.2

357.50

368.47

nmol/l

0.61

526

2750

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

541

2851

2.05

46.74

2.6

2.1

370.16

370.88

nmol/l

0.02

505

2605

Chronic periodontitis, including avohilmo

4617

27387

1.27

46.64

2.4

2.2

365.15

373.80

nmol/l

2.08

4204

25305

Spondylopathies (FG)

758

4409

1.81

46.63

2.3

339.22

381.60

nmol/l

7.44

704

4068

Atopic dermatitis

3032

19734

1.34

46.58

2.1

367.13

376.17

nmol/l

1.77

2767

18285

Cytomegalovirus infection, IBD co-morbidity

183

604

3.66

46.54

3.1

2.2

341.74

370.20

nmol/l

0.77

172

566

Alcohol abuse, main dg, excluding more controls

691

3906

1.85

46.47

2.1

2.4

371.02

371.32

nmol/l

0.01

637

3622

Chronic periodontitis, complicated

517

2694

2.07

46.19

2.6

2.3

363.82

369.00

nmol/l

0.23

484

2473

Psoriasis

1450

9859

1.53

45.99

2.2

352.50

372.11

nmol/l

2.99

1331

9068

Diabetic nephropathy

891

5402

1.74

45.81

1.9

2.2

380.72

375.01

nmol/l

0.36

829

4917

Acute pancreatitis (for exclusion)

974

6075

1.68

45.78

2.3

354.83

371.92

nmol/l

1.54

895

5577

Disorders of psychological development

704

3735

1.85

45.51

2.5

2.0

343.56

377.80

nmol/l

4.76

655

3452

Ischaemic Stroke, excluding all haemorrhages

2530

14221

1.38

45.49

2.1

2.3

383.95

376.15

nmol/l

0.79

2285

13038

Endometriosis of pelvic peritoneum

909

5514

1.71

45.35

2.1

2.2

379.29

380.80

nmol/l

0.08

836

5083

Crohn disease (strict definition, require KELA)

417

2033

2.25

45.25

2.0

2.1

337.61

375.21

nmol/l

3.93

388

1877

Atopic dermatitis, strict definition with reimbursement

1689

11480

1.48

45.24

2.3

2.1

360.65

378.94

nmol/l

3.26

1556

10612

Asthma mixed form (mode)

297

1249

2.57

45.06

2.3

2.0

315.64

382.16

nmol/l

7.91

278

1145

Malnutrition

173

565

3.74

45.00

2.2

2.1

393.77

368.64

nmol/l

0.66

164

515

Unspecified acute lower respiratory infection

785

4661

1.78

44.90

2.5

2.2

347.93

368.45

nmol/l

1.97

741

4286

Respiratory conditions due to other external agents

159

492

3.89

44.77

3.2

2.0

357.63

375.30

nmol/l

0.41

153

442

Crohn disease (strict definition, require KELA, min 2 HDR)

408

1982

2.26

44.70

2.0

2.1

336.21

375.52

nmol/l

4.18

379

1829

Cytomegaloviral disease

186

634

3.51

44.67

3.0

2.1

341.06

371.17

nmol/l

0.85

175

591

Anti-inflammatory and antirheumatic products, non-steroids

1595

5432

1.51

44.54

2.0

2.2

373.59

394.59

nmol/l

3.55

1457

5027

Other/unspecified cytomegaloviral diseases

160

501

3.91

44.54

3.1

2.0

333.93

366.24

nmol/l

0.82

151

468

Sequelae of injuries, of poisoning and of other consequences of external causes

1214

8017

1.58

44.45

2.1

2.2

370.58

368.03

nmol/l

0.16

1117

7390

1756

11684

1.46

44.38

2.6

2.2

373.75

382.27

nmol/l

0.84

1590

10593

Other disorders of optic [2nd] nerve and visual pathways

392

1885

2.29

44.22

3.0

2.1

380.98

372.49

nmol/l

0.16

367

1737

Deviated nasal septum

1560

10812

1.49

44.18

2.4

353.24

375.59

nmol/l

4.85

1430

10022

Hyperosmolality and hypernatraemia

107

252

5.21

44.17

2.5

2.0

363.34

370.53

nmol/l

0.12

100

227

Unspecified/other endometriosis

550

2960

1.98

44.16

2.0

2.1

388.76

382.86

nmol/l

0.27

508

2717

Strabismus

1427

9745

1.52

44.00

2.5

2.2

359.65

373.54

nmol/l

1.95

1325

8997

Wide developmental disorders, excluding more controls

195

669

3.23

43.91

2.2

337.81

361.57

nmol/l

1.02

188

628

Parodontitis and operation codes

4343

27094

1.27

43.85

2.4

2.2

364.11

373.92

nmol/l

2.45

3948

25044

Congenital malformations, deformations and chromosomal abnormalities

3206

23854

1.32

43.79

2.2

369.22

374.91

nmol/l

0.88

2966

22054

Other diseases of stomach and duodenum

354

1634

2.36

43.78

2.5

2.2

362.75

376.96

nmol/l

0.66

324

1493

Abnormal blood-pressure reading, without diagnosis

266

1085

2.70

43.72

2.1

2.2

353.35

377.93

nmol/l

1.12

235

996

Other ulcerative colitis

372

1760

2.32

43.66

2.6

2.2

325.81

374.04

nmol/l

5.00

352

1633

Dislocation, sprain and strain of joints and ligaments at neck level

856

5246

1.72

43.62

2.0

2.1

363.66

374.81

nmol/l

0.89

783

4834

Atypical facial pain

326

1465

2.47

43.59

2.4

2.1

370.60

372.85

nmol/l

0.05

289

1331

Mental and behavioural disorders due to tobacco

481

2505

2.08

43.14

2.3

2.2

364.27

370.00

nmol/l

0.20

433

2326

Systemic lupus erythematosus

261

1075

2.77

43.01

2.1

346.27

375.65

nmol/l

1.52

237

987

Pollen allergy

1093

7040

1.61

42.95

2.1

354.63

374.48

nmol/l

2.95

992

6530

Benign neoplasm: Sigmoid colon

779

4669

1.75

42.75

2.5

1.8

365.73

366.73

nmol/l

0.04

720

4201

Other diseases of pancreas

403

1976

2.21

42.72

2.3

372.95

366.79

nmol/l

0.23

377

1810

Drug-induced osteoporosis

119

318

4.90

42.64

3.0

1.8

317.39

367.94

nmol/l

0.68

109

291

Degeneration of macula and posterior pole

1991

11903

1.42

42.62

2.2

380.15

381.25

nmol/l

0.08

1778

10838

Smoking dependency

481

2516

2.07

42.60

2.3

2.2

364.27

370.54

nmol/l

0.22

433

2331

Other viral diseases, not elsewhere classified

1025

6580

1.63

42.41

2.7

2.2

344.34

370.07

nmol/l

4.34

968

6075

Multiple myeloma, excluding all cancers (controls excluding all cancers)

264

1092

2.69

42.40

2.2

1.8

386.38

363.19

nmol/l

0.94

252

971

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

433

2191

2.15

42.39

2.0

2.1

338.38

375.85

nmol/l

3.92

403

2022

Type1 diabetes, definitions combined, early onset

477

2488

2.07

42.27

1.9

2.2

438.00

361.33

nmol/l

12.49

446

2311

Disorders of tooth development and eruption

341

1531

2.37

42.24

4.2

2.0

310.58

369.61

nmol/l

6.48

323

1438

Other/unspecified rheumatoid arthritis

656

3777

1.84

42.23

2.0

2.1

327.87

380.06

nmol/l

8.32

604

3433

Chronic hepatitis, not elsewhere classified

239

952

2.87

42.18

2.2

2.1

356.57

377.07

nmol/l

0.43

223

874

Multiple myeloma and malignant plasma cell neoplasms

262

1083

2.69

42.14

2.2

1.8

388.70

362.76

nmol/l

1.10

250

962

Other diseases of jaws

400

1964

2.20

42.14

2.8

2.0

370.85

376.29

nmol/l

0.22

375

1817

Seborrhoeic dermatitis

506

2695

2.01

42.04

2.5

2.1

363.16

371.08

nmol/l

0.40

466

2466

Conjunctivitis (acute, non atopic)

1466

10139

1.50

41.90

2.3

2.2

358.11

375.30

nmol/l

2.76

1360

9344

Skin changes due to chronic exposure to nonionizing radiation

1630

10881

1.46

41.84

2.6

2.2

373.70

383.75

nmol/l

1.00

1473

9854

Autism spe, excluding more controls

147

444

3.74

41.82

2.1

341.44

367.25

nmol/l

0.90

141

416

Atherosclerosis, excluding cerebral and coronary sclerosis

1751

9953

1.45

41.71

2.2

2.3

380.86

381.01

nmol/l

0.01

1580

9028

COPD, hospital admissions 1, only main diagnosis

1490

8784

1.49

41.68

2.4

2.3

344.93

379.30

nmol/l

6.68

1344

8020

L04AC Interleukin inhibitors

320

1455

2.44

41.66

2.2

2.1

297.95

370.80

nmol/l

11.01

305

1354

Nontoxic multinodular goitre

958

6093

1.64

41.57

2.2

2.0

366.79

382.75

nmol/l

1.76

880

5533

Iridocyclitis

1156

7668

1.57

41.54

2.3

2.2

359.15

372.48

nmol/l

1.58

1084

7055

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

483

2521

2.01

41.47

3.8

1.7

396.83

365.11

nmol/l

2.38

452

2246

Cholangitis (primary sclerosing, PSC)

341

1586

2.34

41.46

2.6

2.1

347.51

369.77

nmol/l

1.06

323

1450

Intestinal adhesions without obstruction

420

2109

2.13

41.35

2.6

2.3

375.37

374.53

nmol/l

0.03

390

1922

Amputation

465

2416

2.05

41.25

2.2

369.84

375.30

nmol/l

0.21

431

2202

TMD related pain

255

1063

2.73

40.99

2.4

2.1

349.39

375.93

nmol/l

1.13

226

987

Diabetic retinopathy

1809

8199

1.45

40.84

1.9

2.2

383.58

372.56

nmol/l

1.32

1655

7510

Crohn's disease of large intestine

341

1603

2.34

40.79

2.4

2.1

315.93

373.47

nmol/l

6.25

313

1491

Other disorders of nervous system

370

1792

2.25

40.70

2.3

2.1

337.12

373.74

nmol/l

3.34

333

1639

Leisure time condition

921

5843

1.65

40.61

2.2

357.26

376.00

nmol/l

2.05

830

5361

Keratitis

1756

12645

1.43

40.57

2.3

2.2

358.97

374.29

nmol/l

2.80

1609

11614

Disorders of oesophagus in diseases classified elsewhere

148

464

3.76

40.53

2.9

2.0

352.87

382.09

nmol/l

0.66

141

426

Bulimia nervosa (incl. atypical)

259

1090

2.67

40.49

2.0

383.03

390.77

nmol/l

0.23

233

996

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

947

6063

1.64

40.34

2.0

2.1

383.18

382.53

nmol/l

0.04

861

5561

Familial hypercholesterolemia

655

3801

1.80

40.26

2.3

382.08

369.38

nmol/l

0.87

596

3457

Invasive ventilation

401

2008

2.16

40.23

2.3

2.2

347.38

367.16

nmol/l

1.05

371

1836

Streptococcal septicaemia

409

2053

2.13

40.22

2.6

2.2

364.70

372.41

nmol/l

0.23

383

1861

Cluster headache, strict, including avohilmo

324

1504

2.39

40.17

2.3

2.1

345.54

369.84

nmol/l

1.65

303

1399

Cluster headache, wide,, including avohilmo

337

1588

2.34

40.16

2.3

2.1

342.90

372.46

nmol/l

2.30

315

1478

Lateral epicondylitis

685

4050

1.78

39.75

2.2

2.3

362.86

375.46

nmol/l

1.00

627

3764

Dermatitis due to substances taken internally

336

1587

2.32

39.52

3.1

1.9

339.85

376.47

nmol/l

2.71

314

1445

Oligomenorrhoea

253

1063

2.66

39.48

2.3

2.1

371.46

382.66

nmol/l

0.40

232

973

Anaemia in chronic diseases classified elsewhere

167

571

3.40

39.47

2.5

2.0

352.19

380.08

nmol/l

1.05

156

524

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1977

14551

1.40

39.46

2.1

367.29

376.29

nmol/l

1.15

1804

13442

Other disorders of eyelid

1991

14178

1.39

39.45

2.2

369.21

380.44

nmol/l

1.69

1831

12968

Conductive and sensorineural hearing loss

3837

21238

1.27

39.42

2.2

2.3

363.35

375.26

nmol/l

3.04

3480

19554

Vitamin B12 deficiency anaemia

525

2883

1.93

39.32

2.0

2.1

380.49

378.53

nmol/l

0.07

472

2607

Other skin changes

820

5104

1.69

39.18

2.9

2.2

355.91

376.51

nmol/l

2.49

765

4662

Other diseases of oesophagus

470

2496

2.00

39.13

2.4

2.2

371.78

377.82

nmol/l

0.20

430

2282

Thyroiditis

432

2248

2.09

39.09

2.2

2.1

384.14

372.72

nmol/l

0.61

395

2056

Melanocytic naevi

1389

9660

1.49

39.06

2.9

1.8

369.49

369.40

nmol/l

0.01

1295

8801

Other postsurgical states

361

1761

2.23

38.94

2.2

365.64

369.20

nmol/l

0.13

331

1610

Iron deficiency

174

617

3.32

38.85

2.0

407.71

390.10

nmol/l

0.53

163

579

Other disorders involving the immune mechanism, not elsewhere classified

215

848

2.89

38.75

2.6

2.1

338.33

361.70

nmol/l

1.07

198

796

Non-small cell lung cancer, squamous

238

973

2.65

38.54

6.7

2.0

427.64

374.43

nmol/l

3.04

231

868

Non-small cell lung cancer, squamous, helper endpoint

238

973

2.65

38.54

6.7

2.0

427.64

374.43

nmol/l

3.04

231

868

Sensorineural hearing loss

3591

20001

1.28

38.42

2.2

2.3

365.24

375.52

nmol/l

2.22

3249

18407

Emotional disorders starting during childhood or adolescence

350

1689

2.26

38.29

2.2

2.1

385.18

388.38

nmol/l

0.10

319

1563

Osteomyelitis

335

1599

2.27

38.10

2.1

2.2

367.09

371.66

nmol/l

0.12

310

1463

Actinic keratosis

1561

10557

1.45

38.05

2.6

2.2

373.51

384.18

nmol/l

1.05

1409

9551

Parkinson's disease, excluding more controls

507

2694

1.91

38.01

1.8

2.6

392.14

386.40

nmol/l

0.25

446

2495

Visual impairment including blindness (binocular or monocular)

363

1787

2.19

38.00

2.5

2.0

380.54

376.36

nmol/l

0.07

316

1625

Disorders of optic nerve and visual pathways

548

3099

1.89

37.94

2.9

2.1

377.45

369.70

nmol/l

0.19

513

2856

Contact with and exposure to communicable diseases

1745

12650

1.42

37.91

2.2

2.1

358.56

377.37

nmol/l

3.30

1682

11649

Inflammatory disease of uterus

811

5086

1.68

37.86

2.1

362.29

378.06

nmol/l

1.42

743

4677

Diseases of peritoneum

536

3008

1.90

37.80

2.4

2.1

356.54

369.51

nmol/l

0.59

499

2746

Dermatopolymyositis (FG)

117

331

4.28

37.77

1.8

2.2

352.19

396.26

nmol/l

0.59

110

310

Gonarthrosis,primary

4315

22044

1.25

37.75

2.1

2.3

359.83

374.12

nmol/l

4.84

3931

20319

Cerebral palsy and other paralytic syndromes

605

3515

1.82

37.74

2.3

2.2

358.37

368.44

nmol/l

0.60

558

3225

Decubitus ulcer and pressure area

292

1323

2.39

37.73

1.9

2.1

369.56

377.19

nmol/l

0.21

271

1187

Hepatic failure, not elsewhere classified

226

922

2.76

37.73

2.2

336.04

371.70

nmol/l

1.98

210

844

Disorders of continuity of bone

516

2866

1.92

37.72

2.2

2.1

355.57

379.95

nmol/l

1.79

471

2634

Other mental disorders due to brain damage and dysfunction and to physical disease

533

2987

1.89

37.56

2.1

380.80

377.75

nmol/l

0.12

475

2710

Benign neoplasm: Rectum, anus and anal canal

822

5165

1.66

37.35

2.4

1.8

374.37

367.18

nmol/l

0.44

749

4636

Fracture of femur

1122

6867

1.54

37.34

2.2

2.1

377.90

382.63

nmol/l

0.20

1012

6184

Other specified/unspecified soft tissue disorders

283

1274

2.42

37.25

2.1

347.51

387.86

nmol/l

2.80

259

1153

Ocular pain

475

2590

1.98

37.21

2.4

2.1

368.33

372.15

nmol/l

0.15

442

2373

Benign neoplasm: Stomach

469

2537

1.97

37.18

2.5

1.8

356.13

367.22

nmol/l

0.62

418

2281

Other and unspecified tonsillitis

1751

10812

1.41

36.82

2.3

2.1

361.19

379.71

nmol/l

3.60

1638

10019

Acute and subacute iridocyclitis

975

6405

1.59

36.79

2.3

2.2

358.38

372.88

nmol/l

1.56

917

5904

Ulcerative ileocolitis

273

1225

2.47

36.76

2.4

2.1

317.66

372.02

nmol/l

5.05

247

1144

Fibroblastic disorders

1037

6886

1.56

36.64

2.1

2.3

374.40

382.34

nmol/l

0.63

943

6333

Superficial injury of lower leg

1248

8619

1.50

36.61

2.1

351.14

380.91

nmol/l

6.45

1146

7892

Haemorrhoids and perianal venous thrombosis

1275

8822

1.49

36.43

2.5

2.3

366.58

383.14

nmol/l

1.89

1174

8066

Anterior Iridocyclitis

1028

6845

1.57

36.41

2.3

2.2

359.09

372.19

nmol/l

1.40

964

6301

Fracture of lower leg, including ankle

2708

21019

1.31

36.26

2.2

358.70

378.95

nmol/l

5.86

2503

19323

Major coronary heart disease event

3224

17012

1.29

36.16

2.1

2.4

371.92

373.11

nmol/l

0.10

2957

15607

Lichen simplex chronicus and prurigo

354

1763

2.18

36.13

2.3

2.0

349.43

374.24

nmol/l

1.42

325

1599

Anosmia

232

4.42

36.13

2.5

1.6

361.44

379.48

nmol/l

0.33

214

Viral pneumonia (unknown virus, not influenza)

378

1927

2.12

36.09

2.4

2.1

343.78

374.16

nmol/l

1.91

351

1776

Open wound of lower leg

732

4526

1.70

35.94

2.6

2.1

341.65

378.44

nmol/l

4.87

664

4141

Recurring oral aphthae, including avohilmo

723

4466

1.71

35.94

2.4

2.1

365.14

374.53

nmol/l

0.65

655

4092

Vitamin D deficiency

139

454

3.61

35.71

2.6

2.0

356.18

381.29

nmol/l

0.76

129

421

Autoimmune thyroiditis

140

458

3.57

35.71

2.5

1.8

401.77

386.81

nmol/l

0.39

128

421

Colectomy operation

788

4968

1.66

35.70

2.7

2.2

377.33

373.08

nmol/l

0.21

740

4534

Other and unspecified immunodeficiencies with predominantly antibody defects

120

364

4.16

35.57

3.3

1.9

312.35

364.88

nmol/l

1.86

111

343

Superficial injury of head

1102

7468

1.53

35.53

1.9

2.2

369.55

372.98

nmol/l

0.23

1001

6829

Haemorrhage, not elsewhere classified

180

669

2.94

35.51

2.2

2.0

391.92

384.47

nmol/l

0.18

172

596

Flat foot [pes planus] (acquired)

492

2741

1.91

35.46

2.1

2.3

369.10

387.08

nmol/l

1.20

449

2508

Multiple myeloma and malignant plasma cell neoplasms

262

1172

2.47

35.42

2.2

388.70

369.67

nmol/l

0.71

250

1057

Other disorders of gingiva or/and edentulous alveolar ridge

293

1371

2.34

35.33

3.7

2.0

328.30

379.13

nmol/l

3.61

280

1269

Dermatographic urticaria

405

2137

2.05

35.18

2.2

2.0

346.93

377.19

nmol/l

2.71

380

1964

Injuries to the wrist and hand

5245

31776

1.21

35.09

2.1

2.2

366.47

375.43

nmol/l

2.24

4858

29319

Speech disturbances, not elsewhere classified

436

2350

1.98

35.05

2.0

2.1

380.40

375.78

nmol/l

0.18

395

2136

Charcot foot

128

402

3.76

35.05

2.2

2.4

387.45

365.77

nmol/l

0.64

121

376

Other strabismus

1168

8020

1.51

35.00

2.4

2.2

360.65

373.18

nmol/l

1.41

1087

7401

Sequelae of cerebrovascular disease

1473

9229

1.44

34.98

2.0

2.3

379.43

377.56

nmol/l

0.12

1313

8409

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2883

22369

1.30

34.95

2.2

2.1

358.70

377.34

nmol/l

6.02

2652

20565

Coeliac disease

665

4050

1.73

34.95

2.2

375.86

373.77

nmol/l

0.09

615

3726

Hypertrophy of breast in women and men

1042

7026

1.55

34.91

2.0

2.2

353.45

373.47

nmol/l

2.83

963

6466

Unspecified urinary incontinence

464

2558

1.94

34.84

2.0

2.1

363.46

376.81

nmol/l

0.72

389

2325

Dermatopolymyositis

122

376

3.90

34.67

1.8

2.0

357.97

379.70

nmol/l

0.24

115

347

Trigeminal neuralgia

333

1648

2.19

34.59

2.2

2.1

372.08

374.50

nmol/l

0.08

298

1507

Respiratory disorders in diseases classified elsewhere

119

364

4.03

34.55

2.0

338.97

372.67

nmol/l

0.41

109

334

SLE, ICD10

242

1065

2.57

34.54

2.0

345.75

372.44

nmol/l

1.25

221

978

SLE, strict definition

242

1065

2.57

34.54

2.0

345.75

372.44

nmol/l

1.25

221

978

Myocardial infarction, without ST-elevation

1620

10876

1.41

34.49

2.0

2.3

378.67

378.89

nmol/l

0.01

1465

9883

Wegener granulomatosis

127

403

3.78

34.47

2.2

1.9

317.95

381.13

nmol/l

3.45

122

371

Mental and behavioural disorders due to opioids

247

1092

2.50

34.37

2.5

2.0

330.27

365.66

nmol/l

2.06

216

1032

Bronchiectasis

389

2034

2.05

34.30

2.5

2.1

318.92

387.49

nmol/l

9.83

360

1835

Asthma and opportunity respiratory infection

261

1184

2.43

34.14

2.6

2.1

292.24

385.57

nmol/l

11.51

246

1068

Allergic conjunctivitis

3022

23677

1.28

34.14

2.2

2.1

359.00

376.43

nmol/l

5.59

2781

21785

Erosion of teeth

137

458

3.57

34.13

3.9

2.1

303.68

361.32

nmol/l

2.52

130

427

Myocardial infarction

2204

12020

1.35

34.12

2.2

2.4

372.89

376.31

nmol/l

0.25

2011

11023

Major coronary heart disease event excluding revascularizations

2909

15809

1.30

34.11

2.2

2.4

370.86

374.09

nmol/l

0.29

2660

14495

Disorders of vitreous body and globe

2275

17053

1.33

34.02

2.1

2.3

367.48

376.21

nmol/l

1.30

2090

15650

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

197

796

2.81

33.84

2.6

2.2

339.68

361.35

nmol/l

0.89

180

748

Mixed hyperlipidaemia

213

883

2.64

33.83

1.8

2.2

360.78

363.32

nmol/l

0.06

180

814

Glaucoma

2495

17011

1.32

33.80

2.1

2.3

382.26

376.92

nmol/l

0.46

2253

15560

Inflammatory diseases of the central nervous system

460

2558

1.92

33.66

2.6

2.1

349.00

372.49

nmol/l

1.83

432

2343

Malignant neoplasm of skin

2714

16002

1.30

33.64

3.4

2.2

377.24

377.95

nmol/l

0.06

2486

14602

Fitting and adjustment of other devices

1451

9686

1.43

33.62

2.1

2.2

359.46

377.51

nmol/l

2.43

1317

8724

Selective deficiency of immunoglobulin G [IgG] subclasses

200

5.62

33.60

3.5

2.1

309.22

362.85

nmol/l

1.32

185

Gingival hyperplasia

211

882

2.68

33.50

4.2

2.1

309.93

375.06

nmol/l

4.13

205

818

Benign neoplasm: Colon, unspecified

1073

7325

1.52

33.49

2.4

2.2

356.02

378.10

nmol/l

3.08

979

6692

Artificial opening status

290

1381

2.29

33.48

2.7

2.3

365.26

367.03

nmol/l

0.04

273

1267

Disorders of vitreous body

2213

16627

1.34

33.47

2.1

2.3

367.97

376.10

nmol/l

1.13

2031

15255

Other follicular disorders

409

2199

2.00

33.42

2.4

2.1

357.14

373.60

nmol/l

0.97

384

2039

Small fibre neuropathy

182

715

2.92

33.28

3.0

2.1

322.69

373.13

nmol/l

2.47

169

655

Peripheral artery operations in Hilmo

540

3140

1.80

33.04

2.1

2.3

382.99

377.55

nmol/l

0.23

495

2854

Alcoholic liver disease

463

2587

1.90

33.03

2.0

2.3

376.42

367.98

nmol/l

0.25

424

2377

Ulcerative colitis (strict definition, all Crohn cases excluded)

757

4818

1.65

33.03

2.2

330.77

371.84

nmol/l

7.92

701

4432

Phlebitis and thrombophlebitis (not including DVT)

1079

7401

1.51

32.93

2.3

2.2

357.73

377.39

nmol/l

2.62

1006

6752

Papilloedema, unspecified

167

633

3.05

32.85

2.5

2.0

376.43

376.35

nmol/l

0.00

161

581

Cirrhosis of liver, NAS

271

1271

2.34

32.64

2.1

359.75

371.12

nmol/l

0.23

260

1166

Parkinson's disease, strict definition, excluding more controls

454

2462

1.88

32.62

1.8

2.6

391.14

387.82

nmol/l

0.12

397

2281

Other and unspecified visual disturbances

497

2855

1.85

32.58

2.6

2.1

378.00

373.64

nmol/l

0.20

466

2621

Sequelae of injuries of head

301

1470

2.23

32.51

2.0

2.1

393.12

367.41

nmol/l

1.16

273

1369

Acute peritonitis

337

1712

2.12

32.49

2.6

2.1

351.67

369.16

nmol/l

0.56

322

1563

Osteonecrosis

313

1555

2.19

32.30

2.7

2.1

357.00

377.95

nmol/l

1.01

293

1415

Other and unspecified disorders of white blood cells

248

1130

2.43

32.28

2.5

2.2

352.84

372.62

nmol/l

0.86

235

1037

Other disorders of bone

1003

6811

1.53

32.25

2.4

2.2

354.09

376.51

nmol/l

3.08

931

6257

Trigger finger

681

4247

1.68

32.20

2.0

2.3

360.18

382.91

nmol/l

2.21

612

3922

TMD muscular pain linked with fibromyalgia

285

4.54

32.14

2.6

2.0

318.89

369.97

nmol/l

1.95

268

Other/unspecified synovitis and tenosynovitis

575

3438

1.76

32.13

2.1

2.3

358.16

381.72

nmol/l

2.34

533

3158

Other inflammation of eyelid

652

4038

1.70

32.02

2.4

2.2

367.10

375.28

nmol/l

0.44

593

3710

Vitreous haemorrhage

494

2847

1.84

31.87

2.1

2.2

390.45

373.97

nmol/l

1.06

466

2598

Nontoxic goitre/thyroid nodule

1459

10629

1.42

31.82

2.2

2.1

368.72

379.50

nmol/l

1.35

1332

9650

Somnolence, stupor and coma

239

1073

2.42

31.71

2.0

2.1

371.59

372.03

nmol/l

0.01

224

971

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

190

776

2.75

31.71

2.3

2.0

365.89

358.56

nmol/l

0.20

182

707

Other disorders of the musculoskeletal system and connective tissue

706

4467

1.66

31.70

2.2

368.10

370.73

nmol/l

0.12

641

4085

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

362

1876

2.05

31.69

2.3

2.2

355.56

369.87

nmol/l

0.72

335

1753

Benign neoplasm: Rectum

712

4502

1.65

31.66

2.4

1.8

373.49

365.90

nmol/l

0.42

649

4050

DVT of lower extremities

875

5797

1.57

31.66

2.4

2.2

363.30

379.81

nmol/l

1.47

810

5290

Need for other prophylactic measures

322

1632

2.15

31.59

2.8

2.2

393.02

369.13

nmol/l

0.65

308

1492

Non-follicular lymphoma

463

2628

1.87

31.54

2.1

2.2

371.45

371.17

nmol/l

0.01

443

2392

Brain meningioma, excluding all cancers (controls excluding all cancers)

288

1402

2.24

31.50

3.0

1.8

364.05

364.76

nmol/l

0.02

271

1258

Other benign neoplasms of skin

1596

11555

1.39

31.49

2.4

1.8

362.63

369.33

nmol/l

0.69

1444

10468

Polyarteritis nodosa and related conditions

114

358

3.81

31.44

2.8

1.8

298.23

377.70

nmol/l

4.17

108

328

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

433

2401

1.90

31.40

3.3

1.8

416.50

367.55

nmol/l

5.26

410

2160

Benign neoplasm: Ascending colon

537

3173

1.78

31.37

2.3

1.8

364.21

369.72

nmol/l

0.26

499

2845

Diabetic neuropathy

606

3703

1.74

31.35

2.0

2.2

376.83

374.34

nmol/l

0.12

549

3372

Protozoal diseases

186

761

2.79

31.31

3.2

2.1

353.29

374.50

nmol/l

0.45

177

709

Systemic lupus erythematosus, unspecified

212

921

2.61

31.28

1.9

2.1

349.81

374.03

nmol/l

0.97

195

848

Postprocedural disorders of digestive system, not elsewhere classified

204

869

2.63

31.15

2.8

2.2

366.54

368.96

nmol/l

0.05

194

796

Adhesive capsulitis of shoulder

778

5043

1.60

31.08

2.3

352.42

382.75

nmol/l

4.23

723

4642

Female infertility, associated with anovulation

450

2539

1.88

31.07

2.2

2.0

359.85

389.78

nmol/l

2.10

426

2338

Drug-induced cataract

168

658

2.95

31.04

3.4

2.1

270.73

368.96

nmol/l

7.08

160

612

Other specified/unspecified inflammatory spondylopathies

280

1352

2.24

31.02

2.3

2.0

341.14

373.99

nmol/l

2.06

263

1261

Other abnormal findings of blood chemistry

252

1173

2.36

31.01

2.4

2.1

349.57

370.17

nmol/l

0.81

235

1076

Heart failure and coronary heart disease

1323

7032

1.44

31.00

1.9

2.3

392.03

379.43

nmol/l

0.85

1201

6341

Myositis

161

613

2.95

30.91

2.3

2.2

357.50

383.55

nmol/l

0.44

155

556

Rash and other nonspecific skin eruption

517

3052

1.80

30.70

2.5

2.1

357.64

372.61

nmol/l

0.97

485

2790

Psoriatic arthropathies

502

2933

1.80

30.63

2.0

2.3

344.45

383.13

nmol/l

3.66

462

2703

Malignant neoplasm of endocrine gland

406

2244

1.95

30.60

3.3

2.1

384.90

368.49

nmol/l

0.32

382

2054

Abnormal findings on examination of urine, without diagnosis

253

1185

2.34

30.59

2.4

2.1

357.72

366.85

nmol/l

0.31

237

1088

Other disorders of patella

875

5841

1.55

30.50

2.2

2.3

358.31

380.72

nmol/l

3.12

799

5372

Cholangitis (primary sclerosing, PSC), with reimbursement 202

140

505

3.24

30.37

2.9

2.0

342.00

367.84

nmol/l

0.84

134

469

severe traumatic brain injury, does not include concussion

931

6294

1.53

30.36

2.1

2.2

408.34

374.64

nmol/l

3.32

851

5736

Primary biliary cholangitis (PBC)

136

479

3.22

30.29

2.1

2.0

362.33

387.90

nmol/l

0.65

124

429

Appendectomy

3371

26490

1.25

30.27

2.2

371.19

374.04

nmol/l

0.29

3129

24441

Impingement syndrome of shoulder

1101

7694

1.48

30.23

2.4

361.34

378.77

nmol/l

2.30

1018

7129

Lack of expected normal physiological development

163

542

2.93

30.17

3.0

1.9

309.19

373.96

nmol/l

4.39

157

510

Idiopathic pulmonary fibrosis

341

1781

2.04

30.14

2.0

2.1

364.07

370.76

nmol/l

0.15

320

1591

In situ neoplasms

1536

10821

1.39

30.12

2.5

1.8

378.17

371.94

nmol/l

0.51

1415

9768

Mental disorders, not otherwise specified

474

2750

1.83

30.04

1.9

2.1

389.12

373.21

nmol/l

0.98

445

2545

Cardiomyopathy, other and unspecified

369

1979

1.98

29.98

2.4

360.70

368.96

nmol/l

0.32

348

1822

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

464

2658

1.82

29.98

2.8

1.7

378.37

371.58

nmol/l

0.28

423

2329

Other infectious diseases

396

2178

1.94

29.93

2.3

2.2

369.12

374.20

nmol/l

0.13

370

1980

Crohn disease (strict definition, all UC cases excluded)

307

1560

2.14

29.89

1.8

2.1

362.79

374.48

nmol/l

0.48

284

1444

Benign neoplasm: Transverse colon

431

2430

1.88

29.86

2.3

1.8

357.88

363.95

nmol/l

0.27

393

2185

ILD-related respiratory insufficiency

181

744

2.72

29.79

2.0

2.2

336.80

373.23

nmol/l

1.19

172

671

Melanocytic naevi, other sites/unspecified

404

2244

1.92

29.65

3.3

1.8

365.03

365.80

nmol/l

0.03

381

2049

1131

7044

1.46

29.43

2.0

2.1

378.22

384.80

nmol/l

0.44

989

6333

Colonic or urogenital fistula

1292

9342

1.43

29.41

2.1

2.2

368.73

371.46

nmol/l

0.20

1162

8605

Focal brain injury

271

1307

2.18

29.40

2.2

2.3

385.29

392.61

nmol/l

0.15

254

1211

Lesion of ulnar nerve

653

4124

1.65

29.40

2.2

2.3

359.55

373.17

nmol/l

1.03

599

3814

Hallux valgus (acquired)

1588

8514

1.38

29.36

2.0

2.3

375.05

386.76

nmol/l

1.43

1428

7800

Infective dermatitis

558

3395

1.73

29.33

2.3

2.1

365.17

376.34

nmol/l

0.57

515

3112

Hydronephrosis

505

2989

1.77

29.33

2.9

2.2

379.08

374.26

nmol/l

0.20

481

2715

Acute generalized exanthematous pustulosis

265

1287

2.26

29.29

2.9

2.0

340.57

374.31

nmol/l

1.89

250

1182

Alcohol-induced chronic pancreatitis

331

1733

2.05

29.28

2.2

2.4

379.21

362.62

nmol/l

0.74

307

1610

Glaucoma suspect

1587

11856

1.38

29.27

2.0

2.2

382.76

377.84

nmol/l

0.34

1442

10809

Diseases of middle ear and mastoid

3023

20003

1.26

29.26

2.1

369.19

376.74

nmol/l

1.29

2783

18444

Other overlap syndromes

136

494

3.20

29.08

2.0

1.9

348.26

387.09

nmol/l

0.94

129

457

Tonsillectomy and adenotomy

3173

17924

1.26

29.04

2.2

2.1

371.77

371.23

nmol/l

0.05

2926

16651

Dental caries 2 and operation codes

3997

26397

1.22

29.01

2.2

365.73

373.59

nmol/l

1.69

3662

24435

Fracture of skull and facial bones

1000

6925

1.49

28.96

2.1

2.3

373.80

369.18

nmol/l

0.32

932

6388

Sleep disorders, other/unspecified

218

986

2.45

28.95

2.1

2.0

371.30

375.90

nmol/l

0.12

194

911

Peripheral arterial reconstruction

672

4281

1.63

28.91

2.2

376.79

380.54

nmol/l

0.16

602

3869

Injuries to the elbow and forearm

3485

25884

1.24

28.91

2.2

370.04

378.06

nmol/l

1.24

3206

23803

Pneumonitis due to solids and liquids

356

1911

1.97

28.77

2.1

375.66

373.07

nmol/l

0.06

316

1734

Kela reimbursement Agammaglobulinemia (D80-84)

232

4.64

28.74

3.2

1.9

327.08

364.25

nmol/l

0.94

216

Disorders of orbit

262

1276

2.25

28.73

2.5

2.0

352.65

371.86

nmol/l

0.91

241

1177

Vascular disorders of the intestines

292

1466

2.12

28.72

2.5

2.2

385.92

382.83

nmol/l

0.07

271

1320

Infections with a predominantly sexual mode of transmission

1612

12100

1.37

28.72

2.1

387.22

375.15

nmol/l

1.59

1482

11161

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

382

2110

1.94

28.70

1.9

2.1

383.90

379.32

nmol/l

0.15

352

1943

Preparatory care for dialysis

240

1134

2.33

28.56

1.7

2.2

351.43

366.15

nmol/l

0.51

234

1052

Ulcerative rectosigmoiditis

443

2557

1.84

28.54

2.3

2.1

327.79

372.60

nmol/l

5.56

410

2353

Idiopathic thrombocytopenic purpura

192

830

2.59

28.44

2.6

2.1

358.61

373.85

nmol/l

0.27

180

768

Polycystic ovarian syndrome, broad definition

607

3807

1.67

28.36

1.7

367.65

389.23

nmol/l

2.11

568

3497

Primary gonarthrosis, bilateral

2231

15301

1.30

28.25

2.0

2.3

358.59

379.19

nmol/l

5.05

2011

14029

Acute gastritis

372

2041

1.93

28.22

2.2

376.95

375.07

nmol/l

0.06

341

1860

Oesophagitis

277

1380

2.16

28.19

2.5

2.2

352.91

376.09

nmol/l

0.81

263

1267

Diseases of external ear

1563

11718

1.37

28.18

2.3

2.2

364.02

374.55

nmol/l

1.29

1394

10780

Disorders of iron metabolism

106

340

3.68

28.18

2.1

353.49

362.39

nmol/l

0.20

319

Generalized skin eruption due to drugs and medicaments

240

1141

2.32

28.16

3.1

2.0

335.12

375.02

nmol/l

2.23

225

1050

Suppurative and necrotic conditions of lower respiratory tract

274

1362

2.17

28.14

2.5

2.2

386.76

369.81

nmol/l

0.52

257

1247

Acute laryngitis and tracheitis

629

3911

1.65

28.11

2.3

1.9

364.90

381.83

nmol/l

1.48

580

3602

Fracture of foot, except ankle

1179

8464

1.44

28.05

2.3

2.2

370.85

374.11

nmol/l

0.19

1096

7780

Other disorders starting during childhood or adolescence

335

1777

2.02

28.05

2.3

2.2

354.65

370.17

nmol/l

0.78

311

1658

Diabetes mellitus in pregnancy

1808

8911

1.35

27.99

1.9

2.0

379.17

381.16

nmol/l

0.15

1679

8253

Recurring oral aphthae

272

1360

2.19

27.84

2.8

2.2

357.86

370.82

nmol/l

0.49

244

1245

Viral warts

530

3236

1.73

27.75

2.5

2.1

348.71

374.38

nmol/l

2.22

505

2971

Acute alcohol intoxication

1136

8108

1.44

27.71

2.3

369.98

370.97

nmol/l

0.05

1039

7505

Umbilical hernia

1216

8791

1.43

27.65

2.3

2.4

356.77

374.36

nmol/l

1.76

1117

8150

Fracture of shoulder and upper arm

1643

12427

1.35

27.64

2.1

2.2

366.12

377.50

nmol/l

1.37

1489

11361

Benign neoplasm of mouth and pharynx

494

2959

1.75

27.56

2.7

1.8

374.84

365.56

nmol/l

0.48

439

2682

Nasal polyp

857

5819

1.52

27.49

2.5

2.3

338.97

376.49

nmol/l

4.88

782

5371

824

5241

1.54

27.49

2.0

2.1

376.83

384.92

nmol/l

0.46

718

4678

Rare circulating lymphoid malignancy

190

831

2.55

27.39

2.3

2.2

365.89

370.31

nmol/l

0.11

182

761

Other/unspecified enthesopathies of lower limb, excluding foot

363

1997

1.93

27.37

2.2

2.1

369.88

378.56

nmol/l

0.36

333

1849

Amputation of toe

321

1700

2.01

27.31

2.4

2.1

366.54

372.46

nmol/l

0.21

300

1539

Other enthesopathy of foot (+metatarsalgia)

497

2991

1.75

27.28

2.0

2.3

351.78

384.86

nmol/l

3.62

453

2758

Graves disease, strict definition

545

3370

1.71

27.27

2.0

2.1

376.96

373.08

nmol/l

0.19

502

3104

Scoliosis

444

2594

1.81

27.26

2.2

2.1

350.45

389.15

nmol/l

2.71

399

2371

Enteropathic arthropathies

153

607

2.84

27.21

2.5

2.1

312.42

381.52

nmol/l

4.16

144

568

Hypothyroidism due to medicaments and other exogenous substances

258

4.15

27.17

5.7

1.9

376.58

372.69

nmol/l

0.06

232

Secondary uncertain malignant neoplasm

564

3509

1.68

27.10

3.2

2.2

371.23

374.38

nmol/l

0.14

534

3191

Other symptoms and signs involving general sensations and perceptions

212

970

2.38

27.09

2.0

400.00

379.73

nmol/l

0.60

197

875

Speech and linguistic disorders

492

2842

1.75

27.01

2.7

2.1

338.90

372.43

nmol/l

3.38

456

2637

Dental caries 2

4046

26638

1.21

26.96

2.2

366.24

373.41

nmol/l

1.46

3701

24659

Pericarditis

189

824

2.49

26.94

3.2

2.3

340.77

366.87

nmol/l

1.27

176

762

Cardiomyopathies, Primary/intrinsic

515

3134

1.71

26.79

2.4

392.19

369.73

nmol/l

1.33

487

2896

Emphysema

300

1559

2.04

26.75

2.4

2.1

347.14

385.62

nmol/l

2.55

281

1402

Morphin

100

316

3.57

26.70

4.2

1.6

307.55

395.54

nmol/l

3.56

286

Pure hyperglyceridaemia

129

472

3.06

26.69

2.1

2.2

345.94

360.02

nmol/l

0.27

116

437

Later onset COPD

1061

5878

1.46

26.67

2.5

2.2

362.62

383.03

nmol/l

2.17

964

5303

172

729

2.64

26.64

2.4

2.0

348.54

363.51

nmol/l

0.42

159

685

Atopic dermatitis, strict definition

1576

11692

1.36

26.63

2.2

2.1

364.69

376.24

nmol/l

1.47

1453

10796

Abnormal serum enzyme levels

1197

8565

1.42

26.60

2.3

2.4

379.82

370.70

nmol/l

0.59

1130

7918

Other embolism and thrombosis

604

3838

1.64

26.60

2.4

2.2

363.81

377.68

nmol/l

0.87

558

3497

Other blood glucose lowering drugs, excl. Insulins

732

4850

1.57

26.57

2.0

2.3

360.00

376.54

nmol/l

1.43

658

4429

Fall on same level involving ice and snow

2724

22057

1.26

26.56

2.1

2.2

372.92

376.19

nmol/l

0.35

2513

20249

Female genital prolapse

1486

6365

1.38

26.39

1.9

2.2

369.51

380.28

nmol/l

1.17

1378

5817

Ehlers-Danlos syndrome

296

3.94

26.31

2.1

2.0

350.68

383.18

nmol/l

0.86

278

Diffuse brain injury

169

704

2.57

26.29

1.7

2.2

397.80

384.36

nmol/l

0.27

159

649

Herpesviral [herpes simplex] infections

592

3762

1.65

26.29

2.5

2.1

351.25

374.82

nmol/l

2.14

553

3454

Other diseases of biliary tract

404

2324

1.84

26.29

2.4

2.2

375.96

372.11

nmol/l

0.12

380

2118

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1395

10399

1.38

26.19

2.1

2.2

367.03

373.36

nmol/l

0.57

1291

9592

Tinnitus

1086

7785

1.44

26.15

2.3

365.86

373.65

nmol/l

0.68

973

7165

Lymphoid leukaemia

270

1371

2.12

26.13

2.5

1.9

394.14

361.44

nmol/l

1.86

258

1238

Cardiomyopathy (excluding other)

533

3297

1.68

26.02

2.4

393.14

368.21

nmol/l

1.63

505

3049

Congenital malformations of the musculoskeletal system, not elsewhere classified

122

447

3.23

25.99

2.2

2.1

340.03

373.72

nmol/l

1.16

106

424

Cardiodefibrillation

1480

11118

1.36

25.97

2.1

2.4

367.23

378.70

nmol/l

1.15

1386

10156

Encephalitis

185

820

2.52

25.91

2.5

2.0

349.10

370.52

nmol/l

0.85

172

762

Manic episode

179

778

2.52

25.88

2.2

2.1

365.97

374.14

nmol/l

0.21

163

721

Hypertensive Renal Disease

158

644

2.64

25.85

2.0

2.2

338.42

372.85

nmol/l

1.39

147

579

Nonhereditary hypogammaglobulinemia

288

3.91

25.83

4.3

2.0

282.96

368.72

nmol/l

4.06

259

Dermatophytosis

592

3775

1.64

25.76

2.9

2.2

327.76

371.40

nmol/l

6.55

548

3464

Car occupant injured in other and unspecified transport accidents

945

6629

1.48

25.76

2.0

2.2

369.02

376.00

nmol/l

0.52

867

6087

Other encephalitis

173

747

2.59

25.73

2.5

2.1

354.01

369.85

nmol/l

0.54

163

693

Chronic nephritic syndrome

222

1060

2.29

25.62

2.2

328.00

368.85

nmol/l

2.62

212

976

Other or ill-defined heart diseases

254

1268

2.13

25.48

2.5

2.2

382.24

371.93

nmol/l

0.32

230

1172

Other peripheral vascular diseases

413

2417

1.81

25.43

2.3

2.1

393.72

370.41

nmol/l

1.19

391

2205

Psoriasis vulgaris

873

6051

1.50

25.40

2.3

344.84

370.04

nmol/l

3.14

809

5574

Adenomyosis (Endometriosis of uterus)

661

4335

1.59

25.39

2.1

2.2

366.27

381.85

nmol/l

1.33

616

3948

Artificial joint operation, meniscal resection

4345

24448

1.20

25.36

2.2

2.3

360.21

374.80

nmol/l

5.18

3974

22519

Other bursopathies

580

3689

1.64

25.33

2.1

2.3

356.15

384.23

nmol/l

2.35

544

3398

Disorders of breast

2505

18729

1.27

25.30

2.0

2.1

373.88

378.67

nmol/l

0.61

2312

17157

Other hearing loss

1129

8033

1.42

25.25

2.0

2.2

375.14

384.71

nmol/l

0.77

1030

7292

Astigmatism

341

1894

1.93

25.21

2.4

2.2

351.34

369.16

nmol/l

0.94

317

1752

Brain meningioma

279

1459

2.08

25.16

3.0

2.1

364.30

373.83

nmol/l

0.33

262

1322

Metatarsalgia

457

2750

1.75

25.16

2.0

2.3

347.07

383.76

nmol/l

4.09

415

2535

Allergic contact dermatitis

694

4611

1.57

25.12

2.0

2.1

370.17

374.28

nmol/l

0.17

632

4236

Benign neoplasm of brain and other parts of central nervous system

324

1773

1.95

25.08

3.1

1.8

336.45

360.12

nmol/l

1.40

301

1618

Early lumbar disc prolapse, operated

490

3000

1.71

25.07

2.1

2.2

354.57

368.89

nmol/l

0.94

456

2799

Hypertrophy of breast

889

6212

1.49

25.01

2.0

2.1

354.20

374.61

nmol/l

2.55

829

5717

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

217

1036

2.27

24.96

2.0

1.7

373.50

361.43

nmol/l

0.41

208

922

Diffuse large B-cell lymphoma, helper endpoint

217

1036

2.27

24.96

2.0

1.7

373.50

361.43

nmol/l

0.41

208

922

Acute pharyngitis

721

4791

1.55

24.92

2.5

2.1

366.27

379.67

nmol/l

1.12

660

4441

Bruxism

142

572

2.86

24.89

2.3

2.1

352.40

371.67

nmol/l

0.51

124

532

Benign neoplasm: Stomach

469

2859

1.73

24.80

2.5

2.2

356.13

372.98

nmol/l

1.12

418

2611

Magnesium deficiency

8.61

24.79

4.8

2.4

403.25

382.86

nmol/l

0.26

Etanercept

351

1980

1.90

24.79

1.9

2.2

318.79

370.52

nmol/l

6.11

338

1835

Postmenopausal bleeding

1301

5244

1.40

24.71

2.0

2.2

372.81

381.88

nmol/l

0.84

1175

4778

Ulcerative enterocolitis

198

919

2.37

24.70

2.4

2.0

314.29

371.73

nmol/l

4.42

181

851

Acute suppurative otitis media

1388

9728

1.37

24.67

2.2

2.1

361.51

377.94

nmol/l

2.31

1285

8988

Other immunodeficiencies

329

3.63

24.60

3.3

2.1

331.11

372.09

nmol/l

1.06

306

Traumatic subarachnoid haemorrhage

155

642

2.60

24.55

2.0

2.3

409.18

389.75

nmol/l

0.52

142

583

Duodenal ulcer

446

2677

1.74

24.48

2.3

363.07

378.67

nmol/l

0.92

412

2443

Other hammer toe(s) (acquired)

755

4792

1.53

24.47

2.0

2.3

363.43

393.52

nmol/l

3.66

670

4357

Fall on and from stairs and steps

1174

8619

1.40

24.45

2.3

2.2

366.05

376.20

nmol/l

1.01

1065

7905

Female infertility

1572

7360

1.35

24.44

2.2

2.1

372.61

384.72

nmol/l

1.39

1461

6772

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

375

2159

1.84

24.42

2.2

2.0

366.35

371.53

nmol/l

0.19

340

2007

Seropositive rheumatoid arthritis, strict definition

732

4949

1.54

24.40

1.8

2.2

346.66

374.00

nmol/l

3.08

685

4533

Drug-induced hypoglycaemia without coma

109

385

3.24

24.39

1.6

2.0

417.73

384.85

nmol/l

0.80

101

350

Other diseases of blood and blood-forming organs

338

1892

1.90

24.34

2.5

2.1

356.15

370.43

nmol/l

0.72

321

1733

Acne

545

3453

1.65

24.33

2.1

2.0

390.44

385.19

nmol/l

0.23

507

3189

Diseases of appendix

3767

28888

1.21

24.31

2.2

370.31

373.07

nmol/l

0.31

3507

26672

Benign neoplasm: Caecum

421

2504

1.77

24.24

2.3

1.8

373.86

365.91

nmol/l

0.37

388

2242

Acute appendicitis, no complications

2789

22798

1.24

24.21

2.2

366.91

372.29

nmol/l

0.73

2594

21099

Assault

653

4316

1.57

24.14

2.1

363.63

371.46

nmol/l

0.36

601

3991

Benign lipomatous neoplasm

1228

9090

1.39

24.06

2.4

1.8

360.26

365.33

nmol/l

0.42

1142

8254

Benign neoplasm: Sigmoid colon

779

5341

1.51

24.05

2.5

2.3

365.73

373.66

nmol/l

0.48

720

4893

Anxious personality disorder

133

525

2.86

24.03

1.7

2.0

352.88

380.41

nmol/l

0.86

121

488

Secondary parkinsonism, excluding more controls

112

399

3.04

23.96

1.9

2.3

402.68

393.51

nmol/l

0.17

100

365

Bell's palsy

549

3499

1.64

23.94

2.4

2.2

350.22

377.31

nmol/l

2.60

508

3212

Molar incisor enamel hypoplasia

216

1035

2.28

23.90

4.4

2.3

302.41

362.75

nmol/l

4.53

205

978

Personal history of other diseases and conditions

607

3948

1.60

23.88

2.3

2.1

363.29

374.20

nmol/l

0.70

546

3634

Varicose veins

2910

18075

1.24

23.62

2.2

364.07

376.05

nmol/l

2.55

2679

16560

Other and unspecified follicular disorders

221

1090

2.21

23.50

2.6

2.1

347.15

373.31

nmol/l

1.24

212

1013

Oesophageal varices

212

1029

2.24

23.46

2.3

2.2

367.68

369.07

nmol/l

0.02

202

941

Appendicitis, broad definition

3727

28749

1.20

23.42

2.2

370.14

373.10

nmol/l

0.33

3471

26547

Algoneurodystrophy

199

946

2.31

23.40

2.4

2.0

346.42

373.00

nmol/l

1.11

183

869

Anorexia

117

442

3.08

23.39

2.3

2.0

378.21

377.12

nmol/l

0.02

111

406

Postprocedural musculoskeletal disorders, not elsewhere classified

344

1963

1.87

23.34

2.2

352.12

373.57

nmol/l

1.06

312

1790

Systemic sclerosis (FG)

146

610

2.67

23.33

1.6

2.1

351.22

398.13

nmol/l

1.32

134

559

Other and unspecified disorders of skin and subcutaneous tissue

331

1867

1.89

23.28

2.8

2.1

345.85

370.49

nmol/l

1.57

289

1698

Other juvenile arthritis

250

1293

2.09

23.17

2.5

2.0

334.41

386.26

nmol/l

4.16

234

1185

Otalgia

418

2524

1.76

23.10

2.3

2.2

351.65

372.67

nmol/l

1.57

389

2320

Hypoplasia of dental enamel , including avohilmo

202

965

2.32

23.09

4.5

2.3

299.70

364.61

nmol/l

4.86

192

913

Rosacea

563

3649

1.62

23.04

2.3

2.2

356.85

372.46

nmol/l

0.82

510

3363

Allergic urticaria

441

2699

1.73

23.03

2.5

2.1

347.48

374.87

nmol/l

1.95

419

2473

Striking against or struck by other objects

1534

11803

1.33

22.96

2.3

358.17

369.54

nmol/l

1.42

1403

10920

Speech therapy

1237

9252

1.38

22.88

2.2

369.09

375.02

nmol/l

0.48

1170

8459

Plantar fascial fibromatosis

461

2851

1.69

22.83

2.0

2.3

362.92

379.02

nmol/l

0.97

418

2637

Corns and callosities

344

1974

1.85

22.80

2.3

2.1

371.10

374.14

nmol/l

0.11

315

1809

Hypersomnia

107

391

3.19

22.77

2.3

2.0

345.40

365.38

nmol/l

0.59

367

Other noninflammatory disorders of uterus, except cervix

1039

5118

1.43

22.72

2.0

2.3

382.59

383.02

nmol/l

0.02

934

4653

Acute alcohol intoxication, ICD10

900

6400

1.45

22.71

2.2

2.3

375.49

369.77

nmol/l

0.32

826

5895

Prurigo nodularis

148

635

2.60

22.39

2.0

346.66

373.36

nmol/l

0.79

132

583

Cramp and spasm

252

1326

2.05

22.28

2.2

2.1

340.11

371.12

nmol/l

1.78

236

1231

Combinations of oral blood glucose lowering drugs

1157

8597

1.38

22.22

2.1

2.5

376.82

372.62

nmol/l

0.27

1070

7962

Unspecified misadventure during surgical and medical care

278

1512

1.98

22.19

3.2

2.1

374.12

371.71

nmol/l

0.06

259

1380

Subacute thyroiditis

196

944

2.26

22.13

1.9

372.18

373.62

nmol/l

0.04

182

861

Nummular dermatitis

376

2228

1.78

22.08

2.5

2.1

383.54

373.96

nmol/l

0.39

354

2028

Superficial injury of abdomen, lower back and pelvis

714

4896

1.51

22.06

2.3

2.1

351.20

373.90

nmol/l

2.65

652

4488

Other female pelvic inflammatory diseases

818

5765

1.47

22.01

2.1

380.59

378.07

nmol/l

0.13

733

5282

Viral infections of the central nervous system

376

2235

1.78

21.97

2.5

2.1

351.12

375.72

nmol/l

1.74

354

2052

Mixed disorders of conduct and emotions, excluding more controls

121

472

2.77

21.82

2.0

1.9

350.20

400.56

nmol/l

1.87

107

431

Defects in the complement system

207

4.31

21.81

3.5

2.1

316.82

361.51

nmol/l

0.90

193

Open wound of forearm

441

2737

1.69

21.63

2.3

2.1

344.87

377.27

nmol/l

2.91

404

2497

Melanocytic naevi

1389

10648

1.34

21.62

2.9

2.1

369.49

375.75

nmol/l

0.62

1295

9788

Melanocytic naevi, other sites/unspecified

404

2460

1.74

21.60

3.3

2.1

365.03

372.44

nmol/l

0.35

381

2264

Volvulus

143

611

2.57

21.56

2.2

2.3

398.19

380.02

nmol/l

0.39

131

549

Other pulmonary heart/vessel disease

223

1135

2.11

21.56

2.2

2.1

351.94

374.49

nmol/l

0.69

206

1029

Attention to artificial openings

189

905

2.25

21.56

2.6

2.3

377.48

367.54

nmol/l

0.26

171

820

Arthropathic psoriasis

540

3524

1.60

21.40

2.0

2.2

349.87

369.65

nmol/l

1.18

496

3242

Other and unspecified rosacea

425

2629

1.71

21.34

2.3

2.1

356.22

369.21

nmol/l

0.48

387

2421

Maternal care for other conditions predominantly related to pregnancy

1085

7945

1.39

21.23

2.0

372.21

378.49

nmol/l

0.52

1004

7338

Other congenital malformations

473

3005

1.66

21.22

2.3

2.2

356.16

367.90

nmol/l

0.61

441

2781

Sequelae of injuries of neck and trunk

175

823

2.34

21.21

2.1

2.3

367.18

365.19

nmol/l

0.05

162

765

Polyarthritis, unspecified

199

980

2.20

21.17

2.4

2.2

347.12

382.86

nmol/l

1.71

192

897

Convalescence

278

1532

1.94

21.15

2.3

2.1

351.46

366.18

nmol/l

0.66

242

1381

Alcohol withdrawal state with delirium

318

1821

1.85

21.14

2.2

2.4

381.90

360.88

nmol/l

0.38

291

1692

Suppurative and unspecified otitis media

1854

13068

1.28

21.12

2.2

2.1

370.36

378.90

nmol/l

1.00

1719

12058

Paralytic ileus

180

852

2.27

21.06

2.2

2.3

382.94

367.72

nmol/l

0.38

170

768

Correction of physiology of bite - very demanding therapy visit

183

881

2.30

21.06

2.4

2.0

359.00

373.70

nmol/l

0.42

165

809

Superficial injury of thorax

672

4597

1.52

21.03

1.9

2.2

360.41

372.73

nmol/l

0.82

626

4217

Other neurotic disorders

245

1299

2.01

20.95

2.4

2.1

367.36

370.80

nmol/l

0.10

222

1183

Other disorders of veins

1788

14193

1.29

20.92

2.1

2.2

360.70

376.07

nmol/l

2.86

1633

13003

Excessive vomiting in pregnancy

448

2822

1.67

20.88

2.1

371.55

379.75

nmol/l

0.28

419

2600

Secondary right heart disease

202

1005

2.17

20.85

2.1

2.0

353.17

377.75

nmol/l

0.69

185

905

Congenital iodine-deficiency syndrome/hypothyroidism

168

781

2.35

20.85

2.1

1.8

361.79

373.67

nmol/l

0.31

157

703

Spinal instabilities

161

736

2.39

20.78

2.3

2.1

347.68

372.86

nmol/l

0.94

142

692

Gluteal tendinitis

190

926

2.22

20.77

2.0

2.1

353.07

380.72

nmol/l

0.97

170

857

Alzheimer disease, excluding more controls

598

2627

1.56

20.76

1.7

2.4

406.60

390.57

nmol/l

1.03

494

2411

Hodgkin lymphoma

162

745

2.38

20.69

3.3

1.8

371.58

364.85

nmol/l

0.18

153

686

Autonomic disorders

133

564

2.63

20.65

2.4

1.9

401.16

380.38

nmol/l

0.41

123

522

Other specified/unspecified dorsopathies

185

894

2.23

20.61

2.4

2.0

347.01

383.39

nmol/l

1.59

169

823

Symptoms and signs involving appearance and behaviour

217

3.92

20.60

2.1

1.8

382.03

368.86

nmol/l

0.18

199

Autism

152

683

2.45

20.58

2.1

2.0

343.70

382.78

nmol/l

1.84

145

631

Disorder of the sleep-wake schedule

125

519

2.74

20.55

2.4

2.2

406.85

373.00

nmol/l

0.87

114

486

Hemiplegia

262

1430

1.95

20.50

2.3

2.1

378.31

369.08

nmol/l

0.29

237

1305

Pyothorax

201

1005

2.15

20.47

2.4

2.1

388.55

364.77

nmol/l

0.87

190

920

Other coagulation defects

373

2259

1.75

20.41

2.3

2.1

345.35

372.36

nmol/l

2.03

351

2073

Dipeptidyl peptidase 4 (DPP-4) inhibitors

484

3113

1.62

20.34

1.9

2.4

372.20

371.73

nmol/l

0.02

439

2866

Melanocytic naevi of trunk

529

3475

1.59

20.26

3.6

1.8

368.47

367.99

nmol/l

0.02

493

3177

Redundant prepuce, phimosis and paraphimosis

806

5698

1.44

20.26

2.3

2.4

355.25

365.13

nmol/l

0.74

749

5340

Hyperplasia of prostate

1388

6036

1.34

20.26

2.4

2.7

363.87

370.62

nmol/l

0.45

1259

5669

Other abnormalities of plasma proteins

103

393

3.04

20.24

2.5

1.8

360.69

387.75

nmol/l

0.70

365

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1958

10745

1.27

20.17

2.2

1.8

376.15

367.40

nmol/l

0.97

1779

9701

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

367

2218

1.75

20.17

2.6

1.8

385.30

365.07

nmol/l

0.65

344

2014

Retinal detachments and breaks

1449

11265

1.31

20.16

2.3

386.09

374.90

nmol/l

1.22

1330

10307

Anomalies of dental arch relationship, including avohilmo

976

6442

1.40

20.12

2.4

2.2

357.27

376.19

nmol/l

2.14

896

5962

Acute appendicitis

3464

27783

1.19

20.07

2.2

370.71

372.44

nmol/l

0.17

3227

25663

Endocarditis

159

730

2.34

20.06

2.5

2.3

386.74

371.84

nmol/l

0.38

152

670

Endometriosis ASRM stages 1,2

928

6795

1.41

20.01

2.1

378.71

373.48

nmol/l

0.34

854

6236

Juvenile arthritis (FINNGEN)

270

1505

1.91

19.86

2.4

2.1

331.54

386.23

nmol/l

5.05

252

1392

Benign neoplasm: Rectum, anus and anal canal

822

5896

1.44

19.85

2.4

2.3

374.37

374.50

nmol/l

0.01

749

5401

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1673

10293

1.29

19.85

2.6

1.8

410.62

367.41

nmol/l

11.25

1565

9296

Presence of other devices

881

6375

1.42

19.84

2.0

2.2

367.58

385.42

nmol/l

1.50

834

5773

Other noninflammatory disorders of vulva and perineum

441

2796

1.65

19.79

2.1

2.2

393.57

383.98

nmol/l

0.34

404

2552

Acne vulgaris

426

2682

1.66

19.75

2.1

1.9

392.48

382.85

nmol/l

0.40

397

2481

Other and unspecified pemphigoid

225

3.89

19.73

2.3

1.8

353.85

377.18

nmol/l

0.36

201

Secondary and unspecified malignant neoplasm of lymph nodes

382

2345

1.71

19.71

2.7

2.2

365.90

369.55

nmol/l

0.14

361

2133

Sacroiliitis, not elsewhere classified

250

1361

1.95

19.71

2.5

2.0

353.14

381.48

nmol/l

1.74

226

1266

Tubulo-interstitial nephritis, not specified as acute or chronic

321

1878

1.80

19.70

2.3

2.0

358.14

379.81

nmol/l

1.21

291

1688

Other specified/unspecified bacterial intestinal infections

320

1878

1.81

19.68

2.4

2.1

359.73

373.54

nmol/l

0.57

293

1713

Presbycusis

510

3316

1.58

19.67

1.9

2.1

380.34

388.38

nmol/l

0.35

463

2952

Sequelae of other external causes

265

1473

1.92

19.63

2.5

2.1

371.67

370.43

nmol/l

0.03

254

1337

Salpingitis and oophoritis

870

6325

1.42

19.57

2.4

2.2

371.84

373.72

nmol/l

0.10

790

5820

conjunctival haemorrhage

343

2054

1.77

19.55

2.5

2.1

347.16

371.15

nmol/l

1.56

314

1872

Nonsuppurative otitis media

1160

7580

1.36

19.51

2.3

2.0

371.96

385.64

nmol/l

1.48

1066

6959

Pneumothorax

303

1749

1.82

19.51

3.2

2.1

383.13

373.49

nmol/l

0.31

281

1601

Cholecystitis

564

3781

1.54

19.42

2.3

2.2

360.24

377.35

nmol/l

1.07

511

3455

Any dementia, excluding more controls

1208

6339

1.35

19.42

1.8

2.2

404.67

386.35

nmol/l

1.37

1035

5743

Ankylosing spondylitis

405

2525

1.67

19.41

2.2

337.06

376.14

nmol/l

3.43

374

2334

Specific development disorders of scholastic skills

251

1363

1.95

19.38

2.4

2.2

338.19

373.20

nmol/l

2.12

236

1273

Lymphoid leukaemia

270

1517

1.90

19.36

2.5

2.2

394.14

368.09

nmol/l

1.31

258

1383

Spontaneous rupture of synovium and tendon

354

2137

1.74

19.34

2.2

2.3

337.09

381.29

nmol/l

4.44

324

1968

Benign neoplasm of brain and other parts of central nervous system

324

1919

1.79

19.32

3.1

2.2

336.45

368.44

nmol/l

2.27

301

1756

Other/unspecified enthesopathies, not elsewhere classified

388

2398

1.69

19.28

2.4

2.3

355.72

385.31

nmol/l

1.97

359

2198

Idiopathic gout

363

2209

1.72

19.26

2.0

2.3

337.88

374.01

nmol/l

2.96

325

2017

Wide developmental disorders

195

992

2.14

19.19

2.2

2.4

337.81

368.66

nmol/l

1.61

188

930

Disorders of lacrimal system and orbit in diseases classified elsewhere

150

693

2.39

19.13

2.4

2.0

368.26

375.46

nmol/l

0.18

139

641

130

564

2.54

19.11

1.8

2.0

368.12

385.50

nmol/l

0.53

119

517

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

377

2330

1.71

19.05

2.4

2.1

374.69

371.65

nmol/l

0.11

345

2123

Squamous cell neoplasms and carcinomas of the skin

464

2997

1.61

19.05

2.8

2.1

378.37

383.72

nmol/l

0.21

423

2694

Autism spe

147

674

2.40

19.02

2.1

341.44

382.24

nmol/l

1.95

141

625

Otitis externa

1018

7614

1.38

18.97

2.4

2.2

361.25

373.77

nmol/l

1.21

918

7006

Systemic sclerosis

146

671

2.41

18.88

1.6

2.1

351.22

381.51

nmol/l

0.70

134

616

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1905

10544

1.26

18.79

2.3

1.8

373.46

367.35

nmol/l

0.57

1727

9516

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1868

10345

1.27

18.78

2.3

1.8

374.43

367.48

nmol/l

0.68

1696

9336

Seborrhoeic keratosis

919

6775

1.40

18.77

2.3

2.2

376.99

378.43

nmol/l

0.07

835

6174

Benign neoplasm: Brain, supratentorial

106

425

2.82

18.72

3.4

1.8

302.56

365.92

nmol/l

2.63

385

Dental caries 2, only avohilmo

3888

26422

1.18

18.69

2.1

2.2

366.99

373.21

nmol/l

1.19

3553

24457

Blepharochalasis

1221

9386

1.33

18.68

2.2

371.48

379.43

nmol/l

0.72

1124

8561

Acquired haemolytic anaemia

136

610

2.47

18.61

2.3

1.9

354.98

376.16

nmol/l

0.62

128

560

Other maternal disorders predominantly related to pregnancy

2968

15705

1.21

18.59

2.1

372.56

379.84

nmol/l

1.12

2747

14457

Viral pneumonia (known virus, not influenza)

135

605

2.47

18.53

2.7

2.0

352.19

372.88

nmol/l

0.54

121

559

Haemolytic anaemias

185

937

2.14

18.40

2.4

2.1

347.00

368.49

nmol/l

0.81

173

855

Vulvovaginal ulceration/inflammation in other diseases

325

1955

1.77

18.37

2.0

377.43

379.45

nmol/l

0.07

298

1799

Tobacco use

268

1529

1.87

18.34

2.2

2.1

383.32

370.86

nmol/l

0.43

246

1419

Barrett oesophagus

216

1150

2.00

18.33

2.1

2.4

384.00

372.35

nmol/l

0.32

195

1059

Oral lichen ruber planus wide, hypothyreosis or thyroxin

278

1607

1.86

18.32

2.5

2.1

374.37

370.84

nmol/l

0.11

248

1461

Assault by bodily force

381

2381

1.68

18.30

2.1

363.71

373.01

nmol/l

0.42

347

2215

Panniculitis affecting regions of neck and back

189

962

2.10

18.27

2.1

325.34

378.66

nmol/l

3.34

176

882

Covid-19 suspected case

1017

7649

1.37

18.26

2.2

2.1

365.82

376.67

nmol/l

1.23

952

7037

Superficial injury of wrist and hand

935

6945

1.38

18.24

2.0

2.2

349.87

375.40

nmol/l

4.12

875

6384

Injuries to unspecified part of trunk, limb or body region

458

2989

1.60

18.24

2.1

362.06

375.28

nmol/l

0.70

421

2747

Gonarthrosis, primary, with knee surgery

2339

15811

1.23

18.13

2.0

2.3

361.80

379.39

nmol/l

3.83

2116

14506

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

423

2726

1.63

18.04

2.1

2.2

356.12

371.03

nmol/l

0.86

396

2538

Golimumab

190

980

2.10

17.98

1.9

2.1

311.68

371.23

nmol/l

4.85

184

910

Ganglion

939

6987

1.38

17.96

2.2

361.93

383.63

nmol/l

3.02

861

6457

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2333

16936

1.23

17.95

2.0

2.1

358.59

377.80

nmol/l

5.25

2166

15602

Pneumonia due to Streptococcus pneumoniae

198

1030

2.04

17.94

3.0

2.2

361.51

369.36

nmol/l

0.14

181

956

Cardiac murmurs and other cardiac sounds

430

2741

1.61

17.82

2.2

375.54

380.68

nmol/l

0.19

396

2517

Familial hypercholesterolemia, with ischemic heart disease

377

2361

1.66

17.80

2.2

2.4

373.25

375.66

nmol/l

0.08

338

2139

Diffuse large B-cell lymphoma

217

1173

1.99

17.78

2.0

2.2

373.50

370.37

nmol/l

0.08

208

1057

Lupus erythematosus

143

668

2.36

17.77

2.0

356.14

375.41

nmol/l

0.44

127

608

Olecranon bursitis

259

1469

1.85

17.77

2.4

2.5

347.52

373.05

nmol/l

1.06

245

1362

Other diseases of arteries and capillaries

401

2556

1.64

17.67

2.2

2.1

383.10

373.98

nmol/l

0.31

363

2325

Hypermetropia

356

2212

1.70

17.62

2.7

2.2

364.00

369.81

nmol/l

0.19

327

2026

Other and unspecified trigeminal disorders

100

401

2.81

17.62

2.9

2.2

348.89

364.69

nmol/l

0.29

375

Benign neoplasm: Ascending colon

537

3652

1.53

17.53

2.3

2.2

364.21

374.57

nmol/l

0.59

499

3316

Nontoxic single thyroid nodule

333

2035

1.72

17.53

2.3

2.0

365.98

371.81

nmol/l

0.22

305

1864

Deficiency of other B group vitamins

120

523

2.53

17.50

1.6

2.0

408.69

383.81

nmol/l

0.54

107

479

Primary ovarian failure

125

558

2.50

17.44

2.5

1.8

382.75

373.84

nmol/l

0.11

118

517

Diseases of spleen

106

440

2.71

17.40

2.4

1.8

362.62

377.69

nmol/l

0.32

401

Female infertility, cervigal, vaginal, other or unspecified origin

1366

7145

1.31

17.40

2.1

376.01

383.32

nmol/l

0.61

1273

6574

Other erythematous conditions

185

956

2.09

17.39

2.1

2.0

340.99

372.20

nmol/l

1.42

174

876

Reactive arthropathies

401

2564

1.63

17.37

2.1

2.3

351.33

381.29

nmol/l

2.43

371

2354

Pyogenic arthritis

286

1679

1.78

17.35

2.3

348.38

385.02

nmol/l

1.56

269

1525

Pregnancy hypertension

2108

15675

1.24

17.33

2.0

2.1

359.01

377.34

nmol/l

4.33

1953

14455

Use of disulfiram, acamprosate or naltrexone

405

2601

1.63

17.33

2.2

2.3

366.37

363.96

nmol/l

0.09

367

2421

Myocardial infarction, strict

1903

11287

1.25

17.32

2.2

2.4

371.31

376.16

nmol/l

0.35

1731

10340

Reactive arthropathies, FINNGEN

336

2063

1.71

17.32

2.2

345.29

381.56

nmol/l

2.89

314

1886

Benign neoplasm: Transverse colon

431

2823

1.60

16.96

2.3

357.88

373.06

nmol/l

0.92

393

2577

Heterophoria

409

2651

1.62

16.95

2.6

2.1

342.74

377.06

nmol/l

3.04

379

2433

Cardiac arrest

225

1055

1.91

16.94

2.2

2.5

358.34

381.28

nmol/l

0.95

208

981

Unstable angina pectoris

1508

9950

1.28

16.91

2.1

2.4

372.65

377.94

nmol/l

0.37

1378

9037

Alcohol abuse, main dg

691

4951

1.44

16.90

2.1

2.2

371.02

371.65

nmol/l

0.03

637

4576

Procreative management

1608

10895

1.27

16.87

2.5

2.2

372.46

370.63

nmol/l

0.13

1495

10095

Chronic tubulo-interstitial nephritis

194

1026

2.02

16.85

2.6

1.9

357.64

375.07

nmol/l

0.54

184

922

Systemic sclerosis, icd10

145

697

2.30

16.84

1.6

2.1

351.76

377.86

nmol/l

0.57

133

644

Corneal ulcer

824

6081

1.39

16.82

2.2

358.86

370.88

nmol/l

1.10

751

5605

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

398

2.76

16.82

2.2

1.7

300.25

363.34

nmol/l

2.34

369

Benign neoplasm: Brain, supratentorial

106

448

2.67

16.81

3.4

1.9

302.56

368.58

nmol/l

2.85

412

Fracture at wrist and hand level

1532

12259

1.27

16.79

2.0

2.3

369.02

373.31

nmol/l

0.26

1425

11317

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

159

785

2.17

16.76

2.0

1.7

360.38

371.62

nmol/l

0.28

154

705

Abscess of anal and rectal regions

371

2350

1.64

16.73

2.4

2.3

374.76

366.09

nmol/l

0.35

335

2171

Benign neoplasm of mouth and pharynx

494

3338

1.54

16.71

2.7

2.2

374.84

371.18

nmol/l

0.16

439

3065

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1277

10017

1.30

16.70

2.2

2.3

355.00

372.01

nmol/l

2.74

1177

9237

Polyp of the female genital tract

1528

7061

1.28

16.69

2.1

2.2

382.41

380.53

nmol/l

0.13

1397

6460

Other condition

632

4477

1.46

16.61

2.3

2.2

351.52

372.07

nmol/l

2.13

594

4118

Psoriatic arthropathies, ICD10

491

3323

1.54

16.53

2.0

2.2

343.51

368.64

nmol/l

1.80

453

3064

Hodgkin lymphoma, hilmo

162

815

2.16

16.52

3.3

2.0

371.58

376.12

nmol/l

0.11

153

755

Dental pulpitis 3

675

3453

1.45

16.52

1.9

2.0

392.68

401.36

nmol/l

0.41

616

3189

Lactose intolerance

162

812

2.14

16.49

2.2

2.0

378.78

365.52

nmol/l

0.31

145

750

Diseases of tongue

292

1754

1.75

16.46

2.4

2.0

355.68

377.49

nmol/l

1.11

258

1609

Unspecified jaundice

207

1123

1.94

16.42

2.3

2.1

377.39

378.89

nmol/l

0.03

195

1015

Osteonecrosis due to drugs

317

3.04

16.40

2.9

1.9

360.13

371.34

nmol/l

0.17

293

Pulmonary eosinophilia, not elsewhere classified

311

3.03

16.32

2.3

2.0

316.83

370.42

nmol/l

0.49

277

Other disorders of conjunctiva

596

4191

1.47

16.30

2.5

2.2

351.83

377.28

nmol/l

2.47

547

3832

Lichen planus

556

3865

1.49

16.25

2.4

2.2

364.93

375.49

nmol/l

0.62

499

3542

Other menopausal disorders

1299

5852

1.31

16.22

2.1

2.3

365.45

377.66

nmol/l

1.54

1205

5385

Cerebral aneurysm, nonruptured

395

2565

1.61

16.19

2.6

2.2

373.21

368.86

nmol/l

0.19

370

2355

Moderate visual impairment, binocular

147

717

2.21

16.11

2.2

1.9

394.24

381.38

nmol/l

0.30

124

641

Graves ophthalmopathy

147

723

2.24

16.08

2.3

2.1

367.81

372.89

nmol/l

0.12

136

665

Malignant neoplasm of head and neck

338

2117

1.67

16.07

3.5

2.2

421.92

369.65

nmol/l

4.80

319

1926

Other and unspecified abdominal hernia

194

1045

1.98

16.02

2.5

2.0

365.67

367.94

nmol/l

0.05

182

945

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

309

1902

1.71

15.96

2.6

1.8

383.43

361.52

nmol/l

0.68

289

1732

Other keratitis

513

3526

1.51

15.91

2.1

359.65

373.55

nmol/l

0.90

481

3244

Optic atrophy

117

530

2.47

15.86

3.9

2.0

375.98

361.06

nmol/l

0.09

108

488

Calcific aortic valvular stenosis, operated

1066

8045

1.32

15.80

2.0

2.2

394.15

381.39

nmol/l

0.74

962

7271

Calcific aortic valvular stenosis

1066

8045

1.32

15.80

2.0

2.2

394.15

381.39

nmol/l

0.74

962

7271

Benign neoplasm of middle ear and respiratory system

324

2017

1.68

15.77

2.6

1.8

361.19

365.28

nmol/l

0.11

312

1829

D07AA Corticosteroids, weak (group I)

759

5588

1.40

15.73

2.5

2.1

346.61

373.01

nmol/l

3.34

701

5143

Other and unspecified erythematous conditions

166

859

2.09

15.63

2.1

2.0

340.48

373.17

nmol/l

1.39

156

787

Isolated proteinuria

155

785

2.14

15.52

2.0

2.1

357.18

377.98

nmol/l

0.74

148

724

Operations 2 for CAVS

1061

8022

1.32

15.52

2.0

2.2

394.29

381.83

nmol/l

0.71

957

7248

Calcific aortic valvular stenosis, diagnosis (helper)

1061

8022

1.32

15.52

2.0

2.2

394.29

381.83

nmol/l

0.71

957

7248

Benign neoplasm: Rectum

712

5205

1.41

15.51

2.4

2.3

373.49

373.57

nmol/l

0.00

649

4764

Sacrococcygeal disorders, not elsewhere classified

161

824

2.10

15.51

1.9

2.0

346.44

380.61

nmol/l

1.56

147

759

Ulcer of oesophagus

284

1718

1.73

15.50

2.3

2.2

390.68

376.02

nmol/l

0.49

253

1567

Haemorrhage in early pregnancy

1380

10773

1.28

15.43

2.1

364.06

376.80

nmol/l

1.73

1283

9925

Aneurysms, operations, SAH

685

4981

1.42

15.37

2.3

368.58

375.15

nmol/l

0.41

628

4564

Congenital malformations and deformations of the musculoskeletal system

464

3139

1.54

15.36

2.3

2.2

353.36

368.26

nmol/l

0.91

426

2916

Paralytic strabismus

312

1942

1.69

15.36

2.8

2.1

354.69

374.83

nmol/l

1.12

288

1765

Superficial injury of hip and thigh

600

4263

1.45

15.35

2.1

371.08

382.29

nmol/l

0.70

540

3865

Calcific aortic valvular stenosis, including rheumatic fever

1064

8060

1.32

15.25

2.0

2.2

393.86

382.02

nmol/l

0.66

960

7283

Discitis, unspecified

343

2.78

15.23

2.1

2.3

375.32

382.50

nmol/l

0.10

318

Acute and transient psychotic disorders

551

3870

1.47

15.23

1.9

2.2

385.88

371.07

nmol/l

0.94

503

3579

Graves ophthalmopathy, strict

134

651

2.28

15.23

2.4

2.1

360.89

374.27

nmol/l

0.38

123

600

Amyloidosis

100

427

2.56

15.22

2.2

2.0

370.64

373.30

nmol/l

0.04

385

Gestational diabetes (for exclusion)

1884

10989

1.24

15.22

1.9

2.0

365.68

379.63

nmol/l

2.55

1737

10184

Schizoaffective disorder

375

2444

1.60

15.16

1.8

2.1

400.81

370.11

nmol/l

2.16

345

2276

Myeloproliferative diseases

364

2356

1.62

15.16

2.1

2.2

398.63

370.45

nmol/l

1.58

337

2135

Other and unspecified coagulation defects

251

1487

1.80

15.15

2.4

2.1

335.50

373.62

nmol/l

2.51

240

1374

Otitis externa, unspecified

510

3539

1.50

15.13

2.6

2.2

351.74

374.49

nmol/l

1.69

467

3262

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

118

543

2.37

15.13

3.9

1.7

395.03

354.83

nmol/l

1.31

110

494

Radial styloid tenosynovitis [de Quervain]

264

1580

1.76

15.12

2.1

2.2

359.42

383.69

nmol/l

1.29

241

1457

Short Achilles tendon (acquired)

138

674

2.20

15.12

2.1

2.0

406.68

383.35

nmol/l

0.62

129

616

Other disorders of breast

613

4400

1.44

15.11

2.1

381.06

378.71

nmol/l

0.11

562

4030

Other predominantly sexually transmitted diseases, not elsewhere classified

852

6432

1.36

15.08

2.1

395.54

375.79

nmol/l

1.99

787

5930

Mental retardation, excluding more controls

184

975

1.97

15.04

2.5

2.3

363.76

354.63

nmol/l

0.23

174

915

Other surgical follow-up care

169

890

2.03

15.00

2.1

2.0

371.92

371.91

nmol/l

0.00

159

809

IgA nephropathy (IgA glomerulonephritis)

133

646

2.25

14.99

2.4

2.0

348.32

368.32

nmol/l

0.62

120

604

Other peripheral vertigo

406

2700

1.57

14.95

2.1

365.09

373.41

nmol/l

0.40

362

2472

Symptoms and signs involving emotional state

158

815

2.09

14.93

2.1

404.99

376.72

nmol/l

0.95

145

752

Dislocation, sprain and strain of joints and ligaments of knee

2909

23217

1.18

14.91

2.2

354.74

376.18

nmol/l

8.83

2707

21481

Coxarthrosis, primary

2420

17771

1.20

14.91

2.2

2.3

371.50

377.41

nmol/l

0.54

2185

16286

Dystonia

271

1644

1.74

14.91

2.4

2.1

384.10

372.15

nmol/l

0.45

249

1504

Carrier of infectious disease

134

654

2.24

14.90

2.4

2.0

352.79

380.83

nmol/l

0.83

123

597

Other psoriatic arthropathies

472

3238

1.52

14.89

2.0

2.2

343.59

369.48

nmol/l

1.84

437

2985

Thyrotoxicosis factitia

5.62

14.88

2.3

2.1

335.94

387.43

nmol/l

0.81

Ulcerative proctitis

302

1882

1.69

14.86

2.2

2.1

332.44

375.61

nmol/l

3.87

279

1742

Pleural plaque

335

2129

1.63

14.85

2.2

360.77

377.84

nmol/l

0.79

304

1925

Brain glioblastoma and astrocytoma

424

2.58

14.74

2.2

1.9

300.25

382.84

nmol/l

3.62

399

Nail disorders

387

2556

1.58

14.73

2.7

2.1

364.31

373.00

nmol/l

0.40

355

2352

Somnolence

345

2.78

14.73

1.8

1.9

377.60

387.78

nmol/l

0.13

317

Endometriosis of rectovaginal septum and vagina

377

2476

1.59

14.71

2.1

2.2

372.12

381.48

nmol/l

0.40

350

2264

Impotence

216

1231

1.85

14.71

2.1

2.5

351.59

373.50

nmol/l

1.07

203

1145

Disorders of puberty, all

116

540

2.38

14.68

3.4

2.2

357.58

382.16

nmol/l

0.76

110

506

Chorioretinal inflammation

147

745

2.13

14.66

3.0

2.1

343.69

367.70

nmol/l

0.88

137

687

Other epidermal thickening

208

1178

1.88

14.65

2.3

2.1

357.46

375.37

nmol/l

0.57

188

1078

In situ neoplasms

1536

12512

1.25

14.53

2.5

2.1

378.17

379.67

nmol/l

0.09

1415

11381

Hidradenitis suppurativa

195

1088

1.92

14.53

2.2

2.0

363.53

375.65

nmol/l

0.38

180

1012

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

343

2.81

14.53

2.5

2.0

391.19

371.17

nmol/l

0.25

322

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

113

524

2.41

14.53

2.8

2.2

316.65

367.38

nmol/l

2.00

106

489

Other specified disorders of muscle

139

693

2.15

14.38

2.0

2.2

376.05

375.77

nmol/l

0.01

126

642

Nontraumatic intracranial haemmorrhage

755

5625

1.37

14.38

2.1

2.3

377.96

377.16

nmol/l

0.04

687

5126

Inflammatory diseases of prostate (prostatitis)

470

3232

1.50

14.37

2.2

2.5

360.88

371.82

nmol/l

0.59

428

3019

Allergic purpura

164

870

2.03

14.33

2.4

2.0

337.25

375.52

nmol/l

1.80

151

808

Myasthenia gravis

100

443

2.52

14.28

2.0

351.02

375.27

nmol/l

0.60

414

Endometriosis of ovary

780

5840

1.37

14.28

2.0

2.2

376.95

382.62

nmol/l

0.35

720

5346

Chondrocostal junction syndrome [Tietze]

192

1073

1.92

14.26

1.8

2.0

357.25

378.77

nmol/l

0.89

174

983

Pre-eclampsia or eclampsia

1061

8316

1.31

14.25

2.0

2.1

352.61

376.24

nmol/l

3.70

969

7659

Urethritis and urethral syndrome

118

557

2.30

14.20

2.2

2.1

357.41

389.92

nmol/l

1.14

110

505

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

219

1268

1.82

14.17

2.1

384.54

379.54

nmol/l

0.15

207

1176

Retinal vascular occlusion

455

3125

1.50

14.13

2.1

2.2

392.85

375.17

nmol/l

0.78

408

2827

Vasomotor rhinitis (mode)

340

2206

1.61

14.10

2.1

363.33

370.14

nmol/l

0.30

314

2015

Alzheimer’s disease (Atypical or mixed), excluding more controls

230

1154

1.78

14.05

1.6

2.2

404.84

399.90

nmol/l

0.14

186

1052

L01XX Other antineoplastic agents

241

1440

1.77

14.01

3.3

2.2

417.40

372.52

nmol/l

2.13

222

1300

Other and unspecified psoriasis

297

1871

1.67

13.98

2.4

2.2

334.91

370.58

nmol/l

2.43

271

1725

Carcinoma in situ of skin of other and unspecified parts of face

277

1714

1.68

13.86

2.2

1.7

381.76

374.01

nmol/l

0.17

249

1499

Other and unspecified injuries of head

276

1712

1.69

13.83

2.0

2.2

391.50

376.98

nmol/l

0.50

247

1568

Anogenital herpesviral [herpes simplex] infection

322

2078

1.63

13.73

2.0

2.1

372.60

376.76

nmol/l

0.17

295

1924

Retinal vascular disorders

459

3175

1.49

13.72

2.1

2.2

393.06

376.58

nmol/l

0.72

412

2874

Intentional self-harm by sharp object

142

729

2.10

13.70

2.2

1.9

388.59

393.01

nmol/l

0.09

131

676

Other abnormal findings in urine

394

2.57

13.69

3.0

1.9

367.98

372.51

nmol/l

0.07

356

Other and unspecified disorders of vitreous body

1682

13844

1.23

13.66

2.2

2.3

360.39

375.92

nmol/l

2.62

1534

12698

Intracerebral haemorrhage

458

3166

1.49

13.65

2.2

2.1

382.76

380.50

nmol/l

0.08

417

2870

Follow-up examination after treatment for malignant neoplasms

375

2490

1.55

13.64

2.4

2.2

394.45

388.25

nmol/l

0.22

351

2286

Erythema nodosum

163

879

2.00

13.63

2.3

2.0

339.21

375.11

nmol/l

1.43

152

803

Pre-eclampsia

988

7721

1.31

13.63

2.0

2.1

352.86

376.77

nmol/l

3.56

900

7116

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

145

748

2.06

13.59

4.8

1.7

407.76

361.39

nmol/l

2.06

138

667

Disorder of pancreatic internal secretion, other and/or unspecified

198

3.42

13.57

1.9

436.82

365.51

nmol/l

1.84

184

Open wound of ankle and foot

449

3105

1.50

13.57

2.0

2.2

367.91

373.89

nmol/l

0.26

415

2849

Calcific tendinitis of shoulder

261

1603

1.71

13.56

2.4

2.2

325.08

380.55

nmol/l

5.24

246

1483

Nystagmus and other irregular eye movements

423

2.54

13.56

1.9

2.2

364.79

375.20

nmol/l

0.19

399

Urolithiasis

1292

10410

1.26

13.51

2.4

2.3

358.44

372.99

nmol/l

1.70

1183

9604

Outcome of delivery

531

4588

0.70

13.50

2.0

380.05

388.28

nmol/l

0.53

498

4234

Non-Hodgkin lymphoma, all

167

906

1.95

13.48

2.1

370.26

369.96

nmol/l

0.01

155

819

Neovascular glaucoma

185

1037

1.89

13.46

2.1

2.0

371.49

373.31

nmol/l

0.05

175

945

Primary open-angle glaucoma, strict

986

7690

1.31

13.39

2.0

2.2

396.62

383.98

nmol/l

0.55

883

6947

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

192

1089

1.86

13.38

3.6

1.7

433.60

363.62

nmol/l

3.94

180

974

Other and unspecified epidermal thickening

142

736

2.08

13.37

2.0

2.1

352.16

374.10

nmol/l

0.55

128

677

Achilles tendinitis

426

2922

1.51

13.34

2.1

2.3

353.39

376.57

nmol/l

1.41

390

2702

Abnormality of white blood cells, not elsewhere classified

222

3.23

13.34

3.1

1.9

271.07

372.30

nmol/l

4.32

205

Disorder of thyroid, unspecified

294

2.81

13.33

2.3

1.8

378.39

363.53

nmol/l

0.26

267

Unspecified privation

475

3332

1.48

13.32

2.3

2.2

362.65

371.56

nmol/l

0.46

445

3053

Granulomatous disorders of skin and subcutaneous tissue

138

709

2.10

13.31

2.4

2.0

382.35

373.73

nmol/l

0.21

127

652

Peritonsillar abscess

927

7193

1.32

13.31

2.1

2.2

364.18

377.28

nmol/l

1.09

864

6644

Myopia

601

4391

1.41

13.29

2.3

2.1

376.25

376.09

nmol/l

0.01

553

4040

Maltreatment syndromes

263

1630

1.70

13.29

2.0

1.9

359.49

380.02

nmol/l

1.00

241

1510

Other benign neoplasms of skin

1596

13176

1.23

13.27

2.4

2.2

362.63

377.76

nmol/l

2.39

1444

12049

Benign neoplasm: Caecum

421

2894

1.51

13.23

2.3

2.2

373.86

374.09

nmol/l

0.01

388

2626

Palmar fascial fibromatosis [Dupuytren]

558

4018

1.42

13.21

2.1

2.4

383.59

382.89

nmol/l

0.03

510

3702

Lichen ruber planus, wide definition including periferal and oral lichen planus

889

6882

1.32

13.17

2.4

2.2

368.13

373.23

nmol/l

0.33

800

6302

Postzoster neuralgia

332

2.67

13.15

2.8

1.9

344.65

396.73

nmol/l

1.46

302

Other and unspecified injuries of lower leg

350

2321

1.57

13.13

2.1

2.0

355.64

379.13

nmol/l

1.42

320

2143

Benign neoplasm: Descending colon

262

1626

1.69

13.10

2.7

1.8

369.66

358.51

nmol/l

0.44

239

1459

Acute drug-induced interstitial lung disorder

197

3.38

13.06

2.5

1.9

363.20

378.96

nmol/l

0.15

180

Other autoimmune haemolytic anaemias

305

2.79

13.05

2.0

1.9

345.41

384.92

nmol/l

1.06

279

Calculus of kidney and ureter

1204

9667

1.27

13.04

2.4

2.3

357.57

373.58

nmol/l

1.87

1098

8913

Amyloidosis, other/unspecified

357

2.58

13.03

2.3

1.9

370.19

372.94

nmol/l

0.04

327

Valvular operations

515

3668

1.44

13.02

2.1

2.5

381.81

369.65

nmol/l

0.57

483

3364

Abrasion of teeth

1250

7384

1.27

13.02

2.2

2.1

365.49

371.49

nmol/l

0.53

1129

6886

Melanocytic naevi of trunk

529

3799

1.44

13.02

3.6

2.1

368.47

373.22

nmol/l

0.23

493

3492

Other fall from one level to another

975

7640

1.30

13.01

2.2

383.95

370.75

nmol/l

0.93

913

7044

Lichen planus, including avohilmo

767

5832

1.35

12.99

2.4

2.2

367.38

374.73

nmol/l

0.48

683

5336

Glaucoma secondary to other eye disorders

185

1049

1.87

12.97

2.1

371.49

371.58

nmol/l

0.00

175

960

Other and/or unspecified nontoxic goitre

348

2311

1.57

12.92

2.2

2.0

378.12

377.95

nmol/l

0.01

323

2108

Other and unspecified mononeuropathies, also in other diseases

146

772

2.02

12.87

1.9

2.2

397.18

380.91

nmol/l

0.48

133

712

Specific development disorders of speech and language

289

1776

1.64

12.82

2.9

2.2

322.14

370.77

nmol/l

4.43

265

1639

Lichen simplex chronicus

167

924

1.93

12.80

2.7

2.0

359.87

374.35

nmol/l

0.38

159

852

Lactose intolerance, other/unspecified

138

717

2.06

12.80

2.2

2.0

385.15

365.27

nmol/l

0.46

122

667

Acute posthaemorrhagic anaemia

150

800

1.99

12.76

2.9

2.0

388.07

375.29

nmol/l

0.33

140

722

Fracture of forearm

2511

20245

1.18

12.70

2.1

2.2

373.69

377.29

nmol/l

0.31

2311

18537

Superficial injury of ankle and foot

548

3976

1.42

12.66

2.2

342.26

376.47

nmol/l

4.13

516

3671

!Aliquae complicationes praecoces traumatis

196

1141

1.82

12.60

2.4

2.1

327.43

372.91

nmol/l

3.06

182

1044

Early complications of trauma

196

1141

1.82

12.60

2.4

2.1

327.43

372.91

nmol/l

3.06

182

1044

Monoarthritis, not elsewhere classified

197

1147

1.81

12.58

2.1

2.2

342.08

386.28

nmol/l

2.76

185

1049

Causalgia

447

2.38

12.56

2.3

2.0

353.13

366.17

nmol/l

0.27

417

Premenstrual syndrome

316

2.70

12.55

1.8

2.1

336.39

385.72

nmol/l

1.87

293

Amputation of foot

119

593

2.17

12.52

2.0

2.2

392.67

375.92

nmol/l

0.43

114

530

Other noninfective disorders of lymphatic vessels and lymph nodes

173

975

1.89

12.51

2.4

2.0

383.40

376.53

nmol/l

0.10

162

892

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

298

2.72

12.46

3.2

1.6

372.91

368.52

nmol/l

0.06

270

Nonpyogenic thrombosis of intracranial venous system

253

2.95

12.43

3.1

2.0

362.98

359.16

nmol/l

0.05

231

Synovial cyst of popliteal space [Baker]

296

1915

1.61

12.35

1.9

2.2

365.70

385.15

nmol/l

0.86

273

1752

Disorders of speech understanding and production

216

1276

1.76

12.33

3.0

2.2

319.01

362.17

nmol/l

2.96

198

1189

Thyrotoxicosis with toxic multinodular goitre

270

1718

1.65

12.32

2.1

354.57

372.24

nmol/l

0.78

252

1551

Open wound of wrist and hand

1904

15929

1.20

12.23

2.3

363.39

373.34

nmol/l

1.41

1764

14715

Hypotension due to drugs

307

2.67

12.20

2.0

1.9

337.62

384.86

nmol/l

1.29

273

Disorders of puberty

413

2.41

12.20

2.8

2.1

368.51

389.60

nmol/l

0.49

386

Other secondary coxarthrosis

166

932

1.90

12.19

2.3

2.2

381.19

368.03

nmol/l

0.11

150

852

Cystic kidney disease

165

926

1.91

12.17

2.9

2.1

354.06

368.28

nmol/l

0.41

160

861

Other disorders of penis

362

2450

1.53

12.16

2.5

2.4

353.83

361.39

nmol/l

0.34

330

2285

Malignant neoplasm of thyroid gland

318

2106

1.58

12.14

2.6

2.1

387.91

368.82

nmol/l

0.51

297

1920

Ingrowing nail

256

1613

1.67

12.14

2.6

2.0

367.25

375.90

nmol/l

0.31

234

1489

Residual foreign body in soft tissue

209

1248

1.75

12.11

2.4

2.2

342.03

381.01

nmol/l

2.49

200

1150

Other noninflammatory disorders of vagina

348

2346

1.54

12.03

2.0

2.3

382.37

382.69

nmol/l

0.01

312

2141

Left bundle-branch block

266

1688

1.64

12.03

2.4

2.2

369.22

372.77

nmol/l

0.10

247

1540

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

119

600

2.11

11.98

2.0

1.7

341.66

363.29

nmol/l

0.58

114

535

Toxic effect of other and unspecified substances

348

2.55

11.94

1.7

1.9

376.97

370.31

nmol/l

0.10

326

Persistent delusional disorders

333

2230

1.55

11.94

1.8

2.1

390.87

374.37

nmol/l

0.71

304

2033

Intentional self-harm by unspecified means

324

2.61

11.88

1.9

1.7

377.17

407.02

nmol/l

0.62

297

Erythema intertrigo

117

592

2.14

11.85

2.2

1.9

333.30

377.89

nmol/l

1.76

107

541

Chronic iridocyclitis

238

1484

1.69

11.83

2.3

2.1

345.61

375.29

nmol/l

1.86

219

1368

Primary open-angle glaucoma

1175

9267

1.26

11.81

2.0

2.2

393.94

383.58

nmol/l

0.51

1049

8384

Vascular diseases of the intestine

156

864

1.91

11.81

2.5

2.2

382.17

373.66

nmol/l

0.19

145

782

Other or unspecified common variable immunodeficiency

100

4.54

11.67

2.8

2.3

331.86

374.05

nmol/l

0.60

Orchitis and epididymitis

329

2202

1.54

11.63

2.6

2.4

347.34

369.16

nmol/l

1.12

306

2039

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

266

1706

1.62

11.61

3.3

1.8

404.07

361.26

nmol/l

2.61

254

1527

Other and unspecified aplastic anaemias

279

2.74

11.59

2.7

1.9

356.00

381.70

nmol/l

0.49

257

Congenital malformations of the nervous system

135

726

2.02

11.56

2.1

2.2

383.52

360.13

nmol/l

0.64

120

680

Simple and mucopurulent chronic bronchitis

175

1008

1.82

11.55

2.3

2.2

366.19

379.55

nmol/l

0.38

166

910

Other and unspecified disorders of adult personality and behaviour

150

3.52

11.46

2.3

2.0

315.88

404.73

nmol/l

2.31

142

Scleritis and episcleritis

282

1846

1.60

11.37

2.1

357.77

372.43

nmol/l

0.66

264

1708

Dental pulpitis 3, only avohilmo

596

3232

1.38

11.37

1.8

2.0

403.62

402.52

nmol/l

0.04

549

2980

Otitis media, unspecified

546

3705

1.40

11.36

2.7

2.0

364.06

380.16

nmol/l

1.09

519

3412

Beningn neoplasm: Meninges, unspecified

394

2.40

11.36

2.5

1.9

373.08

366.68

nmol/l

0.09

355

Crossbite

348

2203

1.53

11.33

2.9

2.3

335.07

364.87

nmol/l

2.37

321

2069

Follicular cysts of skin and subcutaneous tissue

767

5943

1.32

11.33

2.4

2.2

375.57

372.34

nmol/l

0.19

703

5469

Myeloproliferative diseases (CML excluded)

316

2119

1.55

11.31

2.1

2.2

402.02

372.57

nmol/l

1.48

292

1921

Bronchitis, not specified as acute or chronic

357

2447

1.51

11.30

2.1

338.46

379.20

nmol/l

3.82

322

2241

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

356

2441

1.51

11.28

2.2

365.96

380.78

nmol/l

0.61

320

2260

Aortic aneurysm

782

5958

1.31

11.27

2.4

360.92

372.83

nmol/l

0.78

728

5470

Vascular dementia

264

1635

1.60

11.24

1.8

1.9

394.23

392.53

nmol/l

0.04

232

1449

Sequelae of injuries of upper limb

426

3028

1.45

11.20

2.1

2.2

374.53

365.93

nmol/l

0.38

392

2779

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

218

1343

1.69

11.17

2.8

1.8

411.34

363.84

nmol/l

2.23

201

1200

Dependent personality disorder

111

564

2.13

11.17

2.7

2.1

380.08

369.54

nmol/l

0.23

100

527

Schizoid personality disorder

476

2.24

11.14

2.0

2.1

380.91

369.80

nmol/l

0.18

450

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

291

2.63

11.04

1.8

1.7

285.98

358.99

nmol/l

2.23

267

Ptosis of eyelid

428

3052

1.45

11.04

2.4

2.2

357.99

376.09

nmol/l

1.06

395

2781

Male infertility

194

1166

1.74

10.99

2.5

2.2

350.56

360.08

nmol/l

0.35

178

1079

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

471

2.22

10.97

3.4

1.8

403.78

358.44

nmol/l

1.47

433

Additional codes for the location of defect, injury or illness

258

1671

1.62

10.95

2.0

2.1

373.21

375.52

nmol/l

0.07

246

1529

Open wound of hip and thigh

157

895

1.86

10.95

2.0

2.1

371.98

378.70

nmol/l

0.16

146

834

Crystal arthropathies, rheuma endpoint

419

2.31

10.92

2.1

1.9

332.40

393.94

nmol/l

1.80

379

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

305

2.55

10.85

1.9

1.7

387.89

353.75

nmol/l

0.70

270

Hallux rigidus

543

4031

1.38

10.83

2.0

2.4

365.39

389.72

nmol/l

1.93

485

3678

Other secondary gonarthrosis

230

1454

1.66

10.82

2.2

2.3

366.79

377.46

nmol/l

0.34

211

1325

Congenital malformations of the urinary system

277

1828

1.59

10.81

2.8

2.3

356.81

370.86

nmol/l

0.53

265

1696

Dementia, including avohilmo

1575

9093

1.21

10.79

1.8

2.2

389.00

381.99

nmol/l

0.70

1365

8250

Unspecified visual impairment (binocular)

390

2.37

10.79

3.1

1.9

355.73

373.36

nmol/l

0.32

362

Single delivery by forceps and vacuum extractor

495

4092

0.72

10.79

1.9

2.0

394.35

389.60

nmol/l

0.22

457

3737

Opening and dilatation of root channel of tooth

292

1950

1.56

10.72

2.3

2.1

367.25

372.76

nmol/l

0.16

255

1810

Recurrent dislocation of patella

251

1624

1.61

10.61

2.3

1.9

364.40

386.46

nmol/l

1.04

228

1489

Dysplasia of cervi uteri

1093

6854

1.26

10.61

1.9

2.1

385.06

382.49

nmol/l

0.16

1013

6300

Recurrent dislocation and subluxation of joint

312

2112

1.53

10.60

2.2

356.00

381.51

nmol/l

1.31

279

1956

Right bundle-branch block

141

783

1.89

10.60

3.0

2.4

317.37

368.48

nmol/l

2.43

131

719

Mixed specific developmental disorders

134

686

1.96

10.59

3.0

2.7

325.42

351.00

nmol/l

0.85

126

653

Intermittent heterotropia

292

1958

1.56

10.55

2.4

2.2

348.31

374.88

nmol/l

1.51

267

1816

Malignant neoplasm of bladder

244

1565

1.61

10.55

4.1

2.1

416.91

375.23

nmol/l

2.39

231

1410

Pediculosis, acariasis and other infestations

261

1708

1.60

10.54

2.5

2.2

334.78

372.42

nmol/l

3.08

240

1593

Alzheimer’s disease, wide definition, excluding more controls

480

2358

1.41

10.53

1.7

2.4

409.86

394.81

nmol/l

0.79

394

2160

Beningn neoplasm: Meninges, unspecified

407

2.32

10.52

2.5

1.9

373.07

378.47

nmol/l

0.07

374

Abscess of lung

374

2.38

10.52

2.5

2.1

380.92

363.67

nmol/l

0.17

343

Carcinoma in situ of skin

282

1874

1.56

10.50

2.2

1.8

362.51

371.65

nmol/l

0.28

265

1660

Alopecia areata

139

777

1.92

10.47

2.2

2.1

367.06

369.87

nmol/l

0.06

127

720

Benign neoplasm of middle ear and respiratory system

324

2218

1.51

10.46

2.6

2.2

361.19

370.91

nmol/l

0.31

312

2023

Amiodarone users

379

2673

1.47

10.43

2.1

2.3

402.28

370.89

nmol/l

1.68

357

2452

Third [oculomotor] nerve palsy

469

2.21

10.41

3.3

2.0

359.16

376.47

nmol/l

0.40

432

Dementia in other diseases classified elsewhere

177

1057

1.76

10.38

1.9

2.1

375.77

370.29

nmol/l

0.14

140

951

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

517

3840

1.38

10.35

2.2

1.8

375.87

364.96

nmol/l

0.70

478

3501

Benign neoplasm: Tongue

126

685

1.96

10.31

2.9

1.8

380.53

365.64

nmol/l

0.32

108

622

Alzheimer’s disease (Late onset), excluding more controls

446

2130

1.42

10.30

1.7

2.3

406.85

396.80

nmol/l

0.44

369

1951

Dermatopolymyositis, unspecified

128

3.61

10.26

1.8

1.9

406.77

362.44

nmol/l

0.18

117

Other localized connective tissue disorders

102

519

2.13

10.26

2.3

1.8

326.29

381.99

nmol/l

2.06

479

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

240

2.75

10.25

3.4

1.7

396.43

371.08

nmol/l

0.45

211

Complications of other internal prosthetic devices, implants and grafts

166

980

1.79

10.22

2.3

2.0

378.70

366.64

nmol/l

0.30

147

883

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

4.30

10.20

3.2

2.4

301.81

341.65

nmol/l

0.63

Problems related to social environment

132

729

1.92

10.20

2.0

1.9

358.74

379.27

nmol/l

0.55

120

667

Toxic effects of substances chiefly nonmedicinal as to source

492

3640

1.39

10.17

2.1

2.2

377.88

375.13

nmol/l

0.11

451

3358

Other forms of systemic lupus erythematosus

249

2.76

10.17

1.9

353.22

380.89

nmol/l

0.50

233

Arthropathy in ulcerative colitis

362

2.39

10.11

2.7

2.1

302.74

358.05

nmol/l

1.94

341

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2750

19758

1.15

10.11

2.1

367.79

375.15

nmol/l

1.21

2587

18170

Childhood allergy (age < 16)

727

4663

1.31

10.10

2.0

385.76

396.81

nmol/l

0.81

676

4305

Other and unspecified vascular occlusions

342

2381

1.48

10.06

2.1

2.2

390.02

375.97

nmol/l

0.60

306

2145

Arthropod-borne viral fevers and viral haemorrhagic fevers

398

2852

1.44

10.04

2.2

359.09

369.96

nmol/l

0.52

372

2629

Renal cell carcinoma of kidney

145

828

1.85

10.03

4.8

2.1

407.76

372.87

nmol/l

1.33

138

754

Scabies

206

1293

1.67

10.03

2.3

2.2

334.90

375.38

nmol/l

2.84

186

1208

Acute nasopharyngitis (common cold)

489

3595

1.39

10.02

2.5

2.3

354.84

369.58

nmol/l

1.14

456

3351

Degenerative macular diseases

457

3348

1.40

10.02

2.0

2.2

395.29

374.99

nmol/l

0.95

410

3026

Medical abortion

3282

15837

1.14

10.00

2.1

2.0

380.20

384.91

nmol/l

0.65

2991

14511

Impetigo

216

1373

1.65

10.00

2.9

2.1

323.29

366.11

nmol/l

2.48

206

1278

Atopic conjunctivitis

216

1374

1.65

9.97

2.3

2.0

365.95

380.15

nmol/l

0.51

202

1273

Panniculitis, unspecified

237

2.71

9.95

2.3

1.8

319.53

380.73

nmol/l

1.76

216

Ménière disease

402

2892

1.44

9.94

2.1

2.2

373.68

374.34

nmol/l

0.02

367

2638

Injury of unspecified body region

322

2227

1.50

9.93

2.2

2.1

368.76

376.08

nmol/l

0.26

298

2040

Benign neoplasm: Small intestine

168

1005

1.76

9.91

2.4

1.8

346.42

368.38

nmol/l

0.67

153

905

Benign neoplasm: Skin of eyelid, including canthus

562

4254

1.35

9.89

2.2

1.8

364.93

367.67

nmol/l

0.11

508

3837

Benign lipomatous neoplasm

1228

10188

1.23

9.89

2.4

2.2

360.26

372.68

nmol/l

1.52

1142

9365

Acute lymphadenitis

279

1878

1.55

9.89

2.2

2.1

361.62

376.82

nmol/l

0.77

263

1733

Ankylosing spondylitis, ICD10

396

2848

1.44

9.81

2.2

336.54

366.77

nmol/l

2.23

365

2646

Early lumbar disc prolapse operation

497

3706

1.38

9.80

2.1

353.06

365.32

nmol/l

0.78

463

3448

Episcleritis

242

1586

1.60

9.79

2.1

355.80

372.60

nmol/l

0.72

228

1466

Ulcer of vagina/vulva

127

706

1.93

9.78

1.8

2.1

379.11

383.31

nmol/l

0.08

116

646

Medial epicondylitis

168

1007

1.75

9.77

2.5

2.1

358.26

376.58

nmol/l

0.67

152

936

Personal history of allergy to drugs, medicaments and biological substances

296

2.52

9.76

2.6

2.1

304.29

372.92

nmol/l

2.38

272

Exophthalmic conditions

271

2.58

9.73

3.0

1.9

305.37

387.43

nmol/l

2.91

251

Late syphilis

355

2.37

9.70

2.1

2.0

392.33

361.63

nmol/l

0.68

328

Juvenile rheumatoid arthirtis

116

627

1.97

9.68

2.0

1.8

314.03

388.61

nmol/l

3.84

108

579

Macular pucker

531

4005

1.36

9.66

2.3

380.46

374.68

nmol/l

0.26

481

3651

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

727

5532

1.30

9.65

2.6

2.3

357.55

367.24

nmol/l

0.60

683

5115

Dislocation, sprain and strain of joints and ligaments of head

201

1268

1.66

9.62

2.3

2.2

350.31

365.78

nmol/l

0.59

189

1173

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

111

592

1.99

9.60

1.9

1.7

421.66

362.30

nmol/l

2.42

104

528

Chronic lymphocytic leukaemia, helper endpoint

111

592

1.99

9.60

1.9

1.7

421.66

362.30

nmol/l

2.42

104

528

Personal history of certain other diseases

104

546

2.05

9.58

1.6

1.8

357.75

388.09

nmol/l

1.00

504

Acute lymphocytic leukaemia, helper endpoint

215

2.89

9.56

3.5

2.3

339.13

379.62

nmol/l

0.87

205

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

215

2.89

9.56

3.5

2.3

339.13

379.62

nmol/l

0.87

205

Benign neoplasm: Duodenum

114

617

1.98

9.54

2.5

1.8

318.90

362.20

nmol/l

1.50

101

561

Other crystal arthropathies

443

2.17

9.51

2.1

2.2

332.40

384.33

nmol/l

1.41

399

Lesion of lateral popliteal nerve

206

1309

1.64

9.50

2.0

2.2

376.21

374.52

nmol/l

0.04

189

1203

Mature T/NK-cell lymphomas, hilmo

338

2.38

9.50

3.2

1.9

372.91

380.79

nmol/l

0.11

310

Amputation of ankle bones

504

2.08

9.50

2.1

2.0

368.83

371.64

nmol/l

0.04

452

Tongue abnormality

266

1791

1.55

9.50

2.3

2.1

355.01

374.42

nmol/l

0.85

234

1631

Benign neoplasm of other and unspecified sites

144

838

1.82

9.41

2.8

1.7

359.50

365.17

nmol/l

0.13

132

759

Fall involving bed

130

735

1.88

9.40

1.8

1.9

348.25

372.74

nmol/l

0.75

117

667

Prolonged pregnancy

457

5578

0.73

9.36

2.0

382.75

383.20

nmol/l

0.02

436

5137

Unspecified chronic bronchitis

144

835

1.80

9.36

2.3

2.1

324.06

385.70

nmol/l

4.22

123

751

Other disorders of thyroid

355

2.32

9.25

2.3

1.9

377.13

374.15

nmol/l

0.04

324

Urethral stricture

200

1267

1.64

9.23

2.3

353.41

372.72

nmol/l

0.49

182

1157

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

168

1026

1.73

9.22

2.6

2.1

341.94

376.71

nmol/l

1.57

156

935

Other obstructive and reflux uropathy

191

1201

1.66

9.20

2.4

2.0

367.06

378.14

nmol/l

0.32

172

1094

Hydrocele

394

2852

1.41

9.20

2.5

2.4

340.47

371.61

nmol/l

2.84

363

2648

Other and unspecified diseases of blood and blood-forming organs

119

661

1.92

9.19

2.4

2.0

330.12

378.35

nmol/l

2.11

113

605

Brain glioblastoma

317

2.40

9.16

1.8

285.98

375.28

nmol/l

3.08

296

Iridocyclitis in diseases classified elsewhere

499

2.08

9.15

2.3

2.0

346.74

374.15

nmol/l

0.61

461

Pre-eclampsia or poor fetal growth

1462

12386

1.20

9.14

2.0

2.1

360.85

377.00

nmol/l

2.70

1343

11432

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

139

810

1.82

9.09

2.0

2.1

359.62

372.72

nmol/l

0.34

130

755

Other disorders of bone density and structure

126

714

1.88

9.08

2.6

2.0

361.46

374.88

nmol/l

0.31

112

659

Degeneration of the brain due to alcohol

520

2.04

9.06

2.0

2.2

404.84

363.77

nmol/l

0.91

479

Hydrocephalus

296

2050

1.49

9.06

2.6

2.1

387.18

378.68

nmol/l

0.12

273

1859

Event of undetermined intent

273

1864

1.52

9.05

2.3

2.1

371.83

371.15

nmol/l

0.02

251

1732

Other orthopaedic follow-up care

235

1555

1.57

9.04

2.2

2.1

361.02

372.92

nmol/l

0.46

217

1405

Other disorders of the genitourinary system

522

3971

1.35

9.04

2.1

2.2

376.73

378.37

nmol/l

0.06

470

3614

Other diseases of peritoneum

204

1313

1.63

9.00

2.1

2.0

364.72

373.95

nmol/l

0.28

181

1196

Meningitis

228

1504

1.58

8.99

2.7

2.1

351.93

371.18

nmol/l

0.75

214

1382

Carcinoma in situ of skin of upper limb, including shoulder

480

2.08

8.97

3.1

1.7

394.24

366.78

nmol/l

0.28

421

Portal vein thrombosis

379

2.24

8.96

2.6

2.1

371.57

372.53

nmol/l

0.01

346

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

162

986

1.72

8.93

3.2

1.8

365.07

357.94

nmol/l

0.18

156

894

Thoracic aortic aneurysm

485

3652

1.36

8.93

2.3

2.4

350.01

370.02

nmol/l

1.20

451

3369

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

115

637

1.92

8.92

4.2

1.8

422.10

356.94

nmol/l

2.39

107

576

Carcinoma in situ of skin of other and unspecified parts of face

277

1903

1.51

8.85

2.2

2.0

381.76

381.16

nmol/l

0.01

249

1706

Viral meningitis

177

1107

1.68

8.85

2.6

1.9

347.06

377.23

nmol/l

1.50

162

1030

Other congenital malformations of the digestive system

217

1415

1.60

8.82

2.9

2.3

323.47

359.02

nmol/l

2.04

202

1323

Acute lymphocytic leukaemia

224

2.76

8.81

3.5

2.3

339.13

378.72

nmol/l

0.85

213

Melanoma in situ

157

954

1.73

8.76

3.7

1.8

412.04

361.37

nmol/l

1.12

147

856

Wet age-related macular degeneration

571

4324

1.32

8.75

1.9

2.0

378.06

386.57

nmol/l

0.38

505

3846

Behavioural disorders, excluding more controls

432

2.09

8.75

2.2

2.0

357.36

377.14

nmol/l

0.48

403

Leiomyoma of uterus

2262

11153

1.16

8.75

2.1

1.8

365.68

367.26

nmol/l

0.13

2082

10204

Intussusception

102

549

1.98

8.70

2.3

335.60

366.31

nmol/l

0.86

498

Degeneration of nervous system due to alcohol

528

2.00

8.67

2.0

2.2

404.84

367.40

nmol/l

0.80

486

Coronary revascularization (ANGIO or CABG)

1745

10479

1.18

8.67

2.1

2.4

377.49

377.68

nmol/l

0.01

1601

9593

Other superficial mycoses

105

572

1.97

8.67

2.3

2.0

390.18

373.61

nmol/l

0.17

537

Sudden idiopathic hearing loss

394

2891

1.40

8.67

2.2

371.49

374.24

nmol/l

0.09

359

2649

Thyroiditis, unspecified

370

2.21

8.63

2.3

1.8

368.31

374.53

nmol/l

0.10

339

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

391

2.18

8.60

3.2

1.7

388.85

354.59

nmol/l

0.79

360

Other disorders of binocular movement

120

683

1.88

8.60

2.3

2.0

378.68

378.89

nmol/l

0.00

108

632

Other/unspecified reactive arthropathies

293

2051

1.48

8.58

2.2

2.1

347.08

369.08

nmol/l

1.19

272

1888

Benign neoplasm: Anus and anal canal

117

659

1.88

8.57

2.2

1.8

359.52

365.17

nmol/l

0.12

108

594

Parodontitis, operation under 40 years and operation codes

417

3092

1.39

8.57

2.2

1.9

366.79

387.11

nmol/l

1.36

387

2839

Deep endometriosis

456

3435

1.37

8.57

2.1

377.66

375.96

nmol/l

0.06

421

3139

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

204

1322

1.59

8.54

2.8

1.8

394.66

368.83

nmol/l

1.02

192

1177

Benign neoplasm: Descending colon

262

1797

1.51

8.54

2.7

2.2

369.66

368.64

nmol/l

0.03

239

1630

Spermatocele

260

1774

1.51

8.52

2.6

2.5

349.36

376.44

nmol/l

1.59

239

1641

Infection due to other mycobacteria

359

2.22

8.49

2.0

1.8

293.79

368.62

nmol/l

2.69

322

Dementia

1435

8413

1.19

8.46

1.7

2.2

395.57

381.76

nmol/l

1.12

1235

7628

Postmenopausal atrophic vaginitis

1069

5318

1.23

8.44

2.0

2.3

374.27

380.66

nmol/l

0.47

986

4864

Other contact dermatitis

348

2514

1.43

8.43

2.2

2.0

347.47

376.45

nmol/l

2.09

313

2300

Oral leukoplakia and related diseases, including avohilmo

356

2587

1.42

8.38

2.7

2.2

365.93

370.66

nmol/l

0.17

319

2370

Vertical strabismus

158

975

1.71

8.38

2.2

2.0

358.93

377.24

nmol/l

0.59

143

900

Burns and corrosions

580

4522

1.31

8.34

2.2

368.40

366.63

nmol/l

0.08

544

4178

Acute bronchiolitis

300

1901

1.47

8.33

3.2

2.1

335.91

372.95

nmol/l

1.44

282

1758

UC patients in KELA-register (code 208), prior to 1994

195

1265

1.61

8.33

2.3

2.2

339.31

371.37

nmol/l

1.40

183

1168

Glucosamine medication

1993

13893

1.16

8.33

2.1

2.2

372.64

380.21

nmol/l

0.94

1795

12664

Obstructive hydrocephalus

418

2.13

8.31

3.8

2.1

336.88

370.66

nmol/l

0.97

388

Congenital malformations of the respiratory system

102

562

1.98

8.31

3.0

2.4

298.11

358.73

nmol/l

2.65

529

Pustulosis palmaris et plantaris

189

1219

1.63

8.31

2.3

2.1

368.41

371.65

nmol/l

0.09

173

1122

Benign neoplasm: Other/unspecified site

397

2.15

8.30

3.0

1.7

354.19

364.36

nmol/l

0.19

366

Post-traumatic wound infection, not elsewhere classified

118

675

1.86

8.28

2.5

2.1

315.23

372.89

nmol/l

3.19

110

621

Use of antiglaucoma preparations and miotics

299

2110

1.46

8.27

2.0

382.76

378.59

nmol/l

0.14

266

1886

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2060

14235

1.15

8.27

2.2

2.1

378.18

379.32

nmol/l

0.08

1859

12953

Nontoxic diffuse goitre

138

824

1.76

8.26

2.3

1.9

359.87

381.73

nmol/l

0.72

127

746

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

124

719

1.82

8.26

2.5

1.8

400.74

360.63

nmol/l

0.72

114

643

Benign neoplasm: Skin of other and unspecified parts of face

395

2920

1.39

8.25

2.6

1.8

364.82

369.06

nmol/l

0.16

347

2637

Parodontitis, under 40 years and operation codes

414

3087

1.38

8.23

2.1

1.9

367.29

386.92

nmol/l

1.29

385

2833

Arterial embolism and thrombosis

209

1375

1.57

8.20

2.4

2.2

352.14

371.04

nmol/l

0.57

185

1241

Other specified/unspecified spondylopathies

104

573

1.92

8.18

2.4

2.1

339.88

389.22

nmol/l

1.92

523

Paraplegia, diplegia of upper limbs

103

568

1.93

8.17

2.1

2.0

312.02

382.63

nmol/l

3.24

517

Allergic contact dermatitis due to drugs in contact with skin

112

635

1.89

8.17

2.3

2.0

384.73

375.68

nmol/l

0.15

101

588

Secondary parkinsonism+Parkinsonism in other disease

115

655

1.85

8.14

1.9

2.1

399.02

376.79

nmol/l

0.54

103

592

Coronary angioplasty

1377

8994

1.19

8.09

2.1

2.4

371.77

379.41

nmol/l

0.51

1266

8208

Lesion of radial nerve

156

966

1.69

8.09

2.2

364.03

377.11

nmol/l

0.36

140

888

Poisoning by narcotics and psychodysleptics [hallucinogens]

421

2.09

8.08

2.2

1.9

339.34

392.18

nmol/l

1.54

388

Galactorrhea

295

2.36

8.07

2.2

2.1

371.50

369.47

nmol/l

0.04

274

Other papulosquamous disorders

288

2.37

8.06

2.8

2.0

307.61

369.23

nmol/l

1.57

269

Malignant neoplasm of oral cavity

142

861

1.74

8.06

4.1

2.2

438.75

371.45

nmol/l

3.05

134

784

Other disorders of Eustachian tube

134

801

1.77

8.05

2.9

2.1

350.93

373.17

nmol/l

0.79

119

738

Meralgia paraesthetica

146

892

1.72

8.04

2.0

2.1

343.06

377.66

nmol/l

1.65

136

828

Use of bromocriptine

6.05

8.00

4.8

1.9

286.53

347.09

nmol/l

0.60

Abnormal findings in nipple discharge synovial fluid wound secretions

453

2.06

8.00

3.1

2.0

383.70

378.55

nmol/l

0.08

420

Pustular psoriasis

207

1375

1.57

7.98

2.3

2.1

364.63

369.14

nmol/l

0.13

189

1259

Allergic colitis

126

743

1.80

7.97

2.9

2.2

319.25

375.70

nmol/l

2.65

120

698

Parodontitis, under 40 years, or operation codes

435

3286

1.36

7.93

2.2

1.9

365.88

385.82

nmol/l

1.39

404

3026

Haemangioma, any site

332

2407

1.42

7.92

2.3

1.8

365.36

366.30

nmol/l

0.03

304

2193

Any dementia

1259

7499

1.20

7.90

1.7

2.1

404.15

383.72

nmol/l

1.71

1076

6781

Nonischemic cardiomyopathy

219

1472

1.54

7.88

2.7

2.4

393.78

367.75

nmol/l

1.10

209

1362

Collapsed vertebra, not elsewhere classified

165

2.83

7.88

1.8

2.1

330.86

400.12

nmol/l

0.94

147

Other and unspecified injuries of ankle and foot

193

1266

1.59

7.87

2.0

2.1

388.41

381.14

nmol/l

0.18

182

1176

Chondropathies

661

5280

1.28

7.82

2.3

2.2

357.76

372.44

nmol/l

1.09

614

4853

Embedded and impacted teeth

1205

8661

1.20

7.82

2.1

2.0

391.57

384.11

nmol/l

0.54

1122

7996

Haemangioma and lymphangioma, any site

353

2591

1.40

7.81

2.2

1.9

367.05

364.86

nmol/l

0.08

323

2358

Alcohol-induced acute pancreatitis

150

930

1.69

7.79

2.2

2.3

337.38

364.58

nmol/l

1.07

135

874

Vertigo of central origin

400

2.11

7.79

2.1

1.8

367.89

382.44

nmol/l

0.23

357

Endometriosis ASRM stages 3,4

1060

8893

1.21

7.78

2.0

2.1

376.99

377.11

nmol/l

0.01

981

8128

Polycythaemia vera

136

823

1.73

7.74

2.1

1.7

409.71

364.80

nmol/l

1.33

127

732

Benign lipomatous neoplasm of other sites/unspecified

313

2253

1.43

7.74

2.4

1.8

339.23

366.32

nmol/l

1.67

288

2028

Herpesviral keratitis and keratoconjunctivitis

184

1199

1.60

7.73

2.4

2.1

334.32

371.03

nmol/l

1.84

174

1096

Other and unspecified intracranial injuries

130

778

1.76

7.73

1.9

2.1

384.82

367.30

nmol/l

0.38

118

721

Sixth [abducent] nerve palsy

144

887

1.71

7.72

3.0

2.2

358.01

378.66

nmol/l

0.63

134

807

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

303

2174

1.44

7.70

2.6

1.8

374.56

363.84

nmol/l

0.45

285

1975

Cyst of kidney

258

1801

1.48

7.69

2.3

2.2

332.76

371.88

nmol/l

2.36

240

1632

Viral haemorrhagic fevers, not elsewhere classified/unspecified

322

2337

1.42

7.68

2.1

2.2

363.92

371.19

nmol/l

0.26

302

2158

Injury of muscle and tendon at shoulder and upper arm level

1360

11650

1.18

7.67

2.3

2.4

358.07

373.60

nmol/l

2.33

1281

10770

Papillary adenocarcinoma of thyroid gland

232

1592

1.52

7.66

2.5

2.1

384.68

368.29

nmol/l

0.34

218

1457

Hordeolum and other deep inflammation of eyelid

238

1639

1.51

7.65

2.5

2.1

356.32

374.54

nmol/l

0.63

222

1521

Malignant neoplasm of mesothelium and soft tissue

173

1115

1.62

7.63

3.5

2.2

415.68

370.77

nmol/l

2.14

165

1014

Oesophageal obstruction

133

804

1.73

7.57

2.4

2.3

433.20

374.99

nmol/l

0.85

127

730

Psoriasis (vulgaris), strict definition

142

877

1.70

7.53

2.6

2.2

314.12

367.68

nmol/l

3.31

133

825

Vascular dementia (undefined)

111

630

1.80

7.49

1.8

401.88

407.42

nmol/l

0.10

547

Stenosis and insufficiency of lacrimal passages

376

2807

1.38

7.49

2.3

2.2

376.90

379.00

nmol/l

0.07

343

2566

Parodontitis, under 40 years

431

3280

1.35

7.49

2.1

1.9

366.51

385.83

nmol/l

1.32

401

3020

Benign neoplasm: Tongue

126

757

1.76

7.48

2.9

2.1

380.53

374.04

nmol/l

0.12

108

693

Other/unspecified soft tissue disorders related to use, overuse and pressure

125

747

1.76

7.48

2.1

2.0

371.19

385.38

nmol/l

0.31

116

684

Benign neoplasm: Small intestine

168

1083

1.63

7.47

2.4

2.2

346.42

373.52

nmol/l

0.90

153

987

Superficial injury of shoulder and upper arm

455

3490

1.34

7.47

2.0

2.2

364.54

371.09

nmol/l

0.31

416

3213

Other or unspecified immunodeficiency

103

3.49

7.46

2.9

2.4

357.40

376.22

nmol/l

0.20

Other specified disorders of kidney and ureter

145

903

1.69

7.45

2.2

374.32

370.44

nmol/l

0.07

133

830

Crowding of teeth, including avohilmo

435

2731

1.35

7.43

2.5

2.0

386.25

378.88

nmol/l

0.29

406

2521

Exposure to other and unspecified inanimate mechanical forces

295

2124

1.44

7.42

2.6

2.2

355.89

372.40

nmol/l

0.74

276

1964

Lesion of plantar nerve

253

1773

1.48

7.42

2.1

2.2

359.26

374.48

nmol/l

0.66

226

1618

Convergence insufficiency and excess

394

2.08

7.38

2.7

1.8

375.44

379.05

nmol/l

0.05

365

Other prurigo

292

2.28

7.38

2.0

1.8

311.55

379.15

nmol/l

2.04

267

Memory loss

342

2522

1.39

7.38

1.9

2.2

398.63

376.79

nmol/l

1.02

303

2290

Benign neoplasm of major salivary glands

345

2545

1.39

7.37

2.4

1.8

380.09

362.69

nmol/l

0.76

314

2300

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

278

2.30

7.37

1.4

2.0

380.37

374.31

nmol/l

0.08

258

Bicipital tendinitis

185

1218

1.58

7.37

1.9

2.3

361.20

373.25

nmol/l

0.41

165

1126

Sulfonylureas

1279

8707

1.19

7.35

1.8

2.3

391.97

379.73

nmol/l

1.08

1148

7911

Secondary parkinsonism

112

654

1.81

7.33

1.9

2.0

402.68

373.35

nmol/l

0.76

100

593

Myotonic disorders

222

2.51

7.32

1.7

2.0

344.19

364.32

nmol/l

0.35

206

Other disorders of pigmentation

182

1199

1.58

7.31

2.6

2.1

350.24

373.09

nmol/l

0.77

169

1096

Other bullous disorders

123

740

1.76

7.27

2.5

2.0

342.41

371.88

nmol/l

1.06

116

685

Carcinoma in situ of skin of trunk

105

603

1.83

7.24

3.4

1.7

360.30

367.24

nmol/l

0.12

526

Pneumonia derived septicemia

144

901

1.67

7.23

2.9

2.1

392.50

373.45

nmol/l

0.14

130

824

Benign neoplasm: Duodenum

114

675

1.80

7.19

2.5

2.1

318.90

372.64

nmol/l

2.12

101

620

Use of levodopa decarboxylase inhibitor

450

3463

1.33

7.19

1.8

2.2

389.53

377.74

nmol/l

0.57

399

3143

Contusion of other and unspecified parts of foot

224

1545

1.51

7.18

2.2

2.1

322.50

379.35

nmol/l

5.16

212

1428

Melanocytic naevi of lower limb, including hip

184

1220

1.57

7.18

3.4

1.8

369.88

363.88

nmol/l

0.18

173

1120

Benign neoplasm of other and unspecified sites

144

904

1.67

7.18

2.8

2.0

359.50

373.53

nmol/l

0.39

132

834

Benign neoplasm: Other/unspecified site

419

2.03

7.18

3.0

1.9

354.19

374.47

nmol/l

0.45

384

Filling of root of tooth

137

850

1.70

7.17

2.5

2.1

373.57

368.73

nmol/l

0.09

127

798

Primary coxarthrosis, bilateral

1047

8833

1.20

7.16

2.1

2.2

372.23

381.37

nmol/l

0.74

942

8032

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

933

4718

1.22

7.15

2.5

1.8

367.36

359.17

nmol/l

0.50

868

4296

Pilonidal cyst

367

2749

1.37

7.14

2.2

2.1

362.98

372.12

nmol/l

0.40

339

2534

Chronic Coagulation defects

120

722

1.76

7.13

2.4

2.0

359.21

373.00

nmol/l

0.39

112

669

563

1.86

7.12

2.8

2.0

301.73

380.53

nmol/l

3.05

515

Viral hepatitis

313

2292

1.41

7.11

2.3

2.1

347.68

371.06

nmol/l

1.53

288

2122

Dementia due to Parkinsons disease, excluding more controls

333

2.11

7.10

1.7

2.2

408.38

403.29

nmol/l

0.07

302

Guillain-Barre syndrome

406

2.04

7.10

2.5

2.0

323.67

378.70

nmol/l

2.03

376

Other and unspecified pemphigus

3.61

7.07

1.6

2.0

350.59

382.98

nmol/l

0.27

Open bite

249

1759

1.47

7.07

2.5

2.1

353.11

375.19

nmol/l

1.06

234

1628

Acute epiglottitis

386

2.05

7.02

1.6

1.8

351.82

374.49

nmol/l

0.43

358

Thyrotoxicosis with toxic single thyroid nodule

246

2.40

7.02

1.8

1.9

405.02

371.91

nmol/l

0.65

227

Hypothermia

450

1.97

7.01

1.8

1.9

479.45

372.65

nmol/l

0.62

411

Benign neoplasm of bone and articular cartilage

332

2458

1.39

7.01

2.4

1.8

344.35

369.61

nmol/l

1.66

309

2236

Parkinson's disease, including avohilmo

531

4188

1.29

7.00

1.8

2.3

388.82

375.33

nmol/l

0.83

469

3821

Divergent concomitant strabismus

337

2506

1.38

6.96

2.0

2.1

379.12

371.21

nmol/l

0.32

318

2306

Atrophic disorders of skin

586

4687

1.28

6.94

2.1

368.04

379.06

nmol/l

0.73

540

4295

Impacted teeth

835

6438

1.23

6.94

2.1

1.9

387.77

391.68

nmol/l

0.18

774

5938

184

1218

1.54

6.92

1.8

1.9

412.47

379.93

nmol/l

0.36

169

1072

Preterm labour and delivery

1170

10003

1.19

6.90

2.1

366.87

373.84

nmol/l

0.46

1070

9219

Other congenital malformations of nervous system

308

2.21

6.90

1.8

2.1

385.83

383.39

nmol/l

0.03

288

Other facial nerve disorders

122

742

1.73

6.89

2.0

2.1

365.55

377.04

nmol/l

0.28

112

687

Acquired absence of organs, not elsewhere classified

293

2.22

6.88

2.8

1.9

329.47

376.33

nmol/l

1.06

263

Other renal tubulo-interstitial diseases

110

652

1.78

6.87

2.5

1.9

388.00

374.30

nmol/l

0.31

101

599

Overexertion and strenuous or repetitive movements

410

3141

1.34

6.86

2.1

2.2

387.14

371.03

nmol/l

0.73

372

2900

Universal erythroderma, KELA reimbursement

369

2.07

6.85

2.9

2.0

271.65

382.58

nmol/l

6.10

342

Other/unspecified disorders of vestibular function

161

1049

1.60

6.85

1.8

2.0

363.76

379.40

nmol/l

0.48

148

954

Injury of other and unspecified intrathoracic organs

237

1665

1.47

6.84

2.3

2.2

372.05

376.52

nmol/l

0.12

222

1531

Carcinoma in situ of skin of upper limb, including shoulder

528

1.87

6.80

3.1

1.8

394.24

385.00

nmol/l

0.08

474

Pseudomembranous colitis

229

2.41

6.80

2.3

1.8

382.41

376.20

nmol/l

0.06

213

Other and unspecified nonscarring hair loss

198

2.56

6.80

2.0

1.8

404.28

389.29

nmol/l

0.18

184

Other aneurysm

190

1281

1.53

6.77

2.6

2.2

362.20

368.60

nmol/l

0.16

173

1160

Chronic conjunctivitis

142

903

1.65

6.77

2.4

2.0

379.95

367.68

nmol/l

0.30

130

835

Occupational exposure to risk-factors

141

894

1.65

6.77

2.5

2.2

381.08

363.89

nmol/l

0.47

130

830

Acute nephritic syndrome

100

581

1.82

6.74

2.5

2.2

337.62

374.49

nmol/l

0.96

540

Certain conditions originating in the perinatal period

406

2755

1.34

6.74

2.6

2.1

366.25

383.69

nmol/l

0.70

381

2559

Other and unspecified glaucoma

251

1787

1.45

6.73

2.0

2.1

369.89

382.35

nmol/l

0.44

231

1610

Mental and behavioural disorders due to cannabinoids

135

847

1.66

6.72

2.0

1.9

375.20

377.64

nmol/l

0.05

115

792

Dislocation, sprain and strain of joint and ligaments of hip

143

910

1.64

6.72

2.0

351.70

377.41

nmol/l

0.71

129

833

Bursitis of shoulder

107

633

1.78

6.71

2.8

2.2

338.27

381.18

nmol/l

1.31

582

Spirochaetal infections, other/unspecified

337

2522

1.38

6.71

2.4

2.2

386.32

371.41

nmol/l

0.77

312

2304

Dislocation, sprain and strain of joints and ligaments of thorax

141

896

1.65

6.69

2.0

2.1

367.76

372.89

nmol/l

0.12

131

825

Benign neoplasm: Parotid gland

281

2041

1.42

6.69

2.4

1.8

385.01

363.80

nmol/l

0.88

259

1855

Carcinoma in situ of other and unspecified sites

117

708

1.72

6.69

3.6

1.7

350.95

362.95

nmol/l

0.22

111

630

Background retinopathy and retinal vascular changes

508

1.88

6.68

2.0

1.9

383.10

382.33

nmol/l

0.01

461

Encephalopathy

237

2.36

6.67

1.9

1.8

501.57

384.85

nmol/l

0.41

213

Schizophrenia

668

5443

1.25

6.65

1.7

2.2

397.00

368.70

nmol/l

2.72

601

5033

Other congenital malformations of limb(s)

246

2.35

6.60

1.9

2.1

392.17

382.79

nmol/l

0.10

229

Bitten or struck by other mammals

472

3708

1.30

6.55

2.1

366.44

373.68

nmol/l

0.35

434

3410

Burns and corrosions of external body surface, specified by site

446

3478

1.31

6.54

2.0

2.2

371.02

370.06

nmol/l

0.04

417

3224

Other conditions related to polyarteritis nodosa

3.99

6.54

3.3

1.9

240.77

403.64

nmol/l

3.13

Basal cell carcinoma

2102

14928

1.13

6.47

2.3

2.2

374.72

379.98

nmol/l

0.52

1900

13595

573

1.81

6.47

1.7

1.8

373.64

398.28

nmol/l

0.70

527

Basal cell carcinoma, including avohilmo

2164

15214

1.13

6.47

2.3

2.2

373.74

379.76

nmol/l

0.63

1956

13867

Disorders of purine and pyrimidine metabolism

122

2.94

6.45

2.0

327.85

384.29

nmol/l

0.66

110

Lagophthalmos

301

2.16

6.45

1.9

403.09

377.47

nmol/l

0.43

277

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

880

4393

1.21

6.44

2.5

1.8

368.74

358.75

nmol/l

0.61

819

3995

Mixed disorders of conduct and emotions

121

749

1.70

6.43

2.0

350.20

396.45

nmol/l

1.82

107

690

Abnormal spermatozoa

379

2897

1.34

6.42

2.3

2.5

317.53

370.24

nmol/l

6.70

355

2671

Hypertrophic disorders of skin

251

1806

1.44

6.41

2.1

2.0

383.31

377.90

nmol/l

0.16

237

1660

Parkinson's disease

507

4025

1.28

6.37

1.8

2.3

392.14

375.69

nmol/l

1.07

446

3671

All dysplastic lesions of the vulva

199

1379

1.51

6.36

2.1

2.0

373.25

373.74

nmol/l

0.01

183

1262

Cardiomyopathy, Hypertrophic obstructive

413

1.95

6.36

2.6

2.3

435.11

375.44

nmol/l

0.73

389

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

551

1.80

6.35

3.4

1.7

396.64

363.88

nmol/l

0.81

491

Personality and behavioural disorders due to brain disease, damage and dysfunction

386

1.99

6.32

1.8

2.1

353.34

368.20

nmol/l

0.26

359

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

180

1224

1.53

6.31

3.3

2.1

322.68

368.90

nmol/l

3.11

175

1142

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

162

1077

1.57

6.30

3.2

2.2

365.07

366.80

nmol/l

0.04

156

986

False labour

1503

8248

1.16

6.29

2.0

380.05

381.92

nmol/l

0.13

1392

7621

Chronic lymphocytic leukaemia

111

676

1.73

6.28

1.9

2.2

421.66

376.87

nmol/l

1.58

104

611

Biomechanical lesions, not elsewhere classified

198

1372

1.50

6.27

2.1

368.47

372.85

nmol/l

0.13

180

1252

Idiopathic urticaria

102

610

1.77

6.26

2.1

1.9

372.09

380.40

nmol/l

0.17

567

Essential (haemorrhagic) thrombocythaemia

147

959

1.60

6.24

1.9

1.8

439.54

360.72

nmol/l

3.50

135

861

Mitochondrial myopathy

120

3.02

6.23

2.4

2.1

450.16

369.33

nmol/l

1.18

112

Assault by blunt object

360

2.02

6.22

2.2

2.0

404.82

372.19

nmol/l

0.21

339

Amputation of thigh

100

593

1.76

6.17

1.6

1.9

346.02

392.63

nmol/l

1.23

526

Other nonscarring hair loss

266

2.23

6.17

2.4

1.8

412.61

390.23

nmol/l

0.33

247

113

1802

0.61

6.16

1.7

2.3

435.66

370.26

nmol/l

1.23

105

1650

Epiphora

590

1.78

6.15

1.9

2.0

386.35

382.18

nmol/l

0.08

544

Blindness, monocular

219

2.35

6.14

2.4

1.8

350.48

380.05

nmol/l

0.33

202

Pneumococcal septicemia

139

900

1.61

6.13

2.8

2.1

342.79

368.78

nmol/l

0.60

125

826

Gestational [pregnancy-induced] hypertension

1193

10296

1.17

6.12

2.0

362.81

377.86

nmol/l

2.05

1118

9500

Bacterial, viral and other infectious agents

356

2721

1.34

6.12

2.5

2.2

364.48

366.86

nmol/l

0.07

332

2522

Erythema multiforme

105

636

1.74

6.12

2.2

2.0

309.04

372.66

nmol/l

2.65

587

Eustachian salpingitis and obstruction

354

2706

1.34

6.11

2.0

2.1

361.04

362.44

nmol/l

0.05

325

2510

Perioral dermatitis

105

638

1.74

6.08

2.4

2.1

342.48

380.88

nmol/l

1.26

596

Melanoma in situ

157

1047

1.56

6.06

3.7

2.1

412.04

372.36

nmol/l

0.79

147

949

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

123

776

1.66

6.05

2.5

2.2

383.05

386.21

nmol/l

0.07

116

718

Benign neoplasm: Anus and anal canal

117

730

1.68

6.04

2.2

2.1

359.52

372.90

nmol/l

0.33

108

660

Carcinoma in situ of skin

282

2089

1.39

6.02

2.2

2.1

362.51

378.11

nmol/l

0.56

265

1875

Fracture of neck

212

1499

1.46

5.98

2.2

2.1

382.01

370.96

nmol/l

0.20

195

1367

Carcinoma in situ, bladder

108

661

1.70

5.97

3.6

1.7

350.42

363.92

nmol/l

0.24

102

591

Patellar tendinitis

422

1.90

5.96

1.9

319.06

376.77

nmol/l

2.25

396

Sequelae of injuries of lower limb

383

2969

1.32

5.94

2.3

2.2

354.62

367.74

nmol/l

0.66

353

2733

Other benign neoplasms of connective and other soft tissue

365

2812

1.33

5.90

2.2

1.8

368.96

367.32

nmol/l

0.06

332

2549

Abscess of Bartholin gland

132

855

1.62

5.88

1.7

2.0

376.88

375.44

nmol/l

0.03

120

794

Family history of certain disabilities and chronic diseases leading to disablement

198

1390

1.47

5.86

1.9

2.0

362.04

381.06

nmol/l

0.71

180

1278

Perforation of oesophagus

117

2.89

5.84

1.8

2.0

382.68

362.84

nmol/l

0.14

105

Unspecified dementia

315

2136

1.35

5.84

1.7

1.9

410.26

386.44

nmol/l

0.42

274

1898

Artificial joint re-operation

265

1957

1.40

5.84

1.9

2.2

374.41

372.77

nmol/l

0.04

238

1766

Malignant neoplasm of breast, HER-positive

1092

12456

0.85

5.84

2.2

2.1

383.83

376.62

nmol/l

0.51

994

11373

Shoulder region

355

2.00

5.83

1.5

2.0

378.78

366.10

nmol/l

0.21

330

Nephropathy induced by other drugs, medicaments and biological substances

4.73

5.83

3.3

2.4

422.81

375.64

nmol/l

0.39

Other cranial nerve disorders in other disorders

3.61

5.83

3.3

1.8

333.82

383.65

nmol/l

0.66

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

515

1.80

5.82

3.6

1.9

412.37

359.08

nmol/l

1.39

471

Amblyopia ex anopsia

183

1269

1.50

5.81

2.3

2.2

370.83

373.79

nmol/l

0.07

166

1172

Retinal detachment with retinal break

453

3595

1.28

5.78

2.3

386.22

372.38

nmol/l

0.77

423

3284

Disorder of external ear, unspecified

133

865

1.61

5.78

2.8

2.2

357.66

368.65

nmol/l

0.31

125

801

Contraceptive management

1935

12151

1.13

5.77

2.0

2.2

368.20

371.55

nmol/l

0.34

1803

11267

Other congenital malformations of skin

180

1247

1.50

5.77

2.3

2.2

358.75

372.34

nmol/l

0.39

169

1160

Superficial injury of forearm

393

3074

1.31

5.69

2.0

2.1

365.28

377.52

nmol/l

0.69

358

2815

Other and unspecified myoneural disorders

102

3.07

5.67

2.4

1.9

309.56

351.34

nmol/l

0.69

Antenatal screening

879

5836

0.84

5.66

1.8

2.0

393.10

387.01

nmol/l

0.37

814

5392

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

590

4827

1.24

5.65

2.6

1.8

413.21

371.34

nmol/l

4.02

553

4312

Senility

128

2.61

5.64

1.3

1.6

432.37

406.93

nmol/l

0.22

104

Other disorders of iris and ciliary body

106

657

1.69

5.63

1.8

1.9

374.12

377.07

nmol/l

0.06

100

600

Congenital malformations of the circulatory system

603

4800

1.24

5.63

2.5

2.3

360.05

365.81

nmol/l

0.28

560

4446

Benign neoplasm of eye and adnexa

347

2674

1.33

5.63

2.4

1.8

353.36

367.72

nmol/l

0.77

307

2411

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

142

941

1.56

5.60

3.0

1.7

364.68

364.70

nmol/l

0.00

135

843

Other viral hepatitis

265

1969

1.39

5.60

2.2

2.1

355.83

369.69

nmol/l

0.64

240

1832

Pyoderma

537

1.77

5.59

3.1

2.0

364.22

373.94

nmol/l

0.13

497

Other specific arthropathies, wide

551

1.75

5.59

1.9

2.1

321.79

389.86

nmol/l

2.83

513

Social disorders starting during childhood or adolecense, excluding more controls

168

2.44

5.57

2.9

2.0

317.76

381.11

nmol/l

1.16

154

Inflammatory disease of cervix uteri

269

2007

1.38

5.56

2.3

2.1

385.33

375.38

nmol/l

0.36

237

1823

Other otitis externa (chronic)

261

1938

1.39

5.55

2.1

388.65

372.85

nmol/l

0.62

228

1784

Granuloma annulare

406

1.89

5.49

2.2

1.9

386.25

377.17

nmol/l

0.16

378

Pervasive developmental disorders excl. Autism + Asperger

391

1.92

5.48

2.7

339.76

348.78

nmol/l

0.16

367

Sequelae of infectious and parasitic diseases

306

2328

1.35

5.48

2.1

358.57

371.30

nmol/l

0.53

285

2125

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

258

1911

1.38

5.48

2.7

1.8

419.26

364.41

nmol/l

3.05

240

1702

Malignant neoplasm of oropharynx

399

1.90

5.47

3.5

2.1

406.05

359.31

nmol/l

1.10

366

Female infertility, tubal origin

206

1474

1.44

5.47

2.3

2.2

366.05

373.30

nmol/l

0.20

196

1369

Other disorders of binocular vision

377

1.92

5.47

2.0

1.8

361.31

380.43

nmol/l

0.30

356

Other injuries of upper limb, level unspecified

285

2.09

5.46

3.0

2.0

300.76

386.17

nmol/l

2.35

262

Cysts of oral region, not elsewhere classified

165

1135

1.50

5.43

3.0

2.1

336.95

380.34

nmol/l

2.41

154

1055

Dermatitis due to ingested food

178

1199

1.48

5.42

2.4

2.3

321.15

367.84

nmol/l

3.05

167

1129

Melanocytic naevi of lower limb, including hip

184

1296

1.47

5.42

3.4

2.0

369.88

377.27

nmol/l

0.23

173

1194

Other and unspecified injuries of wrist and hand

163

1122

1.51

5.41

1.8

2.1

346.05

373.59

nmol/l

1.03

157

1030

Other interventions on the root canals of the tooth

505

1.78

5.39

2.1

1.9

382.86

371.73

nmol/l

0.17

472

Abnormal reflex

141

2.64

5.38

2.3

2.1

334.89

373.79

nmol/l

0.55

133

Carcinoma in situ of skin of trunk

105

657

1.67

5.38

3.4

2.1

360.30

381.60

nmol/l

0.46

589

Other congenital malformations of circulatory system

115

738

1.64

5.38

2.2

2.0

380.65

364.62

nmol/l

0.39

108

688

Benign neoplasm of urinary organs

167

1155

1.50

5.37

2.2

1.8

411.24

360.49

nmol/l

2.35

150

1038

Torsion of ovary, ovarian pedicle and fallopian tube

103

643

1.68

5.35

2.3

2.1

354.30

382.57

nmol/l

0.88

599

Benign neoplasm: Rectosigmoid junction

144

969

1.54

5.33

2.1

1.8

392.76

358.43

nmol/l

1.31

130

868

Generalized epilepsy

193

1375

1.45

5.33

1.9

2.1

386.03

365.17

nmol/l

0.70

181

1280

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

148

998

1.52

5.32

4.3

1.8

384.18

374.13

nmol/l

0.23

140

891

Major anomalies of jaw size

125

819

1.60

5.31

2.5

2.2

376.04

368.23

nmol/l

0.17

114

761

Other lack of coordination

432

1.84

5.31

2.6

2.2

377.63

371.44

nmol/l

0.09

401

Parodontitis or/and operation codes

3203

17506

1.10

5.30

2.3

2.2

361.88

369.07

nmol/l

1.16

2917

16181

Chronic myeloproliferative disease

338

1.97

5.30

2.1

1.9

400.04

383.66

nmol/l

0.19

305

Oral leukoplakia and related diseases

218

1587

1.42

5.29

2.7

2.2

373.03

369.14

nmol/l

0.09

192

1450

Dronedarone medication

106

668

1.65

5.28

2.1

2.4

312.04

370.36

nmol/l

2.12

616

Other chondrocalcinosis

289

2.05

5.25

2.4

1.9

336.17

374.85

nmol/l

0.67

260

Sexual dysfunction

382

1.89

5.23

2.3

1.9

372.08

365.43

nmol/l

0.10

358

Sequelae of other and unspecified infectious and parasitic diseases

236

1744

1.39

5.22

2.1

356.27

366.39

nmol/l

0.34

221

1612

Drug-induced acute pancreatitis

4.34

5.20

6.7

1.8

349.25

381.45

nmol/l

0.27

Hypertrophic cardiomyopathy

157

1082

1.51

5.20

2.3

2.2

403.58

365.87

nmol/l

0.92

149

994

Disturbances of smell and taste

161

1114

1.50

5.20

2.1

345.48

372.12

nmol/l

0.94

151

1018

Benign neoplasm: Skin, unspecified

155

1065

1.51

5.19

2.5

1.8

361.49

364.18

nmol/l

0.06

142

967

Moderate visual impairment, monocular

101

2.92

5.15

2.8

1.7

365.19

354.11

nmol/l

0.11

Examination and encounter for administrative purposes

141

950

1.53

5.14

2.5

2.3

386.72

382.86

nmol/l

0.07

130

883

Varicella [chickenpox]

191

1367

1.44

5.12

2.7

2.3

354.18

364.61

nmol/l

0.33

183

1287

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

305

1.99

5.12

2.3

1.9

344.31

383.55

nmol/l

0.82

274

Superficial injuries involving multiple body regions

114

738

1.61

5.11

2.4

1.9

379.57

378.03

nmol/l

0.03

104

680

Peroneal tendinitis

392

1.86

5.10

2.7

2.0

360.52

380.00

nmol/l

0.34

365

Deep bite

489

3477

1.26

5.09

2.6

2.2

352.17

370.65

nmol/l

1.05

458

3241

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

158

1096

1.50

5.07

2.6

2.3

333.07

356.71

nmol/l

0.86

151

1034

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

349

1.91

5.07

1.8

2.1

398.37

375.45

nmol/l

0.24

322

Mental retardation

184

1313

1.45

5.07

2.5

363.76

349.34

nmol/l

0.42

174

1246

Pityriasis rubra pilaris

3.61

5.06

5.7

1.5

263.00

381.16

nmol/l

1.62

Left ventricular outflow tract obstruction (LVOTO), broad definition

387

3071

1.29

5.05

2.4

373.33

362.24

nmol/l

0.33

363

2875

Injury of intra-abdominal organs

105

669

1.64

5.04

1.8

2.0

327.29

368.50

nmol/l

1.16

623

Fistulae involving female genital tract

424

1.82

5.03

1.9

2.3

420.43

381.95

nmol/l

0.76

383

Injury of eye and orbit

546

4498

1.23

5.00

1.8

2.2

381.84

368.86

nmol/l

0.69

508

4151

Other factor of the environment

338

1.93

4.96

3.3

1.8

316.14

379.33

nmol/l

1.71

312

Benign neoplasm of breast

475

3866

1.25

4.96

1.9

1.8

373.74

370.45

nmol/l

0.13

424

3501

Use of rotigotine

303

2.00

4.95

2.2

1.8

398.51

379.56

nmol/l

0.30

282

Other salmonella infections

151

1043

1.50

4.95

1.8

2.1

346.15

373.95

nmol/l

1.02

142

965

Coxarthrosis, primary, with hip surgery

1714

14584

1.12

4.92

2.2

2.3

374.00

378.60

nmol/l

0.29

1565

13315

Mental and behavioural disorders associated with the puerperium

325

1.95

4.91

1.4

1.9

380.37

369.58

nmol/l

0.14

300

Single spontaneous delivery

1616

9625

0.88

4.90

2.0

386.05

391.63

nmol/l

0.46

1479

8723

Entropion and trichiasis of eyelid

271

2063

1.34

4.85

2.1

381.45

379.93

nmol/l

0.04

249

1870

Hypertrophic scar

225

1672

1.39

4.83

2.0

1.9

381.86

377.26

nmol/l

0.13

211

1532

Benign neoplasm of other and unspecified female genital organs

177

1266

1.45

4.83

2.0

1.8

379.48

365.21

nmol/l

0.44

152

1146

Overjet

129

868

1.55

4.83

2.6

2.4

352.28

371.13

nmol/l

0.51

117

823

Benign leiomyoma with endometriosis

615

5148

1.21

4.82

2.1

1.8

373.91

366.25

nmol/l

0.42

558

4651

Mental and behavioural disorders due to use of other stimulants, including caffeine

122

812

1.56

4.82

1.9

2.0

374.20

368.10

nmol/l

0.13

106

760

Other and unspecified mononeuropathies of lower limb

110

716

1.60

4.82

1.9

2.0

386.14

381.52

nmol/l

0.09

656

Parkinson's disease, strict definition

454

3688

1.25

4.79

1.8

2.2

391.14

376.67

nmol/l

0.80

397

3357

Non-allergic asthma

352

2781

1.29

4.78

2.2

357.69

371.25

nmol/l

0.60

333

2557

Supervision of normal pregnancy

849

5651

0.85

4.77

2.0

382.42

386.67

nmol/l

0.28

779

5228

Vestibular neuronitis

334

2625

1.30

4.76

2.3

2.2

356.25

371.80

nmol/l

0.78

298

2420

Aortic valve malfunction, age under 60 years

352

2784

1.29

4.76

2.4

373.21

364.40

nmol/l

0.23

328

2607

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

687

5715

1.20

4.72

3.0

1.8

408.46

371.64

nmol/l

4.31

635

5128

Colorectal cancer, excluding all cancers (controls excluding all cancers)

867

7220

1.17

4.72

2.3

1.8

407.57

369.94

nmol/l

5.20

810

6463

Other acute skin changes due to ultraviolet radiation

137

938

1.51

4.72

2.6

2.1

366.16

374.79

nmol/l

0.18

128

854

Ankylosing spondylitis, strict definition

185

1339

1.43

4.70

2.0

2.1

337.82

366.96

nmol/l

1.39

170

1252

300

1.95

4.69

1.7

2.0

377.57

369.49

nmol/l

0.11

275

Inflammation of lacrimal passages (acute and unspecified)

487

1.73

4.69

3.8

1.9

319.91

376.02

nmol/l

2.08

444

Other bursitis of hip

502

1.71

4.66

2.1

400.89

387.68

nmol/l

0.16

457

Effects of foreign body entering through natural orifice

952

8274

1.16

4.66

2.4

2.3

356.01

368.40

nmol/l

1.38

881

7636

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

517

4277

1.23

4.62

2.2

375.87

368.96

nmol/l

0.38

478

3936

Mental retardation, wide definition

190

1387

1.42

4.61

2.5

365.60

350.39

nmol/l

0.45

179

1310

Heart failure and hypertrophic cardiomyopathy

436

1.77

4.60

2.5

1.9

417.78

382.99

nmol/l

0.36

397

Complications associated with artificial fertilization

512

1.70

4.60

1.7

2.1

377.86

380.18

nmol/l

0.03

476

Other diseases of gallbladder

169

1210

1.44

4.57

1.9

2.1

343.29

372.23

nmol/l

1.27

155

1102

Follicular lymphoma

152

1069

1.47

4.56

2.4

1.8

373.80

361.55

nmol/l

0.34

143

955

Other specified/unspecified disorders of bone/cartilage

110

726

1.58

4.54

2.2

2.1

361.08

367.92

nmol/l

0.15

101

670

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

371

1.84

4.53

2.6

1.8

380.70

366.01

nmol/l

0.23

327

Tooth eruption problems

618

5157

1.20

4.50

2.3

2.0

376.93

387.04

nmol/l

0.59

583

4755

Polyglandular hyperfunction

18.65

4.49

4.3

1.3

406.57

354.13

nmol/l

—

Unspecified event, undetermined intent

105

689

1.59

4.48

1.9

2.0

352.01

371.74

nmol/l

0.44

643

Malignant neoplasm of tongue

509

1.70

4.47

4.6

2.2

424.95

371.52

nmol/l

1.35

467

Convergent concomitant strabismus

250

1910

1.34

4.47

2.6

2.1

367.45

374.37

nmol/l

0.22

233

1772

Separation of retinal layers (serosa)

156

1109

1.45

4.42

2.9

2.2

366.73

368.86

nmol/l

0.05

147

1026

Benign neoplasm of ovary

663

5633

1.19

4.42

2.0

1.8

394.76

368.64

nmol/l

1.94

617

5066

Cryoglobulinemia

4.11

4.38

2.3

1.6

338.00

409.08

nmol/l

0.66

Retinal haemorrhage

581

1.63

4.38

2.2

1.9

385.19

377.67

nmol/l

0.12

525

Chalazion

436

3566

1.24

4.38

2.1

2.2

371.75

373.78

nmol/l

0.07

399

3286

Malignant neoplasm of small intestine

527

1.67

4.37

2.5

2.0

384.21

370.60

nmol/l

0.23

480

Other acquired deformities of musculoskeletal system and connective tissue

184

1348

1.41

4.37

2.3

2.2

410.25

371.68

nmol/l

1.37

168

1244

Undefined dementia

316

2283

1.29

4.36

1.7

1.9

411.48

389.22

nmol/l

0.38

274

1986

Perichondritis of external ear

466

1.72

4.35

1.8

1.9

373.31

376.31

nmol/l

0.04

429

Contact with heat and hot substances

210

1572

1.37

4.33

2.1

363.89

367.03

nmol/l

0.07

190

1452

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

116

781

1.53

4.33

3.4

1.7

430.45

363.54

nmol/l

2.81

110

701

Follow-up care involving plastic surgery

153

1089

1.45

4.32

2.4

2.0

382.13

371.04

nmol/l

0.28

128

987

Malignant neoplasm of tonsil

354

1.83

4.29

3.3

2.0

390.50

363.44

nmol/l

0.46

324

Hyphaema and other vascular disorders of iris and ciliary body

467

1.70

4.29

2.0

1.9

343.93

381.87

nmol/l

1.24

431

Drug-induced dystonia

3.05

4.28

2.0

2.2

362.95

355.61

nmol/l

0.07

Other nutritional anaemias

237

2.02

4.27

2.1

1.8

424.70

375.23

nmol/l

0.68

211

Leiomyoma of uterus

2951

15526

1.09

4.27

2.1

371.91

374.33

nmol/l

0.25

2679

14266

Haemangioma, any site

332

2647

1.28

4.26

2.3

2.2

365.36

369.56

nmol/l

0.15

304

2431

Injuries involving multiple body regions

150

1067

1.45

4.26

2.2

2.0

378.96

374.27

nmol/l

0.11

138

982

Other demyelinating diseases of the central nervous system

162

1170

1.43

4.24

2.2

2.1

358.03

373.63

nmol/l

0.53

148

1096

Combined immunodeficiencies

289

1.92

4.24

4.3

1.8

324.68

383.44

nmol/l

1.38

261

Perforation of tympanic membrane

382

3095

1.26

4.23

2.4

2.1

370.79

370.78

nmol/l

0.00

351

2831

L02BA Anti-estrogens

483

5798

0.82

4.23

2.1

407.42

373.73

nmol/l

2.57

440

5285

Benign neoplasm of bone and articular cartilage

332

2650

1.28

4.22

2.4

2.1

344.35

370.40

nmol/l

1.75

309

2433

Oral lichen ruber planus

103

685

1.58

4.20

2.7

2.1

387.30

367.33

nmol/l

0.42

626

Arterial embolism and thrombosis of lower extremity artery

119

811

1.51

4.19

2.4

2.1

385.74

374.96

nmol/l

0.18

104

737

Congenital malformations of anterior segment of eye

241

2.02

4.17

3.6

2.0

367.98

368.24

nmol/l

0.00

225

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

218

1644

1.35

4.16

2.1

375.02

378.40

nmol/l

0.09

184

1482

Malignant neoplasm of digestive organs

1300

11429

1.13

4.16

2.5

2.2

403.29

377.11

nmol/l

4.42

1206

10379

HSIL lesion of the vulva

489

1.69

4.14

2.5

2.1

362.74

372.13

nmol/l

0.13

455

Chronic viral hepatitis

215

1627

1.36

4.14

2.2

2.1

351.37

364.79

nmol/l

0.55

193

1514

Acute myeloid leukaemia and myelodysplastic syndromes

402

1.74

4.14

2.3

2.0

376.13

368.58

nmol/l

0.11

366

Benign neoplasm: Skin of lower limb, including hip

107

718

1.55

4.14

2.8

1.8

310.53

366.62

nmol/l

2.61

654

Pyogenic granuloma

465

1.70

4.13

2.5

1.9

378.87

380.88

nmol/l

0.03

426

Assault by unspecified means

567

1.62

4.11

1.6

2.0

366.67

366.11

nmol/l

0.01

537

Other specified and unspecified disorders of eye and adnexa

152

1093

1.44

4.07

2.5

2.0

397.69

377.07

nmol/l

0.39

140

995

Haemangioma and lymphangioma, any site

353

2850

1.26

4.07

2.2

367.05

365.59

nmol/l

0.05

323

2612

Mental and behavioural disorders of puerperium, not classified elsewhere

346

1.82

4.06

1.4

2.0

380.37

374.96

nmol/l

0.07

319

Other misadventures during surgical and medical care

578

1.61

4.05

2.2

1.9

386.14

372.23

nmol/l

0.28

536

Other other unspecified disorders of the circulatory system

139

986

1.46

4.03

2.1

2.2

356.76

369.98

nmol/l

0.37

128

900

Other and unspecified nail disorders

547

1.63

4.01

3.2

2.1

324.54

371.11

nmol/l

1.50

510

Benign neoplasm: Kidney

123

854

1.49

4.01

2.1

1.8

417.96

362.88

nmol/l

1.98

111

764

Schizotypal disorder

102

683

1.55

4.00

1.6

2.0

367.67

357.43

nmol/l

0.25

639

Other appendicitis

325

2604

1.27

4.00

2.4

2.2

373.03

369.73

nmol/l

0.11

303

2388

Acute thyroiditis

102

2.61

3.99

2.1

2.0

405.29

361.52

nmol/l

0.31

Open wound of abdomen, lower back and pelvis

122

849

1.49

3.94

2.2

2.1

348.41

371.54

nmol/l

0.69

112

795

Ectopic pregnancy

747

6474

1.17

3.93

2.1

2.2

363.58

373.29

nmol/l

0.73

694

5979

Benign neoplasm: Skin of other and unspecified parts of face

395

3239

1.24

3.92

2.6

2.1

364.82

374.04

nmol/l

0.43

347

2955

Benign neoplasm: Nasopharynx

224

2.01

3.92

1.8

312.25

364.27

nmol/l

0.79

200

Pathological resorption of teeth

115

793

1.50

3.89

2.3

1.9

348.33

383.20

nmol/l

1.10

108

735

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

303

2420

1.28

3.87

2.6

2.1

374.56

367.58

nmol/l

0.26

285

2219

Infectious mononucleosis

362

2947

1.25

3.87

2.1

2.0

366.67

385.08

nmol/l

1.11

331

2710

Other and unspecified mononeuropathies of upper limb

119

828

1.49

3.85

1.9

2.1

375.42

368.77

nmol/l

0.16

111

769

Monoplegia

412

1.72

3.85

2.1

1.8

354.37

374.67

nmol/l

0.34

379

Prepatellar bursitis

153

1111

1.41

3.84

2.2

2.5

351.85

377.81

nmol/l

0.94

141

1031

Injury of muscle and tendon at lower leg level

545

4613

1.20

3.84

2.5

2.3

345.10

371.17

nmol/l

2.68

514

4262

Benign neoplasm: Skin of eyelid, including canthus

562

4772

1.20

3.84

2.2

364.93

375.26

nmol/l

0.58

508

4351

Malignant neoplasm of stomach

164

1206

1.39

3.81

2.6

2.1

393.97

373.04

nmol/l

0.68

155

1083

Other drug-induced secondary parkinsonism

234

1.97

3.80

1.6

1.9

404.87

366.29

nmol/l

0.46

216

Perineal laceration during delivery

573

5984

0.84

3.79

1.8

2.0

384.17

384.25

nmol/l

0.00

534

5503

Traumatic ischaemia of muscle

345

1.77

3.77

2.2

1.9

354.68

374.29

nmol/l

0.31

326

Calcaneal spur

285

1.85

3.75

1.9

2.0

354.73

384.51

nmol/l

0.39

262

Other and unspecified acute skin changes due to ultraviolet radiation

636

1.55

3.74

2.6

2.1

390.93

367.86

nmol/l

0.43

576

Benign neoplasm: Liver/bile ducts

670

1.54

3.73

2.0

1.8

397.51

368.81

nmol/l

0.60

616

Inguinal hernia

2432

15149

1.09

3.72

2.4

2.3

367.22

372.66

nmol/l

0.60

2266

13979

Contact with sharp glass

156

1146

1.40

3.71

2.3

2.1

377.11

367.24

nmol/l

0.25

143

1063

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

112

2.45

3.71

2.2

1.6

396.28

365.50

nmol/l

0.36

Abdominal aortic aneurysm (AAA)

273

2140

1.28

3.70

2.7

2.2

365.39

378.90

nmol/l

0.41

251

1926

Personal history of malignant neoplasm

143

1037

1.42

3.69

2.5

2.1

408.25

381.39

nmol/l

0.88

132

937

Complications predominantly related to the puerperium

1143

10228

1.13

3.68

2.0

2.1

367.66

376.31

nmol/l

0.96

1048

9419

Normotensive glaucoma

285

2275

1.28

3.67

2.1

2.2

423.66

377.57

nmol/l

0.91

256

2048

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

373

3069

1.24

3.66

1.9

2.2

356.11

374.77

nmol/l

1.31

353

2823

Vascular dementia (subcortical)

573

1.56

3.66

1.9

1.8

374.26

388.89

nmol/l

0.29

502

Nonspecific lymphadenitis

241

1887

1.31

3.65

2.4

2.1

375.25

374.13

nmol/l

0.03

226

1744

Benign neoplasm: Skin of trunk

152

1115

1.40

3.64

2.8

1.8

381.06

366.52

nmol/l

0.38

139

1008

Benign neoplasm: Nasopharynx

230

1.95

3.64

1.8

2.0

312.25

364.06

nmol/l

0.79

207

Congenital malformations of breast

522

1.61

3.62

1.8

2.0

396.46

382.30

nmol/l

0.24

481

Carcinoma in situ of other and unspecified sites

117

822

1.47

3.62

3.6

2.2

350.95

370.26

nmol/l

0.40

111

748

Conductive hearing loss, unspecified

315

2549

1.26

3.60

2.4

2.2

353.08

373.57

nmol/l

1.23

295

2338

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

660

1.53

3.60

2.1

2.0

375.74

378.05

nmol/l

0.05

619

Calcinosis cutis

3.51

3.59

2.2

1.8

313.29

381.02

nmol/l

0.59

Benign neoplasm: Skin, unspecified

155

1145

1.39

3.58

2.5

2.1

361.49

371.17

nmol/l

0.26

142

1052

Retinal breaks without detachment

556

4747

1.19

3.58

2.3

380.67

371.51

nmol/l

0.56

522

4362

Injury of muscle and tendon at hip and thigh level

347

2839

1.24

3.57

2.2

351.71

371.76

nmol/l

1.25

326

2623

Medicines for HER+ breast cancer

1213

13122

0.89

3.56

2.1

385.60

377.51

nmol/l

0.65

1105

11976

Tuberculosis of other organs, strict

578

1.56

3.55

2.0

1.8

379.78

382.28

nmol/l

0.02

512

Special screening examination for neoplasms

135

974

1.42

3.53

2.5

2.2

415.51

377.32

nmol/l

1.50

122

899

Dislocation of lens

290

1.80

3.51

1.4

1.9

395.29

369.02

nmol/l

0.35

254

Scleritis

345

1.75

3.51

2.0

1.9

329.47

382.21

nmol/l

1.20

323

therapeutic use

109

761

1.48

3.51

2.3

2.1

385.14

364.04

nmol/l

0.40

696

Impacted cerumen

338

2764

1.24

3.51

2.1

2.2

377.91

373.25

nmol/l

0.16

278

2515

Other and unspecified iridocyclitis

163

1219

1.37

3.48

2.9

2.1

354.87

376.04

nmol/l

0.84

157

1127

Use of biperiden

197

1513

1.33

3.48

1.6

2.1

396.58

370.41

nmol/l

1.07

171

1393

Right hemicolectomy

198

1521

1.33

3.48

2.3

2.1

396.30

367.63

nmol/l

1.17

186

1373

Presbyopia

241

1901

1.30

3.48

2.4

2.2

348.31

365.93

nmol/l

0.80

227

1767

Benign lipomatous neoplasm of other sites/unspecified

313

2541

1.25

3.48

2.4

2.1

339.23

368.63

nmol/l

1.92

288

2325

Unspecified lump in breast

631

5457

1.17

3.48

2.0

2.1

383.52

378.95

nmol/l

0.24

578

4984

Malignant immunoproliferative diseases

219

1.94

3.47

2.6

1.6

329.13

363.65

nmol/l

0.55

200

Other complications of labour and delivery, not elsewhere classified

372

4317

0.82

3.46

1.8

1.9

390.34

384.62

nmol/l

0.23

343

3971

Other intracranial haemorrhages

663

1.51

3.45

2.0

2.2

353.25

369.24

nmol/l

0.41

596

Injury of nerves and spinal cord at thorax level

136

2.25

3.45

1.5

2.0

369.89

373.81

nmol/l

0.03

122

Family history of malignant neoplasm

416

3479

1.22

3.44

2.7

2.2

390.05

374.34

nmol/l

0.77

389

3199

Syphilis

103

715

1.49

3.44

2.3

2.1

388.91

363.96

nmol/l

0.62

671

Benign neoplasm: Rectosigmoid junction

144

1059

1.40

3.44

2.1

392.76

373.18

nmol/l

0.59

130

967

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

184

2.04

3.44

5.3

1.7

391.57

352.94

nmol/l

0.43

161

Benign neoplasm: Skin of ear and external auricular canal

129

930

1.42

3.44

2.9

1.8

380.04

363.93

nmol/l

0.42

116

831

Demyelinating diseases of the central nervous system

357

2945

1.24

3.43

2.0

2.1

353.57

372.32

nmol/l

1.14

325

2730

Brain medulloblastoma

10.20

3.43

5.9

2.5

320.00

318.62

nmol/l

—

Brain medulloblastoma, excluding all cancers (controls excluding all cancers)

10.20

3.43

5.9

2.4

320.00

351.62

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

177

1345

1.36

3.43

2.0

379.48

372.17

nmol/l

0.19

152

1227

Tuberculosis, IBD comorbidity

232

1821

1.30

3.42

2.1

372.20

377.15

nmol/l

0.10

204

1645

Embedded teeth, including avohilmo

384

3191

1.22

3.40

2.1

2.0

390.39

386.14

nmol/l

0.15

364

2935

Other and unspecified paralytic syndromes

387

1.69

3.40

2.6

1.9

358.49

380.20

nmol/l

0.34

357

Benign neoplasm: Liver

594

1.54

3.40

2.0

1.8

409.57

369.08

nmol/l

0.87

545

2.62

3.37

1.5

1.9

404.20

360.40

nmol/l

0.61

Immunodeficiency associated with other major defects

2.68

3.36

3.5

2.4

333.10

386.14

nmol/l

0.86

Campylobacter enteritis

108

760

1.47

3.36

3.3

2.1

340.75

370.60

nmol/l

0.82

101

705

Emergency coronary revascularization (for ACS)

1951

12904

1.09

3.35

2.0

2.4

380.64

376.95

nmol/l

0.26

1792

11767

Tuberculosis of other organs

522

1.57

3.35

2.1

1.8

387.17

383.14

nmol/l

0.03

463

Varicose veins of other sites

231

1820

1.29

3.35

2.4

2.1

359.17

370.80

nmol/l

0.46

211

1668

Other and unspecified injuries of shoulder and upper arm

115

819

1.45

3.34

2.5

2.1

370.95

377.89

nmol/l

0.14

108

763

Foreign body in alimentary tract

204

1585

1.32

3.33

2.4

2.2

354.93

372.85

nmol/l

0.77

187

1459

Pedal cyclist injured in other and unspecified transport accidents

420

3527

1.21

3.33

2.0

2.1

369.57

371.09

nmol/l

0.05

397

3242

Tuberculosis, wide

239

1891

1.29

3.31

2.1

370.80

376.55

nmol/l

0.12

211

1710

Other arterial embolism and thrombosis

636

1.51

3.31

2.4

2.1

306.82

374.13

nmol/l

2.61

581

Cutis laxa senilis

209

1.96

3.30

2.1

1.7

358.63

374.28

nmol/l

0.17

186

Carcinoma in situ, bladder

108

762

1.46

3.30

3.6

2.3

350.42

369.20

nmol/l

0.36

102

696

Other acute viral hepatitis

344

1.72

3.29

2.4

2.2

377.74

384.92

nmol/l

0.10

319

Benign neoplasm of urinary organs

167

1265

1.36

3.29

2.2

411.24

372.13

nmol/l

1.56

150

1147

Pregnancy with abortive outcome

3273

16056

1.07

3.27

2.0

378.40

385.74

nmol/l

1.26

2980

14698

Benign neoplasm: Parotid gland

281

2274

1.26

3.26

2.4

2.2

385.01

371.72

nmol/l

0.46

259

2082

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

334

2748

1.23

3.24

2.6

1.8

401.84

368.19

nmol/l

2.04

310

2448

LSIL lesion of the vulva

127

927

1.42

3.24

1.9

2.0

388.07

371.49

nmol/l

0.39

119

860

Uterine polyps

356

2952

1.23

3.24

2.2

2.3

403.03

377.38

nmol/l

1.13

337

2705

Endometriosis diagnosis and infertility diagnosis occurring together

458

3889

1.20

3.23

2.1

382.45

371.72

nmol/l

0.63

432

3587

Mandibular retrognathia

279

2253

1.26

3.23

2.2

357.10

374.98

nmol/l

0.81

262

2095

Subarachnoid haemorrhage

349

2889

1.23

3.22

1.9

2.2

368.73

375.12

nmol/l

0.25

315

2632

Acute myeloid leukaemia, helper endpoint

232

1.87

3.21

2.0

1.8

410.39

365.03

nmol/l

0.88

211

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

232

1.87

3.21

2.0

1.8

410.39

365.03

nmol/l

0.88

211

Disorders of optic nerve, not elsewhere classified

553

1.55

3.21

2.7

2.0

363.05

375.99

nmol/l

0.23

507

Disorders of eyelid in diseases classified elsewhere

123

893

1.42

3.20

2.1

2.0

359.42

374.00

nmol/l

0.41

114

819

Labour and delivery complicated by fetal stress [distress]

939

7021

0.88

3.20

1.9

2.0

374.93

382.12

nmol/l

0.57

867

6475

Maternal care for known or suspected fetal abnormality and damage

541

5580

0.85

3.20

2.2

2.0

390.21

380.47

nmol/l

0.67

504

5154

Delivery

1677

9672

0.91

3.19

2.0

387.72

391.89

nmol/l

0.34

1540

8762

Other bursal cyst

385

1.66

3.19

1.7

2.1

348.48

391.37

nmol/l

1.00

354

Other melanin hyperpigmentation

578

1.53

3.19

2.5

1.9

384.69

384.70

nmol/l

0.00

524

Other puerperal infections

337

2788

1.23

3.19

2.0

2.1

358.71

379.63

nmol/l

1.46

309

2577

Injury of muscle and tendon at wrist and hand level

501

4287

1.18

3.18

2.4

2.3

370.88

370.83

nmol/l

0.00

470

3955

Crohn's disease (strict) with PSC

3.32

3.15

1.5

1.8

265.23

424.83

nmol/l

2.20

Other and unspecified types of non-Hodgkin lymphoma, hilmo

142

1058

1.38

3.14

3.0

2.1

364.68

371.33

nmol/l

0.17

135

956

Measles

349

1.69

3.13

1.9

2.2

320.12

365.48

nmol/l

1.46

329

Benign neoplasm: Tonsil

318

1.73

3.12

2.8

1.9

392.19

359.03

nmol/l

0.65

291

Acute otitis externa, noninfective

427

1.61

3.12

2.0

338.72

369.69

nmol/l

0.66

397

Benign neoplasm of major salivary glands

345

2865

1.22

3.12

2.4

2.2

380.09

371.02

nmol/l

0.32

314

2616

Polyhydramnios

208

1638

1.30

3.11

1.9

2.1

377.38

373.96

nmol/l

0.09

187

1509

Dissocial personality disorder

411

1.62

3.11

2.1

360.14

359.90

nmol/l

0.00

383

Foreign body or object entering through skin

234

1866

1.28

3.11

2.0

2.1

367.68

372.72

nmol/l

0.15

222

1725

Paranoid personality disorder

516

1.55

3.10

2.1

1.9

341.09

380.31

nmol/l

0.98

480

Follicular lymphoma, hilmo

152

1148

1.36

3.09

2.4

2.2

373.80

369.21

nmol/l

0.11

143

1034

Benign neoplasm: Tonsil

319

1.72

3.09

2.8

2.0

392.19

369.20

nmol/l

0.40

292

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

354

2952

1.22

3.09

1.9

2.1

380.51

367.82

nmol/l

0.61

332

2735

Open wound of shoulder and upper arm

500

1.56

3.08

3.1

2.2

329.88

371.93

nmol/l

0.67

466

Disorder of mineral metabolism, other/unspecified

3.04

3.07

2.7

2.3

394.43

382.51

nmol/l

0.11

Other disorders of cornea

342

2843

1.22

3.07

2.4

2.1

358.94

371.60

nmol/l

0.55

302

2604

Failed attempted abortion

423

1.62

3.06

2.0

357.48

375.09

nmol/l

0.36

391

Other maltreatment syndromes

124

909

1.40

3.06

2.1

376.17

360.12

nmol/l

0.40

115

856

Other infective otitis externa

222

1764

1.29

3.06

2.4

2.1

395.18

372.59

nmol/l

0.83

202

1627

Benign neoplasm: Liver/bile ducts

700

1.47

3.05

2.0

397.51

376.00

nmol/l

0.41

651

Complications of cardiac and vascular prosthetic devices, implants and grafts

469

1.57

3.05

2.0

2.1

361.16

365.05

nmol/l

0.04

423

Other specified/unspecified hearing loss

268

2174

1.25

3.04

2.1

2.2

374.53

373.87

nmol/l

0.01

245

1978

Injury of blood vessels at lower leg level

116

2.25

3.01

2.5

2.1

302.04

379.04

nmol/l

1.24

107

Need for immunization against other single viral diseases

553

1.52

3.01

2.3

2.1

318.85

363.33

nmol/l

1.45

518

Benign neoplasm: Other and unspecified parts of mouth

122

895

1.40

3.00

2.6

1.8

392.18

361.08

nmol/l

0.89

104

812

Exposure to smoke, fire and flames

660

1.47

2.99

1.8

2.0

355.34

380.45

nmol/l

0.78

611

Congenital malformations of genital organs

412

3474

1.20

2.98

2.1

2.2

363.45

370.29

nmol/l

0.28

387

3199

Benign neoplasm: Vulva

604

1.50

2.97

2.1

1.9

367.15

365.15

nmol/l

0.03

540

Personal history of medical treatment

239

1.82

2.95

3.0

1.9

395.49

367.24

nmol/l

0.34

217

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

215

1709

1.28

2.95

2.7

1.8

354.80

361.19

nmol/l

0.21

201

1560

ILD medications: pirfenidone

194

1.90

2.94

1.6

2.3

366.71

394.54

nmol/l

0.26

180

Tooth agenesis EXCLUDE clefts and syndromes

161

1236

1.34

2.93

2.5

2.1

345.18

384.30

nmol/l

1.89

152

1159

Endovascular or surgical operations to intracerebral aneurysms

227

1819

1.27

2.92

2.3

2.2

378.50

369.18

nmol/l

0.35

211

1656

Obstructed labour due to malposition and malpresentation of fetus

823

8685

0.88

2.92

2.1

2.0

366.78

374.88

nmol/l

0.64

760

8019

Motor neuron disease (with DMD)

314

1.67

2.91

1.6

2.4

414.59

386.76

nmol/l

0.50

288

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2243

16433

1.08

2.91

2.0

2.1

377.03

375.89

nmol/l

0.10

2110

15107

Psoas tendinitis

111

2.26

2.90

1.7

1.9

331.35

393.28

nmol/l

0.81

103

Other specified and unspecified retinal disorders

124

918

1.39

2.90

2.3

2.1

398.51

373.61

nmol/l

0.84

112

836

Xerosis cutis

372

1.63

2.88

2.2

1.9

375.87

386.26

nmol/l

0.14

342

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.34

2.88

2.0

1.7

449.19

372.50

nmol/l

0.96

Mild mental retardation

105

759

1.43

2.87

2.3

399.40

363.97

nmol/l

0.88

719

Acute myeloid leukaemia

241

1.79

2.86

2.0

2.2

410.39

364.76

nmol/l

0.89

222

Implicit parasitic Sepsis

126

2.16

2.84

2.3

2.0

358.63

367.49

nmol/l

0.09

116

Other diseases of appendix

303

1.70

2.84

2.1

2.0

375.84

365.28

nmol/l

0.13

282

Other and unspecified hydrocephalus

503

1.53

2.83

2.3

2.0

380.17

385.37

nmol/l

0.07

461

Benign neoplasm: Skin of lower limb, including hip

107

778

1.42

2.82

2.8

2.1

310.53

368.47

nmol/l

2.76

720

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.32

2.82

2.0

449.19

368.41

nmol/l

1.13

Erosion and ectropion of cervix uteri

110

803

1.41

2.82

1.8

2.3

350.13

380.48

nmol/l

0.44

732

Respiratory tuberculosis, confirmed

429

1.57

2.81

2.2

2.0

383.11

380.32

nmol/l

0.04

388

Generalized epilepsy, mode (most common among epilepsy diagnosis)

131

984

1.37

2.81

1.7

2.1

394.85

368.19

nmol/l

0.74

123

919

Glaucoma-related operations

188

1482

1.30

2.80

2.1

381.08

375.86

nmol/l

0.13

163

1341

Polypectomy (DHB20)

235

1900

1.26

2.80

2.5

2.2

311.57

370.78

nmol/l

4.54

220

1757

Optic neuritis

174

1360

1.31

2.80

2.8

2.0

364.70

372.36

nmol/l

0.12

162

1259

Procedures for purposes other than remedying health state

695

1.44

2.79

2.0

364.66

374.16

nmol/l

0.16

637

Other noninflammatory disorders of cervix uteri

180

1413

1.30

2.78

2.3

2.4

353.90

379.51

nmol/l

0.60

160

1287

Injury of nerves at wrist and hand level

139

1055

1.35

2.76

2.0

2.2

376.31

370.46

nmol/l

0.15

131

974

Pedal cyclist injured in transport accident

866

7771

1.12

2.75

2.1

2.2

379.00

372.25

nmol/l

0.49

812

7142

Other retinal artery occlusion

538

1.50

2.75

1.8

2.0

423.63

372.91

nmol/l

0.53

485

Alzheimer’s disease (Atypical or mixed)

234

1887

1.25

2.74

1.6

1.9

405.01

393.17

nmol/l

0.40

187

1656

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

556

4852

1.16

2.73

2.3

1.8

402.47

368.35

nmol/l

3.36

517

4347

Car occupant injured in noncollision transport accident

138

1049

1.35

2.72

2.0

374.57

371.55

nmol/l

0.06

129

971

Benign neoplasm: Kidney

123

920

1.38

2.72

2.1

417.96

374.31

nmol/l

1.38

111

832

Deficiency of other/unspecified nutrient elements

7.50

2.71

5.8

2.1

365.33

411.42

nmol/l

—

Other inflammation of vagina/vulva

153

1183

1.33

2.69

2.1

368.94

380.07

nmol/l

0.30

137

1095

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

130

983

1.36

2.69

2.5

2.2

359.96

367.35

nmol/l

0.17

123

915

Spontaneous abortion

2126

13493

1.08

2.68

2.0

2.1

372.79

379.50

nmol/l

0.83

1956

12430

Respiratory tuberculosis, bacteriologically and histologically confirmed

450

1.54

2.68

2.1

1.9

386.95

381.93

nmol/l

0.08

408

Malignant neoplasm of eye and adnexa

216

1.82

2.68

4.4

1.9

366.59

374.75

nmol/l

0.10

199

Desensitization to allergens

225

1823

1.26

2.67

2.1

2.0

350.95

375.71

nmol/l

1.25

207

1683

Benign neoplasm: Vulva

618

1.46

2.67

2.1

367.15

372.29

nmol/l

0.08

570

Conduct disorder

608

1.46

2.67

2.1

360.67

379.21

nmol/l

0.47

563

Other deformities of toe(s)

128

966

1.36

2.66

2.3

2.2

392.24

390.17

nmol/l

0.04

116

875

Exposure to other and unspecified animate mechanical forces

115

855

1.39

2.66

2.7

2.1

343.88

371.71

nmol/l

0.79

105

795

Use of donepezil

426

4764

0.85

2.65

1.6

2.0

393.98

387.47

nmol/l

0.25

347

4227

Prolapse and hernia of ovary and fallopian tube

132

991

1.35

2.64

1.6

2.0

393.88

392.37

nmol/l

0.03

119

869

Benign neoplasm: Choroid

189

1503

1.28

2.64

2.6

1.8

340.01

362.26

nmol/l

0.98

167

1355

Contusion of ankle

148

1142

1.33

2.63

2.4

2.1

362.48

376.43

nmol/l

0.33

139

1057

Benign neoplasm: Liver

628

1.45

2.63

2.0

409.57

371.38

nmol/l

0.80

583

Parapsoriasis

511

1.50

2.63

2.9

2.0

291.15

378.28

nmol/l

3.56

476

Central retinal artery occlusion

494

1.50

2.62

2.2

2.0

379.68

381.93

nmol/l

0.04

441

Motor neuron disease

292

1.66

2.62

1.5

2.4

423.65

395.01

nmol/l

0.49

267

Chronic myringitis

123

2.11

2.61

1.8

2.1

413.54

399.79

nmol/l

0.13

112

Burns and corrosions confined to eye and internal organs

107

789

1.40

2.61

2.6

2.1

350.39

364.29

nmol/l

0.36

102

736

Embolic stroke with flimmer

501

1.49

2.60

2.0

2.1

404.27

369.83

nmol/l

0.67

449

Anisometropia and aniseikonia

123

928

1.36

2.59

2.2

2.1

364.91

379.81

nmol/l

0.35

113

840

Benign neoplasm of eye and adnexa

347

2940

1.20

2.59

2.4

2.2

353.36

372.13

nmol/l

1.13

307

2696

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

859

7430

1.12

2.58

2.4

1.8

388.98

370.38

nmol/l

1.91

792

6706

Infections of genitourinary tract in pregnancy

393

3366

1.19

2.58

2.3

2.1

380.23

380.24

nmol/l

0.00

365

3087

Impacted maxillary molar

222

1804

1.25

2.57

2.2

1.9

383.19

393.75

nmol/l

0.33

205

1650

Dislocation, sprain and strain of joints and ligaments of elbow

244

2005

1.24

2.54

2.5

2.2

365.46

374.14

nmol/l

0.22

226

1858

Enterohaemorrhagic Escherichia coli infection

3.13

2.53

3.0

1.8

353.09

426.54

nmol/l

0.50

Fall on and from ladder

248

2043

1.23

2.51

2.3

349.60

370.23

nmol/l

1.11

234

1890

Phantom limb syndrome with pain

2.67

2.51

2.2

2.4

408.64

423.02

nmol/l

0.08

Acute inflammation of orbit

168

1.90

2.51

1.9

345.04

371.58

nmol/l

0.31

154

Other benign neoplasms of connective and other soft tissue

365

3116

1.19

2.50

2.2

368.96

371.01

nmol/l

0.07

332

2853

Actinomycosis

2.38

2.50

4.1

1.9

479.65

380.64

nmol/l

0.60

Malignant immunoproliferative diseases

244

1.73

2.49

2.6

1.9

329.12

384.11

nmol/l

1.06

221

Other protozoal intestinal diseases

404

1.55

2.45

1.8

2.0

374.56

371.85

nmol/l

0.04

378

Severe visual impairment, monocular

222

1.76

2.45

1.6

1.7

353.34

378.01

nmol/l

0.35

204

Mandibular prognathia

453

1.51

2.45

2.5

2.2

416.39

363.99

nmol/l

0.44

421

Other abnormal auditory perceptions

308

1.64

2.44

2.3

2.1

417.83

373.85

nmol/l

1.08

288

Dental caries 3 and operation codes, only avohilmo

1645

7659

1.09

2.44

2.1

2.3

364.15

377.73

nmol/l

1.84

1518

7120

Abnormal findings on antenatal screening of mother

345

2940

1.19

2.43

1.9

381.61

388.58

nmol/l

0.27

314

2717

Carcinoma in situ of other and unspecified digestive organs

553

1.45

2.41

2.2

1.8

365.34

358.33

nmol/l

0.12

496

Benign neoplasm: salivary glands, exclude unknown (D119)

303

2557

1.20

2.40

2.5

2.2

384.06

369.38

nmol/l

0.55

279

2339

Other benign neoplasms of uterus

185

1489

1.27

2.38

1.8

1.7

423.93

371.34

nmol/l

2.77

167

1311

Complications following abortion and ectopic and molar pregnancy

141

1100

1.32

2.37

2.0

2.1

379.22

368.61

nmol/l

0.28

125

1004

Delivery, wide proxy

1412

8129

0.92

2.37

1.9

2.0

395.47

396.33

nmol/l

0.05

1291

7336

Benign neoplasm: Skin of trunk

152

1196

1.30

2.37

2.8

2.1

381.06

371.80

nmol/l

0.22

139

1095

Other and unspecified injuries of thorax

481

1.48

2.36

1.8

1.9

374.98

376.81

nmol/l

0.03

441

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

354

3033

1.19

2.36

1.9

2.1

380.51

373.71

nmol/l

0.27

332

2800

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

240

1.71

2.36

4.4

1.7

467.05

373.75

nmol/l

2.13

213

Hypertrophy of tongue papillae

327

1.60

2.35

2.9

1.8

367.56

366.34

nmol/l

0.02

302

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

135

1047

1.32

2.34

2.3

1.8

376.45

363.10

nmol/l

0.32

125

943

Progressive vascular leukoencephalopathy

100

743

1.38

2.34

1.7

2.0

418.71

385.91

nmol/l

0.76

658

Carcinoma in situ of skin of lower limb, including hip

449

1.50

2.34

3.4

1.7

345.50

366.09

nmol/l

0.35

396

Bacterial meningitis

129

996

1.33

2.34

2.5

2.1

337.79

369.85

nmol/l

0.96

118

925

Other porphyria

2.98

2.33

1.6

2.4

365.09

395.43

nmol/l

0.13

Foreign body in respiratory tract

196

1592

1.26

2.33

2.5

2.2

350.83

374.43

nmol/l

1.00

180

1459

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

424

1.51

2.32

2.5

1.8

367.89

363.23

nmol/l

0.08

390

Oral lichen ruber planus, including avohilmo

219

1802

1.24

2.31

2.6

2.2

368.90

369.31

nmol/l

0.01

209

1652

Multiple delivery

265

3151

0.83

2.31

2.4

2.1

367.48

376.81

nmol/l

0.42

251

2883

Lichen sclerosus et atrophicus

354

3038

1.18

2.30

2.0

2.1

373.07

375.58

nmol/l

0.09

318

2783

Diseases of thymus

2.40

2.30

2.0

1.6

347.13

382.24

nmol/l

0.33

Benign neoplasm of thyroid gland

119

911

1.34

2.30

2.8

1.8

353.22

365.59

nmol/l

0.28

103

824

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

326

2780

1.19

2.30

2.5

1.8

398.70

373.95

nmol/l

1.28

297

2470

Abnormal findings in peritoneal fluid saliva

2.19

2.30

1.4

2.0

296.47

376.72

nmol/l

0.93

Behavioural disorders

627

1.41

2.29

2.2

2.1

357.36

382.43

nmol/l

0.70

578

Guttate psoriasis

386

1.54

2.28

1.7

2.0

348.55

372.75

nmol/l

0.42

357

Maternal care for known or suspected abnormality of pelvic organs

1152

7301

1.10

2.26

2.0

369.74

377.58

nmol/l

0.72

1087

6724

Familial erythrocytosis

123

2.00

2.24

3.3

2.0

321.57

373.85

nmol/l

0.77

112

Benign neoplasm of breast

475

4176

1.15

2.23

1.9

2.1

373.74

378.99

nmol/l

0.23

424

3820

Motorcycle rider injured in other and unspecified transport accidents

211

1735

1.24

2.22

2.2

2.1

405.64

370.44

nmol/l

0.51

204

1623

Crystalline deposits in vitreous body

229

1.70

2.21

2.9

2.0

368.13

378.76

nmol/l

0.13

209

Malignant neoplasm of bone and articular cartilage

237

1.69

2.21

4.5

2.1

367.00

374.66

nmol/l

0.13

218

Inflammatory disorders of breast

252

2112

1.21

2.20

2.0

2.1

360.61

383.55

nmol/l

1.01

236

1925

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

632

1.40

2.20

2.4

1.8

359.17

361.65

nmol/l

0.04

572

Labyrinthitis

2.26

2.20

2.3

487.94

367.21

nmol/l

0.69

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

2.61

2.20

1.9

1.6

521.08

410.41

nmol/l

0.25

Burn and corrosion of shoulder and upper limb, except wrist and hand

599

1.41

2.19

1.8

2.1

356.43

371.64

nmol/l

0.38

560

Degenerative diseases of the nervous system

1004

6909

1.10

2.19

1.7

2.1

408.05

383.89

nmol/l

3.06

850

6231

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

285

2417

1.20

2.18

1.8

2.1

371.83

370.95

nmol/l

0.03

265

2261

Other disorders of choroid

349

1.55

2.18

2.4

1.9

355.35

377.69

nmol/l

0.32

313

Other secondary gout

2.37

2.16

2.4

2.2

364.33

380.23

nmol/l

0.07

Melanocytic naevi of other and unspecified parts of face

207

1705

1.23

2.16

2.3

1.8

378.06

370.30

nmol/l

0.24

191

1548

Persons encountering health services in circumstances related to reproduction

2619

16804

1.06

2.15

2.2

2.3

369.83

369.48

nmol/l

0.03

2452

15580

Sequelae of inflammatory diseases of the central nervous system

2.24

2.15

2.8

1.7

276.18

388.07

nmol/l

2.65

Malignant neoplasm of gum

104

2.08

2.14

3.4

2.2

437.45

369.10

nmol/l

0.75

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

2.22

2.13

2.4

2.0

359.29

333.60

nmol/l

0.37

Malignant neoplasm of testis

383

1.51

2.13

2.4

2.1

374.43

366.14

nmol/l

0.14

355

Malignant neoplasm of renal pelvis

118

1.98

2.12

1.8

1.7

398.95

395.81

nmol/l

0.02

103

Other vitreous opacities

134

1055

1.30

2.12

2.4

2.1

381.09

372.63

nmol/l

0.17

121

954

Benign neoplasm: Vagina

377

1.52

2.11

1.5

1.9

397.26

369.40

nmol/l

0.54

348

Contact with other and unspecified heat and hot substances

163

1.82

2.10

1.5

2.0

352.19

385.85

nmol/l

0.49

151

Acute alcohol intoxication ICD-9

112

862

1.33

2.09

2.4

2.2

362.15

369.91

nmol/l

0.15

103

797

Malignant neoplasm of breast

1891

14516

0.93

2.08

2.2

2.1

386.41

375.14

nmol/l

1.48

1728

13269

Contusion of toe(s) without damage to nail

725

1.36

2.08

1.8

2.0

326.52

376.07

nmol/l

1.91

675

Maxillary retrognathism

545

1.42

2.08

2.1

2.0

333.67

373.64

nmol/l

0.99

507

Torsion of testis

493

1.44

2.08

2.6

2.0

366.24

355.27

nmol/l

0.17

456

Congenital malformations of heart and great arteries

504

4328

1.14

2.07

2.6

2.3

355.66

362.60

nmol/l

0.31

470

4013

Malignant neoplasm of liver and intrahepatic bile ducts

724

1.36

2.07

2.9

2.1

401.36

372.36

nmol/l

0.62

645

Benign neoplasm: Vagina

379

1.51

2.07

1.5

1.8

397.26

366.27

nmol/l

0.63

345

Benign neoplasm: Skin of ear and external auricular canal

129

1014

1.30

2.06

2.9

2.1

380.04

374.76

nmol/l

0.11

116

924

LSIL lesion of the cervix uteri, vagina or vulva

582

5212

1.13

2.05

2.1

385.36

373.91

nmol/l

0.66

544

4795

Malignant neoplasm of nasopharynx

2.25

2.04

2.1

1.8

386.69

375.97

nmol/l

0.09

Congenital malformations of eye, ear, face and neck

258

2186

1.20

2.02

2.5

2.2

360.62

372.33

nmol/l

0.40

238

2029

Haemorrhagic disorder due to circulating anticoagulants

258

1.61

2.02

1.9

1.7

370.63

394.96

nmol/l

0.27

228

Spinal enthesopathy

544

1.40

2.01

2.0

1.8

375.95

405.17

nmol/l

0.59

478

Atypical virus infections of central nervous system

259

1.62

2.01

2.9

1.9

349.51

373.61

nmol/l

0.36

244

Precocious puberty

143

1.86

2.00

3.2

2.2

416.92

404.77

nmol/l

0.11

133

All dysplastic lesions of the vagina

101

774

1.34

2.00

2.3

2.0

378.18

375.31

nmol/l

0.05

718

Other specified disorders of external ear

119

931

1.31

1.99

2.4

2.2

346.09

367.70

nmol/l

0.60

111

862

Melanoma in situ, other sites/unspecified

2.22

1.98

3.6

2.0

548.06

408.71

nmol/l

0.34

Melanoma in situ, other sites/unspecified

2.22

1.98

3.6

1.7

548.06

399.38

nmol/l

0.37

Cyst of Bartholin Gland

152

1227

1.27

1.98

1.8

2.1

388.93

373.97

nmol/l

0.40

137

1130

Use of pergolide

0.00

1.96

0.0

1.8

—

403.04

—

Benign leiomyoma with endometriosis

615

5542

1.12

1.96

2.1

373.91

377.54

nmol/l

0.17

558

5055

Suppurative otitis media, unspecified

750

1.34

1.95

1.8

2.0

377.91

375.22

nmol/l

0.04

691

Embolic stroke

132

1047

1.28

1.94

2.2

2.1

389.90

377.60

nmol/l

0.28

118

939

Burn and corrosion of trunk

105

813

1.32

1.92

2.5

2.1

381.76

366.09

nmol/l

0.46

757

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

560

1.38

1.92

2.1

1.7

377.65

369.05

nmol/l

0.16

500

Malignant neoplasm of other connective and soft tissue

588

1.38

1.91

2.2

2.0

374.56

379.05

nmol/l

0.07

539

Erythema in diseases classified elsewhere

2.34

1.91

2.5

2.0

366.57

379.13

nmol/l

0.10

Injury of nerves and spinal cord at neck level

571

1.39

1.90

2.3

2.2

377.18

370.33

nmol/l

0.11

529

Other disorders of male genital organs

116

910

1.30

1.90

2.3

2.2

351.44

362.82

nmol/l

0.34

106

841

Secondary lactase deficiency

3.12

1.89

2.1

2.9

333.75

398.58

nmol/l

—

Vascular dementia (other)

108

1.94

1.89

2.0

1.7

425.43

405.56

nmol/l

0.12

Sleep terrors [night terrors]

2.31

1.89

1.6

1.8

328.64

376.41

nmol/l

0.41

Paget disease

116

1.93

1.89

3.0

1.7

291.90

388.43

nmol/l

1.07

106

Cytomegaloviral hepatitis

2.22

1.87

2.1

1.9

361.60

387.41

nmol/l

0.17

Ovarian hyperstimulation (induction)

566

1.39

1.86

1.8

2.0

384.24

379.75

nmol/l

0.07

528

Other specified/unspecified nutritional deficiencies

201

1.67

1.85

2.4

2.0

459.72

389.06

nmol/l

0.66

186

Inguinal or femoral hernia, bilateral

313

2712

1.17

1.85

2.8

2.4

373.79

371.58

nmol/l

0.07

291

2510

Superficial injury of neck

575

1.38

1.84

2.3

2.0

371.55

370.97

nmol/l

0.01

532

Other disorders of optic disc

364

1.48

1.83

2.1

1.9

374.40

374.96

nmol/l

0.01

331

Benign neoplasm: Lip

532

1.39

1.83

2.9

1.8

360.60

366.49

nmol/l

0.09

483

Carcinoma in situ of skin of lower limb, including hip

473

1.42

1.83

3.4

1.8

345.50

382.84

nmol/l

0.78

420

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

2.02

1.82

2.7

2.0

394.17

375.96

nmol/l

0.14

Phantom limb syndrome

2.24

1.81

2.2

1.9

408.64

353.46

nmol/l

0.45

Dementia in Alzheimer disease

464

3529

1.13

1.79

1.6

2.0

393.07

386.50

nmol/l

0.28

369

3153

109

834

1.31

1.78

3.5

2.7

320.38

349.53

nmol/l

0.78

104

800

Pemphigus vulgaris

2.40

1.78

1.8

2.1

401.00

402.73

nmol/l

0.01

Benign neoplasm: Other and unspecified parts of mouth

122

975

1.28

1.77

2.6

2.1

392.18

378.01

nmol/l

0.31

104

899

Periodontal disease, other/unspecified

112

1.92

1.76

4.2

2.1

331.70

371.01

nmol/l

0.42

104

Chronic mastoiditis

684

1.33

1.75

2.7

2.1

409.88

377.81

nmol/l

0.49

624

Benign neoplasm: Long bones of lower limb

112

887

1.29

1.74

2.1

1.9

346.30

370.48

nmol/l

0.75

102

821

Orthopaedic devices associated with adverse incidents

444

1.42

1.73

2.1

352.24

367.16

nmol/l

0.29

405

Social disorders starting during childhood or adolescence

253

1.57

1.73

2.9

2.2

317.76

384.80

nmol/l

1.31

234

Benign neoplasm of ovary

663

6043

1.11

1.72

2.0

2.1

394.76

377.46

nmol/l

1.02

617

5508

Status post-ami

131

1330

0.80

1.72

1.9

2.2

363.11

391.72

nmol/l

1.03

115

1177

Malignant neoplasm of breast, HER2-negative

1838

14280

0.94

1.72

2.2

2.1

386.18

375.34

nmol/l

1.35

1678

13043

Dyshidrosis [pompholyx]

436

1.42

1.72

1.7

1.9

380.60

363.13

nmol/l

0.34

403

Long labour

928

8757

0.92

1.71

2.1

2.0

374.78

376.74

nmol/l

0.11

862

8077

Hand

143

1.78

1.71

1.6

1.7

382.46

379.85

nmol/l

0.03

131

Puerperal sepsis

503

4524

1.12

1.71

2.1

2.2

367.92

370.01

nmol/l

0.09

456

4169

Benign neoplasm: Conjunctiva

105

828

1.29

1.70

2.5

1.9

359.00

360.46

nmol/l

0.02

752

Other specified/unspecified deforming dorsopathies

462

1.40

1.69

2.1

1.9

348.91

381.52

nmol/l

0.45

432

Carcinoma in situ of prostate

128

1.81

1.69

2.3

1.5

444.41

374.22

nmol/l

0.54

117

Porphyria cutanea tarda

3.10

1.68

1.0

1.6

423.29

462.75

nmol/l

—

Other disorders of amniotic fluid and membranes

582

5231

1.11

1.67

2.1

2.0

351.33

378.91

nmol/l

3.45

541

4818

Maternal care for other known or suspected fetal problems

1113

6643

1.08

1.67

1.9

2.0

385.63

384.05

nmol/l

0.10

1024

6124

Contact with other hot metals

422

1.42

1.66

1.7

2.1

396.77

361.86

nmol/l

0.72

390

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

2.99

1.66

2.9

2.2

449.57

422.27

nmol/l

—

Subclinical iodine-deficiency hypothyroidism

2.98

1.65

3.4

2.1

315.86

299.62

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

130

1054

1.25

1.65

2.7

2.1

416.03

369.15

nmol/l

1.54

120

947

Other obstructed labour

304

2660

1.16

1.64

2.3

2.1

382.45

373.68

nmol/l

0.43

285

2443

Congenital deformities of feet

755

1.30

1.62

2.5

2.0

333.12

370.34

nmol/l

1.12

699

Carcinoma in situ of skin of ear and external auricular canal

248

1.54

1.61

2.2

1.6

344.65

354.98

nmol/l

0.13

217

Beta thalassaemia

3.37

1.61

2.8

1.4

365.83

396.94

nmol/l

—

Benign neoplasm: Skin of scalp and neck

650

1.32

1.60

2.2

1.9

366.00

365.80

nmol/l

0.00

599

Anomalies of pupillary function

607

1.34

1.60

1.8

2.1

379.30

372.62

nmol/l

0.13

569

Birth asphyxia

211

1.61

1.58

3.6

2.6

260.69

359.03

nmol/l

2.72

201

Wilms' tumor, excluding all cancers (controls excluding all cancers)

154

1.70

1.58

3.1

2.1

362.68

356.50

nmol/l

0.06

135

Hepatocellular carcinoma

425

1.40

1.58

3.4

2.2

367.92

378.19

nmol/l

0.15

381

2.16

1.57

1.7

1.4

371.08

417.27

nmol/l

0.35

L02BG Aromatase inhibitors

956

10275

0.92

1.57

2.1

379.03

378.92

nmol/l

0.01

872

9361

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

170

1.66

1.57

2.3

1.6

321.85

365.28

nmol/l

0.69

153

Other benign neoplasm of uterus: Other parts/unspecified

137

1126

1.24

1.57

1.8

1.7

424.06

370.48

nmol/l

2.36

124

976

Other and specified injuries of hip and thigh

547

1.35

1.57

2.0

1.9

361.51

384.55

nmol/l

0.44

498

Unspecified parasitic disease

235

1.56

3.0

2.1

341.29

372.94

nmol/l

0.46

216

Macular hole

173

1456

1.21

1.55

2.3

2.2

378.99

367.39

nmol/l

0.32

156

1320

Unspecified abortion

195

1659

1.19

1.54

2.4

2.2

351.09

369.10

nmol/l

0.73

181

1533

Congenital malformations of ovaries, fallopian tubes and broad ligaments

227

1957

1.18

1.53

2.1

2.0

367.27

375.43

nmol/l

0.26

212

1805

Melanoma in situ of scalp and neck

2.30

1.53

2.8

1.5

370.55

402.49

nmol/l

0.15

Qualitative platelet defects

110

1.85

1.52

2.9

2.4

397.11

375.98

nmol/l

0.26

101

malignant neoplasm of female genital organs

532

4834

1.11

1.52

2.9

2.0

414.25

381.48

nmol/l

2.83

491

4354

Viral infections of central nervous system, not elsewhere classified/unspecified

319

1.46

1.52

2.9

1.9

346.27

380.75

nmol/l

0.59

292

Other specified and unspecified disorders of iris and ciliary body

110

1.84

1.52

1.6

2.2

448.63

358.28

nmol/l

1.22

101

Epileptic seizures related to drugs

2.05

1.52

1.6

2.0

346.71

400.83

nmol/l

0.46

Inguinal hernia, bilateral

302

2655

1.15

1.51

2.8

2.4

370.53

370.94

nmol/l

0.01

281

2461

Benign neoplasm of thyroid gland

119

969

1.25

1.51

2.8

2.0

353.22

375.17

nmol/l

0.58

103

886

Ectropion of eyelid

106

850

1.27

1.51

2.8

2.0

408.16

378.28

nmol/l

0.67

756

Other congenital malformations of urinary system

157

1.69

1.51

4.7

2.2

211.88

344.12

nmol/l

4.86

147

120

934

1.26

1.51

3.4

2.6

321.87

350.88

nmol/l

0.89

115

894

Benign neoplasm of male genital organs

403

1.39

1.50

1.7

376.31

360.23

nmol/l

0.26

366

Cardiomyopathies, Secondary/extrinsic

141

1.70

1.48

2.6

2.2

425.61

359.37

nmol/l

1.38

131

Myocardial infarction, with ST-elevation

510

4628

1.11

1.47

2.4

2.3

396.34

375.47

nmol/l

0.60

463

4207

Benign lipomatous neoplasm of of intra-abdominal organs

2.03

1.47

2.9

1.9

288.71

350.63

nmol/l

0.49

Other benign neoplasms of uterus

185

1575

1.19

1.47

1.8

2.0

423.93

382.33

nmol/l

1.89

167

1406

Squamous cell neoplasms and carcinoma of cervix

179

0.48

1.47

1.3

1.8

381.67

371.62

nmol/l

—

163

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

180

0.48

1.47

1.3

1.7

381.67

371.51

nmol/l

—

166

Malignant neoplasm of ureter

2.17

1.46

7.4

2.0

436.17

405.87

nmol/l

0.19

Benign mammary dysplasia

530

4826

1.11

1.46

2.0

2.1

388.52

380.97

nmol/l

0.39

486

4383

Intrahepatic Cholestasis of Pregnancy (ICP)

285

2507

1.15

1.46

1.8

2.1

371.83

373.82

nmol/l

0.06

265

2327

Fourth [trochlear] nerve palsy

607

1.32

1.46

2.3

2.0

349.57

377.30

nmol/l

0.58

561

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

678

1.30

1.45

2.4

2.0

359.17

370.70

nmol/l

0.21

618

Rheumatic fever with heart involvement

119

1.77

1.45

1.8

2.1

332.75

350.18

nmol/l

0.21

106

Enteropathogenic Escherichia coli infection

1.97

1.45

2.7

1.8

395.27

371.00

nmol/l

0.16

Viral conjunctivitis

600

1.31

1.43

2.6

1.9

345.35

364.29

nmol/l

0.44

553

Maternal care for cervical incompetence

152

1278

1.21

1.42

2.3

2.0

387.68

377.61

nmol/l

0.20

143

1160

Oral leukoplakia, including avohilmo

734

1.28

1.41

2.7

2.2

395.12

370.72

nmol/l

0.49

680

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.89

1.41

1.4

1.9

431.37

362.18

nmol/l

0.60

Lesion of sciatic nerve

132

1094

1.22

1.40

2.1

405.12

383.64

nmol/l

0.44

121

987

Defect, injury or illness of neck

152

1.66

1.40

2.2

1.9

378.08

391.39

nmol/l

0.17

138

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

2.30

1.39

1.2

1.5

430.44

404.26

nmol/l

—

Malignant neoplasm of corpus uteri

272

2395

1.15

1.39

2.3

2.1

402.12

381.56

nmol/l

0.84

247

2153

Dementia due to Parkinson's disease

515

1.33

1.37

1.7

2.0

408.38

390.22

nmol/l

0.30

456

Other disorders of breast and lactation associated with childbirth

569

1.32

1.37

1.7

1.9

405.18

380.94

nmol/l

0.62

526

Chronic suppurative otitis media, including avohilmo

286

2528

1.14

1.37

2.2

372.25

371.10

nmol/l

0.03

264

2318

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

144

1208

1.21

1.36

2.0

1.9

361.71

357.63

nmol/l

0.10

126

1106

Left hemicolectomy

587

1.31

1.35

2.6

2.0

401.34

372.70

nmol/l

0.56

533

Other sexually transmitted chlamydial diseases

252

2211

1.15

1.35

1.8

2.0

399.12

380.21

nmol/l

0.75

221

2033

Bilateral sagittal split ramus osteotomy operation

126

1046

1.23

1.35

2.0

365.32

371.67

nmol/l

0.12

114

972

Calculus of lower urinary tract

151

1273

1.20

1.35

2.5

2.2

349.61

369.05

nmol/l

0.58

142

1157

Exposure to uncontrolled fire, not in building or structure

2.16

1.35

1.5

1.8

338.09

377.85

nmol/l

0.39

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

138

1.69

1.35

4.2

2.2

378.82

374.75

nmol/l

0.05

127

Femoral hernia

138

1155

1.21

1.34

2.5

2.1

365.34

371.76

nmol/l

0.14

128

1052

Other degenerative diseases of the basal ganglia

379

1.38

1.34

1.9

2.0

401.53

380.51

nmol/l

0.39

345

Other and unspecified corneal deformities and disorders

110

902

1.24

1.33

2.2

2.0

333.40

371.58

nmol/l

1.27

828

Benign neoplasm: Lip

562

1.31

1.33

2.9

1.9

360.60

374.97

nmol/l

0.24

517

Other obstetric trauma

160

1877

0.84

1.33

2.1

2.0

398.27

374.24

nmol/l

1.07

148

1731

Varus deformity, not elsewhere classified

294

1.44

1.32

3.4

2.1

386.50

374.32

nmol/l

0.16

271

Hypertensive encephalopathy

1.85

1.32

1.3

2.1

455.31

367.60

nmol/l

1.56

Hereditary motor and sensory neuropathy

219

1.51

1.32

2.8

1.9

347.53

359.65

nmol/l

0.13

204

Osteosarcoma, excluding all cancers (controls excluding all cancers)

1.84

1.32

3.2

2.4

328.31

351.09

nmol/l

0.25

Mixed conductive and sensorineural hearing loss

393

3549

1.12

1.30

2.3

2.2

367.94

377.40

nmol/l

0.43

351

3250

All dysplastic lesions of the cervix uteri, vagina or vulva

1242

11663

1.06

1.30

2.0

2.1

382.18

374.31

nmol/l

0.73

1152

10759

Dental caries 2 and operation codes, only avohilmo

3471

20807

1.04

1.30

2.1

2.2

365.32

370.89

nmol/l

0.92

3173

19239

Wilms' tumor

163

1.60

1.30

3.1

2.3

362.68

381.30

nmol/l

0.21

148

Other congenital malformations of peripheral vascular system

390

1.37

1.30

2.4

2.0

379.20

380.84

nmol/l

0.02

364

Melanocytic naevi of other and unspecified parts of face

207

1799

1.17

1.29

2.3

2.1

378.06

377.44

nmol/l

0.02

191

1650

Dental caries 1 and operation codes, only avohilmo

1379

6556

1.06

1.29

2.1

2.4

360.54

379.17

nmol/l

2.97

1274

6085

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

132

1107

1.21

1.28

2.7

2.2

386.76

369.25

nmol/l

0.50

119

1027

Postdysenteric arthropathy

263

1.46

1.27

2.3

2.2

331.38

384.36

nmol/l

0.98

242

Burn and corrosion of wrist and hand

133

1118

1.21

1.26

1.9

2.1

365.43

369.82

nmol/l

0.08

122

1041

Use of interferon beta-1a

740

0.75

1.26

1.9

2.1

315.23

372.65

nmol/l

1.67

693

Motorcycle rider injured in noncollision transport accidents

104

854

1.24

1.25

1.8

2.1

437.46

379.83

nmol/l

0.39

798

LeFortI or BSSRO operation

151

1286

1.19

1.24

2.0

2.1

369.78

370.11

nmol/l

0.01

138

1200

Use of memantine

671

5415

1.08

1.22

1.6

2.0

398.56

387.47

nmol/l

0.78

559

4836

Use of other anti-dementia drugs

671

5415

1.08

1.22

1.6

2.0

398.56

387.47

nmol/l

0.78

559

4836

Blood alcohol or alcohol intoxication level

668

1.27

1.22

1.9

2.1

374.32

377.11

nmol/l

0.04

622

Circumscribed brain atrophy

446

1.33

1.21

1.6

2.1

375.44

376.33

nmol/l

0.01

404

Viral agents as the cause of diseases classified to other chapters

661

1.27

1.20

2.9

2.2

356.61

365.94

nmol/l

0.16

618

Congenital malformations of cardiac septa

263

2261

1.14

1.20

2.8

2.4

348.26

359.43

nmol/l

0.34

247

2110

Obstructed labour due to maternal pelvic abnormality

510

5542

0.91

1.20

2.0

2.2

379.77

369.17

nmol/l

0.45

481

5096

Chromomycosis and phaeomycotic abscess

2.20

1.19

3.7

1.6

377.25

383.75

nmol/l

—

Carcinoma in situ of lip, oral cavity and pharynx

2.03

1.18

2.1

2.0

334.00

384.68

nmol/l

0.32

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

422

1.33

1.18

2.2

1.8

412.54

359.28

nmol/l

0.97

384

Complications of labour and delivery

2754

15922

0.96

1.17

2.2

2.1

376.84

381.19

nmol/l

0.50

2563

14616

Kidney diseases associated to Fabry's disease

2.14

1.17

2.9

2.3

268.00

364.29

nmol/l

—

Ependymoma

2.06

1.16

2.0

2.8

220.09

326.15

nmol/l

1.68

Down's syndrome

120

1.68

1.16

3.4

2.4

346.37

351.51

nmol/l

0.04

109

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

363

1.36

1.16

2.1

2.0

376.71

382.13

nmol/l

0.07

333

Hereditary corneal dystrophies

102

845

1.23

1.16

2.8

2.1

393.40

377.60

nmol/l

0.30

770

Legal intervention and operations of war

2.45

1.15

2.6

1.8

376.14

421.72

nmol/l

—

Benign neoplasm: Bladder

209

1.48

1.15

2.5

1.6

378.84

364.92

nmol/l

0.13

188

Contact with nonpowered hand tool

143

1222

1.19

1.15

2.3

2.2

376.81

371.20

nmol/l

0.10

133

1140

Other nonautoimmune haemolytic anaemias

2.12

1.14

2.8

1.7

375.60

373.91

nmol/l

—

Benign neoplasm: Short bones of upper limb

416

1.33

1.14

2.9

1.9

335.10

365.33

nmol/l

0.60

386

Contact with other hot fluids

107

892

1.22

1.14

2.6

2.1

350.13

364.63

nmol/l

0.25

100

827

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

335

3025

1.11

1.14

1.9

1.8

411.99

366.91

nmol/l

3.99

311

2712

Pregnancy examination and test

757

4413

1.08

1.14

2.0

389.70

391.92

nmol/l

0.10

695

4072

Disease of thymus, other/unspecified

2.10

1.14

1.2

1.8

373.90

406.76

nmol/l

—

Carcinoma in situ of other and unspecified digestive organs

630

1.26

1.13

2.2

365.34

370.46

nmol/l

0.09

578

Failed induction of labour

233

2066

1.14

1.13

1.7

1.9

389.04

378.63

nmol/l

0.36

214

1903

Carcinoma in situ of skin of ear and external auricular canal

269

1.41

1.13

2.2

1.8

344.65

377.46

nmol/l

0.50

239

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

105

1.71

1.13

2.2

1.9

316.94

381.32

nmol/l

0.77

Crushing injury of ankle and foot

1.74

1.13

1.6

2.1

344.09

373.63

nmol/l

0.30

Operations 1 for CAVS

1.79

1.12

1.9

2.5

426.60

320.35

nmol/l

1.40

Lower leg

153

1.57

1.12

1.5

1.9

375.33

357.85

nmol/l

0.19

142

Lumbosacral plexus disorders

1.80

1.11

1.6

2.2

360.79

351.70

nmol/l

0.07

Respiratory tuberculosis, clinically confirmed

270

1.40

1.10

2.2

2.0

375.84

374.25

nmol/l

0.02

240

Vascular syndromes of brain in cerebrovascular disorders

128

1089

1.19

1.09

2.2

344.60

370.13

nmol/l

0.86

108

989

Sphingolipidosis, other/unspecified

2.10

1.09

2.7

2.2

266.89

408.48

nmol/l

—

Sequelae of poisoning by drugs, medicaments and biological substances

2.09

1.09

1.6

2.0

420.22

428.05

nmol/l

—

Other osteochondropathies

245

2184

1.13

1.09

2.7

2.1

351.35

371.58

nmol/l

0.75

229

2022

Diaper [napkin] dermatitis

2.08

1.08

3.6

2.7

285.67

378.12

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

215

1902

1.14

1.08

2.7

2.2

354.80

367.69

nmol/l

0.50

201

1749

Septal defects

246

2148

1.13

1.08

2.7

2.4

353.57

353.95

nmol/l

0.01

230

2008

Persistent hyperplasia of thymus

2.54

1.08

3.0

1.3

309.00

336.41

nmol/l

—

Benign neoplasm: Short bones of upper limb

420

1.32

1.08

2.9

2.1

335.10

364.56

nmol/l

0.59

392

Benign neoplasm: Choroid

189

1659

1.15

1.08

2.6

2.2

340.01

369.80

nmol/l

1.53

167

1511

Hip and thigh

1.90

1.07

2.3

1.9

322.08

380.14

nmol/l

0.31

Pedestrian injured in collision with car, pick-up truck or van

698

1.24

1.07

1.8

1.9

421.61

372.76

nmol/l

0.66

638

Benign neoplasm: Peripheral nerves and autonomic nervous system

394

1.32

1.07

2.5

1.8

366.57

372.83

nmol/l

0.08

365

Other disorders of skin and subcutaneous tissue related to radiation

2.03

1.06

1.8

382.22

349.37

nmol/l

—

Disorders of sexual preference

2.01

1.06

2.6

1.8

341.00

359.09

nmol/l

—

Effects of other deprivation

1.88

1.06

4.8

2.2

377.58

363.68

nmol/l

0.10

Benign neoplasm: Skin of scalp and neck

690

1.24

1.06

2.2

2.0

366.00

372.56

nmol/l

0.11

641

Malignant neoplasm of other and unspecified urinary organs

1.99

1.06

6.8

1.8

556.80

371.77

nmol/l

—

Glaucoma, exfoliation

315

2851

1.11

1.05

1.9

2.0

380.71

382.48

nmol/l

0.04

272

2535

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

2.18

1.05

1.4

1.9

257.29

368.28

nmol/l

—

Other and unspecified neuropathies

1.69

1.05

3.4

2.2

286.75

363.10

nmol/l

0.94

Carcinoma in situ of oral cavity and pharynx

2.15

1.04

2.7

2.1

369.57

360.79

nmol/l

—

Malignant neoplasm of thymus

1.80

1.04

3.9

2.2

330.15

375.30

nmol/l

0.51

Carcinoma in situ of breast, lobular

200

0.58

1.04

2.4

1.9

316.00

368.93

nmol/l

0.38

190

Coronary artery bypass grafting

839

6009

1.07

1.03

2.0

2.5

391.74

379.31

nmol/l

0.89

766

5464

N06DA Anticholinesterases

830

7132

0.94

1.02

1.7

2.1

392.73

388.36

nmol/l

0.25

694

6395

Use of anticholinesterases

830

7132

0.94

1.02

1.7

2.1

392.73

388.36

nmol/l

0.25

694

6395

Placenta praevia

141

1628

0.86

1.02

1.9

2.1

355.92

370.71

nmol/l

0.48

130

1506

Relapsing polychondritis

1.82

1.02

3.5

2.1

286.31

361.60

nmol/l

0.70

Carcinoma in situ of breast, lobular

199

0.58

1.02

2.4

2.1

316.00

351.94

nmol/l

0.24

186

Carcinoma in situ of oropharynx, excluding all cancers

2.08

1.01

2.7

1.9

369.57

396.10

nmol/l

—

Benign neoplasm: Long bones of lower limb

112

951

1.20

1.01

2.1

346.30

370.92

nmol/l

0.78

102

886

Disorders of globe

622

1.24

1.00

2.1

1.9

357.24

382.74

nmol/l

0.63

559

Carcinoma in situ of lip, oral cavity and pharynx

1.89

0.99

2.1

2.6

334.00

338.26

nmol/l

0.02

Benign neoplasm: Bladder

216

1.43

0.99

2.5

2.0

378.84

390.58

nmol/l

0.10

197

Alzheimer’s disease (Early onset), excluding more controls

628

1.23

0.99

1.7

2.2

420.21

402.35

nmol/l

0.30

573

Ulcer of oesophagus, drug-induced

125

1.58

0.99

2.3

2.0

317.21

386.94

nmol/l

0.85

109

Toxic encephalopathy

1.87

0.99

1.3

1.7

314.22

349.84

nmol/l

—

Other congenital malformations of upper alimentary tract

200

1.45

0.99

2.9

2.1

336.71

365.89

nmol/l

0.38

189

Acute hepatitis A

117

1.61

0.99

2.9

1.9

312.83

388.28

nmol/l

1.14

108

Other lesions of median nerve

724

1.22

0.98

1.6

2.1

367.68

389.32

nmol/l

0.48

652

Laparoscopic right hemicolectomy

169

1485

1.15

0.98

2.8

2.1

394.13

375.19

nmol/l

0.63

160

1348

Disorder of bilirubin metabolism, other/unspecified

2.39

0.97

4.2

2.1

390.17

382.32

nmol/l

—

Benign lipomatous neoplasm of of intra-abdominal organs

1.72

0.96

2.9

2.0

288.71

378.65

nmol/l

0.80

LSIL lesion of the vagina

428

1.29

0.96

2.4

2.1

396.28

370.02

nmol/l

0.50

399

Alzheimer’s disease (Early onset)

976

0.82

0.96

1.7

1.9

420.21

387.99

nmol/l

0.64

860

Carcinoma in situ of prostate

151

1.52

0.96

2.3

2.2

444.41

364.81

nmol/l

0.65

137

Benign neoplasm: Other parts of oropharynx

244

1.39

0.95

2.5

1.9

364.03

366.34

nmol/l

0.03

221

Retinoschisis and retinal cysts

599

1.24

0.95

2.6

2.1

409.64

373.20

nmol/l

0.78

544

Corneal degeneration

384

1.31

0.95

2.0

1.9

322.42

376.97

nmol/l

1.21

348

LSIL lesion of the cervix uteri

442

4092

1.09

0.95

2.1

384.88

376.73

nmol/l

0.35

416

3770

Single delivery by caesarean section

870

4755

1.06

0.95

2.0

379.51

387.66

nmol/l

0.58

815

4347

Malignant neoplasm of colon

438

4051

1.09

0.94

2.6

2.2

398.13

374.44

nmol/l

1.54

408

3677

Malignant neoplasm of vulva

245

1.39

0.94

2.8

1.7

371.04

381.16

nmol/l

0.09

223

Bus occupant injured in other and unspecified transport accidents

169

1.47

0.92

1.7

1.8

363.17

384.47

nmol/l

0.21

159

ILD medications: nintedanib

119

1.57

0.92

2.1

2.3

331.78

390.37

nmol/l

0.73

113

Other acantholytic disorders

1.83

0.91

3.2

2.2

316.36

391.74

nmol/l

0.73

Other benign neoplasm of uterus: Other parts/unspecified

137

1195

1.16

0.90

1.8

2.0

424.06

388.96

nmol/l

1.22

124

1069

Contact with machinery

331

3035

1.10

0.89

2.4

2.3

352.64

366.74

nmol/l

0.72

307

2810

Systemic atrophies primarily affecting the central nervous system

124

1074

1.17

0.89

2.1

2.2

376.89

365.54

nmol/l

0.28

110

990

Distal bite

152

1328

1.15

0.89

3.0

2.3

319.43

374.26

nmol/l

3.29

139

1249

Mandibular retrognathia AND surgery (BSSRO)

769

1.20

0.89

1.9

2.0

364.80

369.54

nmol/l

0.07

719

230

1.39

0.89

2.4

2.0

378.83

355.61

nmol/l

0.21

208

Other abnormal products of conception

1439

9195

1.05

0.89

2.0

374.02

376.69

nmol/l

0.19

1352

8505

Myelodysplastic syndrome

187

1.43

0.88

2.7

1.7

322.12

370.53

nmol/l

0.51

163

Benign neoplasm: Conjunctiva

105

899

1.18

0.88

2.5

2.1

359.00

373.63

nmol/l

0.30

830

Neurofibromatosis, type 2

1.83

0.88

2.5

1.9

344.73

386.03

nmol/l

0.40

Carcinoma in situ of breast, intraductal

240

2651

0.90

0.88

2.4

2.2

384.09

374.32

nmol/l

0.32

214

2434

Benign neoplasm: Other parts of oropharynx

248

1.37

0.88

2.5

1.8

364.03

369.00

nmol/l

0.06

227

Pedestrian injured in collision with two- or three-wheeled motor vehicle

112

0.51

0.88

2.3

2.0

537.50

369.97

nmol/l

—

101

Melanoma in situ of scalp and neck

1.81

0.88

2.8

1.6

370.55

390.22

nmol/l

0.09

Unspecific neurodegenerative disorder

1211

7980

1.05

0.87

1.7

2.1

396.64

385.44

nmol/l

1.10

1028

7196

Toxic effect of contact with venomous animals

132

1152

1.16

0.87

2.2

2.1

391.13

372.91

nmol/l

0.52

124

1062

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.79

0.87

1.5

2.5

325.55

385.28

nmol/l

0.53

Congenital lactase deficiency

1.79

0.87

2.6

386.18

387.11

nmol/l

0.01

Carcinoma in situ of cervix uteri

333

3062

1.10

0.86

1.8

1.9

395.60

377.66

nmol/l

0.87

311

2800

Pedestrian injured in transport accident

227

2049

1.12

0.86

2.0

2.1

392.74

374.46

nmol/l

0.47

210

1872

conjunctival degenerations and deposits

598

1.22

0.86

2.0

360.21

370.60

nmol/l

0.17

550

Calcium deposit in bursa

1.83

0.86

1.6

1.5

459.00

371.77

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

258

2346

1.11

0.85

2.2

2.1

381.58

372.68

nmol/l

0.31

240

2176

Benign lipomatous neoplasm of spermatic cord

2.00

0.85

1.3

1.6

313.50

384.41

nmol/l

—

Struck by thrown, projected or falling objec

157

1389

1.14

0.85

1.8

2.1

373.71

369.50

nmol/l

0.10

147

1294

Benign neoplasm: Peripheral nerves and autonomic nervous system

409

1.27

0.85

2.5

1.8

366.57

379.82

nmol/l

0.17

378

Severe mental retardation

1.67

0.84

2.0

2.6

357.86

325.71

nmol/l

0.23

Glanders and melioidosis

0.00

0.84

0.0

2.0

—

336.33

—

Foreign body on external eye

486

4542

1.08

0.83

2.4

2.3

357.78

366.02

nmol/l

0.52

455

4218

Mumps

758

1.19

0.82

2.2

2.1

339.09

363.97

nmol/l

0.68

706

Labour and delivery complicated by umbilical cord complications

190

1708

1.12

0.80

2.0

2.1

366.18

370.04

nmol/l

0.12

172

1579

Other superficial injuries of ankle and foot

183

1.41

0.80

1.9

2.1

370.36

375.37

nmol/l

0.05

170

Pregnancy, childbirth and the puerperium

1279

6974

0.96

0.80

1.9

2.0

388.07

400.54

nmol/l

1.21

1165

6268

Other diseases caused by chlamydiae

368

1.28

0.80

2.6

2.0

354.49

373.32

nmol/l

0.26

343

Sleepwalking [somnambulism]

1.68

0.79

1.3

2.1

373.67

399.09

nmol/l

0.25

Perioral dermatitis, drug-induced

2.02

0.79

2.7

2.1

209.14

364.67

nmol/l

—

Malignant neoplasm of pancreas

167

1491

1.13

0.79

2.8

2.1

420.06

372.57

nmol/l

2.07

155

1342

Inhalation and ingestion of other objects causing obstruction of respiratory tract

175

1.42

0.78

2.6

1.9

362.92

378.67

nmol/l

0.17

161

Schistosomiasis [bilharziasis]

2.00

0.78

1.7

366.86

350.50

nmol/l

—

Acute poliomyelitis

387

1.27

0.78

2.7

1.9

377.50

386.78

nmol/l

0.12

354

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1104

9348

0.95

0.78

2.2

1.8

384.39

367.32

nmol/l

1.82

1005

8480

Benign neoplasm: Short bones of lower limb

280

1.32

0.78

2.9

1.8

320.50

372.75

nmol/l

1.49

261

Acute disseminated encephalitis/encephalomyelitis

1.74

0.77

3.8

2.0

228.33

380.08

nmol/l

—

Other haemoglobinopathies

1.73

0.77

2.2

231.78

394.11

nmol/l

—

Inflammatory myopathy

1.97

0.77

3.7

1.7

274.57

408.26

nmol/l

—

Left side

108

1.54

0.77

1.7

2.1

328.81

364.44

nmol/l

0.31

Other fusion of spine

1.95

0.77

2.9

1.5

343.71

400.91

nmol/l

—

Tuberculosis

172

1541

1.12

0.76

2.1

376.66

377.62

nmol/l

0.01

152

1378

Toxic effect of ethanol

135

1193

1.14

0.76

2.1

371.15

379.09

nmol/l

0.15

125

1108

Adenocarcinoma and ductal carcinoma of pancreas

819

0.83

0.76

1.8

2.1

423.80

373.40

nmol/l

1.00

737

Hypospadias

117

1.51

0.76

2.2

2.1

365.00

336.37

nmol/l

0.30

110

Sequelae of tuberculosis

370

1.26

0.75

2.0

1.8

368.50

390.48

nmol/l

0.27

322

Effects of air pressure and water pressure

143

1.45

0.74

1.8

2.0

321.80

376.21

nmol/l

0.63

135

Adenocarcinoma and papilloma adenocarcinoma of rectum

230

2518

0.91

0.74

1.8

2.2

403.54

371.83

nmol/l

1.60

214

2288

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

1.56

0.72

5.4

1.7

342.14

377.27

nmol/l

0.41

Other and unspecified firearm discharge, undetermined intent

1.79

0.72

3.6

1.5

287.43

382.50

nmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

239

2609

0.91

0.72

1.8

2.2

406.67

370.46

nmol/l

1.97

221

2369

Benign neoplasm: Cranial nerves

740

1.18

0.72

2.9

1.8

361.22

360.98

nmol/l

0.00

677

Adenocarcinoma and papillary adenocarcinoma of stomach

647

1.19

0.72

2.1

2.0

377.65

376.45

nmol/l

0.02

586

Carcinoma in situ of bronchus and lung

1.96

0.71

2.6

1.5

441.00

313.68

nmol/l

—

Benign neoplasm: Floor of mouth

1.55

0.70

3.6

1.6

387.43

360.06

nmol/l

0.31

Labyrinthine fistula

0.50

0.70

1.8

480.40

351.04

nmol/l

—

Benign neoplasm: Short bones of lower limb

285

1.29

0.70

2.9

2.0

320.50

376.79

nmol/l

1.67

264

Cholera

130

1155

1.14

0.70

2.0

2.1

359.31

380.03

nmol/l

0.61

121

1038

Injury of nerves at hip and thigh level

111

1.50

0.70

2.9

2.0

337.38

354.28

nmol/l

0.12

103

Foreign body entering into or through eye or natural orifice

268

2473

1.09

0.69

2.6

2.2

359.74

372.30

nmol/l

0.60

254

2291

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

145

1.42

0.68

1.8

387.95

378.07

nmol/l

0.08

130

Benign neoplasm: Vertebral column

1.69

0.68

1.8

1.7

365.70

426.54

nmol/l

—

Other ill-defined and unspecified causes of mortality

154

1384

1.12

0.68

2.6

2.0

371.21

373.15

nmol/l

0.04

137

1244

Tick-borne viral encephalitis

112

1.49

0.67

2.0

1.8

264.56

368.22

nmol/l

1.88

101

Enteritis due to Yersinia enterocolitica

129

1.44

0.66

2.6

2.2

426.39

398.18

nmol/l

0.24

116

Postpartum hemorraghe, parous women as controls

1029

8660

1.04

0.66

2.0

374.26

371.68

nmol/l

0.19

976

8041

Benign neoplasm: Connective and other soft tissue of abdomen

1.59

0.66

1.3

1.9

342.42

367.47

nmol/l

0.15

Use of amantadine

460

1.22

0.66

2.4

1.8

339.98

377.22

nmol/l

0.79

418

Use of rasagiline

654

1.18

0.66

1.7

2.1

387.52

369.78

nmol/l

0.31

603

Primary angle-closure glaucoma

126

1123

1.13

0.65

2.0

357.77

379.39

nmol/l

0.67

111

1013

Foreign body in ear

544

1.19

0.65

2.0

2.1

362.09

384.51

nmol/l

0.37

504

Butylpyrazolidines

0.00

0.64

0.0

2.1

—

432.95

—

Malignant neoplasm of rectum

232

2517

0.92

0.64

1.9

2.2

399.43

370.76

nmol/l

1.49

211

2281

Pityriasis lichenoides chronica

105

1.48

0.63

2.0

2.2

316.87

377.21

nmol/l

0.51

MS-disease / Multiple Sclerosis

266

2467

1.09

0.63

2.0

2.1

350.88

372.26

nmol/l

1.14

241

2285

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

148

1.39

0.62

2.3

2.2

277.80

371.59

nmol/l

1.26

136

malignant neoplasm of male genital organs

1201

7355

1.04

0.62

2.4

2.6

368.50

372.47

nmol/l

0.24

1117

6795

Myocardial infarction, unclassifiable

576

5405

0.95

0.62

2.1

2.2

387.57

378.83

nmol/l

0.35

524

4840

Other and unspecified disorders of psychological development

366

1.23

0.62

2.2

2.5

335.13

355.02

nmol/l

0.26

348

Atrial septal defect

143

1282

1.12

0.61

3.1

2.4

333.86

354.18

nmol/l

0.49

133

1206

HSIL lesion of the vagina

391

1.22

0.61

2.4

2.1

351.60

369.35

nmol/l

0.24

368

Right side

158

1.37

0.60

2.6

2.0

381.57

388.70

nmol/l

0.07

148

Hereditary factor VIII deficiency

1.55

0.60

3.2

2.0

322.92

368.65

nmol/l

0.36

Malignant neoplasm of breast, HER-negative

747

7149

1.05

0.60

2.1

390.10

377.09

nmol/l

0.96

685

6462

Eclampsia

0.54

0.59

2.2

1.8

329.20

388.29

nmol/l

—

Haemorrhagic and haematological disorders of fetus and newborn

758

1.15

0.59

3.5

2.9

322.99

335.95

nmol/l

0.29

732

Drug-induced myopathy

1.57

0.59

3.4

2.2

404.00

365.06

nmol/l

0.22

Chronic suppurative otitis media

227

2099

1.09

0.58

2.1

2.2

373.05

369.36

nmol/l

0.10

207

1922

Benign neoplasm: other/unspecified salivary gland

652

1.16

0.58

2.3

1.8

355.48

366.08

nmol/l

0.15

590

Pedal cyclist injured in noncollision transport accidents

387

3648

1.07

0.58

2.1

2.2

385.74

371.03

nmol/l

0.88

363

3364

Chondromalacia

831

1.14

0.58

2.1

350.18

371.49

nmol/l

0.51

762

Use of selegiline

129

1163

1.12

0.57

1.7

2.2

378.79

368.46

nmol/l

0.25

110

1044

Oesophagitis, drug-induced

1.56

0.57

1.8

2.4

408.44

358.00

nmol/l

—

Abnormalities of forces of labour

364

3860

0.94

0.56

2.3

2.1

352.13

370.50

nmol/l

1.19

347

3566

Glaucoma secondary to eye inflammation

204

1.30

0.56

3.5

1.9

312.92

363.43

nmol/l

0.77

188

Colon adenocarcinoma

334

3140

1.07

0.55

2.6

2.2

401.84

375.30

nmol/l

1.43

310

2832

Respiratory tuberculosis

147

1337

1.11

0.55

2.1

363.85

374.75

nmol/l

0.31

130

1197

Respiratory tuberculosis, confirmed and not-confirmed

147

1337

1.11

0.55

2.1

363.85

374.75

nmol/l

0.31

130

1197

Malignant neoplasm of bone and articular cartilage of limbs

117

1.41

0.55

4.9

2.0

350.75

372.05

nmol/l

0.21

110

Vascular dementia (sudden onset)

1.50

0.54

2.8

1.4

417.67

402.88

nmol/l

—

Toxic effect of other gases, fumes and vapours

152

1.35

0.54

2.4

2.1

310.45

392.32

nmol/l

1.56

142

Embolism and thrombosis of abdominal aorta

1.59

0.54

2.8

1.7

376.00

416.41

nmol/l

—

Carcinoma in situ of skin of lip

1.47

0.54

1.1

1.6

471.11

379.54

nmol/l

—

Other mosquito-borne viral fevers

1.46

0.54

1.7

2.1

278.78

384.25

nmol/l

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.45

0.53

3.0

1.9

401.33

378.75

nmol/l

—

Macular cyst

630

1.16

0.53

2.7

2.2

393.18

368.63

nmol/l

0.38

566

Other and unspecified disease of Bartholin gland

866

1.13

0.53

1.7

2.1

407.07

374.10

nmol/l

0.90

781

Endometriosis in cutaneous scar

1.51

0.53

2.9

2.2

373.36

386.61

nmol/l

0.12

Carcinoma in situ of skin of lip

1.42

0.52

1.1

1.6

471.11

409.27

nmol/l

—

Generalized epilepsy, strict definition

697

1.15

0.52

1.7

2.1

407.00

369.14

nmol/l

0.77

660

Benign neoplasm: Floor of mouth

101

1.43

0.52

3.6

1.9

387.43

351.10

nmol/l

0.44

Benign neoplasm: Connective and other soft tissue of abdomen

1.49

0.52

1.3

2.2

342.42

362.85

nmol/l

0.12

Injury of urinary and pelvic organs

529

1.17

0.51

1.8

2.0

332.76

371.61

nmol/l

0.97

490

Open wounds involving multiple body regions

106

0.64

0.51

1.0

2.2

389.14

411.70

nmol/l

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.61

0.51

2.0

1.7

308.71

358.38

nmol/l

—

Fetus and newborn affected by maternal complications of pregnancy

288

0.78

0.50

3.0

295.74

345.72

nmol/l

0.76

276

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

119

1.38

0.50

2.5

1.7

300.25

381.14

nmol/l

1.30

107

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

1.58

0.50

2.4

2.5

344.14

387.78

nmol/l

—

Lens-induced iridocyclitis

1.55

0.50

5.3

1.9

408.14

402.98

nmol/l

—

Benign neoplasm: Vertebral column

1.53

0.49

1.8

2.1

365.70

402.80

nmol/l

—

Carcinoma in situ of oral cavity

1.54

0.49

2.6

2.0

371.57

327.10

nmol/l

—

Colorectal cancer

701

6744

1.04

0.49

2.3

2.2

399.40

378.42

nmol/l

1.85

650

6122

Melanocytic naevi of scalp and neck

644

1.15

0.49

2.6

1.7

355.07

377.19

nmol/l

0.43

587

Congenital malformations of ear causing impairment of hearing

117

0.66

0.48

1.4

2.6

447.88

357.85

nmol/l

—

107

HSIL lesion of the cervix uteri, vagina or vulva

795

7674

1.04

0.48

2.0

383.26

376.18

nmol/l

0.47

732

7083

Other and unspecified heterotropia

1.48

0.48

1.9

326.73

367.72

nmol/l

0.36

Toxic effect of alcohol

580

1.15

0.47

2.4

2.1

382.44

363.65

nmol/l

0.27

538

Pneumoconiosis due to asbestos and other mineral fibres

402

1.18

0.47

2.3

2.1

373.65

372.46

nmol/l

0.01

356

Alzheimer’s disease, wide definition

579

5046

0.96

0.47

1.6

2.0

411.66

385.89

nmol/l

2.19

473

4503

Benign neoplasm of male genital organs

478

1.16

0.46

1.7

2.2

376.31

365.04

nmol/l

0.17

435

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

349

1.19

0.45

2.4

2.0

323.69

366.50

nmol/l

0.83

319

Malignant neoplasm of ovary

127

1384

0.91

0.45

2.8

2.1

467.84

373.79

nmol/l

3.89

119

1257

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

245

2302

1.07

0.44

1.8

406.03

367.52

nmol/l

2.20

228

2072

Burn and corrosion of respiratory tract

1.64

0.44

2.4

1.8

330.60

427.52

nmol/l

—

Carcinoma in situ of oesophagus

1.64

0.44

1.6

1.8

415.20

344.63

nmol/l

—

Taeniasis

0.00

0.44

0.0

1.9

—

374.07

—

Disorders of ornithine metabolism

0.00

0.44

0.0

3.7

—

282.14

—

Postpartum haemorrhage due to anatomy

353

3710

0.95

0.44

1.9

387.30

378.21

nmol/l

0.46

331

3445

Muscle wasting and atrophy, not elsewhere classified

122

1.34

0.44

1.5

1.8

374.75

408.99

nmol/l

0.41

113

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

158

1.29

0.43

1.8

1.9

387.95

376.99

nmol/l

0.10

142

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

144

1332

1.09

0.42

2.0

2.2

361.71

368.76

nmol/l

0.19

126

1226

Keratoconus

662

1.13

0.42

2.4

2.1

353.29

364.88

nmol/l

0.18

624

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

154

1657

0.92

0.41

1.9

2.1

368.20

370.48

nmol/l

0.06

146

1526

Duodenal ulcer - Acute with haemorrhage, drug-induced

1.50

0.41

1.4

1.6

308.20

422.32

nmol/l

—

Carcinoma in situ of bronchus and lung

1.48

0.41

2.6

1.8

441.00

328.40

nmol/l

—

Congenital malformations of pulmonary and tricuspid valves

298

1.20

0.41

3.5

2.8

357.70

346.49

nmol/l

0.13

284

Rheumatic fever incl heart disease

788

1.11

0.40

1.7

1.9

345.43

372.95

nmol/l

0.82

716

Congenital malformations of aortic and mitral valves

131

1211

1.09

0.40

2.6

2.4

360.46

361.06

nmol/l

0.01

119

1134

Accidental poisoning by and exposure to alcohol

485

1.15

0.40

1.8

1.9

377.52

395.83

nmol/l

0.20

438

Shigellosis

1.39

0.39

1.3

1.8

361.92

379.33

nmol/l

0.12

Pterygium

732

1.12

0.39

2.1

362.28

367.72

nmol/l

0.07

672

Medical treatment for female infertility

870

8431

1.03

0.39

2.2

2.0

367.81

375.82

nmol/l

0.55

828

7799

Sequelae of injuries involving multiple and unspecified body regions

1.50

0.37

1.5

2.0

345.67

395.11

nmol/l

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

1.45

0.37

1.2

1.9

488.33

430.11

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

508

1.13

0.36

2.7

1.8

333.75

370.40

nmol/l

0.80

465

Carcinoma in situ of rectum

190

1.23

0.36

2.6

1.6

420.83

359.81

nmol/l

1.22

174

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

200

0.79

0.35

2.6

1.8

320.63

378.91

nmol/l

0.62

182

Brain mixed glioma

1.38

0.35

1.2

2.1

488.33

387.50

nmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

250

2376

1.06

0.34

1.8

410.93

366.82

nmol/l

2.73

232

2142

Fibrosarcoma

177

0.78

0.34

2.8

1.9

283.14

395.20

nmol/l

1.59

161

Idiopathic progressive neuropathy

1.34

0.34

2.5

1.7

389.33

358.27

nmol/l

—

Sequelae of poliomyelitis

201

1.21

0.33

2.8

1.9

363.17

359.38

nmol/l

0.03

186

Ill-defined and unknown causes of mortality

170

1600

1.07

0.33

2.6

2.1

373.35

377.34

nmol/l

0.08

152

1439

Deep bite that required surgery

360

1.15

0.33

1.9

2.1

388.81

374.75

nmol/l

0.12

339

Adhesive middle ear disease

464

1.13

0.33

2.0

1.8

372.72

381.02

nmol/l

0.10

423

Benign neoplasm: Cranial nerves

789

1.10

0.33

2.9

2.1

361.22

376.39

nmol/l

0.26

727

Evidence of alcohol involvement determined by level of intoxication

285

1.17

0.33

2.0

1.9

377.08

385.41

nmol/l

0.08

263

Malignant neoplasm of prostate

1147

7077

1.02

0.33

2.4

2.6

367.98

372.72

nmol/l

0.28

1068

6533

Benign neoplasm: Respiratory system, unspecified

1.41

0.32

1.1

1.9

494.00

336.33

nmol/l

—

Malignant neoplasm of other and ill-defined sites

1.34

0.31

1.4

1.6

482.86

436.88

nmol/l

—

Infections specific to the perinatal period

439

1.13

0.31

2.2

2.7

374.05

351.07

nmol/l

0.34

420

Respiratory tuberculosis, not confirmed

973

0.92

0.30

2.0

2.1

351.27

374.22

nmol/l

0.54

871

L02BB Anti-androgens

204

1939

1.06

0.30

2.7

2.3

373.15

374.44

nmol/l

0.03

193

1762

Complications specific to multiple gestation

130

1.26

0.30

3.3

2.0

447.69

387.53

nmol/l

0.75

121

373

3597

1.04

0.30

1.8

2.0

375.53

382.12

nmol/l

0.30

340

3328

Rickettsioses

1.36

0.30

3.0

2.0

370.63

364.70

nmol/l

—

Congenital malformation syndromes predominantly affecting facial appearance

1.31

0.29

1.6

2.7

220.08

351.74

nmol/l

2.49

Female infertility, uterine origin

112

1.27

0.29

1.4

2.3

354.86

390.87

nmol/l

0.42

104

Toxoplasmosis

158

1.22

0.29

4.7

1.9

349.89

385.79

nmol/l

0.39

142

Left ventricular outflow tract obstruction, narrow definition

157

1484

1.06

0.29

2.6

2.4

366.34

361.39

nmol/l

0.10

145

1392

Carcinoma in situ of cervix uteri

333

3207

1.04

0.29

1.8

2.1

395.60

379.13

nmol/l

0.77

311

2949

Scissor bite

100

930

1.08

0.28

2.2

2.3

352.69

377.35

nmol/l

0.74

873

Other parasitologically confirmed or unspecified malaria

1.23

0.27

3.9

2.7

273.38

372.33

nmol/l

—

Alzheimer disease

799

5882

1.03

0.27

1.7

2.0

409.12

386.30

nmol/l

2.43

663

5274

Disorder of visual pathways, unspecified

1.29

0.27

2.4

370.00

372.82

nmol/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1747

11234

1.02

0.27

2.3

1.8

384.59

366.13

nmol/l

3.15

1610

10223

Congenital malformations of cardiac chambers and connections

235

1.17

0.27

3.3

2.8

353.04

337.64

nmol/l

0.15

222

Acute appendicitis, with complications

675

6589

1.03

0.26

2.2

2.3

386.27

368.48

nmol/l

0.72

633

6058

Use of rivastigmine

326

3369

0.96

0.26

1.5

2.0

392.68

389.53

nmol/l

0.11

279

2966

Caught, crushed, jammed or pinched in or between objects

150

1423

1.06

0.26

2.2

353.89

368.43

nmol/l

0.42

137

1333

Melanocytic naevi of scalp and neck

676

1.09

0.25

2.6

1.9

355.07

379.05

nmol/l

0.48

630

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.29

0.25

5.6

1.9

333.45

394.55

nmol/l

0.66

Colorectal neuroendocrine tumor and carcinoma

369

1.12

0.25

2.4

1.9

323.69

366.29

nmol/l

0.82

343

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1745

11232

1.02

0.25

2.3

1.8

384.19

366.14

nmol/l

3.03

1608

10221

Bicuspidal aortic valve syndrome

1013

0.93

0.24

2.3

369.85

360.51

nmol/l

0.20

947

Malignant neoplasm of peripheral nerves and autonomic nervous system

1.40

0.24

1.8

2.4

416.00

427.52

nmol/l

—

Pedal cyclist injured in collision with motor vehicle

891

1.07

0.24

1.6

1.9

375.29

373.44

nmol/l

0.03

825

Femoral hernia, unilateral

688

1.08

0.24

3.2

2.1

377.23

371.70

nmol/l

0.07

632

Inguinal of femoral hernia, unilateral

688

1.08

0.24

3.2

2.1

377.23

371.70

nmol/l

0.07

632

Inguinal hernia, unilateral

688

1.08

0.24

3.2

2.1

377.23

371.70

nmol/l

0.07

632

Explosion of other materials

0.75

0.23

1.4

2.2

414.71

397.39

nmol/l

—

Discharge from other and unspecified firearms

0.75

0.23

2.0

1.9

244.43

378.96

nmol/l

—

Other transitory neonatal endocrine disorders

0.00

0.23

0.0

4.3

—

242.10

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

741

0.93

0.22

1.8

1.7

423.80

358.82

nmol/l

1.45

662

Carcinoma in situ of rectum

201

1.16

0.22

2.6

2.1

420.83

377.63

nmol/l

0.74

183

Malignant neoplasm of lip

163

1.18

0.22

3.3

1.9

399.74

393.33

nmol/l

0.08

139

Benign neoplasm: other/unspecified salivary gland

701

1.08

0.22

2.3

2.1

355.48

376.55

nmol/l

0.34

637

Drowning and submersion while in natural water

104

0.76

0.22

4.0

2.3

340.38

402.15

nmol/l

—

Unspecified hairloss

1.32

0.21

1.3

1.9

407.33

361.64

nmol/l

—

Antepartum haemorrhage, not elsewhere classified

331

3213

1.03

0.21

2.0

368.60

375.31

nmol/l

0.17

309

2965

Postpartum haemorrhage due to retained placenta

427

4380

0.97

0.21

1.9

2.0

374.18

372.50

nmol/l

0.07

403

4074

Brucellosis

0.00

0.21

0.0

2.4

—

301.00

—

Intrauterine hypoxia

0.00

0.21

0.0

1.5

—

279.79

—

Toxic erythema

1.25

0.20

2.5

2.1

327.17

407.84

nmol/l

—

Assault by drugs, medicaments and biological substances

1.20

0.20

1.7

2.2

332.50

399.51

nmol/l

—

Complications of the puerperium, not elsewhere classified

133

1392

0.95

0.20

2.1

2.0

375.54

377.38

nmol/l

0.05

123

1290

Airway disease due to specific organic dust

1.26

0.19

1.7

329.00

347.68

nmol/l

—

Other specified transport accidents

137

1.18

0.19

2.3

2.1

414.88

385.60

nmol/l

0.23

126

Malignant neoplasm of penis

1.26

0.19

2.8

2.3

329.90

393.01

nmol/l

—

Traumatic amputation of wrist and hand

107

1125

0.95

0.19

2.2

400.56

367.91

nmol/l

0.84

1036

Otosclerosis

225

2325

0.97

0.19

2.4

2.2

349.61

370.27

nmol/l

0.94

207

2130

Malignant neoplasm of gallbladder

100

1.22

0.18

2.4

1.8

403.17

397.01

nmol/l

0.04

Epidermolysis bullosa

1.17

0.18

1.4

2.2

379.71

348.78

nmol/l

—

All dysplastic lesions of the cervix uteri

1045

10283

1.02

0.18

2.0

382.90

376.03

nmol/l

0.55

972

9484

Malignant neoplasm of anus and anal canal

110

1.20

0.18

4.1

1.8

512.15

355.42

nmol/l

1.10

Acne varioliformis

1.21

0.17

2.6

1.8

379.63

364.58

nmol/l

—

Dissection of aorta

728

1.06

0.17

2.1

2.2

366.06

369.58

nmol/l

0.05

657

Erectile dysfunction

200

1936

1.04

0.17

2.3

2.4

359.12

368.00

nmol/l

0.27

186

1784

Benign neoplasm: Skin of upper limb, including shoulder

534

1.07

0.17

2.7

1.9

333.75

381.54

nmol/l

1.18

496

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

192

1859

1.04

0.16

3.2

1.8

446.75

370.04

nmol/l

4.08

182

1664

Eccrine sweat disorders

0.76

0.16

6.3

1.7

355.33

367.34

nmol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2000

11660

1.01

0.16

2.1

374.46

378.04

nmol/l

0.34

1871

10740

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.23

0.16

1.3

1.9

342.40

365.78

nmol/l

—

Malignant neoplasm of other and unspecified major salivary glands

0.75

0.16

2.5

2.2

437.00

361.41

nmol/l

—

Granulosa cell carcinoma of ovary

1.19

0.16

1.6

1.9

358.11

371.37

nmol/l

—

Twin gestation

337

3293

1.03

0.16

2.3

2.1

365.47

372.60

nmol/l

0.35

325

3039

Degenerative conditions of globe

119

0.83

0.16

1.8

2.0

303.70

394.45

nmol/l

—

104

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

1.15

0.16

1.6

358.11

355.23

nmol/l

—

Hereditary spherocytosis

1.14

0.15

5.4

2.1

435.33

373.53

nmol/l

—

Foreign object accidentally left in body during surgical and medical care

0.78

0.15

3.0

1.9

273.57

367.25

nmol/l

—

Benign neoplasm: Scrotum

0.78

0.15

1.3

1.8

394.71

364.07

nmol/l

—

Reduction defects of upper limb

0.82

0.14

2.1

2.2

411.38

353.87

nmol/l

—

Noise effects on inner ear

100

1042

0.96

0.14

2.5

2.2

440.55

363.44

nmol/l

1.30

970

Multiple gestation

348

3411

1.02

0.14

2.3

2.1

366.71

373.19

nmol/l

0.32

336

3148

Supervision of high-risk pregnancy

916

5473

1.01

0.13

2.1

2.0

366.01

384.70

nmol/l

2.45

858

5066

Postpartum haemorrhage

1029

9051

0.99

0.13

2.0

374.26

378.27

nmol/l

0.32

976

8350

Use of levodopa decarbox-comt-inhibitor

784

0.95

0.13

1.7

2.1

426.24

368.19

nmol/l

1.79

702

Use of ropinirole

101

975

1.04

0.12

2.1

2.3

383.61

366.53

nmol/l

0.32

888

Acute hepatitis B

124

1.14

0.11

1.7

2.1

366.07

372.49

nmol/l

0.04

112

Other operation for atrial fibrillation

124

1.14

0.11

2.4

2.1

346.14

386.39

nmol/l

0.52

112

Congenital malformations of oesophagus

146

0.88

0.11

1.8

2.3

347.46

375.69

nmol/l

0.20

134

Premature separation of placenta [abruptio placentae]

778

0.96

0.10

2.8

2.1

418.39

369.34

nmol/l

0.61

717

Assault by other and unspecified firearm discharge

1.15

0.09

1.0

2.6

306.50

403.44

nmol/l

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

744

1.04

0.09

3.9

1.8

423.63

361.91

nmol/l

1.68

664

Abscess of mediastinum

0.82

0.08

1.8

1.7

449.80

355.81

nmol/l

—

Upper arm

1.04

0.08

1.3

1.9

284.17

415.00

nmol/l

—

Frostbite involving multiple body regions and unspecified frostbite

1.04

0.08

4.2

1.5

434.17

400.57

nmol/l

—

Haemophilus septicemia

0.78

0.08

3.8

2.2

1635.20

443.44

nmol/l

—

Benign neoplasm: Appendix

277

0.93

0.08

3.2

1.9

352.73

382.84

nmol/l

0.45

251

Colorectal adenocarcinoma

556

5504

1.01

0.08

2.3

402.47

377.02

nmol/l

2.08

517

5005

Sequelae of burns, corrosions and frostbite

127

1.11

0.08

1.4

2.1

423.07

379.40

nmol/l

0.53

118

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.03

0.08

1.9

1.8

299.57

334.97

nmol/l

—

Bradycardia, unspecified, drug-induced

0.82

0.08

1.5

1.8

406.33

384.63

nmol/l

—

HSIL lesion of the cervix uteri

705

6991

1.01

0.08

2.0

387.53

376.79

nmol/l

0.77

653

6446

Other endophthalmitis

137

1.10

0.08

1.3

1.9

423.07

361.44

nmol/l

1.06

122

Mental and behavioural disorders due to use of volatile solvents

1.09

0.07

1.4

1.9

274.50

362.74

nmol/l

—

Laparoscopic left hemicolectomy

451

1.05

0.07

1.9

2.0

348.63

372.89

nmol/l

0.15

417

Carcinoma in situ of breast

143

0.90

0.07

1.7

2.0

310.92

362.13

nmol/l

0.56

137

Discontinuity and dislocation of ear ossicles

147

1.10

0.07

3.7

2.0

397.38

372.00

nmol/l

0.24

136

Oher contracture of tendon (sheath)

1.03

0.07

1.3

1.6

314.62

366.40

nmol/l

—

Benign neoplasm: Scrotum

0.85

0.07

1.3

1.5

394.71

400.79

nmol/l

—

Toxic effect of other noxious substances eaten as food

1.06

0.07

1.9

2.2

301.67

377.39

nmol/l

—

Contact with other sharp object(s)

205

2021

1.02

0.06

1.9

2.1

380.49

373.52

nmol/l

0.22

191

1878

Carcinoma in situ of breast, intraductal

240

2430

0.99

0.06

2.4

1.8

384.09

367.68

nmol/l

0.63

214

2198

Operations for atrial fibrillation

395

0.96

0.06

3.0

2.2

402.61

370.04

nmol/l

0.64

365

Alzheimer’s disease (Late onset)

530

4576

0.99

0.06

1.6

2.0

408.84

387.27

nmol/l

1.56

436

4075

Pedal cyclist injured in collision with pedestrian or animal

188

1.07

0.05

2.3

1.9

346.40

376.68

nmol/l

0.37

174

Defect, injury or illness of lumbar spine

1.12

0.05

2.4

1.8

350.30

397.64

nmol/l

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

100

1.11

0.05

1.7

2.1

335.18

406.15

nmol/l

0.75

Lyme disease

867

8717

0.99

0.05

2.2

2.3

378.68

372.06

nmol/l

0.43

800

8020

Retrobulbar neuritis in diseases classified elsewhere

110

1.10

0.05

2.3

2.0

331.92

371.30

nmol/l

0.26

100

Carcinoma in situ of vagina

120

0.91

0.05

3.2

1.7

320.00

361.25

nmol/l

0.29

110

Postpartum care and examination

621

3985

0.99

0.04

2.1

2.0

388.96

392.71

nmol/l

0.19

574

3670

Use of galantamine

153

1551

0.99

0.04

2.0

1.9

411.78

396.32

nmol/l

0.47

125

1371

Other spirochaetal diseases

886

8818

1.01

0.04

2.3

378.68

371.96

nmol/l

0.45

816

8113

Maternal care for (suspected) damage to fetus from alcohol

109

0.91

0.04

2.1

1.8

416.30

385.43

nmol/l

—

104

Infections of breast associated with childbirth

122

1203

1.02

0.04

2.0

359.54

380.12

nmol/l

0.67

112

1111

Poor fetal growth

462

4648

0.99

0.04

2.0

379.49

379.39

nmol/l

0.00

432

4295

Cholinergic urticaria

131

1.07

0.03

3.4

1.8

370.07

387.67

nmol/l

0.19

118

Cholesteatoma of middle ear

147

1453

1.01

0.03

2.1

2.2

390.29

370.79

nmol/l

0.61

129

1328

Maternal care for known or suspected malpresentation of fetus

764

5711

1.00

0.02

2.0

390.52

378.76

nmol/l

0.72

709

5266

Rheumatic fever without mention of heart involvement

1.08

0.02

1.9

2.0

333.20

392.42

nmol/l

—

Transient global amnesia

260

2613

0.99

0.02

2.3

368.99

370.45

nmol/l

0.04

233

2384

Dysplastic lesion of unknown severity of the cervix uteri

302

1.03

0.02

1.7

2.0

378.59

373.56

nmol/l

0.05

284

Carcinoma in situ of vagina

117

0.94

0.02

3.2

1.8

320.00

380.21

nmol/l

0.46

109

Intentional self-harm by hanging, strangulation and suffocation

137

0.95

0.01

1.6

2.0

396.31

375.65

nmol/l

0.29

124

Postpartum hemorraghe, all women as controls

1029

10226

1.00

0.01

2.0

374.26

377.17

nmol/l

0.22

976

9432

Maternal care for known or suspected disproportion

160

1590

1.01

0.01

1.9

2.1

375.98

364.52

nmol/l

0.41

150

1468

Carcinoma in situ of breast, other/unspecified

377

0.98

0.01

1.8

1.9

370.66

374.40

nmol/l

0.04

347

Carcinoma in situ of endometrium

126

0.95

0.00

2.3

2.0

402.67

373.47

nmol/l

0.48

119

Carcinoma in situ of breast, other/unspecified

376

0.98

0.00

1.8

370.66

360.06

nmol/l

0.11

340

Normal-pressure hydrocephalus

121

1204

1.01

0.00

2.2

2.0

368.06

379.70

nmol/l

0.28

108

1075

Premature rupture of membranes

900

6619

1.00

0.00

2.0

381.17

383.27

nmol/l

0.11

831

6100

Alzheimer disease, including avohilmo

938

6766

1.00

0.00

1.7

2.1

400.93

387.21

nmol/l

1.21

796

6069

Benign neoplasm: Appendix

262

0.99

0.00

3.2

1.8

352.73

363.86

nmol/l

0.14

235

Carcinoma in situ of endometrium

124

0.97

0.00

2.3

1.9

402.67

351.87

nmol/l

1.06

117

Crushing injury of wrist and hand

382

0.99

0.00

1.5

2.2

403.59

358.12

nmol/l

0.81

352

Retained placenta and membranes, without haemorrhage

444

4443

1.00

0.00

2.3

2.2

357.72

371.56

nmol/l

0.82

416

4082

Rheumatic valve diseases

553

0.99

0.00

1.7

1.9

351.21

390.33

nmol/l

0.83

496

Alcoholic cardiomyopathy

113

0.97

0.00

2.1

2.0

426.36

353.00

nmol/l

1.01

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

137

1.02

0.00

2.7

2.0

375.43

360.58

nmol/l

0.09

127

Melanocytic naevi of lip

237

1.01

0.00

1.3

2.0

391.13

378.68

nmol/l

0.11

216

Other congenital malformations of face and neck

885

0.99

0.00

2.8

2.1

356.32

368.85

nmol/l

0.26

825

Balanced rearrangements and structural markers, not elsewhere classified

115

1.05

0.00

1.7

1.8

369.08

389.74

nmol/l

0.18

105

Cardiovascular disorders originating in the perinatal period

174

0.97

0.00

4.2

2.7

282.18

348.68

nmol/l

0.76

166

Small plaque parapsoriasis

0.94

0.00

3.0

1.7

188.00

362.34

nmol/l

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.97

0.00

1.9

2.0

299.57

370.06

nmol/l

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

2.9

—

377.78

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

1.6

—

410.20

—

Bilateral

0.00

0.0

2.3

—

444.50

—

Elastosis perforans serpiginosa

0.00

0.0

2.0

—

363.60

—

Intentional self-harm by smoke, fire and flames

1.00

0.00

7.0

2.0

421.40

382.64

nmol/l

—

Ovarian dysfunction: androgen excess, drug-induced

0.00

0.0

1.4

—

364.71

—

Folliculitis decalvans

0.89

0.00

1.2

2.0

300.50

354.25

nmol/l

—

Defects in glycoprotein degradation

0.00

0.0

4.1

—

358.57

—

Other specified/unspecified disorders of ear

0.94

0.00

3.6

2.2

282.29

376.67

nmol/l

—

Tympanosclerosis

1.00

0.00

2.3

1.6

435.50

381.98

nmol/l

—

Congenital syphilis

0.00

0.0

2.3

—

336.00

—

Accidental poisoning by and exposure to pesticides

0.89

0.00

2.4

1.9

287.00

361.48

nmol/l

—

Thoracic root disorders

0.92

0.00

3.0

1.5

568.80

403.18

nmol/l

—

Acute necrotizing ulcerative gingivitis

0.00

0.0

1.3

—

330.00

—

Other congenital infectious and parasitic diseases

0.00

0.0

4.9

—

427.00

—

Cleft lip

1.00

0.00

2.6

421.33

356.93

nmol/l

—

Radiological devices associated with adverse incidents

0.00

0.0

3.5

—

296.50

—

Chondrosarcoma

0.91

0.00

2.6

2.2

318.38

379.03

nmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.94

0.00

1.4

2.2

353.50

383.14

nmol/l

—

Crushing injury of lower leg

0.98

0.00

1.4

1.8

322.43

359.66

nmol/l

—

Other infestations

0.92

0.00

3.2

2.0

353.00

407.00

nmol/l

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

2.0

—

541.17

—

Malignant neoplasm of placenta

0.00

0.0

2.3

—

364.00

—

Transient retinal artery occlusion

1.00

0.00

4.7

1.9

267.50

404.81

nmol/l

—

Melanocytic naevi of lip

240

1.00

0.00

1.3

2.1

391.13

379.51

nmol/l

0.10

220

Testicular hypofunction, drug-induced

0.00

0.0

1.3

—

307.83

—

Choroidal haemorrhage and rupture

0.95

0.00

3.1

1.8

400.38

378.40

nmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS